(dp0
S'TAP1'
p1
(lp2
(dp3
S'pharmacologicAction'
p4
Vunknown
p5
sS'uri'
p6
Vhttp://bio2rdf.org/drugbank_resource:DB03431_5300
p7
sS'label'
p8
Vdrug-target interaction Adenosine-5'-Diphosphate and Antigen peptide transporter 1 [drugbank_resource:DB03431_5300]
p9
sS'source'
p10
S'http://drugbank.bio2rdf.org/sparql'
p11
sS'targetURI'
p12
Vhttp://bio2rdf.org/drugbank_target:5300
p13
sS'drugURI'
p14
Vhttp://bio2rdf.org/drugbank:DB03431
p15
sS'drugGeneric'
p16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p17
sasS'PROS1'
p18
(lp19
(dp20
g4
Vunknown
p21
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00055_1245
p22
sg8
Vdrug-target interaction Drotrecogin alfa and Vitamin K-dependent protein S [drugbank_resource:DB00055_1245]
p23
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1245
p24
sg14
Vhttp://bio2rdf.org/drugbank:DB00055
p25
sg16
VDrotrecogin alfa [drugbank:DB00055]
p26
sa(dp27
g4
Vunknown
p28
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00170_1245
p29
sg8
Vdrug-target interaction Menadione and Vitamin K-dependent protein S [drugbank_resource:DB00170_1245]
p30
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1245
p31
sg14
Vhttp://bio2rdf.org/drugbank:DB00170
p32
sg16
VMenadione [drugbank:DB00170]
p33
sa(dp34
g4
Vyes
p35
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00464_1245
p36
sg8
Vdrug-target interaction Sodium Tetradecyl Sulfate and Vitamin K-dependent protein S [drugbank_resource:DB00464_1245]
p37
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1245
p38
sg14
Vhttp://bio2rdf.org/drugbank:DB00464
p39
sg16
VSodium Tetradecyl Sulfate [drugbank:DB00464]
p40
sasS'TGM3'
p41
(lp42
(dp43
g4
Vunknown
p44
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01972_2339
p45
sg8
Vdrug-target interaction Guanosine-5'-Monophosphate and Protein-glutamine gamma-glutamyltransferase E [drugbank_resource:DB01972_2339]
p46
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2339
p47
sg14
Vhttp://bio2rdf.org/drugbank:DB01972
p48
sg16
VGuanosine-5'-Monophosphate [drugbank:DB01972]
p49
sa(dp50
g4
Vunknown
p51
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01864_2339
p52
sg8
Vdrug-target interaction 5'-Guanosine-Diphosphate-Monothiophosphate and Protein-glutamine gamma-glutamyltransferase E [drugbank_resource:DB01864_2339]
p53
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2339
p54
sg14
Vhttp://bio2rdf.org/drugbank:DB01864
p55
sg16
V5'-Guanosine-Diphosphate-Monothiophosphate [drugbank:DB01864]
p56
sa(dp57
g4
Vunknown
p58
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03152_2339
p59
sg8
Vdrug-target interaction B-2-Octylglucoside and Protein-glutamine gamma-glutamyltransferase E [drugbank_resource:DB03152_2339]
p60
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2339
p61
sg14
Vhttp://bio2rdf.org/drugbank:DB03152
p62
sg16
VB-2-Octylglucoside [drugbank:DB03152]
p63
sa(dp64
g4
Vunknown
p65
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04315_2339
p66
sg8
Vdrug-target interaction Guanosine-5'-Diphosphate and Protein-glutamine gamma-glutamyltransferase E [drugbank_resource:DB04315_2339]
p67
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2339
p68
sg14
Vhttp://bio2rdf.org/drugbank:DB04315
p69
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p70
sasS'PPP3R1'
p71
(lp72
(dp73
g4
Vunknown
p74
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08231_394
p75
sg8
Vdrug-target interaction MYRISTIC ACID and Calcineurin subunit B isoform 1 [drugbank_resource:DB08231_394]
p76
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:394
p77
sg14
Vhttp://bio2rdf.org/drugbank:DB08231
p78
sg16
VMYRISTIC ACID [drugbank:DB08231]
p79
sasS'PCSK2'
p80
(lp81
(dp82
g4
Vunknown
p83
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00071_3847
p84
sg8
Vdrug-target interaction Insulin, porcine and Neuroendocrine convertase 2 [drugbank_resource:DB00071_3847]
p85
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3847
p86
sg14
Vhttp://bio2rdf.org/drugbank:DB00071
p87
sg16
VInsulin, porcine [drugbank:DB00071]
p88
sa(dp89
g4
Vunknown
p90
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00030_3847
p91
sg8
Vdrug-target interaction Insulin recombinant and Neuroendocrine convertase 2 [drugbank_resource:DB00030_3847]
p92
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3847
p93
sg14
Vhttp://bio2rdf.org/drugbank:DB00030
p94
sg16
VInsulin recombinant [drugbank:DB00030]
p95
sasS'NISCH'
p96
(lp97
(dp98
g4
Vno
p99
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00697_6070
p100
sg8
Vdrug-target interaction Tizanidine and Nischarin [drugbank_resource:DB00697_6070]
p101
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6070
p102
sg14
Vhttp://bio2rdf.org/drugbank:DB00697
p103
sg16
VTizanidine [drugbank:DB00697]
p104
sasS'CLK1'
p105
(lp106
(dp107
g4
Vunknown
p108
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04367_3318
p109
sg8
Vdrug-target interaction Debromohymenialdisine and Dual specificity protein kinase CLK1 [drugbank_resource:DB04367_3318]
p110
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3318
p111
sg14
Vhttp://bio2rdf.org/drugbank:DB04367
p112
sg16
VDebromohymenialdisine [drugbank:DB04367]
p113
sa(dp114
g4
Vunknown
p115
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08691_3318
p116
sg8
Vdrug-target interaction ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate and Dual specificity protein kinase CLK1 [drugbank_resource:DB08691_3318]
p117
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3318
p118
sg14
Vhttp://bio2rdf.org/drugbank:DB08691
p119
sg16
Vethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate [drugbank:DB08691]
p120
sasS'SLC6A1'
p121
(lp122
(dp123
g4
Vyes
p124
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00906_276
p125
sg8
Vdrug-target interaction Tiagabine and Sodium- and chloride-dependent GABA transporter 1 [drugbank_resource:DB00906_276]
p126
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:276
p127
sg14
Vhttp://bio2rdf.org/drugbank:DB00906
p128
sg16
VTiagabine [drugbank:DB00906]
p129
sasS'QDPR'
p130
(lp131
(dp132
g4
Vunknown
p133
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00157_597
p134
sg8
Vdrug-target interaction NADH and Dihydropteridine reductase [drugbank_resource:DB00157_597]
p135
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:597
p136
sg14
Vhttp://bio2rdf.org/drugbank:DB00157
p137
sg16
VNADH [drugbank:DB00157]
p138
sa(dp139
g4
Vunknown
p140
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01907_597
p141
sg8
Vdrug-target interaction Nicotinamide-Adenine-Dinucleotide and Dihydropteridine reductase [drugbank_resource:DB01907_597]
p142
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:597
p143
sg14
Vhttp://bio2rdf.org/drugbank:DB01907
p144
sg16
VNicotinamide-Adenine-Dinucleotide [drugbank:DB01907]
p145
sa(dp146
g4
Vunknown
p147
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03814_597
p148
sg8
Vdrug-target interaction 2-(N-Morpholino)-Ethanesulfonic Acid and Dihydropteridine reductase [drugbank_resource:DB03814_597]
p149
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:597
p150
sg14
Vhttp://bio2rdf.org/drugbank:DB03814
p151
sg16
V2-(N-Morpholino)-Ethanesulfonic Acid [drugbank:DB03814]
p152
sasS'IKBKB'
p153
(lp154
(dp155
g4
Vunknown
p156
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00244_2038
p157
sg8
Vdrug-target interaction Mesalazine and Inhibitor of nuclear factor kappa-B kinase subunit beta [drugbank_resource:DB00244_2038]
p158
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2038
p159
sg14
Vhttp://bio2rdf.org/drugbank:DB00244
p160
sg16
VMesalazine [drugbank:DB00244]
p161
sa(dp162
g4
Vunknown
p163
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00795_2038
p164
sg8
Vdrug-target interaction Sulfasalazine and Inhibitor of nuclear factor kappa-B kinase subunit beta [drugbank_resource:DB00795_2038]
p165
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2038
p166
sg14
Vhttp://bio2rdf.org/drugbank:DB00795
p167
sg16
VSulfasalazine [drugbank:DB00795]
p168
sa(dp169
g4
Vyes
p170
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00995_2038
p171
sg8
Vdrug-target interaction Auranofin and Inhibitor of nuclear factor kappa-B kinase subunit beta [drugbank_resource:DB00995_2038]
p172
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2038
p173
sg14
Vhttp://bio2rdf.org/drugbank:DB00995
p174
sg16
VAuranofin [drugbank:DB00995]
p175
sa(dp176
g4
Vyes
p177
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01169_2038
p178
sg8
Vdrug-target interaction Arsenic trioxide and Inhibitor of nuclear factor kappa-B kinase subunit beta [drugbank_resource:DB01169_2038]
p179
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2038
p180
sg14
Vhttp://bio2rdf.org/drugbank:DB01169
p181
sg16
VArsenic trioxide [drugbank:DB01169]
p182
sasS'AKT1'
p183
(lp184
(dp185
g4
Vunknown
p186
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00171_476
p187
sg8
Vdrug-target interaction Adenosine triphosphate and RAC-alpha serine/threonine-protein kinase [drugbank_resource:DB00171_476]
p188
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:476
p189
sg14
Vhttp://bio2rdf.org/drugbank:DB00171
p190
sg16
VAdenosine triphosphate [drugbank:DB00171]
p191
sa(dp192
g4
Vunknown
p193
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01169_476
p194
sg8
Vdrug-target interaction Arsenic trioxide and RAC-alpha serine/threonine-protein kinase [drugbank_resource:DB01169_476]
p195
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:476
p196
sg14
Vhttp://bio2rdf.org/drugbank:DB01169
p197
sg16
VArsenic trioxide [drugbank:DB01169]
p198
sa(dp199
g4
Vunknown
p200
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01863_476
p201
sg8
Vdrug-target interaction Inositol 1,3,4,5-Tetrakisphosphate and RAC-alpha serine/threonine-protein kinase [drugbank_resource:DB01863_476]
p202
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:476
p203
sg14
Vhttp://bio2rdf.org/drugbank:DB01863
p204
sg16
VInositol 1,3,4,5-Tetrakisphosphate [drugbank:DB01863]
p205
sa(dp206
g4
Vunknown
p207
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07584_476
p208
sg8
Vdrug-target interaction N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine and RAC-alpha serine/threonine-protein kinase [drugbank_resource:DB07584_476]
p209
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:476
p210
sg14
Vhttp://bio2rdf.org/drugbank:DB07584
p211
sg16
VN-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine [drugbank:DB07584]
p212
sa(dp213
g4
Vunknown
p214
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07585_476
p215
sg8
Vdrug-target interaction 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and RAC-alpha serine/threonine-protein kinase [drugbank_resource:DB07585_476]
p216
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:476
p217
sg14
Vhttp://bio2rdf.org/drugbank:DB07585
p218
sg16
V5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine [drugbank:DB07585]
p219
sasS'P4HA1'
p220
(lp221
(dp222
g4
Vunknown
p223
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00139_67
p224
sg8
Vdrug-target interaction Succinic acid and Prolyl 4-hydroxylase subunit alpha-1 [drugbank_resource:DB00139_67]
p225
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:67
p226
sg14
Vhttp://bio2rdf.org/drugbank:DB00139
p227
sg16
VSuccinic acid [drugbank:DB00139]
p228
sa(dp229
g4
Vunknown
p230
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00172_67
p231
sg8
Vdrug-target interaction L-Proline and Prolyl 4-hydroxylase subunit alpha-1 [drugbank_resource:DB00172_67]
p232
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:67
p233
sg14
Vhttp://bio2rdf.org/drugbank:DB00172
p234
sg16
VL-Proline [drugbank:DB00172]
p235
sa(dp236
g4
Vunknown
p237
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00126_67
p238
sg8
Vdrug-target interaction Vitamin C and Prolyl 4-hydroxylase subunit alpha-1 [drugbank_resource:DB00126_67]
p239
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:67
p240
sg14
Vhttp://bio2rdf.org/drugbank:DB00126
p241
sg16
VVitamin C [drugbank:DB00126]
p242
sa(dp243
g4
Vunknown
p244
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01275_67
p245
sg8
Vdrug-target interaction Hydralazine and Prolyl 4-hydroxylase subunit alpha-1 [drugbank_resource:DB01275_67]
p246
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:67
p247
sg14
Vhttp://bio2rdf.org/drugbank:DB01275
p248
sg16
VHydralazine [drugbank:DB01275]
p249
sasS'RB1'
p250
(lp251
(dp252
g4
Vunknown
p253
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00030_3846
p254
sg8
Vdrug-target interaction Insulin recombinant and Retinoblastoma-associated protein [drugbank_resource:DB00030_3846]
p255
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3846
p256
sg14
Vhttp://bio2rdf.org/drugbank:DB00030
p257
sg16
VInsulin recombinant [drugbank:DB00030]
p258
sa(dp259
g4
Vunknown
p260
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00071_3846
p261
sg8
Vdrug-target interaction Insulin, porcine and Retinoblastoma-associated protein [drugbank_resource:DB00071_3846]
p262
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3846
p263
sg14
Vhttp://bio2rdf.org/drugbank:DB00071
p264
sg16
VInsulin, porcine [drugbank:DB00071]
p265
sasS'CHI3L1'
p266
(lp267
(dp268
g4
Vunknown
p269
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02687_7113
p270
sg8
Vdrug-target interaction Beta-D-Mannose and Chitinase-3-like protein 1 [drugbank_resource:DB02687_7113]
p271
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7113
p272
sg14
Vhttp://bio2rdf.org/drugbank:DB02687
p273
sg16
VBeta-D-Mannose [drugbank:DB02687]
p274
sa(dp275
g4
Vunknown
p276
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02944_7113
p277
sg8
Vdrug-target interaction Alpha-D-Mannose and Chitinase-3-like protein 1 [drugbank_resource:DB02944_7113]
p278
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7113
p279
sg14
Vhttp://bio2rdf.org/drugbank:DB02944
p280
sg16
VAlpha-D-Mannose [drugbank:DB02944]
p281
sasS'GABRB1'
p282
(lp283
(dp284
g4
Vyes
p285
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00186_4098
p286
sg8
Vdrug-target interaction Lorazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00186_4098]
p287
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p288
sg14
Vhttp://bio2rdf.org/drugbank:DB00186
p289
sg16
VLorazepam [drugbank:DB00186]
p290
sa(dp291
g4
Vyes
p292
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00189_4098
p293
sg8
Vdrug-target interaction Ethchlorvynol and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00189_4098]
p294
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p295
sg14
Vhttp://bio2rdf.org/drugbank:DB00189
p296
sg16
VEthchlorvynol [drugbank:DB00189]
p297
sa(dp298
g4
Vyes
p299
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00231_4098
p300
sg8
Vdrug-target interaction Temazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00231_4098]
p301
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p302
sg14
Vhttp://bio2rdf.org/drugbank:DB00231
p303
sg16
VTemazepam [drugbank:DB00231]
p304
sa(dp305
g4
Vyes
p306
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00431_4098
p307
sg8
Vdrug-target interaction Lindane and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00431_4098]
p308
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p309
sg14
Vhttp://bio2rdf.org/drugbank:DB00431
p310
sg16
VLindane [drugbank:DB00431]
p311
sa(dp312
g4
Vyes
p313
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00546_4098
p314
sg8
Vdrug-target interaction Adinazolam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00546_4098]
p315
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p316
sg14
Vhttp://bio2rdf.org/drugbank:DB00546
p317
sg16
VAdinazolam [drugbank:DB00546]
p318
sa(dp319
g4
Vyes
p320
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00475_4098
p321
sg8
Vdrug-target interaction Chlordiazepoxide and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00475_4098]
p322
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p323
sg14
Vhttp://bio2rdf.org/drugbank:DB00475
p324
sg16
VChlordiazepoxide [drugbank:DB00475]
p325
sa(dp326
g4
Vyes
p327
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00349_4098
p328
sg8
Vdrug-target interaction Clobazam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00349_4098]
p329
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p330
sg14
Vhttp://bio2rdf.org/drugbank:DB00349
p331
sg16
VClobazam [drugbank:DB00349]
p332
sa(dp333
g4
Vyes
p334
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00404_4098
p335
sg8
Vdrug-target interaction Alprazolam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00404_4098]
p336
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p337
sg14
Vhttp://bio2rdf.org/drugbank:DB00404
p338
sg16
VAlprazolam [drugbank:DB00404]
p339
sa(dp340
g4
Vyes
p341
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00628_4098
p342
sg8
Vdrug-target interaction Clorazepate and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00628_4098]
p343
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p344
sg14
Vhttp://bio2rdf.org/drugbank:DB00628
p345
sg16
VClorazepate [drugbank:DB00628]
p346
sa(dp347
g4
Vyes
p348
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00690_4098
p349
sg8
Vdrug-target interaction Flurazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00690_4098]
p350
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p351
sg14
Vhttp://bio2rdf.org/drugbank:DB00690
p352
sg16
VFlurazepam [drugbank:DB00690]
p353
sa(dp354
g4
Vyes
p355
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00842_4098
p356
sg8
Vdrug-target interaction Oxazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00842_4098]
p357
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p358
sg14
Vhttp://bio2rdf.org/drugbank:DB00842
p359
sg16
VOxazepam [drugbank:DB00842]
p360
sa(dp361
g4
Vyes
p362
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00683_4098
p363
sg8
Vdrug-target interaction Midazolam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00683_4098]
p364
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p365
sg14
Vhttp://bio2rdf.org/drugbank:DB00683
p366
sg16
VMidazolam [drugbank:DB00683]
p367
sa(dp368
g4
Vyes
p369
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00897_4098
p370
sg8
Vdrug-target interaction Triazolam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00897_4098]
p371
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p372
sg14
Vhttp://bio2rdf.org/drugbank:DB00897
p373
sg16
VTriazolam [drugbank:DB00897]
p374
sa(dp375
g4
Vyes
p376
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00801_4098
p377
sg8
Vdrug-target interaction Halazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00801_4098]
p378
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p379
sg14
Vhttp://bio2rdf.org/drugbank:DB00801
p380
sg16
VHalazepam [drugbank:DB00801]
p381
sa(dp382
g4
Vyes
p383
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00829_4098
p384
sg8
Vdrug-target interaction Diazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB00829_4098]
p385
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p386
sg14
Vhttp://bio2rdf.org/drugbank:DB00829
p387
sg16
VDiazepam [drugbank:DB00829]
p388
sa(dp389
g4
Vyes
p390
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01068_4098
p391
sg8
Vdrug-target interaction Clonazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01068_4098]
p392
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p393
sg14
Vhttp://bio2rdf.org/drugbank:DB01068
p394
sg16
VClonazepam [drugbank:DB01068]
p395
sa(dp396
g4
Vyes
p397
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01440_4098
p398
sg8
Vdrug-target interaction Gamma Hydroxybutyric Acid and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01440_4098]
p399
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p400
sg14
Vhttp://bio2rdf.org/drugbank:DB01440
p401
sg16
VGamma Hydroxybutyric Acid [drugbank:DB01440]
p402
sa(dp403
g4
Vyes
p404
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01558_4098
p405
sg8
Vdrug-target interaction Bromazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01558_4098]
p406
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p407
sg14
Vhttp://bio2rdf.org/drugbank:DB01558
p408
sg16
VBromazepam [drugbank:DB01558]
p409
sa(dp410
g4
Vyes
p411
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01567_4098
p412
sg8
Vdrug-target interaction Fludiazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01567_4098]
p413
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p414
sg14
Vhttp://bio2rdf.org/drugbank:DB01567
p415
sg16
VFludiazepam [drugbank:DB01567]
p416
sa(dp417
g4
Vyes
p418
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01587_4098
p419
sg8
Vdrug-target interaction Ketazolam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01587_4098]
p420
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p421
sg14
Vhttp://bio2rdf.org/drugbank:DB01587
p422
sg16
VKetazolam [drugbank:DB01587]
p423
sa(dp424
g4
Vyes
p425
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01588_4098
p426
sg8
Vdrug-target interaction Prazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01588_4098]
p427
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p428
sg14
Vhttp://bio2rdf.org/drugbank:DB01588
p429
sg16
VPrazepam [drugbank:DB01588]
p430
sa(dp431
g4
Vyes
p432
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01594_4098
p433
sg8
Vdrug-target interaction Cinolazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01594_4098]
p434
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p435
sg14
Vhttp://bio2rdf.org/drugbank:DB01594
p436
sg16
VCinolazepam [drugbank:DB01594]
p437
sa(dp438
g4
Vyes
p439
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01215_4098
p440
sg8
Vdrug-target interaction Estazolam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01215_4098]
p441
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p442
sg14
Vhttp://bio2rdf.org/drugbank:DB01215
p443
sg16
VEstazolam [drugbank:DB01215]
p444
sa(dp445
g4
Vyes
p446
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01559_4098
p447
sg8
Vdrug-target interaction Clotiazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01559_4098]
p448
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p449
sg14
Vhttp://bio2rdf.org/drugbank:DB01559
p450
sg16
VClotiazepam [drugbank:DB01559]
p451
sa(dp452
g4
Vyes
p453
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01589_4098
p454
sg8
Vdrug-target interaction Quazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01589_4098]
p455
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p456
sg14
Vhttp://bio2rdf.org/drugbank:DB01589
p457
sg16
VQuazepam [drugbank:DB01589]
p458
sa(dp459
g4
Vyes
p460
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01595_4098
p461
sg8
Vdrug-target interaction Nitrazepam and Gamma-aminobutyric-acid receptor subunit beta-1 [drugbank_resource:DB01595_4098]
p462
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4098
p463
sg14
Vhttp://bio2rdf.org/drugbank:DB01595
p464
sg16
VNitrazepam [drugbank:DB01595]
p465
sasS'TYK2'
p466
(lp467
(dp468
g4
Vunknown
p469
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04716_6650
p470
sg8
Vdrug-target interaction 2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE and Non-receptor tyrosine-protein kinase TYK2 [drugbank_resource:DB04716_6650]
p471
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6650
p472
sg14
Vhttp://bio2rdf.org/drugbank:DB04716
p473
sg16
V2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE [drugbank:DB04716]
p474
sa(dp475
g4
Vunknown
p476
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08183_6650
p477
sg8
Vdrug-target interaction 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile and Non-receptor tyrosine-protein kinase TYK2 [drugbank_resource:DB08183_6650]
p478
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6650
p479
sg14
Vhttp://bio2rdf.org/drugbank:DB08183
p480
sg16
V3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile [drugbank:DB08183]
p481
sasS'PAM'
p482
(lp483
(dp484
g4
Vunknown
p485
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00126_3943
p486
sg8
Vdrug-target interaction Vitamin C and Peptidyl-glycine alpha-amidating monooxygenase [drugbank_resource:DB00126_3943]
p487
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3943
p488
sg14
Vhttp://bio2rdf.org/drugbank:DB00126
p489
sg16
VVitamin C [drugbank:DB00126]
p490
sa(dp491
g4
Vunknown
p492
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02598_3943
p493
sg8
Vdrug-target interaction N-Alpha-Acetyl-3,5-Diiodotyrosylglycine and Peptidyl-glycine alpha-amidating monooxygenase [drugbank_resource:DB02598_3943]
p494
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3943
p495
sg14
Vhttp://bio2rdf.org/drugbank:DB02598
p496
sg16
VN-Alpha-Acetyl-3,5-Diiodotyrosylglycine [drugbank:DB02598]
p497
sa(dp498
g4
Vunknown
p499
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04150_3943
p500
sg8
Vdrug-target interaction Threonine Derivative and Peptidyl-glycine alpha-amidating monooxygenase [drugbank_resource:DB04150_3943]
p501
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3943
p502
sg14
Vhttp://bio2rdf.org/drugbank:DB04150
p503
sg16
VThreonine Derivative [drugbank:DB04150]
p504
sasS'KIF2C'
p505
(lp506
(dp507
g4
Vunknown
p508
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03431_7132
p509
sg8
Vdrug-target interaction Adenosine-5'-Diphosphate and Kinesin-like protein KIF2C [drugbank_resource:DB03431_7132]
p510
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7132
p511
sg14
Vhttp://bio2rdf.org/drugbank:DB03431
p512
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p513
sa(dp514
g4
Vunknown
p515
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04395_7132
p516
sg8
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Kinesin-like protein KIF2C [drugbank_resource:DB04395_7132]
p517
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7132
p518
sg14
Vhttp://bio2rdf.org/drugbank:DB04395
p519
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p520
sasS'GSN'
p521
(lp522
(dp523
g4
Vunknown
p524
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02621_6666
p525
sg8
Vdrug-target interaction Latrunculin A and Gelsolin [drugbank_resource:DB02621_6666]
p526
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6666
p527
sg14
Vhttp://bio2rdf.org/drugbank:DB02621
p528
sg16
VLatrunculin A [drugbank:DB02621]
p529
sasS'TAT'
p530
(lp531
(dp532
g4
Vunknown
p533
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00114_763
p534
sg8
Vdrug-target interaction Pyridoxal Phosphate and Tyrosine aminotransferase [drugbank_resource:DB00114_763]
p535
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:763
p536
sg14
Vhttp://bio2rdf.org/drugbank:DB00114
p537
sg16
VPyridoxal Phosphate [drugbank:DB00114]
p538
sa(dp539
g4
Vunknown
p540
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00120_763
p541
sg8
Vdrug-target interaction L-Phenylalanine and Tyrosine aminotransferase [drugbank_resource:DB00120_763]
p542
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:763
p543
sg14
Vhttp://bio2rdf.org/drugbank:DB00120
p544
sg16
VL-Phenylalanine [drugbank:DB00120]
p545
sa(dp546
g4
Vunknown
p547
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00135_763
p548
sg8
Vdrug-target interaction L-Tyrosine and Tyrosine aminotransferase [drugbank_resource:DB00135_763]
p549
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:763
p550
sg14
Vhttp://bio2rdf.org/drugbank:DB00135
p551
sg16
VL-Tyrosine [drugbank:DB00135]
p552
sa(dp553
g4
Vunknown
p554
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00142_763
p555
sg8
Vdrug-target interaction L-Glutamic Acid and Tyrosine aminotransferase [drugbank_resource:DB00142_763]
p556
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:763
p557
sg14
Vhttp://bio2rdf.org/drugbank:DB00142
p558
sg16
VL-Glutamic Acid [drugbank:DB00142]
p559
sasS'SCNN1G'
p560
(lp561
(dp562
g4
Vyes
p563
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00594_552
p564
sg8
Vdrug-target interaction Amiloride and Amiloride-sensitive sodium channel subunit gamma [drugbank_resource:DB00594_552]
p565
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:552
p566
sg14
Vhttp://bio2rdf.org/drugbank:DB00594
p567
sg16
VAmiloride [drugbank:DB00594]
p568
sa(dp569
g4
Vyes
p570
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00384_552
p571
sg8
Vdrug-target interaction Triamterene and Amiloride-sensitive sodium channel subunit gamma [drugbank_resource:DB00384_552]
p572
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:552
p573
sg14
Vhttp://bio2rdf.org/drugbank:DB00384
p574
sg16
VTriamterene [drugbank:DB00384]
p575
sasS'OGDH'
p576
(lp577
(dp578
g4
Vunknown
p579
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00157_182
p580
sg8
Vdrug-target interaction NADH and 2-oxoglutarate dehydrogenase E1 component, mitochondrial [drugbank_resource:DB00157_182]
p581
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:182
p582
sg14
Vhttp://bio2rdf.org/drugbank:DB00157
p583
sg16
VNADH [drugbank:DB00157]
p584
sasS'HTR1E'
p585
(lp586
(dp587
g4
Vunknown
p588
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00246_528
p589
sg8
Vdrug-target interaction Ziprasidone and 5-hydroxytryptamine 1E receptor [drugbank_resource:DB00246_528]
p590
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:528
p591
sg14
Vhttp://bio2rdf.org/drugbank:DB00246
p592
sg16
VZiprasidone [drugbank:DB00246]
p593
sa(dp594
g4
Vunknown
p595
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00216_528
p596
sg8
Vdrug-target interaction Eletriptan and 5-hydroxytryptamine 1E receptor [drugbank_resource:DB00216_528]
p597
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:528
p598
sg14
Vhttp://bio2rdf.org/drugbank:DB00216
p599
sg16
VEletriptan [drugbank:DB00216]
p600
sa(dp601
g4
Vunknown
p602
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00334_528
p603
sg8
Vdrug-target interaction Olanzapine and 5-hydroxytryptamine 1E receptor [drugbank_resource:DB00334_528]
p604
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:528
p605
sg14
Vhttp://bio2rdf.org/drugbank:DB00334
p606
sg16
VOlanzapine [drugbank:DB00334]
p607
sa(dp608
g4
Vunknown
p609
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00363_528
p610
sg8
Vdrug-target interaction Clozapine and 5-hydroxytryptamine 1E receptor [drugbank_resource:DB00363_528]
p611
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:528
p612
sg14
Vhttp://bio2rdf.org/drugbank:DB00363
p613
sg16
VClozapine [drugbank:DB00363]
p614
sa(dp615
g4
Vunknown
p616
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01224_528
p617
sg8
Vdrug-target interaction Quetiapine and 5-hydroxytryptamine 1E receptor [drugbank_resource:DB01224_528]
p618
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:528
p619
sg14
Vhttp://bio2rdf.org/drugbank:DB01224
p620
sg16
VQuetiapine [drugbank:DB01224]
p621
sa(dp622
g4
Vunknown
p623
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01238_528
p624
sg8
Vdrug-target interaction Aripiprazole and 5-hydroxytryptamine 1E receptor [drugbank_resource:DB01238_528]
p625
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:528
p626
sg14
Vhttp://bio2rdf.org/drugbank:DB01238
p627
sg16
VAripiprazole [drugbank:DB01238]
p628
sasS'NCAN'
p629
(lp630
(dp631
g4
Vunknown
p632
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02379_7022
p633
sg8
Vdrug-target interaction Beta-D-Glucose and Neurocan core protein [drugbank_resource:DB02379_7022]
p634
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7022
p635
sg14
Vhttp://bio2rdf.org/drugbank:DB02379
p636
sg16
VBeta-D-Glucose [drugbank:DB02379]
p637
sa(dp638
g4
Vunknown
p639
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04396_7022
p640
sg8
Vdrug-target interaction Thiodigalactoside and Neurocan core protein [drugbank_resource:DB04396_7022]
p641
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7022
p642
sg14
Vhttp://bio2rdf.org/drugbank:DB04396
p643
sg16
VThiodigalactoside [drugbank:DB04396]
p644
sasS'ABL2'
p645
(lp646
(dp647
g4
Vunknown
p648
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00171_484
p649
sg8
Vdrug-target interaction Adenosine triphosphate and Tyrosine-protein kinase ABL2 [drugbank_resource:DB00171_484]
p650
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:484
p651
sg14
Vhttp://bio2rdf.org/drugbank:DB00171
p652
sg16
VAdenosine triphosphate [drugbank:DB00171]
p653
sa(dp654
g4
Vunknown
p655
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01254_484
p656
sg8
Vdrug-target interaction Dasatinib and Tyrosine-protein kinase ABL2 [drugbank_resource:DB01254_484]
p657
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:484
p658
sg14
Vhttp://bio2rdf.org/drugbank:DB01254
p659
sg16
VDasatinib [drugbank:DB01254]
p660
sa(dp661
g4
Vunknown
p662
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07664_484
p663
sg8
Vdrug-target interaction 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE and Tyrosine-protein kinase ABL2 [drugbank_resource:DB07664_484]
p664
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:484
p665
sg14
Vhttp://bio2rdf.org/drugbank:DB07664
p666
sg16
V5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE [drugbank:DB07664]
p667
sasS'TSPO'
p668
(lp669
(dp670
g4
Vunknown
p671
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00186_811
p672
sg8
Vdrug-target interaction Lorazepam and Translocator protein [drugbank_resource:DB00186_811]
p673
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:811
p674
sg14
Vhttp://bio2rdf.org/drugbank:DB00186
p675
sg16
VLorazepam [drugbank:DB00186]
p676
sa(dp677
g4
Vunknown
p678
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00231_811
p679
sg8
Vdrug-target interaction Temazepam and Translocator protein [drugbank_resource:DB00231_811]
p680
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:811
p681
sg14
Vhttp://bio2rdf.org/drugbank:DB00231
p682
sg16
VTemazepam [drugbank:DB00231]
p683
sa(dp684
g4
Vunknown
p685
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00404_811
p686
sg8
Vdrug-target interaction Alprazolam and Translocator protein [drugbank_resource:DB00404_811]
p687
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:811
p688
sg14
Vhttp://bio2rdf.org/drugbank:DB00404
p689
sg16
VAlprazolam [drugbank:DB00404]
p690
sa(dp691
g4
Vyes
p692
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00402_811
p693
sg8
Vdrug-target interaction Eszopiclone and Translocator protein [drugbank_resource:DB00402_811]
p694
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:811
p695
sg14
Vhttp://bio2rdf.org/drugbank:DB00402
p696
sg16
VEszopiclone [drugbank:DB00402]
p697
sa(dp698
g4
Vunknown
p699
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00628_811
p700
sg8
Vdrug-target interaction Clorazepate and Translocator protein [drugbank_resource:DB00628_811]
p701
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:811
p702
sg14
Vhttp://bio2rdf.org/drugbank:DB00628
p703
sg16
VClorazepate [drugbank:DB00628]
p704
sa(dp705
g4
Vunknown
p706
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00829_811
p707
sg8
Vdrug-target interaction Diazepam and Translocator protein [drugbank_resource:DB00829_811]
p708
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:811
p709
sg14
Vhttp://bio2rdf.org/drugbank:DB00829
p710
sg16
VDiazepam [drugbank:DB00829]
p711
sa(dp712
g4
Vunknown
p713
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00897_811
p714
sg8
Vdrug-target interaction Triazolam and Translocator protein [drugbank_resource:DB00897_811]
p715
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:811
p716
sg14
Vhttp://bio2rdf.org/drugbank:DB00897
p717
sg16
VTriazolam [drugbank:DB00897]
p718
sa(dp719
g4
Vyes
p720
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00962_811
p721
sg8
Vdrug-target interaction Zaleplon and Translocator protein [drugbank_resource:DB00962_811]
p722
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:811
p723
sg14
Vhttp://bio2rdf.org/drugbank:DB00962
p724
sg16
VZaleplon [drugbank:DB00962]
p725
sa(dp726
g4
Vunknown
p727
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01068_811
p728
sg8
Vdrug-target interaction Clonazepam and Translocator protein [drugbank_resource:DB01068_811]
p729
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:811
p730
sg14
Vhttp://bio2rdf.org/drugbank:DB01068
p731
sg16
VClonazepam [drugbank:DB01068]
p732
sa(dp733
g4
Vunknown
p734
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01198_811
p735
sg8
Vdrug-target interaction Zopiclone and Translocator protein [drugbank_resource:DB01198_811]
p736
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:811
p737
sg14
Vhttp://bio2rdf.org/drugbank:DB01198
p738
sg16
VZopiclone [drugbank:DB01198]
p739
sa(dp740
g4
Vyes
p741
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01587_811
p742
sg8
Vdrug-target interaction Ketazolam and Translocator protein [drugbank_resource:DB01587_811]
p743
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:811
p744
sg14
Vhttp://bio2rdf.org/drugbank:DB01587
p745
sg16
VKetazolam [drugbank:DB01587]
p746
sa(dp747
g4
Vyes
p748
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01178_811
p749
sg8
Vdrug-target interaction Chlormezanone and Translocator protein [drugbank_resource:DB01178_811]
p750
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:811
p751
sg14
Vhttp://bio2rdf.org/drugbank:DB01178
p752
sg16
VChlormezanone [drugbank:DB01178]
p753
sa(dp754
g4
Vyes
p755
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01544_811
p756
sg8
Vdrug-target interaction Flunitrazepam and Translocator protein [drugbank_resource:DB01544_811]
p757
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:811
p758
sg14
Vhttp://bio2rdf.org/drugbank:DB01544
p759
sg16
VFlunitrazepam [drugbank:DB01544]
p760
sasS'PARK7'
p761
(lp762
(dp763
g4
Vunknown
p764
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01769_1434
p765
sg8
Vdrug-target interaction Double Oxidized Cysteine and Protein DJ-1 [drugbank_resource:DB01769_1434]
p766
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1434
p767
sg14
Vhttp://bio2rdf.org/drugbank:DB01769
p768
sg16
VDouble Oxidized Cysteine [drugbank:DB01769]
p769
sasS'DNMT1'
p770
(lp771
(dp772
g4
Vunknown
p773
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01035_1064
p774
sg8
Vdrug-target interaction Procainamide and DNA (cytosine-5)-methyltransferase 1 [drugbank_resource:DB01035_1064]
p775
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1064
p776
sg14
Vhttp://bio2rdf.org/drugbank:DB01035
p777
sg16
VProcainamide [drugbank:DB01035]
p778
sa(dp779
g4
Vyes
p780
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00928_1064
p781
sg8
Vdrug-target interaction Azacitidine and DNA (cytosine-5)-methyltransferase 1 [drugbank_resource:DB00928_1064]
p782
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1064
p783
sg14
Vhttp://bio2rdf.org/drugbank:DB00928
p784
sg16
VAzacitidine [drugbank:DB00928]
p785
sa(dp786
g4
Vunknown
p787
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01099_1064
p788
sg8
Vdrug-target interaction Flucytosine and DNA (cytosine-5)-methyltransferase 1 [drugbank_resource:DB01099_1064]
p789
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1064
p790
sg14
Vhttp://bio2rdf.org/drugbank:DB01099
p791
sg16
VFlucytosine [drugbank:DB01099]
p792
sa(dp793
g4
Vyes
p794
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01262_1064
p795
sg8
Vdrug-target interaction Decitabine and DNA (cytosine-5)-methyltransferase 1 [drugbank_resource:DB01262_1064]
p796
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1064
p797
sg14
Vhttp://bio2rdf.org/drugbank:DB01262
p798
sg16
VDecitabine [drugbank:DB01262]
p799
sasS'NTRK2'
p800
(lp801
(dp802
g4
Vunknown
p803
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00321_6100
p804
sg8
Vdrug-target interaction Amitriptyline and BDNF/NT-3 growth factors receptor [drugbank_resource:DB00321_6100]
p805
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6100
p806
sg14
Vhttp://bio2rdf.org/drugbank:DB00321
p807
sg16
VAmitriptyline [drugbank:DB00321]
p808
sasS'FGFR3'
p809
(lp810
(dp811
g4
Vunknown
p812
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00039_3856
p813
sg8
Vdrug-target interaction Palifermin and Fibroblast growth factor receptor 3 [drugbank_resource:DB00039_3856]
p814
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3856
p815
sg14
Vhttp://bio2rdf.org/drugbank:DB00039
p816
sg16
VPalifermin [drugbank:DB00039]
p817
sasS'HSP90AB1'
p818
(lp819
(dp820
g4
Vunknown
p821
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02754_3456
p822
sg8
Vdrug-target interaction 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine and Heat shock protein HSP 90-beta [drugbank_resource:DB02754_3456]
p823
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3456
p824
sg14
Vhttp://bio2rdf.org/drugbank:DB02754
p825
sg16
V9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine [drugbank:DB02754]
p826
sa(dp827
g4
Vunknown
p828
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02424_3456
p829
sg8
Vdrug-target interaction Geldanamycin and Heat shock protein HSP 90-beta [drugbank_resource:DB02424_3456]
p830
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3456
p831
sg14
Vhttp://bio2rdf.org/drugbank:DB02424
p832
sg16
VGeldanamycin [drugbank:DB02424]
p833
sa(dp834
g4
Vunknown
p835
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03758_3456
p836
sg8
Vdrug-target interaction Radicicol and Heat shock protein HSP 90-beta [drugbank_resource:DB03758_3456]
p837
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3456
p838
sg14
Vhttp://bio2rdf.org/drugbank:DB03758
p839
sg16
VRadicicol [drugbank:DB03758]
p840
sa(dp841
g4
Vunknown
p842
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03431_3456
p843
sg8
Vdrug-target interaction Adenosine-5'-Diphosphate and Heat shock protein HSP 90-beta [drugbank_resource:DB03431_3456]
p844
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3456
p845
sg14
Vhttp://bio2rdf.org/drugbank:DB03431
p846
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p847
sa(dp848
g4
Vunknown
p849
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08153_3456
p850
sg8
Vdrug-target interaction (5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE and Heat shock protein HSP 90-beta [drugbank_resource:DB08153_3456]
p851
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3456
p852
sg14
Vhttp://bio2rdf.org/drugbank:DB08153
p853
sg16
V(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE [drugbank:DB08153]
p854
sa(dp855
g4
Vunknown
p856
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08464_3456
p857
sg8
Vdrug-target interaction METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE and Heat shock protein HSP 90-beta [drugbank_resource:DB08464_3456]
p858
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3456
p859
sg14
Vhttp://bio2rdf.org/drugbank:DB08464
p860
sg16
VMETHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE [drugbank:DB08464]
p861
sa(dp862
g4
Vunknown
p863
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07877_3456
p864
sg8
Vdrug-target interaction 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE and Heat shock protein HSP 90-beta [drugbank_resource:DB07877_3456]
p865
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3456
p866
sg14
Vhttp://bio2rdf.org/drugbank:DB07877
p867
sg16
V8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE [drugbank:DB07877]
p868
sa(dp869
g4
Vunknown
p870
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08045_3456
p871
sg8
Vdrug-target interaction 4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL and Heat shock protein HSP 90-beta [drugbank_resource:DB08045_3456]
p872
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3456
p873
sg14
Vhttp://bio2rdf.org/drugbank:DB08045
p874
sg16
V4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL [drugbank:DB08045]
p875
sa(dp876
g4
Vunknown
p877
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08346_3456
p878
sg8
Vdrug-target interaction (5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE and Heat shock protein HSP 90-beta [drugbank_resource:DB08346_3456]
p879
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3456
p880
sg14
Vhttp://bio2rdf.org/drugbank:DB08346
p881
sg16
V(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE [drugbank:DB08346]
p882
sa(dp883
g4
Vunknown
p884
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07594_3456
p885
sg8
Vdrug-target interaction 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL and Heat shock protein HSP 90-beta [drugbank_resource:DB07594_3456]
p886
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3456
p887
sg14
Vhttp://bio2rdf.org/drugbank:DB07594
p888
sg16
V4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL [drugbank:DB07594]
p889
sa(dp890
g4
Vunknown
p891
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08292_3456
p892
sg8
Vdrug-target interaction (5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE and Heat shock protein HSP 90-beta [drugbank_resource:DB08292_3456]
p893
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3456
p894
sg14
Vhttp://bio2rdf.org/drugbank:DB08292
p895
sg16
V(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE [drugbank:DB08292]
p896
sa(dp897
g4
Vunknown
p898
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08293_3456
p899
sg8
Vdrug-target interaction (5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE and Heat shock protein HSP 90-beta [drugbank_resource:DB08293_3456]
p900
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3456
p901
sg14
Vhttp://bio2rdf.org/drugbank:DB08293
p902
sg16
V(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE [drugbank:DB08293]
p903
sa(dp904
g4
Vunknown
p905
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08465_3456
p906
sg8
Vdrug-target interaction 2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE and Heat shock protein HSP 90-beta [drugbank_resource:DB08465_3456]
p907
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3456
p908
sg14
Vhttp://bio2rdf.org/drugbank:DB08465
p909
sg16
V2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE [drugbank:DB08465]
p910
sasS'PLK1'
p911
(lp912
(dp913
g4
Vunknown
p914
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06897_6246
p915
sg8
Vdrug-target interaction 3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol and Serine/threonine-protein kinase PLK1 [drugbank_resource:DB06897_6246]
p916
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6246
p917
sg14
Vhttp://bio2rdf.org/drugbank:DB06897
p918
sg16
V3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol [drugbank:DB06897]
p919
sa(dp920
g4
Vunknown
p921
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06963_6246
p922
sg8
Vdrug-target interaction 3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide and Serine/threonine-protein kinase PLK1 [drugbank_resource:DB06963_6246]
p923
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6246
p924
sg14
Vhttp://bio2rdf.org/drugbank:DB06963
p925
sg16
V3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide [drugbank:DB06963]
p926
sa(dp927
g4
Vunknown
p928
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07186_6246
p929
sg8
Vdrug-target interaction 4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE and Serine/threonine-protein kinase PLK1 [drugbank_resource:DB07186_6246]
p930
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6246
p931
sg14
Vhttp://bio2rdf.org/drugbank:DB07186
p932
sg16
V4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE [drugbank:DB07186]
p933
sa(dp934
g4
Vunknown
p935
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07789_6246
p936
sg8
Vdrug-target interaction 1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea and Serine/threonine-protein kinase PLK1 [drugbank_resource:DB07789_6246]
p937
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6246
p938
sg14
Vhttp://bio2rdf.org/drugbank:DB07789
p939
sg16
V1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea [drugbank:DB07789]
p940
sa(dp941
g4
Vunknown
p942
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08059_6246
p943
sg8
Vdrug-target interaction (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE and Serine/threonine-protein kinase PLK1 [drugbank_resource:DB08059_6246]
p944
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6246
p945
sg14
Vhttp://bio2rdf.org/drugbank:DB08059
p946
sg16
V(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE [drugbank:DB08059]
p947
sasS'CDK5R1'
p948
(lp949
(dp950
g4
Vunknown
p951
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02052_6321
p952
sg8
Vdrug-target interaction Indirubin-3'-Monoxime and Cyclin-dependent kinase 5 activator 1 [drugbank_resource:DB02052_6321]
p953
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6321
p954
sg14
Vhttp://bio2rdf.org/drugbank:DB02052
p955
sg16
VIndirubin-3'-Monoxime [drugbank:DB02052]
p956
sa(dp957
g4
Vunknown
p958
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07364_6321
p959
sg8
Vdrug-target interaction 6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE and Cyclin-dependent kinase 5 activator 1 [drugbank_resource:DB07364_6321]
p960
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6321
p961
sg14
Vhttp://bio2rdf.org/drugbank:DB07364
p962
sg16
V6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE [drugbank:DB07364]
p963
sasS'GRIN1'
p964
(lp965
(dp966
g4
Vunknown
p967
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00142_401
p968
sg8
Vdrug-target interaction L-Glutamic Acid and Glutamate [NMDA] receptor subunit zeta-1 [drugbank_resource:DB00142_401]
p969
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:401
p970
sg14
Vhttp://bio2rdf.org/drugbank:DB00142
p971
sg16
VL-Glutamic Acid [drugbank:DB00142]
p972
sa(dp973
g4
Vunknown
p974
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00454_401
p975
sg8
Vdrug-target interaction Meperidine and Glutamate [NMDA] receptor subunit zeta-1 [drugbank_resource:DB00454_401]
p976
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:401
p977
sg14
Vhttp://bio2rdf.org/drugbank:DB00454
p978
sg16
VMeperidine [drugbank:DB00454]
p979
sa(dp980
g4
Vyes
p981
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01173_401
p982
sg8
Vdrug-target interaction Orphenadrine and Glutamate [NMDA] receptor subunit zeta-1 [drugbank_resource:DB01173_401]
p983
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:401
p984
sg14
Vhttp://bio2rdf.org/drugbank:DB01173
p985
sg16
VOrphenadrine [drugbank:DB01173]
p986
sa(dp987
g4
Vunknown
p988
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01931_401
p989
sg8
Vdrug-target interaction Dcka, 5,7-Dichlorokynurenic Acid and Glutamate [NMDA] receptor subunit zeta-1 [drugbank_resource:DB01931_401]
p990
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:401
p991
sg14
Vhttp://bio2rdf.org/drugbank:DB01931
p992
sg16
VDcka, 5,7-Dichlorokynurenic Acid [drugbank:DB01931]
p993
sa(dp994
g4
Vunknown
p995
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03929_401
p996
sg8
Vdrug-target interaction D-Serine and Glutamate [NMDA] receptor subunit zeta-1 [drugbank_resource:DB03929_401]
p997
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:401
p998
sg14
Vhttp://bio2rdf.org/drugbank:DB03929
p999
sg16
VD-Serine [drugbank:DB03929]
p1000
sa(dp1001
g4
Vunknown
p1002
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04620_401
p1003
sg8
Vdrug-target interaction Cycloleucine and Glutamate [NMDA] receptor subunit zeta-1 [drugbank_resource:DB04620_401]
p1004
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:401
p1005
sg14
Vhttp://bio2rdf.org/drugbank:DB04620
p1006
sg16
VCycloleucine [drugbank:DB04620]
p1007
sasS'GOT1'
p1008
(lp1009
(dp1010
g4
Vunknown
p1011
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00114_586
p1012
sg8
Vdrug-target interaction Pyridoxal Phosphate and Aspartate aminotransferase, cytoplasmic [drugbank_resource:DB00114_586]
p1013
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:586
p1014
sg14
Vhttp://bio2rdf.org/drugbank:DB00114
p1015
sg16
VPyridoxal Phosphate [drugbank:DB00114]
p1016
sa(dp1017
g4
Vunknown
p1018
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00151_586
p1019
sg8
Vdrug-target interaction L-Cysteine and Aspartate aminotransferase, cytoplasmic [drugbank_resource:DB00151_586]
p1020
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:586
p1021
sg14
Vhttp://bio2rdf.org/drugbank:DB00151
p1022
sg16
VL-Cysteine [drugbank:DB00151]
p1023
sa(dp1024
g4
Vunknown
p1025
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00128_586
p1026
sg8
Vdrug-target interaction L-Aspartic Acid and Aspartate aminotransferase, cytoplasmic [drugbank_resource:DB00128_586]
p1027
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:586
p1028
sg14
Vhttp://bio2rdf.org/drugbank:DB00128
p1029
sg16
VL-Aspartic Acid [drugbank:DB00128]
p1030
sa(dp1031
g4
Vunknown
p1032
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00142_586
p1033
sg8
Vdrug-target interaction L-Glutamic Acid and Aspartate aminotransferase, cytoplasmic [drugbank_resource:DB00142_586]
p1034
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:586
p1035
sg14
Vhttp://bio2rdf.org/drugbank:DB00142
p1036
sg16
VL-Glutamic Acid [drugbank:DB00142]
p1037
sa(dp1038
g4
Vunknown
p1039
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04299_586
p1040
sg8
Vdrug-target interaction Maleic Acid and Aspartate aminotransferase, cytoplasmic [drugbank_resource:DB04299_586]
p1041
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:586
p1042
sg14
Vhttp://bio2rdf.org/drugbank:DB04299
p1043
sg16
VMaleic Acid [drugbank:DB04299]
p1044
sasS'PYGL'
p1045
(lp1046
(dp1047
g4
Vunknown
p1048
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00131_10
p1049
sg8
Vdrug-target interaction Adenosine monophosphate and Glycogen phosphorylase, liver form [drugbank_resource:DB00131_10]
p1050
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:10
p1051
sg14
Vhttp://bio2rdf.org/drugbank:DB00131
p1052
sg16
VAdenosine monophosphate [drugbank:DB00131]
p1053
sa(dp1054
g4
Vunknown
p1055
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00114_10
p1056
sg8
Vdrug-target interaction Pyridoxal Phosphate and Glycogen phosphorylase, liver form [drugbank_resource:DB00114_10]
p1057
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:10
p1058
sg14
Vhttp://bio2rdf.org/drugbank:DB00114
p1059
sg16
VPyridoxal Phosphate [drugbank:DB00114]
p1060
sa(dp1061
g4
Vunknown
p1062
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02089_10
p1063
sg8
Vdrug-target interaction CP-526423 and Glycogen phosphorylase, liver form [drugbank_resource:DB02089_10]
p1064
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:10
p1065
sg14
Vhttp://bio2rdf.org/drugbank:DB02089
p1066
sg16
VCP-526423 [drugbank:DB02089]
p1067
sa(dp1068
g4
Vunknown
p1069
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01696_10
p1070
sg8
Vdrug-target interaction 7,9-Dihydro-1h-Purine-2,6,8(3h)-Trione and Glycogen phosphorylase, liver form [drugbank_resource:DB01696_10]
p1071
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:10
p1072
sg14
Vhttp://bio2rdf.org/drugbank:DB01696
p1073
sg16
V7,9-Dihydro-1h-Purine-2,6,8(3h)-Trione [drugbank:DB01696]
p1074
sa(dp1075
g4
Vunknown
p1076
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02379_10
p1077
sg8
Vdrug-target interaction Beta-D-Glucose and Glycogen phosphorylase, liver form [drugbank_resource:DB02379_10]
p1078
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:10
p1079
sg14
Vhttp://bio2rdf.org/drugbank:DB02379
p1080
sg16
VBeta-D-Glucose [drugbank:DB02379]
p1081
sa(dp1082
g4
Vunknown
p1083
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02320_10
p1084
sg8
Vdrug-target interaction 1-N-Acetyl-Beta-D-Glucosamine and Glycogen phosphorylase, liver form [drugbank_resource:DB02320_10]
p1085
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:10
p1086
sg14
Vhttp://bio2rdf.org/drugbank:DB02320
p1087
sg16
V1-N-Acetyl-Beta-D-Glucosamine [drugbank:DB02320]
p1088
sa(dp1089
g4
Vunknown
p1090
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03288_10
p1091
sg8
Vdrug-target interaction 5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide and Glycogen phosphorylase, liver form [drugbank_resource:DB03288_10]
p1092
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:10
p1093
sg14
Vhttp://bio2rdf.org/drugbank:DB03288
p1094
sg16
V5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide [drugbank:DB03288]
p1095
sa(dp1096
g4
Vunknown
p1097
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03744_10
p1098
sg8
Vdrug-target interaction Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate and Glycogen phosphorylase, liver form [drugbank_resource:DB03744_10]
p1099
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:10
p1100
sg14
Vhttp://bio2rdf.org/drugbank:DB03744
p1101
sg16
VCp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate [drugbank:DB03744]
p1102
sa(dp1103
g4
Vunknown
p1104
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04522_10
p1105
sg8
Vdrug-target interaction Phosphonoserine and Glycogen phosphorylase, liver form [drugbank_resource:DB04522_10]
p1106
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:10
p1107
sg14
Vhttp://bio2rdf.org/drugbank:DB04522
p1108
sg16
VPhosphonoserine [drugbank:DB04522]
p1109
sa(dp1110
g4
Vunknown
p1111
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07395_10
p1112
sg8
Vdrug-target interaction 4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid and Glycogen phosphorylase, liver form [drugbank_resource:DB07395_10]
p1113
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:10
p1114
sg14
Vhttp://bio2rdf.org/drugbank:DB07395
p1115
sg16
V4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid [drugbank:DB07395]
p1116
sa(dp1117
g4
Vunknown
p1118
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07315_10
p1119
sg8
Vdrug-target interaction 5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide and Glycogen phosphorylase, liver form [drugbank_resource:DB07315_10]
p1120
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:10
p1121
sg14
Vhttp://bio2rdf.org/drugbank:DB07315
p1122
sg16
V5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide [drugbank:DB07315]
p1123
sa(dp1124
g4
Vunknown
p1125
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07396_10
p1126
sg8
Vdrug-target interaction 1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid and Glycogen phosphorylase, liver form [drugbank_resource:DB07396_10]
p1127
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:10
p1128
sg14
Vhttp://bio2rdf.org/drugbank:DB07396
p1129
sg16
V1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid [drugbank:DB07396]
p1130
sa(dp1131
g4
Vunknown
p1132
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07968_10
p1133
sg8
Vdrug-target interaction N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA and Glycogen phosphorylase, liver form [drugbank_resource:DB07968_10]
p1134
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:10
p1135
sg14
Vhttp://bio2rdf.org/drugbank:DB07968
p1136
sg16
VN-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA [drugbank:DB07968]
p1137
sasS'PYGM'
p1138
(lp1139
(dp1140
g4
Vunknown
p1141
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00114_1152
p1142
sg8
Vdrug-target interaction Pyridoxal Phosphate and Glycogen phosphorylase, muscle form [drugbank_resource:DB00114_1152]
p1143
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1144
sg14
Vhttp://bio2rdf.org/drugbank:DB00114
p1145
sg16
VPyridoxal Phosphate [drugbank:DB00114]
p1146
sa(dp1147
g4
Vunknown
p1148
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01823_1152
p1149
sg8
Vdrug-target interaction Beta-D-Glucopyranose Spirohydantoin and Glycogen phosphorylase, muscle form [drugbank_resource:DB01823_1152]
p1150
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1151
sg14
Vhttp://bio2rdf.org/drugbank:DB01823
p1152
sg16
VBeta-D-Glucopyranose Spirohydantoin [drugbank:DB01823]
p1153
sa(dp1154
g4
Vunknown
p1155
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01843_1152
p1156
sg8
Vdrug-target interaction 3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione and Glycogen phosphorylase, muscle form [drugbank_resource:DB01843_1152]
p1157
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1158
sg14
Vhttp://bio2rdf.org/drugbank:DB01843
p1159
sg16
V3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione [drugbank:DB01843]
p1160
sa(dp1161
g4
Vunknown
p1162
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02007_1152
p1163
sg8
Vdrug-target interaction Alpha-D-Glucose-6-Phosphate and Glycogen phosphorylase, muscle form [drugbank_resource:DB02007_1152]
p1164
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1165
sg14
Vhttp://bio2rdf.org/drugbank:DB02007
p1166
sg16
VAlpha-D-Glucose-6-Phosphate [drugbank:DB02007]
p1167
sa(dp1168
g4
Vunknown
p1169
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02719_1152
p1170
sg8
Vdrug-target interaction C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide and Glycogen phosphorylase, muscle form [drugbank_resource:DB02719_1152]
p1171
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1172
sg14
Vhttp://bio2rdf.org/drugbank:DB02719
p1173
sg16
VC-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide [drugbank:DB02719]
p1174
sa(dp1175
g4
Vunknown
p1176
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02447_1152
p1177
sg8
Vdrug-target interaction 3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione and Glycogen phosphorylase, muscle form [drugbank_resource:DB02447_1152]
p1178
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1179
sg14
Vhttp://bio2rdf.org/drugbank:DB02447
p1180
sg16
V3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione [drugbank:DB02447]
p1181
sa(dp1182
g4
Vunknown
p1183
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02519_1152
p1184
sg8
Vdrug-target interaction Indirubin-5-Sulphonate and Glycogen phosphorylase, muscle form [drugbank_resource:DB02519_1152]
p1185
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1186
sg14
Vhttp://bio2rdf.org/drugbank:DB02519
p1187
sg16
VIndirubin-5-Sulphonate [drugbank:DB02519]
p1188
sa(dp1189
g4
Vunknown
p1190
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02604_1152
p1191
sg8
Vdrug-target interaction 2-Deoxy-Glucose-6-Phosphate and Glycogen phosphorylase, muscle form [drugbank_resource:DB02604_1152]
p1192
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1193
sg14
Vhttp://bio2rdf.org/drugbank:DB02604
p1194
sg16
V2-Deoxy-Glucose-6-Phosphate [drugbank:DB02604]
p1195
sa(dp1196
g4
Vunknown
p1197
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02720_1152
p1198
sg8
Vdrug-target interaction Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide and Glycogen phosphorylase, muscle form [drugbank_resource:DB02720_1152]
p1199
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1200
sg14
Vhttp://bio2rdf.org/drugbank:DB02720
p1201
sg16
VAlpha-D-Glucopyranosyl-2-Carboxylic Acid Amide [drugbank:DB02720]
p1202
sa(dp1203
g4
Vunknown
p1204
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03067_1152
p1205
sg8
Vdrug-target interaction 4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid and Glycogen phosphorylase, muscle form [drugbank_resource:DB03067_1152]
p1206
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1207
sg14
Vhttp://bio2rdf.org/drugbank:DB03067
p1208
sg16
V4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid [drugbank:DB03067]
p1209
sa(dp1210
g4
Vunknown
p1211
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02320_1152
p1212
sg8
Vdrug-target interaction 1-N-Acetyl-Beta-D-Glucosamine and Glycogen phosphorylase, muscle form [drugbank_resource:DB02320_1152]
p1213
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1214
sg14
Vhttp://bio2rdf.org/drugbank:DB02320
p1215
sg16
V1-N-Acetyl-Beta-D-Glucosamine [drugbank:DB02320]
p1216
sa(dp1217
g4
Vunknown
p1218
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02348_1152
p1219
sg8
Vdrug-target interaction Fluoro-Phosphite Ion and Glycogen phosphorylase, muscle form [drugbank_resource:DB02348_1152]
p1220
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1221
sg14
Vhttp://bio2rdf.org/drugbank:DB02348
p1222
sg16
VFluoro-Phosphite Ion [drugbank:DB02348]
p1223
sa(dp1224
g4
Vunknown
p1225
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02379_1152
p1226
sg8
Vdrug-target interaction Beta-D-Glucose and Glycogen phosphorylase, muscle form [drugbank_resource:DB02379_1152]
p1227
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1228
sg14
Vhttp://bio2rdf.org/drugbank:DB02379
p1229
sg16
VBeta-D-Glucose [drugbank:DB02379]
p1230
sa(dp1231
g4
Vunknown
p1232
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02471_1152
p1233
sg8
Vdrug-target interaction Nojirimycine Tetrazole and Glycogen phosphorylase, muscle form [drugbank_resource:DB02471_1152]
p1234
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1235
sg14
Vhttp://bio2rdf.org/drugbank:DB02471
p1236
sg16
VNojirimycine Tetrazole [drugbank:DB02471]
p1237
sa(dp1238
g4
Vunknown
p1239
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03218_1152
p1240
sg8
Vdrug-target interaction N-Acetyl-N'-Beta-D-Glucopyranosyl Urea and Glycogen phosphorylase, muscle form [drugbank_resource:DB03218_1152]
p1241
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1242
sg14
Vhttp://bio2rdf.org/drugbank:DB03218
p1243
sg16
VN-Acetyl-N'-Beta-D-Glucopyranosyl Urea [drugbank:DB03218]
p1244
sa(dp1245
g4
Vunknown
p1246
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03250_1152
p1247
sg8
Vdrug-target interaction 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole and Glycogen phosphorylase, muscle form [drugbank_resource:DB03250_1152]
p1248
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1249
sg14
Vhttp://bio2rdf.org/drugbank:DB03250
p1250
sg16
V2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole [drugbank:DB03250]
p1251
sa(dp1252
g4
Vunknown
p1253
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03286_1152
p1254
sg8
Vdrug-target interaction C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide and Glycogen phosphorylase, muscle form [drugbank_resource:DB03286_1152]
p1255
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1256
sg14
Vhttp://bio2rdf.org/drugbank:DB03286
p1257
sg16
VC-(1-Azido-Alpha-D-Glucopyranosyl) Formamide [drugbank:DB03286]
p1258
sa(dp1259
g4
Vunknown
p1260
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02843_1152
p1261
sg8
Vdrug-target interaction Alpha-D-Glucose-1-Phosphate and Glycogen phosphorylase, muscle form [drugbank_resource:DB02843_1152]
p1262
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1263
sg14
Vhttp://bio2rdf.org/drugbank:DB02843
p1264
sg16
VAlpha-D-Glucose-1-Phosphate [drugbank:DB02843]
p1265
sa(dp1266
g4
Vunknown
p1267
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02964_1152
p1268
sg8
Vdrug-target interaction 8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One and Glycogen phosphorylase, muscle form [drugbank_resource:DB02964_1152]
p1269
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1270
sg14
Vhttp://bio2rdf.org/drugbank:DB02964
p1271
sg16
V8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One [drugbank:DB02964]
p1272
sa(dp1273
g4
Vunknown
p1274
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03133_1152
p1275
sg8
Vdrug-target interaction 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole and Glycogen phosphorylase, muscle form [drugbank_resource:DB03133_1152]
p1276
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1277
sg14
Vhttp://bio2rdf.org/drugbank:DB03133
p1278
sg16
V2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole [drugbank:DB03133]
p1279
sa(dp1280
g4
Vunknown
p1281
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03496_1152
p1282
sg8
Vdrug-target interaction Flavopiridol and Glycogen phosphorylase, muscle form [drugbank_resource:DB03496_1152]
p1283
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1284
sg14
Vhttp://bio2rdf.org/drugbank:DB03496
p1285
sg16
VFlavopiridol [drugbank:DB03496]
p1286
sa(dp1287
g4
Vunknown
p1288
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03354_1152
p1289
sg8
Vdrug-target interaction 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole and Glycogen phosphorylase, muscle form [drugbank_resource:DB03354_1152]
p1290
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1291
sg14
Vhttp://bio2rdf.org/drugbank:DB03354
p1292
sg16
V2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole [drugbank:DB03354]
p1293
sa(dp1294
g4
Vunknown
p1295
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03383_1152
p1296
sg8
Vdrug-target interaction 5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide and Glycogen phosphorylase, muscle form [drugbank_resource:DB03383_1152]
p1297
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1298
sg14
Vhttp://bio2rdf.org/drugbank:DB03383
p1299
sg16
V5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide [drugbank:DB03383]
p1300
sa(dp1301
g4
Vunknown
p1302
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03392_1152
p1303
sg8
Vdrug-target interaction (3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester and Glycogen phosphorylase, muscle form [drugbank_resource:DB03392_1152]
p1304
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1305
sg14
Vhttp://bio2rdf.org/drugbank:DB03392
p1306
sg16
V(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester [drugbank:DB03392]
p1307
sa(dp1308
g4
Vunknown
p1309
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04055_1152
p1310
sg8
Vdrug-target interaction 2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium and Glycogen phosphorylase, muscle form [drugbank_resource:DB04055_1152]
p1311
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1312
sg14
Vhttp://bio2rdf.org/drugbank:DB04055
p1313
sg16
V2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium [drugbank:DB04055]
p1314
sa(dp1315
g4
Vunknown
p1316
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04195_1152
p1317
sg8
Vdrug-target interaction Heptulose-2-Phosphate and Glycogen phosphorylase, muscle form [drugbank_resource:DB04195_1152]
p1318
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1319
sg14
Vhttp://bio2rdf.org/drugbank:DB04195
p1320
sg16
VHeptulose-2-Phosphate [drugbank:DB04195]
p1321
sa(dp1322
g4
Vunknown
p1323
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03479_1152
p1324
sg8
Vdrug-target interaction 8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione and Glycogen phosphorylase, muscle form [drugbank_resource:DB03479_1152]
p1325
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1326
sg14
Vhttp://bio2rdf.org/drugbank:DB03479
p1327
sg16
V8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione [drugbank:DB03479]
p1328
sa(dp1329
g4
Vunknown
p1330
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03657_1152
p1331
sg8
Vdrug-target interaction 1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose and Glycogen phosphorylase, muscle form [drugbank_resource:DB03657_1152]
p1332
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1333
sg14
Vhttp://bio2rdf.org/drugbank:DB03657
p1334
sg16
V1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose [drugbank:DB03657]
p1335
sa(dp1336
g4
Vunknown
p1337
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03835_1152
p1338
sg8
Vdrug-target interaction N-(8,9,10-Trihydroxy-7-Hydroxymethyl-2,4-Dioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Dec-3-Yl-Acetamide and Glycogen phosphorylase, muscle form [drugbank_resource:DB03835_1152]
p1339
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1340
sg14
Vhttp://bio2rdf.org/drugbank:DB03835
p1341
sg16
VN-(8,9,10-Trihydroxy-7-Hydroxymethyl-2,4-Dioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Dec-3-Yl-Acetamide [drugbank:DB03835]
p1342
sa(dp1343
g4
Vunknown
p1344
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04013_1152
p1345
sg8
Vdrug-target interaction 1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide and Glycogen phosphorylase, muscle form [drugbank_resource:DB04013_1152]
p1346
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1347
sg14
Vhttp://bio2rdf.org/drugbank:DB04013
p1348
sg16
V1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide [drugbank:DB04013]
p1349
sa(dp1350
g4
Vunknown
p1351
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04083_1152
p1352
sg8
Vdrug-target interaction N'-Pyridoxyl-Lysine-5'-Monophosphate and Glycogen phosphorylase, muscle form [drugbank_resource:DB04083_1152]
p1353
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1354
sg14
Vhttp://bio2rdf.org/drugbank:DB04083
p1355
sg16
VN'-Pyridoxyl-Lysine-5'-Monophosphate [drugbank:DB04083]
p1356
sa(dp1357
g4
Vunknown
p1358
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04295_1152
p1359
sg8
Vdrug-target interaction N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea and Glycogen phosphorylase, muscle form [drugbank_resource:DB04295_1152]
p1360
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1361
sg14
Vhttp://bio2rdf.org/drugbank:DB04295
p1362
sg16
VN-Benzoyl-N'-Beta-D-Glucopyranosyl Urea [drugbank:DB04295]
p1363
sa(dp1364
g4
Vunknown
p1365
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04044_1152
p1366
sg8
Vdrug-target interaction 4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid and Glycogen phosphorylase, muscle form [drugbank_resource:DB04044_1152]
p1367
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1368
sg14
Vhttp://bio2rdf.org/drugbank:DB04044
p1369
sg16
V4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid [drugbank:DB04044]
p1370
sa(dp1371
g4
Vunknown
p1372
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04544_1152
p1373
sg8
Vdrug-target interaction 1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide and Glycogen phosphorylase, muscle form [drugbank_resource:DB04544_1152]
p1374
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1375
sg14
Vhttp://bio2rdf.org/drugbank:DB04544
p1376
sg16
V1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide [drugbank:DB04544]
p1377
sa(dp1378
g4
Vunknown
p1379
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04643_1152
p1380
sg8
Vdrug-target interaction 4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID and Glycogen phosphorylase, muscle form [drugbank_resource:DB04643_1152]
p1381
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1382
sg14
Vhttp://bio2rdf.org/drugbank:DB04643
p1383
sg16
V4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID [drugbank:DB04643]
p1384
sa(dp1385
g4
Vunknown
p1386
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04522_1152
p1387
sg8
Vdrug-target interaction Phosphonoserine and Glycogen phosphorylase, muscle form [drugbank_resource:DB04522_1152]
p1388
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1389
sg14
Vhttp://bio2rdf.org/drugbank:DB04522
p1390
sg16
VPhosphonoserine [drugbank:DB04522]
p1391
sa(dp1392
g4
Vunknown
p1393
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04566_1152
p1394
sg8
Vdrug-target interaction Inosinic Acid and Glycogen phosphorylase, muscle form [drugbank_resource:DB04566_1152]
p1395
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1396
sg14
Vhttp://bio2rdf.org/drugbank:DB04566
p1397
sg16
VInosinic Acid [drugbank:DB04566]
p1398
sa(dp1399
g4
Vunknown
p1400
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04645_1152
p1401
sg8
Vdrug-target interaction 5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID and Glycogen phosphorylase, muscle form [drugbank_resource:DB04645_1152]
p1402
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1403
sg14
Vhttp://bio2rdf.org/drugbank:DB04645
p1404
sg16
V5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID [drugbank:DB04645]
p1405
sa(dp1406
g4
Vunknown
p1407
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04642_1152
p1408
sg8
Vdrug-target interaction 7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID and Glycogen phosphorylase, muscle form [drugbank_resource:DB04642_1152]
p1409
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1410
sg14
Vhttp://bio2rdf.org/drugbank:DB04642
p1411
sg16
V7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID [drugbank:DB04642]
p1412
sa(dp1413
g4
Vunknown
p1414
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04644_1152
p1415
sg8
Vdrug-target interaction 4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID and Glycogen phosphorylase, muscle form [drugbank_resource:DB04644_1152]
p1416
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1417
sg14
Vhttp://bio2rdf.org/drugbank:DB04644
p1418
sg16
V4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID [drugbank:DB04644]
p1419
sa(dp1420
g4
Vunknown
p1421
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06986_1152
p1422
sg8
Vdrug-target interaction 2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE and Glycogen phosphorylase, muscle form [drugbank_resource:DB06986_1152]
p1423
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1424
sg14
Vhttp://bio2rdf.org/drugbank:DB06986
p1425
sg16
V2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE [drugbank:DB06986]
p1426
sa(dp1427
g4
Vunknown
p1428
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07066_1152
p1429
sg8
Vdrug-target interaction 2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE and Glycogen phosphorylase, muscle form [drugbank_resource:DB07066_1152]
p1430
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1431
sg14
Vhttp://bio2rdf.org/drugbank:DB07066
p1432
sg16
V2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE [drugbank:DB07066]
p1433
sa(dp1434
g4
Vunknown
p1435
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07792_1152
p1436
sg8
Vdrug-target interaction (S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE and Glycogen phosphorylase, muscle form [drugbank_resource:DB07792_1152]
p1437
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1438
sg14
Vhttp://bio2rdf.org/drugbank:DB07792
p1439
sg16
V(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE [drugbank:DB07792]
p1440
sa(dp1441
g4
Vunknown
p1442
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08151_1152
p1443
sg8
Vdrug-target interaction (5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol and Glycogen phosphorylase, muscle form [drugbank_resource:DB08151_1152]
p1444
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1445
sg14
Vhttp://bio2rdf.org/drugbank:DB08151
p1446
sg16
V(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol [drugbank:DB08151]
p1447
sa(dp1448
g4
Vunknown
p1449
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08503_1152
p1450
sg8
Vdrug-target interaction (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol and Glycogen phosphorylase, muscle form [drugbank_resource:DB08503_1152]
p1451
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1452
sg14
Vhttp://bio2rdf.org/drugbank:DB08503
p1453
sg16
V(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol [drugbank:DB08503]
p1454
sa(dp1455
g4
Vunknown
p1456
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07807_1152
p1457
sg8
Vdrug-target interaction (3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL and Glycogen phosphorylase, muscle form [drugbank_resource:DB07807_1152]
p1458
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1459
sg14
Vhttp://bio2rdf.org/drugbank:DB07807
p1460
sg16
V(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL [drugbank:DB07807]
p1461
sa(dp1462
g4
Vunknown
p1463
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07949_1152
p1464
sg8
Vdrug-target interaction ({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID and Glycogen phosphorylase, muscle form [drugbank_resource:DB07949_1152]
p1465
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1466
sg14
Vhttp://bio2rdf.org/drugbank:DB07949
p1467
sg16
V({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID [drugbank:DB07949]
p1468
sa(dp1469
g4
Vunknown
p1470
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07793_1152
p1471
sg8
Vdrug-target interaction (2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE and Glycogen phosphorylase, muscle form [drugbank_resource:DB07793_1152]
p1472
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1473
sg14
Vhttp://bio2rdf.org/drugbank:DB07793
p1474
sg16
V(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE [drugbank:DB07793]
p1475
sa(dp1476
g4
Vunknown
p1477
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08322_1152
p1478
sg8
Vdrug-target interaction 2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID and Glycogen phosphorylase, muscle form [drugbank_resource:DB08322_1152]
p1479
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1480
sg14
Vhttp://bio2rdf.org/drugbank:DB08322
p1481
sg16
V2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID [drugbank:DB08322]
p1482
sa(dp1483
g4
Vunknown
p1484
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08500_1152
p1485
sg8
Vdrug-target interaction (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol and Glycogen phosphorylase, muscle form [drugbank_resource:DB08500_1152]
p1486
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1152
p1487
sg14
Vhttp://bio2rdf.org/drugbank:DB08500
p1488
sg16
V(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol [drugbank:DB08500]
p1489
sasS'PFAS'
p1490
(lp1491
(dp1492
g4
Vunknown
p1493
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00142_3982
p1494
sg8
Vdrug-target interaction L-Glutamic Acid and Phosphoribosylformylglycinamidine synthase [drugbank_resource:DB00142_3982]
p1495
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3982
p1496
sg14
Vhttp://bio2rdf.org/drugbank:DB00142
p1497
sg16
VL-Glutamic Acid [drugbank:DB00142]
p1498
sasS'AURKA'
p1499
(lp1500
(dp1501
g4
Vunknown
p1502
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02482_1422
p1503
sg8
Vdrug-target interaction Phosphonothreonine and Serine/threonine-protein kinase 6 [drugbank_resource:DB02482_1422]
p1504
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1422
p1505
sg14
Vhttp://bio2rdf.org/drugbank:DB02482
p1506
sg16
VPhosphonothreonine [drugbank:DB02482]
p1507
sa(dp1508
g4
Vunknown
p1509
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03431_1422
p1510
sg8
Vdrug-target interaction Adenosine-5'-Diphosphate and Serine/threonine-protein kinase 6 [drugbank_resource:DB03431_1422]
p1511
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1422
p1512
sg14
Vhttp://bio2rdf.org/drugbank:DB03431
p1513
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p1514
sa(dp1515
g4
Vunknown
p1516
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07186_1422
p1517
sg8
Vdrug-target interaction 4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE and Serine/threonine-protein kinase 6 [drugbank_resource:DB07186_1422]
p1518
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1422
p1519
sg14
Vhttp://bio2rdf.org/drugbank:DB07186
p1520
sg16
V4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE [drugbank:DB07186]
p1521
sa(dp1522
g4
Vunknown
p1523
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07266_1422
p1524
sg8
Vdrug-target interaction 8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one and Serine/threonine-protein kinase 6 [drugbank_resource:DB07266_1422]
p1525
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1422
p1526
sg14
Vhttp://bio2rdf.org/drugbank:DB07266
p1527
sg16
V8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one [drugbank:DB07266]
p1528
sa(dp1529
g4
Vunknown
p1530
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07361_1422
p1531
sg8
Vdrug-target interaction 1-(3-chlorophenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}urea and Serine/threonine-protein kinase 6 [drugbank_resource:DB07361_1422]
p1532
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1422
p1533
sg14
Vhttp://bio2rdf.org/drugbank:DB07361
p1534
sg16
V1-(3-chlorophenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}urea [drugbank:DB07361]
p1535
sa(dp1536
g4
Vunknown
p1537
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07360_1422
p1538
sg8
Vdrug-target interaction 1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea and Serine/threonine-protein kinase 6 [drugbank_resource:DB07360_1422]
p1539
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1422
p1540
sg14
Vhttp://bio2rdf.org/drugbank:DB07360
p1541
sg16
V1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea [drugbank:DB07360]
p1542
sa(dp1543
g4
Vunknown
p1544
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07362_1422
p1545
sg8
Vdrug-target interaction 1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea and Serine/threonine-protein kinase 6 [drugbank_resource:DB07362_1422]
p1546
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1422
p1547
sg14
Vhttp://bio2rdf.org/drugbank:DB07362
p1548
sg16
V1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea [drugbank:DB07362]
p1549
sa(dp1550
g4
Vunknown
p1551
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07545_1422
p1552
sg8
Vdrug-target interaction N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE and Serine/threonine-protein kinase 6 [drugbank_resource:DB07545_1422]
p1553
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1422
p1554
sg14
Vhttp://bio2rdf.org/drugbank:DB07545
p1555
sg16
VN-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE [drugbank:DB07545]
p1556
sa(dp1557
g4
Vunknown
p1558
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08066_1422
p1559
sg8
Vdrug-target interaction N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE and Serine/threonine-protein kinase 6 [drugbank_resource:DB08066_1422]
p1560
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1422
p1561
sg14
Vhttp://bio2rdf.org/drugbank:DB08066
p1562
sg16
VN-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE [drugbank:DB08066]
p1563
sa(dp1564
g4
Vunknown
p1565
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07801_1422
p1566
sg8
Vdrug-target interaction N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide and Serine/threonine-protein kinase 6 [drugbank_resource:DB07801_1422]
p1567
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1422
p1568
sg14
Vhttp://bio2rdf.org/drugbank:DB07801
p1569
sg16
VN-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide [drugbank:DB07801]
p1570
sa(dp1571
g4
Vunknown
p1572
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08065_1422
p1573
sg8
Vdrug-target interaction 2-(1H-pyrazol-3-yl)-1H-benzimidazole and Serine/threonine-protein kinase 6 [drugbank_resource:DB08065_1422]
p1574
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1422
p1575
sg14
Vhttp://bio2rdf.org/drugbank:DB08065
p1576
sg16
V2-(1H-pyrazol-3-yl)-1H-benzimidazole [drugbank:DB08065]
p1577
sasS'ERBB2'
p1578
(lp1579
(dp1580
g4
Vyes
p1581
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00072_567
p1582
sg8
Vdrug-target interaction Trastuzumab and Receptor tyrosine-protein kinase erbB-2 [drugbank_resource:DB00072_567]
p1583
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:567
p1584
sg14
Vhttp://bio2rdf.org/drugbank:DB00072
p1585
sg16
VTrastuzumab [drugbank:DB00072]
p1586
sa(dp1587
g4
Vyes
p1588
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01259_567
p1589
sg8
Vdrug-target interaction Lapatinib and Receptor tyrosine-protein kinase erbB-2 [drugbank_resource:DB01259_567]
p1590
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:567
p1591
sg14
Vhttp://bio2rdf.org/drugbank:DB01259
p1592
sg16
VLapatinib [drugbank:DB01259]
p1593
sasS'LRP2'
p1594
(lp1595
(dp1596
g4
Vunknown
p1597
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00013_1244
p1598
sg8
Vdrug-target interaction Urokinase and Low-density lipoprotein receptor-related protein 2 [drugbank_resource:DB00013_1244]
p1599
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1244
p1600
sg14
Vhttp://bio2rdf.org/drugbank:DB00013
p1601
sg16
VUrokinase [drugbank:DB00013]
p1602
sa(dp1603
g4
Vunknown
p1604
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00030_1244
p1605
sg8
Vdrug-target interaction Insulin recombinant and Low-density lipoprotein receptor-related protein 2 [drugbank_resource:DB00030_1244]
p1606
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1244
p1607
sg14
Vhttp://bio2rdf.org/drugbank:DB00030
p1608
sg16
VInsulin recombinant [drugbank:DB00030]
p1609
sa(dp1610
g4
Vunknown
p1611
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00071_1244
p1612
sg8
Vdrug-target interaction Insulin, porcine and Low-density lipoprotein receptor-related protein 2 [drugbank_resource:DB00071_1244]
p1613
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1244
p1614
sg14
Vhttp://bio2rdf.org/drugbank:DB00071
p1615
sg16
VInsulin, porcine [drugbank:DB00071]
p1616
sa(dp1617
g4
Vno
p1618
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00798_1244
p1619
sg8
Vdrug-target interaction Gentamicin and Low-density lipoprotein receptor-related protein 2 [drugbank_resource:DB00798_1244]
p1620
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1244
p1621
sg14
Vhttp://bio2rdf.org/drugbank:DB00798
p1622
sg16
VGentamicin [drugbank:DB00798]
p1623
sasS'IGF1R'
p1624
(lp1625
(dp1626
g4
Vunknown
p1627
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00030_958
p1628
sg8
Vdrug-target interaction Insulin recombinant and Insulin-like growth factor 1 receptor [drugbank_resource:DB00030_958]
p1629
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:958
p1630
sg14
Vhttp://bio2rdf.org/drugbank:DB00030
p1631
sg16
VInsulin recombinant [drugbank:DB00030]
p1632
sa(dp1633
g4
Vunknown
p1634
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00046_958
p1635
sg8
Vdrug-target interaction Insulin Lispro and Insulin-like growth factor 1 receptor [drugbank_resource:DB00046_958]
p1636
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:958
p1637
sg14
Vhttp://bio2rdf.org/drugbank:DB00046
p1638
sg16
VInsulin Lispro [drugbank:DB00046]
p1639
sa(dp1640
g4
Vunknown
p1641
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00071_958
p1642
sg8
Vdrug-target interaction Insulin, porcine and Insulin-like growth factor 1 receptor [drugbank_resource:DB00071_958]
p1643
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:958
p1644
sg14
Vhttp://bio2rdf.org/drugbank:DB00071
p1645
sg16
VInsulin, porcine [drugbank:DB00071]
p1646
sa(dp1647
g4
Vunknown
p1648
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00047_958
p1649
sg8
Vdrug-target interaction Insulin Glargine and Insulin-like growth factor 1 receptor [drugbank_resource:DB00047_958]
p1650
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:958
p1651
sg14
Vhttp://bio2rdf.org/drugbank:DB00047
p1652
sg16
VInsulin Glargine [drugbank:DB00047]
p1653
sa(dp1654
g4
Vyes
p1655
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01277_958
p1656
sg8
Vdrug-target interaction Mecasermin and Insulin-like growth factor 1 receptor [drugbank_resource:DB01277_958]
p1657
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:958
p1658
sg14
Vhttp://bio2rdf.org/drugbank:DB01277
p1659
sg16
VMecasermin [drugbank:DB01277]
p1660
sa(dp1661
g4
Vunknown
p1662
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02944_958
p1663
sg8
Vdrug-target interaction Alpha-D-Mannose and Insulin-like growth factor 1 receptor [drugbank_resource:DB02944_958]
p1664
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:958
p1665
sg14
Vhttp://bio2rdf.org/drugbank:DB02944
p1666
sg16
VAlpha-D-Mannose [drugbank:DB02944]
p1667
sa(dp1668
g4
Vunknown
p1669
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04395_958
p1670
sg8
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Insulin-like growth factor 1 receptor [drugbank_resource:DB04395_958]
p1671
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:958
p1672
sg14
Vhttp://bio2rdf.org/drugbank:DB04395
p1673
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p1674
sa(dp1675
g4
Vunknown
p1676
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07156_958
p1677
sg8
Vdrug-target interaction (4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione and Insulin-like growth factor 1 receptor [drugbank_resource:DB07156_958]
p1678
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:958
p1679
sg14
Vhttp://bio2rdf.org/drugbank:DB07156
p1680
sg16
V(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione [drugbank:DB07156]
p1681
sa(dp1682
g4
Vunknown
p1683
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07474_958
p1684
sg8
Vdrug-target interaction 3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE and Insulin-like growth factor 1 receptor [drugbank_resource:DB07474_958]
p1685
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:958
p1686
sg14
Vhttp://bio2rdf.org/drugbank:DB07474
p1687
sg16
V3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE [drugbank:DB07474]
p1688
sasS'LYN'
p1689
(lp1690
(dp1691
g4
Vunknown
p1692
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03023_6824
p1693
sg8
Vdrug-target interaction 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine and Tyrosine-protein kinase Lyn [drugbank_resource:DB03023_6824]
p1694
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6824
p1695
sg14
Vhttp://bio2rdf.org/drugbank:DB03023
p1696
sg16
V1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine [drugbank:DB03023]
p1697
sasS'SOD2'
p1698
(lp1699
(dp1700
g4
Vunknown
p1701
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03297_6963
p1702
sg8
Vdrug-target interaction Benzylsulfinic Acid and Superoxide dismutase [Mn], mitochondrial [drugbank_resource:DB03297_6963]
p1703
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6963
p1704
sg14
Vhttp://bio2rdf.org/drugbank:DB03297
p1705
sg16
VBenzylsulfinic Acid [drugbank:DB03297]
p1706
sa(dp1707
g4
Vunknown
p1708
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04436_6963
p1709
sg8
Vdrug-target interaction 3-Fluorotyrosine and Superoxide dismutase [Mn], mitochondrial [drugbank_resource:DB04436_6963]
p1710
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6963
p1711
sg14
Vhttp://bio2rdf.org/drugbank:DB04436
p1712
sg16
V3-Fluorotyrosine [drugbank:DB04436]
p1713
sasS'OXCT1'
p1714
(lp1715
(dp1716
g4
Vunknown
p1717
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00139_4003
p1718
sg8
Vdrug-target interaction Succinic acid and Succinyl-CoA:3-ketoacid-coenzyme A transferase 1, mitochondrial [drugbank_resource:DB00139_4003]
p1719
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4003
p1720
sg14
Vhttp://bio2rdf.org/drugbank:DB00139
p1721
sg16
VSuccinic acid [drugbank:DB00139]
p1722
sa(dp1723
g4
Vunknown
p1724
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02731_4003
p1725
sg8
Vdrug-target interaction Thimerosal and Succinyl-CoA:3-ketoacid-coenzyme A transferase 1, mitochondrial [drugbank_resource:DB02731_4003]
p1726
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4003
p1727
sg14
Vhttp://bio2rdf.org/drugbank:DB02731
p1728
sg16
VThimerosal [drugbank:DB02731]
p1729
sasS'AQP1'
p1730
(lp1731
(dp1732
g4
Vunknown
p1733
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00819_1025
p1734
sg8
Vdrug-target interaction Acetazolamide and Aquaporin-1 [drugbank_resource:DB00819_1025]
p1735
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1025
p1736
sg14
Vhttp://bio2rdf.org/drugbank:DB00819
p1737
sg16
VAcetazolamide [drugbank:DB00819]
p1738
sasS'CACNA2D2'
p1739
(lp1740
(dp1741
g4
Vyes
p1742
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00270_4160
p1743
sg8
Vdrug-target interaction Isradipine and Voltage-dependent calcium channel subunit alpha-2/delta-2 [drugbank_resource:DB00270_4160]
p1744
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4160
p1745
sg14
Vhttp://bio2rdf.org/drugbank:DB00270
p1746
sg16
VIsradipine [drugbank:DB00270]
p1747
sa(dp1748
g4
Vyes
p1749
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00996_4160
p1750
sg8
Vdrug-target interaction Gabapentin and Voltage-dependent calcium channel subunit alpha-2/delta-2 [drugbank_resource:DB00996_4160]
p1751
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4160
p1752
sg14
Vhttp://bio2rdf.org/drugbank:DB00996
p1753
sg16
VGabapentin [drugbank:DB00996]
p1754
sa(dp1755
g4
Vunknown
p1756
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01054_4160
p1757
sg8
Vdrug-target interaction Nitrendipine and Voltage-dependent calcium channel subunit alpha-2/delta-2 [drugbank_resource:DB01054_4160]
p1758
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4160
p1759
sg14
Vhttp://bio2rdf.org/drugbank:DB01054
p1760
sg16
VNitrendipine [drugbank:DB01054]
p1761
sa(dp1762
g4
Vunknown
p1763
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01023_4160
p1764
sg8
Vdrug-target interaction Felodipine and Voltage-dependent calcium channel subunit alpha-2/delta-2 [drugbank_resource:DB01023_4160]
p1765
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4160
p1766
sg14
Vhttp://bio2rdf.org/drugbank:DB01023
p1767
sg16
VFelodipine [drugbank:DB01023]
p1768
sa(dp1769
g4
Vyes
p1770
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01118_4160
p1771
sg8
Vdrug-target interaction Amiodarone and Voltage-dependent calcium channel subunit alpha-2/delta-2 [drugbank_resource:DB01118_4160]
p1772
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4160
p1773
sg14
Vhttp://bio2rdf.org/drugbank:DB01118
p1774
sg16
VAmiodarone [drugbank:DB01118]
p1775
sa(dp1776
g4
Vyes
p1777
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01244_4160
p1778
sg8
Vdrug-target interaction Bepridil and Voltage-dependent calcium channel subunit alpha-2/delta-2 [drugbank_resource:DB01244_4160]
p1779
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4160
p1780
sg14
Vhttp://bio2rdf.org/drugbank:DB01244
p1781
sg16
VBepridil [drugbank:DB01244]
p1782
sasS'P4HB'
p1783
(lp1784
(dp1785
g4
Vunknown
p1786
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03615_4240
p1787
sg8
Vdrug-target interaction Ribostamycin and Protein disulfide-isomerase [drugbank_resource:DB03615_4240]
p1788
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4240
p1789
sg14
Vhttp://bio2rdf.org/drugbank:DB03615
p1790
sg16
VRibostamycin [drugbank:DB03615]
p1791
sasS'CAMK2G'
p1792
(lp1793
(dp1794
g4
Vunknown
p1795
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08699_6893
p1796
sg8
Vdrug-target interaction 1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine and Calcium/calmodulin-dependent protein kinase type II gamma chain [drugbank_resource:DB08699_6893]
p1797
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6893
p1798
sg14
Vhttp://bio2rdf.org/drugbank:DB08699
p1799
sg16
V1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine [drugbank:DB08699]
p1800
sasS'PPP2R2A'
p1801
(lp1802
(dp1803
g4
Vunknown
p1804
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02506_6313
p1805
sg8
Vdrug-target interaction 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid and Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform [drugbank_resource:DB02506_6313]
p1806
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6313
p1807
sg14
Vhttp://bio2rdf.org/drugbank:DB02506
p1808
sg16
V2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid [drugbank:DB02506]
p1809
sasS'CAMK2A'
p1810
(lp1811
(dp1812
g4
Vunknown
p1813
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04447_6579
p1814
sg8
Vdrug-target interaction 1,4-Dithiothreitol and Calcium/calmodulin-dependent protein kinase type II alpha chain [drugbank_resource:DB04447_6579]
p1815
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6579
p1816
sg14
Vhttp://bio2rdf.org/drugbank:DB04447
p1817
sg16
V1,4-Dithiothreitol [drugbank:DB04447]
p1818
sa(dp1819
g4
Vunknown
p1820
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04119_6579
p1821
sg8
Vdrug-target interaction Hexatantalum Dodecabromide and Calcium/calmodulin-dependent protein kinase type II alpha chain [drugbank_resource:DB04119_6579]
p1822
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6579
p1823
sg14
Vhttp://bio2rdf.org/drugbank:DB04119
p1824
sg16
VHexatantalum Dodecabromide [drugbank:DB04119]
p1825
sa(dp1826
g4
Vunknown
p1827
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07766_6579
p1828
sg8
Vdrug-target interaction (2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME} and Calcium/calmodulin-dependent protein kinase type II alpha chain [drugbank_resource:DB07766_6579]
p1829
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6579
p1830
sg14
Vhttp://bio2rdf.org/drugbank:DB07766
p1831
sg16
V(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME} [drugbank:DB07766]
p1832
sasS'CAMK2B'
p1833
(lp1834
(dp1835
g4
Vunknown
p1836
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07168_6294
p1837
sg8
Vdrug-target interaction [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile and Calcium/calmodulin-dependent protein kinase type II beta chain [drugbank_resource:DB07168_6294]
p1838
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6294
p1839
sg14
Vhttp://bio2rdf.org/drugbank:DB07168
p1840
sg16
V[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile [drugbank:DB07168]
p1841
sasS'RBP1'
p1842
(lp1843
(dp1844
g4
Vunknown
p1845
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00162_331
p1846
sg8
Vdrug-target interaction Vitamin A and Retinol-binding protein I, cellular [drugbank_resource:DB00162_331]
p1847
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:331
p1848
sg14
Vhttp://bio2rdf.org/drugbank:DB00162
p1849
sg16
VVitamin A [drugbank:DB00162]
p1850
sa(dp1851
g4
Vunknown
p1852
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00459_331
p1853
sg8
Vdrug-target interaction Acitretin and Retinol-binding protein I, cellular [drugbank_resource:DB00459_331]
p1854
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:331
p1855
sg14
Vhttp://bio2rdf.org/drugbank:DB00459
p1856
sg16
VAcitretin [drugbank:DB00459]
p1857
sasS'LPL'
p1858
(lp1859
(dp1860
g4
Vyes
p1861
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06439_266
p1862
sg8
Vdrug-target interaction Tyloxapol and Lipoprotein lipase [drugbank_resource:DB06439_266]
p1863
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:266
p1864
sg14
Vhttp://bio2rdf.org/drugbank:DB06439
p1865
sg16
VTyloxapol [drugbank:DB06439]
p1866
sasS'CCND1'
p1867
(lp1868
(dp1869
g4
Vyes
p1870
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01169_1569
p1871
sg8
Vdrug-target interaction Arsenic trioxide and G1/S-specific cyclin-D1 [drugbank_resource:DB01169_1569]
p1872
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1569
p1873
sg14
Vhttp://bio2rdf.org/drugbank:DB01169
p1874
sg16
VArsenic trioxide [drugbank:DB01169]
p1875
sasS'RET'
p1876
(lp1877
(dp1878
g4
Vyes
p1879
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00619_1864
p1880
sg8
Vdrug-target interaction Imatinib and RET proto-oncogene [drugbank_resource:DB00619_1864]
p1881
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1864
p1882
sg14
Vhttp://bio2rdf.org/drugbank:DB00619
p1883
sg16
VImatinib [drugbank:DB00619]
p1884
sa(dp1885
g4
Vunknown
p1886
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01809_4177
p1887
sg8
Vdrug-target interaction 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine and Proto-oncogene tyrosine-protein kinase receptor ret [drugbank_resource:DB01809_4177]
p1888
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4177
p1889
sg14
Vhttp://bio2rdf.org/drugbank:DB01809
p1890
sg16
V1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine [drugbank:DB01809]
p1891
sa(dp1892
g4
Vunknown
p1893
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08764_4177
p1894
sg8
Vdrug-target interaction 4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE and Proto-oncogene tyrosine-protein kinase receptor ret [drugbank_resource:DB08764_4177]
p1895
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4177
p1896
sg14
Vhttp://bio2rdf.org/drugbank:DB08764
p1897
sg16
V4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE [drugbank:DB08764]
p1898
sasS'KLK6'
p1899
(lp1900
(dp1901
g4
Vunknown
p1902
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03127_2889
p1903
sg8
Vdrug-target interaction Benzamidine and Kallikrein-6 [drugbank_resource:DB03127_2889]
p1904
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2889
p1905
sg14
Vhttp://bio2rdf.org/drugbank:DB03127
p1906
sg16
VBenzamidine [drugbank:DB03127]
p1907
sasS'OAS1'
p1908
(lp1909
(dp1910
g4
Vunknown
p1911
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02987_7095
p1912
sg8
Vdrug-target interaction Cysteine-S-Acetamide and 2'-5'-oligoadenylate synthase 1 [drugbank_resource:DB02987_7095]
p1913
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7095
p1914
sg14
Vhttp://bio2rdf.org/drugbank:DB02987
p1915
sg16
VCysteine-S-Acetamide [drugbank:DB02987]
p1916
sasS'LY96'
p1917
(lp1918
(dp1919
g4
Vunknown
p1920
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02767_6527
p1921
sg8
Vdrug-target interaction 3-Hydroxy-Myristic Acid and Lymphocyte antigen 96 [drugbank_resource:DB02767_6527]
p1922
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6527
p1923
sg14
Vhttp://bio2rdf.org/drugbank:DB02767
p1924
sg16
V3-Hydroxy-Myristic Acid [drugbank:DB02767]
p1925
sa(dp1926
g4
Vunknown
p1927
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08231_6527
p1928
sg8
Vdrug-target interaction MYRISTIC ACID and Lymphocyte antigen 96 [drugbank_resource:DB08231_6527]
p1929
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6527
p1930
sg14
Vhttp://bio2rdf.org/drugbank:DB08231
p1931
sg16
VMYRISTIC ACID [drugbank:DB08231]
p1932
sasS'CXCL10'
p1933
(lp1934
(dp1935
g4
Vunknown
p1936
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04487_1209
p1937
sg8
Vdrug-target interaction N-Methylleucine and Small inducible cytokine B10 [drugbank_resource:DB04487_1209]
p1938
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1209
p1939
sg14
Vhttp://bio2rdf.org/drugbank:DB04487
p1940
sg16
VN-Methylleucine [drugbank:DB04487]
p1941
sasS'MDM2'
p1942
(lp1943
(dp1944
g4
Vunknown
p1945
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02872_1485
p1946
sg8
Vdrug-target interaction Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone and Ubiquitin-protein ligase E3 Mdm2 [drugbank_resource:DB02872_1485]
p1947
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1485
p1948
sg14
Vhttp://bio2rdf.org/drugbank:DB02872
p1949
sg16
VCis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone [drugbank:DB02872]
p1950
sa(dp1951
g4
Vunknown
p1952
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04144_1485
p1953
sg8
Vdrug-target interaction Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone and Ubiquitin-protein ligase E3 Mdm2 [drugbank_resource:DB04144_1485]
p1954
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1485
p1955
sg14
Vhttp://bio2rdf.org/drugbank:DB04144
p1956
sg16
VCis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone [drugbank:DB04144]
p1957
sasS'PIK3C3'
p1958
(lp1959
(dp1960
g4
Vunknown
p1961
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06836_6229
p1962
sg8
Vdrug-target interaction N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE and Phosphatidylinositol 3-kinase catalytic subunit type 3 [drugbank_resource:DB06836_6229]
p1963
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6229
p1964
sg14
Vhttp://bio2rdf.org/drugbank:DB06836
p1965
sg16
VN-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE [drugbank:DB06836]
p1966
sasS'FGFR2'
p1967
(lp1968
(dp1969
g4
Vyes
p1970
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00039_823
p1971
sg8
Vdrug-target interaction Palifermin and Fibroblast growth factor receptor 2 [drugbank_resource:DB00039_823]
p1972
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:823
p1973
sg14
Vhttp://bio2rdf.org/drugbank:DB00039
p1974
sg16
VPalifermin [drugbank:DB00039]
p1975
sa(dp1976
g4
Vyes
p1977
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01041_823
p1978
sg8
Vdrug-target interaction Thalidomide and Fibroblast growth factor receptor 2 [drugbank_resource:DB01041_823]
p1979
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:823
p1980
sg14
Vhttp://bio2rdf.org/drugbank:DB01041
p1981
sg16
VThalidomide [drugbank:DB01041]
p1982
sa(dp1983
g4
Vunknown
p1984
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02058_823
p1985
sg8
Vdrug-target interaction SU4984 and Fibroblast growth factor receptor 2 [drugbank_resource:DB02058_823]
p1986
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:823
p1987
sg14
Vhttp://bio2rdf.org/drugbank:DB02058
p1988
sg16
VSU4984 [drugbank:DB02058]
p1989
sa(dp1990
g4
Vunknown
p1991
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02491_823
p1992
sg8
Vdrug-target interaction 4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine and Fibroblast growth factor receptor 2 [drugbank_resource:DB02491_823]
p1993
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:823
p1994
sg14
Vhttp://bio2rdf.org/drugbank:DB02491
p1995
sg16
V4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine [drugbank:DB02491]
p1996
sasS'EPRS'
p1997
(lp1998
(dp1999
g4
Vunknown
p2000
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00142_210
p2001
sg8
Vdrug-target interaction L-Glutamic Acid and Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase [drugbank_resource:DB00142_210]
p2002
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:210
p2003
sg14
Vhttp://bio2rdf.org/drugbank:DB00142
p2004
sg16
VL-Glutamic Acid [drugbank:DB00142]
p2005
sa(dp2006
g4
Vunknown
p2007
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00172_210
p2008
sg8
Vdrug-target interaction L-Proline and Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase [drugbank_resource:DB00172_210]
p2009
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:210
p2010
sg14
Vhttp://bio2rdf.org/drugbank:DB00172
p2011
sg16
VL-Proline [drugbank:DB00172]
p2012
sa(dp2013
g4
Vunknown
p2014
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02510_210
p2015
sg8
Vdrug-target interaction '5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine and Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase [drugbank_resource:DB02510_210]
p2016
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:210
p2017
sg14
Vhttp://bio2rdf.org/drugbank:DB02510
p2018
sg16
V'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine [drugbank:DB02510]
p2019
sa(dp2020
g4
Vunknown
p2021
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02684_210
p2022
sg8
Vdrug-target interaction 5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine and Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase [drugbank_resource:DB02684_210]
p2023
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:210
p2024
sg14
Vhttp://bio2rdf.org/drugbank:DB02684
p2025
sg16
V5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine [drugbank:DB02684]
p2026
sa(dp2027
g4
Vunknown
p2028
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03376_210
p2029
sg8
Vdrug-target interaction '5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine and Bifunctional aminoacyl-tRNA synthetase [Includes: Glutamyl-tRNA synthetase [drugbank_resource:DB03376_210]
p2030
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:210
p2031
sg14
Vhttp://bio2rdf.org/drugbank:DB03376
p2032
sg16
V'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine [drugbank:DB03376]
p2033
sasS'CSNK2A1'
p2034
(lp2035
(dp2036
g4
Vunknown
p2037
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01765_2236
p2038
sg8
Vdrug-target interaction (5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid and Casein kinase II subunit alpha [drugbank_resource:DB01765_2236]
p2039
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2040
sg14
Vhttp://bio2rdf.org/drugbank:DB01765
p2041
sg16
V(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid [drugbank:DB01765]
p2042
sa(dp2043
g4
Vunknown
p2044
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02709_2236
p2045
sg8
Vdrug-target interaction Resveratrol and Casein kinase II subunit alpha [drugbank_resource:DB02709_2236]
p2046
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2047
sg14
Vhttp://bio2rdf.org/drugbank:DB02709
p2048
sg16
VResveratrol [drugbank:DB02709]
p2049
sa(dp2050
g4
Vunknown
p2051
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02170_2236
p2052
sg8
Vdrug-target interaction 1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One and Casein kinase II subunit alpha [drugbank_resource:DB02170_2236]
p2053
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2054
sg14
Vhttp://bio2rdf.org/drugbank:DB02170
p2055
sg16
V1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One [drugbank:DB02170]
p2056
sa(dp2057
g4
Vunknown
p2058
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03035_2236
p2059
sg8
Vdrug-target interaction 1,8-Di-Hydroxy-4-Nitro-Anthraquinone and Casein kinase II subunit alpha [drugbank_resource:DB03035_2236]
p2060
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2061
sg14
Vhttp://bio2rdf.org/drugbank:DB03035
p2062
sg16
V1,8-Di-Hydroxy-4-Nitro-Anthraquinone [drugbank:DB03035]
p2063
sa(dp2064
g4
Vunknown
p2065
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03127_2236
p2066
sg8
Vdrug-target interaction Benzamidine and Casein kinase II subunit alpha [drugbank_resource:DB03127_2236]
p2067
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2068
sg14
Vhttp://bio2rdf.org/drugbank:DB03127
p2069
sg16
VBenzamidine [drugbank:DB03127]
p2070
sa(dp2071
g4
Vunknown
p2072
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03924_2236
p2073
sg8
Vdrug-target interaction 5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone and Casein kinase II subunit alpha [drugbank_resource:DB03924_2236]
p2074
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2075
sg14
Vhttp://bio2rdf.org/drugbank:DB03924
p2076
sg16
V5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone [drugbank:DB03924]
p2077
sa(dp2078
g4
Vunknown
p2079
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04395_2236
p2080
sg8
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Casein kinase II subunit alpha [drugbank_resource:DB04395_2236]
p2081
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2082
sg14
Vhttp://bio2rdf.org/drugbank:DB04395
p2083
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p2084
sa(dp2085
g4
Vunknown
p2086
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04462_2236
p2087
sg8
Vdrug-target interaction Tetrabromo-2-Benzotriazole and Casein kinase II subunit alpha [drugbank_resource:DB04462_2236]
p2088
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2089
sg14
Vhttp://bio2rdf.org/drugbank:DB04462
p2090
sg16
VTetrabromo-2-Benzotriazole [drugbank:DB04462]
p2091
sa(dp2092
g4
Vunknown
p2093
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04719_2236
p2094
sg8
Vdrug-target interaction DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE and Casein kinase II subunit alpha [drugbank_resource:DB04719_2236]
p2095
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2096
sg14
Vhttp://bio2rdf.org/drugbank:DB04719
p2097
sg16
VDIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE [drugbank:DB04719]
p2098
sa(dp2099
g4
Vunknown
p2100
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04721_2236
p2101
sg8
Vdrug-target interaction N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE and Casein kinase II subunit alpha [drugbank_resource:DB04721_2236]
p2102
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2103
sg14
Vhttp://bio2rdf.org/drugbank:DB04721
p2104
sg16
VN1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE [drugbank:DB04721]
p2105
sa(dp2106
g4
Vunknown
p2107
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04720_2236
p2108
sg8
Vdrug-target interaction S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE and Casein kinase II subunit alpha [drugbank_resource:DB04720_2236]
p2109
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2110
sg14
Vhttp://bio2rdf.org/drugbank:DB04720
p2111
sg16
VS-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE [drugbank:DB04720]
p2112
sa(dp2113
g4
Vunknown
p2114
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07802_2236
p2115
sg8
Vdrug-target interaction 3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE and Casein kinase II subunit alpha [drugbank_resource:DB07802_2236]
p2116
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2117
sg14
Vhttp://bio2rdf.org/drugbank:DB07802
p2118
sg16
V3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE [drugbank:DB07802]
p2119
sa(dp2120
g4
Vunknown
p2121
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08354_2236
p2122
sg8
Vdrug-target interaction 2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE and Casein kinase II subunit alpha [drugbank_resource:DB08354_2236]
p2123
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2124
sg14
Vhttp://bio2rdf.org/drugbank:DB08354
p2125
sg16
V2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE [drugbank:DB08354]
p2126
sa(dp2127
g4
Vunknown
p2128
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08360_2236
p2129
sg8
Vdrug-target interaction 2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE and Casein kinase II subunit alpha [drugbank_resource:DB08360_2236]
p2130
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2131
sg14
Vhttp://bio2rdf.org/drugbank:DB08360
p2132
sg16
V2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE [drugbank:DB08360]
p2133
sa(dp2134
g4
Vunknown
p2135
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08362_2236
p2136
sg8
Vdrug-target interaction N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE and Casein kinase II subunit alpha [drugbank_resource:DB08362_2236]
p2137
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2138
sg14
Vhttp://bio2rdf.org/drugbank:DB08362
p2139
sg16
VN-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE [drugbank:DB08362]
p2140
sa(dp2141
g4
Vunknown
p2142
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07715_2236
p2143
sg8
Vdrug-target interaction 3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE and Casein kinase II subunit alpha [drugbank_resource:DB07715_2236]
p2144
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2145
sg14
Vhttp://bio2rdf.org/drugbank:DB07715
p2146
sg16
V3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE [drugbank:DB07715]
p2147
sa(dp2148
g4
Vunknown
p2149
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08340_2236
p2150
sg8
Vdrug-target interaction N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE and Casein kinase II subunit alpha [drugbank_resource:DB08340_2236]
p2151
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2152
sg14
Vhttp://bio2rdf.org/drugbank:DB08340
p2153
sg16
VN,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE [drugbank:DB08340]
p2154
sa(dp2155
g4
Vunknown
p2156
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08345_2236
p2157
sg8
Vdrug-target interaction 4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE and Casein kinase II subunit alpha [drugbank_resource:DB08345_2236]
p2158
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2159
sg14
Vhttp://bio2rdf.org/drugbank:DB08345
p2160
sg16
V4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE [drugbank:DB08345]
p2161
sa(dp2162
g4
Vunknown
p2163
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08468_2236
p2164
sg8
Vdrug-target interaction 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione and Casein kinase II subunit alpha [drugbank_resource:DB08468_2236]
p2165
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2166
sg14
Vhttp://bio2rdf.org/drugbank:DB08468
p2167
sg16
V2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione [drugbank:DB08468]
p2168
sa(dp2169
g4
Vunknown
p2170
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08473_2236
p2171
sg8
Vdrug-target interaction 5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole and Casein kinase II subunit alpha [drugbank_resource:DB08473_2236]
p2172
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2173
sg14
Vhttp://bio2rdf.org/drugbank:DB08473
p2174
sg16
V5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole [drugbank:DB08473]
p2175
sa(dp2176
g4
Vunknown
p2177
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08660_2236
p2178
sg8
Vdrug-target interaction 1,2,5,8-tetrahydroxyanthracene-9,10-dione and Casein kinase II subunit alpha [drugbank_resource:DB08660_2236]
p2179
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2180
sg14
Vhttp://bio2rdf.org/drugbank:DB08660
p2181
sg16
V1,2,5,8-tetrahydroxyanthracene-9,10-dione [drugbank:DB08660]
p2182
sa(dp2183
g4
Vunknown
p2184
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08338_2236
p2185
sg8
Vdrug-target interaction 19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one and Casein kinase II subunit alpha [drugbank_resource:DB08338_2236]
p2186
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2187
sg14
Vhttp://bio2rdf.org/drugbank:DB08338
p2188
sg16
V19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one [drugbank:DB08338]
p2189
sa(dp2190
g4
Vunknown
p2191
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08353_2236
p2192
sg8
Vdrug-target interaction 2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE and Casein kinase II subunit alpha [drugbank_resource:DB08353_2236]
p2193
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2236
p2194
sg14
Vhttp://bio2rdf.org/drugbank:DB08353
p2195
sg16
V2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE [drugbank:DB08353]
p2196
sasS'KCNJ6'
p2197
(lp2198
(dp2199
g4
Vunknown
p2200
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01159_1581
p2201
sg8
Vdrug-target interaction Halothane and G protein-activated inward rectifier potassium channel 2 [drugbank_resource:DB01159_1581]
p2202
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1581
p2203
sg14
Vhttp://bio2rdf.org/drugbank:DB01159
p2204
sg16
VHalothane [drugbank:DB01159]
p2205
sasS'ACCN1'
p2206
(lp2207
(dp2208
g4
Vunknown
p2209
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00594_749
p2210
sg8
Vdrug-target interaction Amiloride and Amiloride-sensitive cation channel 1, neuronal [drugbank_resource:DB00594_749]
p2211
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:749
p2212
sg14
Vhttp://bio2rdf.org/drugbank:DB00594
p2213
sg16
VAmiloride [drugbank:DB00594]
p2214
sasS'AR'
p2215
(lp2216
(dp2217
g4
Vunknown
p2218
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00421_146
p2219
sg8
Vdrug-target interaction Spironolactone and Androgen receptor [drugbank_resource:DB00421_146]
p2220
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2221
sg14
Vhttp://bio2rdf.org/drugbank:DB00421
p2222
sg16
VSpironolactone [drugbank:DB00421]
p2223
sa(dp2224
g4
Vyes
p2225
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00621_146
p2226
sg8
Vdrug-target interaction Oxandrolone and Androgen receptor [drugbank_resource:DB00621_146]
p2227
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2228
sg14
Vhttp://bio2rdf.org/drugbank:DB00621
p2229
sg16
VOxandrolone [drugbank:DB00621]
p2230
sa(dp2231
g4
Vunknown
p2232
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00367_146
p2233
sg8
Vdrug-target interaction Levonorgestrel and Androgen receptor [drugbank_resource:DB00367_146]
p2234
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2235
sg14
Vhttp://bio2rdf.org/drugbank:DB00367
p2236
sg16
VLevonorgestrel [drugbank:DB00367]
p2237
sa(dp2238
g4
Vyes
p2239
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00499_146
p2240
sg8
Vdrug-target interaction Flutamide and Androgen receptor [drugbank_resource:DB00499_146]
p2241
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2242
sg14
Vhttp://bio2rdf.org/drugbank:DB00499
p2243
sg16
VFlutamide [drugbank:DB00499]
p2244
sa(dp2245
g4
Vyes
p2246
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00624_146
p2247
sg8
Vdrug-target interaction Testosterone and Androgen receptor [drugbank_resource:DB00624_146]
p2248
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2249
sg14
Vhttp://bio2rdf.org/drugbank:DB00624
p2250
sg16
VTestosterone [drugbank:DB00624]
p2251
sa(dp2252
g4
Vunknown
p2253
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00687_146
p2254
sg8
Vdrug-target interaction Fludrocortisone and Androgen receptor [drugbank_resource:DB00687_146]
p2255
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2256
sg14
Vhttp://bio2rdf.org/drugbank:DB00687
p2257
sg16
VFludrocortisone [drugbank:DB00687]
p2258
sa(dp2259
g4
Vyes
p2260
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00984_146
p2261
sg8
Vdrug-target interaction Nandrolone phenpropionate and Androgen receptor [drugbank_resource:DB00984_146]
p2262
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2263
sg14
Vhttp://bio2rdf.org/drugbank:DB00984
p2264
sg16
VNandrolone phenpropionate [drugbank:DB00984]
p2265
sa(dp2266
g4
Vyes
p2267
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00665_146
p2268
sg8
Vdrug-target interaction Nilutamide and Androgen receptor [drugbank_resource:DB00665_146]
p2269
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2270
sg14
Vhttp://bio2rdf.org/drugbank:DB00665
p2271
sg16
VNilutamide [drugbank:DB00665]
p2272
sa(dp2273
g4
Vyes
p2274
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01128_146
p2275
sg8
Vdrug-target interaction Bicalutamide and Androgen receptor [drugbank_resource:DB01128_146]
p2276
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2277
sg14
Vhttp://bio2rdf.org/drugbank:DB01128
p2278
sg16
VBicalutamide [drugbank:DB01128]
p2279
sa(dp2280
g4
Vyes
p2281
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00858_146
p2282
sg8
Vdrug-target interaction Drostanolone and Androgen receptor [drugbank_resource:DB00858_146]
p2283
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2284
sg14
Vhttp://bio2rdf.org/drugbank:DB00858
p2285
sg16
VDrostanolone [drugbank:DB00858]
p2286
sa(dp2287
g4
Vyes
p2288
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01406_146
p2289
sg8
Vdrug-target interaction Danazol and Androgen receptor [drugbank_resource:DB01406_146]
p2290
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2291
sg14
Vhttp://bio2rdf.org/drugbank:DB01406
p2292
sg16
VDanazol [drugbank:DB01406]
p2293
sa(dp2294
g4
Vyes
p2295
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01185_146
p2296
sg8
Vdrug-target interaction Fluoxymesterone and Androgen receptor [drugbank_resource:DB01185_146]
p2297
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2298
sg14
Vhttp://bio2rdf.org/drugbank:DB01185
p2299
sg16
VFluoxymesterone [drugbank:DB01185]
p2300
sa(dp2301
g4
Vyes
p2302
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01420_146
p2303
sg8
Vdrug-target interaction Testosterone Propionate and Androgen receptor [drugbank_resource:DB01420_146]
p2304
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2305
sg14
Vhttp://bio2rdf.org/drugbank:DB01420
p2306
sg16
VTestosterone Propionate [drugbank:DB01420]
p2307
sa(dp2308
g4
Vyes
p2309
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01481_146
p2310
sg8
Vdrug-target interaction Delta1-dihydrotestosterone and Androgen receptor [drugbank_resource:DB01481_146]
p2311
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2312
sg14
Vhttp://bio2rdf.org/drugbank:DB01481
p2313
sg16
VDelta1-dihydrotestosterone [drugbank:DB01481]
p2314
sa(dp2315
g4
Vyes
p2316
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01395_146
p2317
sg8
Vdrug-target interaction Drospirenone and Androgen receptor [drugbank_resource:DB01395_146]
p2318
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2319
sg14
Vhttp://bio2rdf.org/drugbank:DB01395
p2320
sg16
VDrospirenone [drugbank:DB01395]
p2321
sa(dp2322
g4
Vyes
p2323
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01541_146
p2324
sg8
Vdrug-target interaction Boldenone and Androgen receptor [drugbank_resource:DB01541_146]
p2325
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2326
sg14
Vhttp://bio2rdf.org/drugbank:DB01541
p2327
sg16
VBoldenone [drugbank:DB01541]
p2328
sa(dp2329
g4
Vyes
p2330
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01564_146
p2331
sg8
Vdrug-target interaction Calusterone and Androgen receptor [drugbank_resource:DB01564_146]
p2332
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2333
sg14
Vhttp://bio2rdf.org/drugbank:DB01564
p2334
sg16
VCalusterone [drugbank:DB01564]
p2335
sa(dp2336
g4
Vunknown
p2337
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02266_146
p2338
sg8
Vdrug-target interaction Flufenamic Acid and Androgen receptor [drugbank_resource:DB02266_146]
p2339
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2340
sg14
Vhttp://bio2rdf.org/drugbank:DB02266
p2341
sg16
VFlufenamic Acid [drugbank:DB02266]
p2342
sa(dp2343
g4
Vunknown
p2344
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02932_146
p2345
sg8
Vdrug-target interaction (2r)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-3-[(4-Fluorophenyl)Sulfonyl]-2-Hydroxy-2-Methylpropanamide and Androgen receptor [drugbank_resource:DB02932_146]
p2346
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2347
sg14
Vhttp://bio2rdf.org/drugbank:DB02932
p2348
sg16
V(2r)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-3-[(4-Fluorophenyl)Sulfonyl]-2-Hydroxy-2-Methylpropanamide [drugbank:DB02932]
p2349
sa(dp2350
g4
Vunknown
p2351
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02998_146
p2352
sg8
Vdrug-target interaction Methyltrienolone and Androgen receptor [drugbank_resource:DB02998_146]
p2353
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2354
sg14
Vhttp://bio2rdf.org/drugbank:DB02998
p2355
sg16
VMethyltrienolone [drugbank:DB02998]
p2356
sa(dp2357
g4
Vunknown
p2358
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02901_146
p2359
sg8
Vdrug-target interaction Dihydrotestosterone and Androgen receptor [drugbank_resource:DB02901_146]
p2360
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2361
sg14
Vhttp://bio2rdf.org/drugbank:DB02901
p2362
sg16
VDihydrotestosterone [drugbank:DB02901]
p2363
sa(dp2364
g4
Vunknown
p2365
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07286_146
p2366
sg8
Vdrug-target interaction 2-CHLORO-4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-3-METHYLBENZONITRILE and Androgen receptor [drugbank_resource:DB07286_146]
p2367
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2368
sg14
Vhttp://bio2rdf.org/drugbank:DB07286
p2369
sg16
V2-CHLORO-4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-3-METHYLBENZONITRILE [drugbank:DB07286]
p2370
sa(dp2371
g4
Vyes
p2372
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06710_146
p2373
sg8
Vdrug-target interaction Methyltestosterone and Androgen receptor [drugbank_resource:DB06710_146]
p2374
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2375
sg14
Vhttp://bio2rdf.org/drugbank:DB06710
p2376
sg16
VMethyltestosterone [drugbank:DB06710]
p2377
sa(dp2378
g4
Vunknown
p2379
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07419_146
p2380
sg8
Vdrug-target interaction (2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide and Androgen receptor [drugbank_resource:DB07419_146]
p2381
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2382
sg14
Vhttp://bio2rdf.org/drugbank:DB07419
p2383
sg16
V(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide [drugbank:DB07419]
p2384
sa(dp2385
g4
Vunknown
p2386
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04709_146
p2387
sg8
Vdrug-target interaction (3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE and Androgen receptor [drugbank_resource:DB04709_146]
p2388
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2389
sg14
Vhttp://bio2rdf.org/drugbank:DB04709
p2390
sg16
V(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE [drugbank:DB04709]
p2391
sa(dp2392
g4
Vyes
p2393
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04839_146
p2394
sg8
Vdrug-target interaction Cyproterone and Androgen receptor [drugbank_resource:DB04839_146]
p2395
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2396
sg14
Vhttp://bio2rdf.org/drugbank:DB04839
p2397
sg16
VCyproterone [drugbank:DB04839]
p2398
sa(dp2399
g4
Vunknown
p2400
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06870_146
p2401
sg8
Vdrug-target interaction 17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE and Androgen receptor [drugbank_resource:DB06870_146]
p2402
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2403
sg14
Vhttp://bio2rdf.org/drugbank:DB06870
p2404
sg16
V17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE [drugbank:DB06870]
p2405
sa(dp2406
g4
Vunknown
p2407
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07039_146
p2408
sg8
Vdrug-target interaction (2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and Androgen receptor [drugbank_resource:DB07039_146]
p2409
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2410
sg14
Vhttp://bio2rdf.org/drugbank:DB07039
p2411
sg16
V(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide [drugbank:DB07039]
p2412
sa(dp2413
g4
Vunknown
p2414
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07422_146
p2415
sg8
Vdrug-target interaction (2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide and Androgen receptor [drugbank_resource:DB07422_146]
p2416
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2417
sg14
Vhttp://bio2rdf.org/drugbank:DB07422
p2418
sg16
V(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide [drugbank:DB07422]
p2419
sa(dp2420
g4
Vunknown
p2421
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07454_146
p2422
sg8
Vdrug-target interaction (R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE and Androgen receptor [drugbank_resource:DB07454_146]
p2423
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2424
sg14
Vhttp://bio2rdf.org/drugbank:DB07454
p2425
sg16
V(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE [drugbank:DB07454]
p2426
sa(dp2427
g4
Vunknown
p2428
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07421_146
p2429
sg8
Vdrug-target interaction 4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile and Androgen receptor [drugbank_resource:DB07421_146]
p2430
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2431
sg14
Vhttp://bio2rdf.org/drugbank:DB07421
p2432
sg16
V4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile [drugbank:DB07421]
p2433
sa(dp2434
g4
Vunknown
p2435
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07423_146
p2436
sg8
Vdrug-target interaction (2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide and Androgen receptor [drugbank_resource:DB07423_146]
p2437
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2438
sg14
Vhttp://bio2rdf.org/drugbank:DB07423
p2439
sg16
V(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide [drugbank:DB07423]
p2440
sa(dp2441
g4
Vunknown
p2442
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07769_146
p2443
sg8
Vdrug-target interaction S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE and Androgen receptor [drugbank_resource:DB07769_146]
p2444
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2445
sg14
Vhttp://bio2rdf.org/drugbank:DB07769
p2446
sg16
VS-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE [drugbank:DB07769]
p2447
sa(dp2448
g4
Vunknown
p2449
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08035_146
p2450
sg8
Vdrug-target interaction 1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE and Androgen receptor [drugbank_resource:DB08035_146]
p2451
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2452
sg14
Vhttp://bio2rdf.org/drugbank:DB08035
p2453
sg16
V1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE [drugbank:DB08035]
p2454
sa(dp2455
g4
Vunknown
p2456
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08089_146
p2457
sg8
Vdrug-target interaction 6-[BIS(2,2,2-TRIFLUOROETHYL)AMINO]-4-(TRIFLUOROMETHYL)QUINOLIN-2(1H)-ONE and Androgen receptor [drugbank_resource:DB08089_146]
p2458
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2459
sg14
Vhttp://bio2rdf.org/drugbank:DB08089
p2460
sg16
V6-[BIS(2,2,2-TRIFLUOROETHYL)AMINO]-4-(TRIFLUOROMETHYL)QUINOLIN-2(1H)-ONE [drugbank:DB08089]
p2461
sa(dp2462
g4
Vunknown
p2463
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07717_146
p2464
sg8
Vdrug-target interaction (5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE and Androgen receptor [drugbank_resource:DB07717_146]
p2465
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2466
sg14
Vhttp://bio2rdf.org/drugbank:DB07717
p2467
sg16
V(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE [drugbank:DB07717]
p2468
sa(dp2469
g4
Vunknown
p2470
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08087_146
p2471
sg8
Vdrug-target interaction 4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE and Androgen receptor [drugbank_resource:DB08087_146]
p2472
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2473
sg14
Vhttp://bio2rdf.org/drugbank:DB08087
p2474
sg16
V4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE [drugbank:DB08087]
p2475
sa(dp2476
g4
Vunknown
p2477
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08088_146
p2478
sg8
Vdrug-target interaction 2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile and Androgen receptor [drugbank_resource:DB08088_146]
p2479
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2480
sg14
Vhttp://bio2rdf.org/drugbank:DB08088
p2481
sg16
V2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile [drugbank:DB08088]
p2482
sa(dp2483
g4
Vunknown
p2484
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08461_146
p2485
sg8
Vdrug-target interaction 3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL and Androgen receptor [drugbank_resource:DB08461_146]
p2486
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2487
sg14
Vhttp://bio2rdf.org/drugbank:DB08461
p2488
sg16
V3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL [drugbank:DB08461]
p2489
sa(dp2490
g4
Vyes
p2491
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08804_146
p2492
sg8
Vdrug-target interaction Nandrolone decanoate and Androgen receptor [drugbank_resource:DB08804_146]
p2493
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:146
p2494
sg14
Vhttp://bio2rdf.org/drugbank:DB08804
p2495
sg16
VNandrolone decanoate [drugbank:DB08804]
p2496
sasS'KCNMB4'
p2497
(lp2498
(dp2499
g4
Vunknown
p2500
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01110_6933
p2501
sg8
Vdrug-target interaction Miconazole and Calcium-activated potassium channel subunit beta-4 [drugbank_resource:DB01110_6933]
p2502
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6933
p2503
sg14
Vhttp://bio2rdf.org/drugbank:DB01110
p2504
sg16
VMiconazole [drugbank:DB01110]
p2505
sasS'PLD2'
p2506
(lp2507
(dp2508
g4
Vunknown
p2509
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00122_3922
p2510
sg8
Vdrug-target interaction Choline and Phospholipase D2 [drugbank_resource:DB00122_3922]
p2511
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3922
p2512
sg14
Vhttp://bio2rdf.org/drugbank:DB00122
p2513
sg16
VCholine [drugbank:DB00122]
p2514
sasS'PPP2CA'
p2515
(lp2516
(dp2517
g4
Vunknown
p2518
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00163_4078
p2519
sg8
Vdrug-target interaction Vitamin E and Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform [drugbank_resource:DB00163_4078]
p2520
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4078
p2521
sg14
Vhttp://bio2rdf.org/drugbank:DB00163
p2522
sg16
VVitamin E [drugbank:DB00163]
p2523
sa(dp2524
g4
Vunknown
p2525
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02506_4078
p2526
sg8
Vdrug-target interaction 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid and Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform [drugbank_resource:DB02506_4078]
p2527
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4078
p2528
sg14
Vhttp://bio2rdf.org/drugbank:DB02506
p2529
sg16
V2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid [drugbank:DB02506]
p2530
sa(dp2531
g4
Vunknown
p2532
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06905_4078
p2533
sg8
Vdrug-target interaction (2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid and Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform [drugbank_resource:DB06905_4078]
p2534
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4078
p2535
sg14
Vhttp://bio2rdf.org/drugbank:DB06905
p2536
sg16
V(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid [drugbank:DB06905]
p2537
sasS'APP'
p2538
(lp2539
(dp2540
g4
Vunknown
p2541
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02235_5800
p2542
sg8
Vdrug-target interaction Methionine Sulfoxide and Amyloid beta A4 protein [drugbank_resource:DB02235_5800]
p2543
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5800
p2544
sg14
Vhttp://bio2rdf.org/drugbank:DB02235
p2545
sg16
VMethionine Sulfoxide [drugbank:DB02235]
p2546
sasS'ITPKA'
p2547
(lp2548
(dp2549
g4
Vunknown
p2550
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01863_2950
p2551
sg8
Vdrug-target interaction Inositol 1,3,4,5-Tetrakisphosphate and Inositol-trisphosphate 3-kinase A [drugbank_resource:DB01863_2950]
p2552
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2950
p2553
sg14
Vhttp://bio2rdf.org/drugbank:DB01863
p2554
sg16
VInositol 1,3,4,5-Tetrakisphosphate [drugbank:DB01863]
p2555
sa(dp2556
g4
Vunknown
p2557
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03401_2950
p2558
sg8
Vdrug-target interaction D-Myo-Inositol-1,4,5-Triphosphate and Inositol-trisphosphate 3-kinase A [drugbank_resource:DB03401_2950]
p2559
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2950
p2560
sg14
Vhttp://bio2rdf.org/drugbank:DB03401
p2561
sg16
VD-Myo-Inositol-1,4,5-Triphosphate [drugbank:DB03401]
p2562
sa(dp2563
g4
Vunknown
p2564
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04395_2950
p2565
sg8
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Inositol-trisphosphate 3-kinase A [drugbank_resource:DB04395_2950]
p2566
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2950
p2567
sg14
Vhttp://bio2rdf.org/drugbank:DB04395
p2568
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p2569
sa(dp2570
g4
Vunknown
p2571
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03431_2950
p2572
sg8
Vdrug-target interaction Adenosine-5'-Diphosphate and Inositol-trisphosphate 3-kinase A [drugbank_resource:DB03431_2950]
p2573
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2950
p2574
sg14
Vhttp://bio2rdf.org/drugbank:DB03431
p2575
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p2576
sasS'KAT5'
p2577
(lp2578
(dp2579
g4
Vunknown
p2580
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02039_7088
p2581
sg8
Vdrug-target interaction S-Acetyl-Cysteine and Histone acetyltransferase KAT5 [drugbank_resource:DB02039_7088]
p2582
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7088
p2583
sg14
Vhttp://bio2rdf.org/drugbank:DB02039
p2584
sg16
VS-Acetyl-Cysteine [drugbank:DB02039]
p2585
sa(dp2586
g4
Vunknown
p2587
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01992_7088
p2588
sg8
Vdrug-target interaction Coenzyme A and Histone acetyltransferase KAT5 [drugbank_resource:DB01992_7088]
p2589
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7088
p2590
sg14
Vhttp://bio2rdf.org/drugbank:DB01992
p2591
sg16
VCoenzyme A [drugbank:DB01992]
p2592
sasS'GSK3B'
p2593
(lp2594
(dp2595
g4
Vunknown
p2596
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01356_1721
p2597
sg8
Vdrug-target interaction Lithium and Glycogen synthase kinase-3 beta [drugbank_resource:DB01356_1721]
p2598
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2599
sg14
Vhttp://bio2rdf.org/drugbank:DB01356
p2600
sg16
VLithium [drugbank:DB01356]
p2601
sa(dp2602
g4
Vunknown
p2603
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01950_1721
p2604
sg8
Vdrug-target interaction N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea and Glycogen synthase kinase-3 beta [drugbank_resource:DB01950_1721]
p2605
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2606
sg14
Vhttp://bio2rdf.org/drugbank:DB01950
p2607
sg16
VN-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea [drugbank:DB01950]
p2608
sa(dp2609
g4
Vunknown
p2610
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01793_1721
p2611
sg8
Vdrug-target interaction I-5 and Glycogen synthase kinase-3 beta [drugbank_resource:DB01793_1721]
p2612
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2613
sg14
Vhttp://bio2rdf.org/drugbank:DB01793
p2614
sg16
VI-5 [drugbank:DB01793]
p2615
sa(dp2616
g4
Vunknown
p2617
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02010_1721
p2618
sg8
Vdrug-target interaction Staurosporine and Glycogen synthase kinase-3 beta [drugbank_resource:DB02010_1721]
p2619
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2620
sg14
Vhttp://bio2rdf.org/drugbank:DB02010
p2621
sg16
VStaurosporine [drugbank:DB02010]
p2622
sa(dp2623
g4
Vunknown
p2624
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01772_1721
p2625
sg8
Vdrug-target interaction 3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione and Glycogen synthase kinase-3 beta [drugbank_resource:DB01772_1721]
p2626
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2627
sg14
Vhttp://bio2rdf.org/drugbank:DB01772
p2628
sg16
V3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione [drugbank:DB01772]
p2629
sa(dp2630
g4
Vunknown
p2631
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02052_1721
p2632
sg8
Vdrug-target interaction Indirubin-3'-Monoxime and Glycogen synthase kinase-3 beta [drugbank_resource:DB02052_1721]
p2633
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2634
sg14
Vhttp://bio2rdf.org/drugbank:DB02052
p2635
sg16
VIndirubin-3'-Monoxime [drugbank:DB02052]
p2636
sa(dp2637
g4
Vunknown
p2638
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03444_1721
p2639
sg8
Vdrug-target interaction (3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime and Glycogen synthase kinase-3 beta [drugbank_resource:DB03444_1721]
p2640
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2641
sg14
Vhttp://bio2rdf.org/drugbank:DB03444
p2642
sg16
V(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime [drugbank:DB03444]
p2643
sa(dp2644
g4
Vunknown
p2645
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03431_1721
p2646
sg8
Vdrug-target interaction Adenosine-5'-Diphosphate and Glycogen synthase kinase-3 beta [drugbank_resource:DB03431_1721]
p2647
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2648
sg14
Vhttp://bio2rdf.org/drugbank:DB03431
p2649
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p2650
sa(dp2651
g4
Vunknown
p2652
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04014_1721
p2653
sg8
Vdrug-target interaction Alsterpaullone and Glycogen synthase kinase-3 beta [drugbank_resource:DB04014_1721]
p2654
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2655
sg14
Vhttp://bio2rdf.org/drugbank:DB04014
p2656
sg16
VAlsterpaullone [drugbank:DB04014]
p2657
sa(dp2658
g4
Vunknown
p2659
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04395_1721
p2660
sg8
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Glycogen synthase kinase-3 beta [drugbank_resource:DB04395_1721]
p2661
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2662
sg14
Vhttp://bio2rdf.org/drugbank:DB04395
p2663
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p2664
sa(dp2665
g4
Vunknown
p2666
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07149_1721
p2667
sg8
Vdrug-target interaction (7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one and Glycogen synthase kinase-3 beta [drugbank_resource:DB07149_1721]
p2668
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2669
sg14
Vhttp://bio2rdf.org/drugbank:DB07149
p2670
sg16
V(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one [drugbank:DB07149]
p2671
sa(dp2672
g4
Vunknown
p2673
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07058_1721
p2674
sg8
Vdrug-target interaction 5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione and Glycogen synthase kinase-3 beta [drugbank_resource:DB07058_1721]
p2675
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2676
sg14
Vhttp://bio2rdf.org/drugbank:DB07058
p2677
sg16
V5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione [drugbank:DB07058]
p2678
sa(dp2679
g4
Vunknown
p2680
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07014_1721
p2681
sg8
Vdrug-target interaction 2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole and Glycogen synthase kinase-3 beta [drugbank_resource:DB07014_1721]
p2682
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2683
sg14
Vhttp://bio2rdf.org/drugbank:DB07014
p2684
sg16
V2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole [drugbank:DB07014]
p2685
sa(dp2686
g4
Vunknown
p2687
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07584_1721
p2688
sg8
Vdrug-target interaction N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine and Glycogen synthase kinase-3 beta [drugbank_resource:DB07584_1721]
p2689
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2690
sg14
Vhttp://bio2rdf.org/drugbank:DB07584
p2691
sg16
VN-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine [drugbank:DB07584]
p2692
sa(dp2693
g4
Vunknown
p2694
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07585_1721
p2695
sg8
Vdrug-target interaction 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and Glycogen synthase kinase-3 beta [drugbank_resource:DB07585_1721]
p2696
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2697
sg14
Vhttp://bio2rdf.org/drugbank:DB07585
p2698
sg16
V5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine [drugbank:DB07585]
p2699
sa(dp2700
g4
Vunknown
p2701
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08073_1721
p2702
sg8
Vdrug-target interaction (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE and Glycogen synthase kinase-3 beta [drugbank_resource:DB08073_1721]
p2703
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2704
sg14
Vhttp://bio2rdf.org/drugbank:DB08073
p2705
sg16
V(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE [drugbank:DB08073]
p2706
sa(dp2707
g4
Vunknown
p2708
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07859_1721
p2709
sg8
Vdrug-target interaction 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE and Glycogen synthase kinase-3 beta [drugbank_resource:DB07859_1721]
p2710
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2711
sg14
Vhttp://bio2rdf.org/drugbank:DB07859
p2712
sg16
V4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE [drugbank:DB07859]
p2713
sa(dp2714
g4
Vunknown
p2715
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07676_1721
p2716
sg8
Vdrug-target interaction 3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one and Glycogen synthase kinase-3 beta [drugbank_resource:DB07676_1721]
p2717
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2718
sg14
Vhttp://bio2rdf.org/drugbank:DB07676
p2719
sg16
V3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one [drugbank:DB07676]
p2720
sa(dp2721
g4
Vunknown
p2722
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07812_1721
p2723
sg8
Vdrug-target interaction N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide and Glycogen synthase kinase-3 beta [drugbank_resource:DB07812_1721]
p2724
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2725
sg14
Vhttp://bio2rdf.org/drugbank:DB07812
p2726
sg16
VN-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide [drugbank:DB07812]
p2727
sa(dp2728
g4
Vunknown
p2729
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07947_1721
p2730
sg8
Vdrug-target interaction ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE and Glycogen synthase kinase-3 beta [drugbank_resource:DB07947_1721]
p2731
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1721
p2732
sg14
Vhttp://bio2rdf.org/drugbank:DB07947
p2733
sg16
VISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE [drugbank:DB07947]
p2734
sasS'TLR2'
p2735
(lp2736
(dp2737
g4
Vyes
p2738
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00045_2090
p2739
sg8
Vdrug-target interaction OspA lipoprotein and Toll-like receptor 2 [drugbank_resource:DB00045_2090]
p2740
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2090
p2741
sg14
Vhttp://bio2rdf.org/drugbank:DB00045
p2742
sg16
VOspA lipoprotein [drugbank:DB00045]
p2743
sa(dp2744
g4
Vunknown
p2745
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03963_2090
p2746
sg8
Vdrug-target interaction S-(Dimethylarsenic)Cysteine and Toll-like receptor 2 [drugbank_resource:DB03963_2090]
p2747
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2090
p2748
sg14
Vhttp://bio2rdf.org/drugbank:DB03963
p2749
sg16
VS-(Dimethylarsenic)Cysteine [drugbank:DB03963]
p2750
sasS'F2R'
p2751
(lp2752
(dp2753
g4
Vunknown
p2754
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00086_1193
p2755
sg8
Vdrug-target interaction Streptokinase and Proteinase-activated receptor 1 [drugbank_resource:DB00086_1193]
p2756
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1193
p2757
sg14
Vhttp://bio2rdf.org/drugbank:DB00086
p2758
sg16
VStreptokinase [drugbank:DB00086]
p2759
sasS'GRB2'
p2760
(lp2761
(dp2762
g4
Vunknown
p2763
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00061_1157
p2764
sg8
Vdrug-target interaction Pegademase bovine and Growth factor receptor-bound protein 2 [drugbank_resource:DB00061_1157]
p2765
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1157
p2766
sg14
Vhttp://bio2rdf.org/drugbank:DB00061
p2767
sg16
VPegademase bovine [drugbank:DB00061]
p2768
sa(dp2769
g4
Vunknown
p2770
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03276_1157
p2771
sg8
Vdrug-target interaction 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid and Growth factor receptor-bound protein 2 [drugbank_resource:DB03276_1157]
p2772
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1157
p2773
sg14
Vhttp://bio2rdf.org/drugbank:DB03276
p2774
sg16
V4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid [drugbank:DB03276]
p2775
sasS'NPY'
p2776
(lp2777
(dp2778
g4
Vunknown
p2779
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02952_5925
p2780
sg8
Vdrug-target interaction Alpha-Aminoisobutyric Acid and Neuropeptide Y [drugbank_resource:DB02952_5925]
p2781
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5925
p2782
sg14
Vhttp://bio2rdf.org/drugbank:DB02952
p2783
sg16
VAlpha-Aminoisobutyric Acid [drugbank:DB02952]
p2784
sa(dp2785
g4
Vunknown
p2786
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03380_5925
p2787
sg8
Vdrug-target interaction L-Tyrosinamide and Neuropeptide Y [drugbank_resource:DB03380_5925]
p2788
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5925
p2789
sg14
Vhttp://bio2rdf.org/drugbank:DB03380
p2790
sg16
VL-Tyrosinamide [drugbank:DB03380]
p2791
sasS'PLEKHA1'
p2792
(lp2793
(dp2794
g4
Vunknown
p2795
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04272_5586
p2796
sg8
Vdrug-target interaction Citric Acid and Pleckstrin homology domain-containing family A member 1 [drugbank_resource:DB04272_5586]
p2797
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5586
p2798
sg14
Vhttp://bio2rdf.org/drugbank:DB04272
p2799
sg16
VCitric Acid [drugbank:DB04272]
p2800
sasS'UBC'
p2801
(lp2802
(dp2803
g4
Vunknown
p2804
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04464_6590
p2805
sg8
Vdrug-target interaction N-Formylmethionine and Polyubiquitin-C [drugbank_resource:DB04464_6590]
p2806
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6590
p2807
sg14
Vhttp://bio2rdf.org/drugbank:DB04464
p2808
sg16
VN-Formylmethionine [drugbank:DB04464]
p2809
sasS'GRM3'
p2810
(lp2811
(dp2812
g4
Vunknown
p2813
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00659_4096
p2814
sg8
Vdrug-target interaction Acamprosate and Metabotropic glutamate receptor 3 [drugbank_resource:DB00659_4096]
p2815
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4096
p2816
sg14
Vhttp://bio2rdf.org/drugbank:DB00659
p2817
sg16
VAcamprosate [drugbank:DB00659]
p2818
sasS'SCN3A'
p2819
(lp2820
(dp2821
g4
Vyes
p2822
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00909_3803
p2823
sg8
Vdrug-target interaction Zonisamide and Sodium channel protein type 3 subunit alpha [drugbank_resource:DB00909_3803]
p2824
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3803
p2825
sg14
Vhttp://bio2rdf.org/drugbank:DB00909
p2826
sg16
VZonisamide [drugbank:DB00909]
p2827
sasS'SCN3B'
p2828
(lp2829
(dp2830
g4
Vyes
p2831
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00909_6134
p2832
sg8
Vdrug-target interaction Zonisamide and Sodium channel subunit beta-3 [drugbank_resource:DB00909_6134]
p2833
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6134
p2834
sg14
Vhttp://bio2rdf.org/drugbank:DB00909
p2835
sg16
VZonisamide [drugbank:DB00909]
p2836
sasS'CCR5'
p2837
(lp2838
(dp2839
g4
Vyes
p2840
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04835_1129
p2841
sg8
Vdrug-target interaction Maraviroc and C-C chemokine receptor type 5 [drugbank_resource:DB04835_1129]
p2842
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1129
p2843
sg14
Vhttp://bio2rdf.org/drugbank:DB04835
p2844
sg16
VMaraviroc [drugbank:DB04835]
p2845
sasS'CCL2'
p2846
(lp2847
(dp2848
g4
Vyes
p2849
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01055_1649
p2850
sg8
Vdrug-target interaction Mimosine and Small inducible cytokine A2 [drugbank_resource:DB01055_1649]
p2851
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1649
p2852
sg14
Vhttp://bio2rdf.org/drugbank:DB01055
p2853
sg16
VMimosine [drugbank:DB01055]
p2854
sa(dp2855
g4
Vunknown
p2856
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01406_1649
p2857
sg8
Vdrug-target interaction Danazol and Small inducible cytokine A2 [drugbank_resource:DB01406_1649]
p2858
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1649
p2859
sg14
Vhttp://bio2rdf.org/drugbank:DB01406
p2860
sg16
VDanazol [drugbank:DB01406]
p2861
sasS'ITGB1'
p2862
(lp2863
(dp2864
g4
Vyes
p2865
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00098_6065
p2866
sg8
Vdrug-target interaction Antithymocyte globulin and Integrin beta-1 [drugbank_resource:DB00098_6065]
p2867
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6065
p2868
sg14
Vhttp://bio2rdf.org/drugbank:DB00098
p2869
sg16
VAntithymocyte globulin [drugbank:DB00098]
p2870
sasS'GABBR1'
p2871
(lp2872
(dp2873
g4
Vyes
p2874
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00181_240
p2875
sg8
Vdrug-target interaction Baclofen and Gamma-aminobutyric acid type B receptor, subunit 1 [drugbank_resource:DB00181_240]
p2876
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:240
p2877
sg14
Vhttp://bio2rdf.org/drugbank:DB00181
p2878
sg16
VBaclofen [drugbank:DB00181]
p2879
sa(dp2880
g4
Vyes
p2881
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01080_240
p2882
sg8
Vdrug-target interaction Vigabatrin and Gamma-aminobutyric acid type B receptor, subunit 1 [drugbank_resource:DB01080_240]
p2883
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:240
p2884
sg14
Vhttp://bio2rdf.org/drugbank:DB01080
p2885
sg16
VVigabatrin [drugbank:DB01080]
p2886
sa(dp2887
g4
Vyes
p2888
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00837_240
p2889
sg8
Vdrug-target interaction Progabide and Gamma-aminobutyric acid type B receptor, subunit 1 [drugbank_resource:DB00837_240]
p2890
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:240
p2891
sg14
Vhttp://bio2rdf.org/drugbank:DB00837
p2892
sg16
VProgabide [drugbank:DB00837]
p2893
sasS'ACTA1'
p2894
(lp2895
(dp2896
g4
Vunknown
p2897
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02621_3822
p2898
sg8
Vdrug-target interaction Latrunculin A and Actin, alpha skeletal muscle [drugbank_resource:DB02621_3822]
p2899
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3822
p2900
sg14
Vhttp://bio2rdf.org/drugbank:DB02621
p2901
sg16
VLatrunculin A [drugbank:DB02621]
p2902
sa(dp2903
g4
Vunknown
p2904
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02772_3822
p2905
sg8
Vdrug-target interaction Sucrose and Actin, alpha skeletal muscle [drugbank_resource:DB02772_3822]
p2906
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3822
p2907
sg14
Vhttp://bio2rdf.org/drugbank:DB02772
p2908
sg16
VSucrose [drugbank:DB02772]
p2909
sa(dp2910
g4
Vunknown
p2911
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03021_3822
p2912
sg8
Vdrug-target interaction Ulapualide A and Actin, alpha skeletal muscle [drugbank_resource:DB03021_3822]
p2913
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3822
p2914
sg14
Vhttp://bio2rdf.org/drugbank:DB03021
p2915
sg16
VUlapualide A [drugbank:DB03021]
p2916
sa(dp2917
g4
Vunknown
p2918
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03850_3822
p2919
sg8
Vdrug-target interaction Jaspisamide A and Actin, alpha skeletal muscle [drugbank_resource:DB03850_3822]
p2920
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3822
p2921
sg14
Vhttp://bio2rdf.org/drugbank:DB03850
p2922
sg16
VJaspisamide A [drugbank:DB03850]
p2923
sa(dp2924
g4
Vunknown
p2925
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03616_3822
p2926
sg8
Vdrug-target interaction Kabiramide C and Actin, alpha skeletal muscle [drugbank_resource:DB03616_3822]
p2927
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3822
p2928
sg14
Vhttp://bio2rdf.org/drugbank:DB03616
p2929
sg16
VKabiramide C [drugbank:DB03616]
p2930
sa(dp2931
g4
Vunknown
p2932
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03431_3822
p2933
sg8
Vdrug-target interaction Adenosine-5'-Diphosphate and Actin, alpha skeletal muscle [drugbank_resource:DB03431_3822]
p2934
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3822
p2935
sg14
Vhttp://bio2rdf.org/drugbank:DB03431
p2936
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p2937
sa(dp2938
g4
Vunknown
p2939
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03903_3822
p2940
sg8
Vdrug-target interaction Tmr and Actin, alpha skeletal muscle [drugbank_resource:DB03903_3822]
p2941
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3822
p2942
sg14
Vhttp://bio2rdf.org/drugbank:DB03903
p2943
sg16
VTmr [drugbank:DB03903]
p2944
sa(dp2945
g4
Vunknown
p2946
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04151_3822
p2947
sg8
Vdrug-target interaction 4-Methyl-Histidine and Actin, alpha skeletal muscle [drugbank_resource:DB04151_3822]
p2948
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3822
p2949
sg14
Vhttp://bio2rdf.org/drugbank:DB04151
p2950
sg16
V4-Methyl-Histidine [drugbank:DB04151]
p2951
sa(dp2952
g4
Vunknown
p2953
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04395_3822
p2954
sg8
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Actin, alpha skeletal muscle [drugbank_resource:DB04395_3822]
p2955
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3822
p2956
sg14
Vhttp://bio2rdf.org/drugbank:DB04395
p2957
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p2958
sa(dp2959
g4
Vunknown
p2960
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04629_3822
p2961
sg8
Vdrug-target interaction Aplyronine A and Actin, alpha skeletal muscle [drugbank_resource:DB04629_3822]
p2962
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3822
p2963
sg14
Vhttp://bio2rdf.org/drugbank:DB04629
p2964
sg16
VAplyronine A [drugbank:DB04629]
p2965
sa(dp2966
g4
Vunknown
p2967
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04774_3822
p2968
sg8
Vdrug-target interaction Reidispongiolide A and Actin, alpha skeletal muscle [drugbank_resource:DB04774_3822]
p2969
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3822
p2970
sg14
Vhttp://bio2rdf.org/drugbank:DB04774
p2971
sg16
VReidispongiolide A [drugbank:DB04774]
p2972
sa(dp2973
g4
Vunknown
p2974
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04775_3822
p2975
sg8
Vdrug-target interaction Reidispongiolide C and Actin, alpha skeletal muscle [drugbank_resource:DB04775_3822]
p2976
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3822
p2977
sg14
Vhttp://bio2rdf.org/drugbank:DB04775
p2978
sg16
VReidispongiolide C [drugbank:DB04775]
p2979
sa(dp2980
g4
Vunknown
p2981
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04783_3822
p2982
sg8
Vdrug-target interaction Sphinxolide B and Actin, alpha skeletal muscle [drugbank_resource:DB04783_3822]
p2983
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3822
p2984
sg14
Vhttp://bio2rdf.org/drugbank:DB04783
p2985
sg16
VSphinxolide B [drugbank:DB04783]
p2986
sa(dp2987
g4
Vunknown
p2988
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08080_3822
p2989
sg8
Vdrug-target interaction LATRUNCULIN B and Actin, alpha skeletal muscle [drugbank_resource:DB08080_3822]
p2990
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3822
p2991
sg14
Vhttp://bio2rdf.org/drugbank:DB08080
p2992
sg16
VLATRUNCULIN B [drugbank:DB08080]
p2993
sasS'ATP6V1A'
p2994
(lp2995
(dp2996
g4
Vunknown
p2997
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00630_6057
p2998
sg8
Vdrug-target interaction Alendronate and V-type proton ATPase catalytic subunit A [drugbank_resource:DB00630_6057]
p2999
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6057
p3000
sg14
Vhttp://bio2rdf.org/drugbank:DB00630
p3001
sg16
VAlendronate [drugbank:DB00630]
p3002
sa(dp3003
g4
Vunknown
p3004
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01077_6057
p3005
sg8
Vdrug-target interaction Etidronic acid and V-type proton ATPase catalytic subunit A [drugbank_resource:DB01077_6057]
p3006
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6057
p3007
sg14
Vhttp://bio2rdf.org/drugbank:DB01077
p3008
sg16
VEtidronic acid [drugbank:DB01077]
p3009
sa(dp3010
g4
Vunknown
p3011
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01133_6057
p3012
sg8
Vdrug-target interaction Tiludronate and V-type proton ATPase catalytic subunit A [drugbank_resource:DB01133_6057]
p3013
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6057
p3014
sg14
Vhttp://bio2rdf.org/drugbank:DB01133
p3015
sg16
VTiludronate [drugbank:DB01133]
p3016
sa(dp3017
g4
Vyes
p3018
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06733_6057
p3019
sg8
Vdrug-target interaction Bafilomycin A1 and V-type proton ATPase catalytic subunit A [drugbank_resource:DB06733_6057]
p3020
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6057
p3021
sg14
Vhttp://bio2rdf.org/drugbank:DB06733
p3022
sg16
VBafilomycin A1 [drugbank:DB06733]
p3023
sa(dp3024
g4
Vyes
p3025
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06734_6057
p3026
sg8
Vdrug-target interaction Bafilomycin B1 and V-type proton ATPase catalytic subunit A [drugbank_resource:DB06734_6057]
p3027
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6057
p3028
sg14
Vhttp://bio2rdf.org/drugbank:DB06734
p3029
sg16
VBafilomycin B1 [drugbank:DB06734]
p3030
sasS'GABRG2'
p3031
(lp3032
(dp3033
g4
Vyes
p3034
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00186_6086
p3035
sg8
Vdrug-target interaction Lorazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00186_6086]
p3036
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3037
sg14
Vhttp://bio2rdf.org/drugbank:DB00186
p3038
sg16
VLorazepam [drugbank:DB00186]
p3039
sa(dp3040
g4
Vyes
p3041
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00231_6086
p3042
sg8
Vdrug-target interaction Temazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00231_6086]
p3043
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3044
sg14
Vhttp://bio2rdf.org/drugbank:DB00231
p3045
sg16
VTemazepam [drugbank:DB00231]
p3046
sa(dp3047
g4
Vyes
p3048
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00475_6086
p3049
sg8
Vdrug-target interaction Chlordiazepoxide and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00475_6086]
p3050
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3051
sg14
Vhttp://bio2rdf.org/drugbank:DB00475
p3052
sg16
VChlordiazepoxide [drugbank:DB00475]
p3053
sa(dp3054
g4
Vyes
p3055
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00349_6086
p3056
sg8
Vdrug-target interaction Clobazam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00349_6086]
p3057
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3058
sg14
Vhttp://bio2rdf.org/drugbank:DB00349
p3059
sg16
VClobazam [drugbank:DB00349]
p3060
sa(dp3061
g4
Vyes
p3062
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00404_6086
p3063
sg8
Vdrug-target interaction Alprazolam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00404_6086]
p3064
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3065
sg14
Vhttp://bio2rdf.org/drugbank:DB00404
p3066
sg16
VAlprazolam [drugbank:DB00404]
p3067
sa(dp3068
g4
Vyes
p3069
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00546_6086
p3070
sg8
Vdrug-target interaction Adinazolam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00546_6086]
p3071
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3072
sg14
Vhttp://bio2rdf.org/drugbank:DB00546
p3073
sg16
VAdinazolam [drugbank:DB00546]
p3074
sa(dp3075
g4
Vyes
p3076
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00628_6086
p3077
sg8
Vdrug-target interaction Clorazepate and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00628_6086]
p3078
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3079
sg14
Vhttp://bio2rdf.org/drugbank:DB00628
p3080
sg16
VClorazepate [drugbank:DB00628]
p3081
sa(dp3082
g4
Vyes
p3083
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00690_6086
p3084
sg8
Vdrug-target interaction Flurazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00690_6086]
p3085
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3086
sg14
Vhttp://bio2rdf.org/drugbank:DB00690
p3087
sg16
VFlurazepam [drugbank:DB00690]
p3088
sa(dp3089
g4
Vyes
p3090
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00829_6086
p3091
sg8
Vdrug-target interaction Diazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00829_6086]
p3092
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3093
sg14
Vhttp://bio2rdf.org/drugbank:DB00829
p3094
sg16
VDiazepam [drugbank:DB00829]
p3095
sa(dp3096
g4
Vyes
p3097
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00842_6086
p3098
sg8
Vdrug-target interaction Oxazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00842_6086]
p3099
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3100
sg14
Vhttp://bio2rdf.org/drugbank:DB00842
p3101
sg16
VOxazepam [drugbank:DB00842]
p3102
sa(dp3103
g4
Vyes
p3104
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00683_6086
p3105
sg8
Vdrug-target interaction Midazolam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00683_6086]
p3106
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3107
sg14
Vhttp://bio2rdf.org/drugbank:DB00683
p3108
sg16
VMidazolam [drugbank:DB00683]
p3109
sa(dp3110
g4
Vyes
p3111
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00801_6086
p3112
sg8
Vdrug-target interaction Halazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00801_6086]
p3113
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3114
sg14
Vhttp://bio2rdf.org/drugbank:DB00801
p3115
sg16
VHalazepam [drugbank:DB00801]
p3116
sa(dp3117
g4
Vyes
p3118
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00897_6086
p3119
sg8
Vdrug-target interaction Triazolam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB00897_6086]
p3120
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3121
sg14
Vhttp://bio2rdf.org/drugbank:DB00897
p3122
sg16
VTriazolam [drugbank:DB00897]
p3123
sa(dp3124
g4
Vyes
p3125
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01068_6086
p3126
sg8
Vdrug-target interaction Clonazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01068_6086]
p3127
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3128
sg14
Vhttp://bio2rdf.org/drugbank:DB01068
p3129
sg16
VClonazepam [drugbank:DB01068]
p3130
sa(dp3131
g4
Vunknown
p3132
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01381_6086
p3133
sg8
Vdrug-target interaction Ginkgo biloba and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01381_6086]
p3134
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3135
sg14
Vhttp://bio2rdf.org/drugbank:DB01381
p3136
sg16
VGinkgo biloba [drugbank:DB01381]
p3137
sa(dp3138
g4
Vyes
p3139
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01567_6086
p3140
sg8
Vdrug-target interaction Fludiazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01567_6086]
p3141
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3142
sg14
Vhttp://bio2rdf.org/drugbank:DB01567
p3143
sg16
VFludiazepam [drugbank:DB01567]
p3144
sa(dp3145
g4
Vyes
p3146
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01588_6086
p3147
sg8
Vdrug-target interaction Prazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01588_6086]
p3148
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3149
sg14
Vhttp://bio2rdf.org/drugbank:DB01588
p3150
sg16
VPrazepam [drugbank:DB01588]
p3151
sa(dp3152
g4
Vyes
p3153
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01215_6086
p3154
sg8
Vdrug-target interaction Estazolam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01215_6086]
p3155
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3156
sg14
Vhttp://bio2rdf.org/drugbank:DB01215
p3157
sg16
VEstazolam [drugbank:DB01215]
p3158
sa(dp3159
g4
Vyes
p3160
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01558_6086
p3161
sg8
Vdrug-target interaction Bromazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01558_6086]
p3162
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3163
sg14
Vhttp://bio2rdf.org/drugbank:DB01558
p3164
sg16
VBromazepam [drugbank:DB01558]
p3165
sa(dp3166
g4
Vyes
p3167
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01559_6086
p3168
sg8
Vdrug-target interaction Clotiazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01559_6086]
p3169
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3170
sg14
Vhttp://bio2rdf.org/drugbank:DB01559
p3171
sg16
VClotiazepam [drugbank:DB01559]
p3172
sa(dp3173
g4
Vyes
p3174
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01589_6086
p3175
sg8
Vdrug-target interaction Quazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01589_6086]
p3176
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3177
sg14
Vhttp://bio2rdf.org/drugbank:DB01589
p3178
sg16
VQuazepam [drugbank:DB01589]
p3179
sa(dp3180
g4
Vyes
p3181
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01594_6086
p3182
sg8
Vdrug-target interaction Cinolazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01594_6086]
p3183
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3184
sg14
Vhttp://bio2rdf.org/drugbank:DB01594
p3185
sg16
VCinolazepam [drugbank:DB01594]
p3186
sa(dp3187
g4
Vyes
p3188
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01595_6086
p3189
sg8
Vdrug-target interaction Nitrazepam and Gamma-aminobutyric acid receptor subunit gamma-2 [drugbank_resource:DB01595_6086]
p3190
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6086
p3191
sg14
Vhttp://bio2rdf.org/drugbank:DB01595
p3192
sg16
VNitrazepam [drugbank:DB01595]
p3193
sasS'HLA-A'
p3194
(lp3195
(dp3196
g4
Vunknown
p3197
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02740_5948
p3198
sg8
Vdrug-target interaction 3-Indolebutyric Acid and HLA class I histocompatibility antigen, A-2 alpha chain [drugbank_resource:DB02740_5948]
p3199
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5948
p3200
sg14
Vhttp://bio2rdf.org/drugbank:DB02740
p3201
sg16
V3-Indolebutyric Acid [drugbank:DB02740]
p3202
sasS'HSPG2'
p3203
(lp3204
(dp3205
g4
Vunknown
p3206
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00039_1585
p3207
sg8
Vdrug-target interaction Palifermin and Basement membrane-specific heparan sulfate proteoglycan core protein [drugbank_resource:DB00039_1585]
p3208
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1585
p3209
sg14
Vhttp://bio2rdf.org/drugbank:DB00039
p3210
sg16
VPalifermin [drugbank:DB00039]
p3211
sasS'ITGA4'
p3212
(lp3213
(dp3214
g4
Vyes
p3215
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00108_647
p3216
sg8
Vdrug-target interaction Natalizumab and Integrin alpha-4 [drugbank_resource:DB00108_647]
p3217
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:647
p3218
sg14
Vhttp://bio2rdf.org/drugbank:DB00108
p3219
sg16
VNatalizumab [drugbank:DB00108]
p3220
sa(dp3221
g4
Vunknown
p3222
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06822_647
p3223
sg8
Vdrug-target interaction Tinzaparin and Integrin alpha-4 [drugbank_resource:DB06822_647]
p3224
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:647
p3225
sg14
Vhttp://bio2rdf.org/drugbank:DB06822
p3226
sg16
VTinzaparin [drugbank:DB06822]
p3227
sasS'GAPDH'
p3228
(lp3229
(dp3230
g4
Vunknown
p3231
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00157_599
p3232
sg8
Vdrug-target interaction NADH and Glyceraldehyde-3-phosphate dehydrogenase [drugbank_resource:DB00157_599]
p3233
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:599
p3234
sg14
Vhttp://bio2rdf.org/drugbank:DB00157
p3235
sg16
VNADH [drugbank:DB00157]
p3236
sa(dp3237
g4
Vunknown
p3238
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02059_599
p3239
sg8
Vdrug-target interaction Adenosine-5-Diphosphoribose and Glyceraldehyde-3-phosphate dehydrogenase [drugbank_resource:DB02059_599]
p3240
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:599
p3241
sg14
Vhttp://bio2rdf.org/drugbank:DB02059
p3242
sg16
VAdenosine-5-Diphosphoribose [drugbank:DB02059]
p3243
sa(dp3244
g4
Vunknown
p3245
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01907_599
p3246
sg8
Vdrug-target interaction Nicotinamide-Adenine-Dinucleotide and Glyceraldehyde-3-phosphate dehydrogenase [drugbank_resource:DB01907_599]
p3247
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:599
p3248
sg14
Vhttp://bio2rdf.org/drugbank:DB01907
p3249
sg16
VNicotinamide-Adenine-Dinucleotide [drugbank:DB01907]
p3250
sa(dp3251
g4
Vunknown
p3252
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03893_599
p3253
sg8
Vdrug-target interaction Thionicotinamide-Adenine-Dinucleotide and Glyceraldehyde-3-phosphate dehydrogenase [drugbank_resource:DB03893_599]
p3254
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:599
p3255
sg14
Vhttp://bio2rdf.org/drugbank:DB03893
p3256
sg16
VThionicotinamide-Adenine-Dinucleotide [drugbank:DB03893]
p3257
sa(dp3258
g4
Vunknown
p3259
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07347_599
p3260
sg8
Vdrug-target interaction 4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE and Glyceraldehyde-3-phosphate dehydrogenase [drugbank_resource:DB07347_599]
p3261
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:599
p3262
sg14
Vhttp://bio2rdf.org/drugbank:DB07347
p3263
sg16
V4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE [drugbank:DB07347]
p3264
sasS'KAT2A'
p3265
(lp3266
(dp3267
g4
Vunknown
p3268
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01992_7093
p3269
sg8
Vdrug-target interaction Coenzyme A and Histone acetyltransferase KAT2A [drugbank_resource:DB01992_7093]
p3270
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7093
p3271
sg14
Vhttp://bio2rdf.org/drugbank:DB01992
p3272
sg16
VCoenzyme A [drugbank:DB01992]
p3273
sasS'C1QB'
p3274
(lp3275
(dp3276
g4
Vunknown
p3277
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00056_3816
p3278
sg8
Vdrug-target interaction Gemtuzumab ozogamicin and Complement C1q subcomponent subunit B [drugbank_resource:DB00056_3816]
p3279
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3280
sg14
Vhttp://bio2rdf.org/drugbank:DB00056
p3281
sg16
VGemtuzumab ozogamicin [drugbank:DB00056]
p3282
sa(dp3283
g4
Vunknown
p3284
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00074_3816
p3285
sg8
Vdrug-target interaction Basiliximab and Complement C1q subcomponent subunit B [drugbank_resource:DB00074_3816]
p3286
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3287
sg14
Vhttp://bio2rdf.org/drugbank:DB00074
p3288
sg16
VBasiliximab [drugbank:DB00074]
p3289
sa(dp3290
g4
Vunknown
p3291
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00081_3816
p3292
sg8
Vdrug-target interaction Tositumomab and Complement C1q subcomponent subunit B [drugbank_resource:DB00081_3816]
p3293
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3294
sg14
Vhttp://bio2rdf.org/drugbank:DB00081
p3295
sg16
VTositumomab [drugbank:DB00081]
p3296
sa(dp3297
g4
Vunknown
p3298
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00095_3816
p3299
sg8
Vdrug-target interaction Efalizumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00095_3816]
p3300
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3301
sg14
Vhttp://bio2rdf.org/drugbank:DB00095
p3302
sg16
VEfalizumab [drugbank:DB00095]
p3303
sa(dp3304
g4
Vunknown
p3305
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00108_3816
p3306
sg8
Vdrug-target interaction Natalizumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00108_3816]
p3307
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3308
sg14
Vhttp://bio2rdf.org/drugbank:DB00108
p3309
sg16
VNatalizumab [drugbank:DB00108]
p3310
sa(dp3311
g4
Vunknown
p3312
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00112_3816
p3313
sg8
Vdrug-target interaction Bevacizumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00112_3816]
p3314
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3315
sg14
Vhttp://bio2rdf.org/drugbank:DB00112
p3316
sg16
VBevacizumab [drugbank:DB00112]
p3317
sa(dp3318
g4
Vunknown
p3319
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00002_3816
p3320
sg8
Vdrug-target interaction Cetuximab and Complement C1q subcomponent subunit B [drugbank_resource:DB00002_3816]
p3321
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3322
sg14
Vhttp://bio2rdf.org/drugbank:DB00002
p3323
sg16
VCetuximab [drugbank:DB00002]
p3324
sa(dp3325
g4
Vunknown
p3326
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00092_3816
p3327
sg8
Vdrug-target interaction Alefacept and Complement C1q subcomponent subunit B [drugbank_resource:DB00092_3816]
p3328
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3329
sg14
Vhttp://bio2rdf.org/drugbank:DB00092
p3330
sg16
VAlefacept [drugbank:DB00092]
p3331
sa(dp3332
g4
Vunknown
p3333
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00110_3816
p3334
sg8
Vdrug-target interaction Palivizumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00110_3816]
p3335
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3336
sg14
Vhttp://bio2rdf.org/drugbank:DB00110
p3337
sg16
VPalivizumab [drugbank:DB00110]
p3338
sa(dp3339
g4
Vunknown
p3340
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00005_3816
p3341
sg8
Vdrug-target interaction Etanercept and Complement C1q subcomponent subunit B [drugbank_resource:DB00005_3816]
p3342
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3343
sg14
Vhttp://bio2rdf.org/drugbank:DB00005
p3344
sg16
VEtanercept [drugbank:DB00005]
p3345
sa(dp3346
g4
Vunknown
p3347
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00051_3816
p3348
sg8
Vdrug-target interaction Adalimumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00051_3816]
p3349
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3350
sg14
Vhttp://bio2rdf.org/drugbank:DB00051
p3351
sg16
VAdalimumab [drugbank:DB00051]
p3352
sa(dp3353
g4
Vunknown
p3354
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00054_3816
p3355
sg8
Vdrug-target interaction Abciximab and Complement C1q subcomponent subunit B [drugbank_resource:DB00054_3816]
p3356
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3357
sg14
Vhttp://bio2rdf.org/drugbank:DB00054
p3358
sg16
VAbciximab [drugbank:DB00054]
p3359
sa(dp3360
g4
Vunknown
p3361
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00072_3816
p3362
sg8
Vdrug-target interaction Trastuzumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00072_3816]
p3363
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3364
sg14
Vhttp://bio2rdf.org/drugbank:DB00072
p3365
sg16
VTrastuzumab [drugbank:DB00072]
p3366
sa(dp3367
g4
Vunknown
p3368
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00073_3816
p3369
sg8
Vdrug-target interaction Rituximab and Complement C1q subcomponent subunit B [drugbank_resource:DB00073_3816]
p3370
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3371
sg14
Vhttp://bio2rdf.org/drugbank:DB00073
p3372
sg16
VRituximab [drugbank:DB00073]
p3373
sa(dp3374
g4
Vunknown
p3375
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00075_3816
p3376
sg8
Vdrug-target interaction Muromonab and Complement C1q subcomponent subunit B [drugbank_resource:DB00075_3816]
p3377
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3378
sg14
Vhttp://bio2rdf.org/drugbank:DB00075
p3379
sg16
VMuromonab [drugbank:DB00075]
p3380
sa(dp3381
g4
Vunknown
p3382
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00078_3816
p3383
sg8
Vdrug-target interaction Ibritumomab and Complement C1q subcomponent subunit B [drugbank_resource:DB00078_3816]
p3384
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3385
sg14
Vhttp://bio2rdf.org/drugbank:DB00078
p3386
sg16
VIbritumomab [drugbank:DB00078]
p3387
sa(dp3388
g4
Vunknown
p3389
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00087_3816
p3390
sg8
Vdrug-target interaction Alemtuzumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00087_3816]
p3391
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3392
sg14
Vhttp://bio2rdf.org/drugbank:DB00087
p3393
sg16
VAlemtuzumab [drugbank:DB00087]
p3394
sa(dp3395
g4
Vunknown
p3396
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00111_3816
p3397
sg8
Vdrug-target interaction Daclizumab and Complement C1q subcomponent subunit B [drugbank_resource:DB00111_3816]
p3398
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3816
p3399
sg14
Vhttp://bio2rdf.org/drugbank:DB00111
p3400
sg16
VDaclizumab [drugbank:DB00111]
p3401
sasS'ABL1'
p3402
(lp3403
(dp3404
g4
Vunknown
p3405
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00171_17
p3406
sg8
Vdrug-target interaction Adenosine triphosphate and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB00171_17]
p3407
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:17
p3408
sg14
Vhttp://bio2rdf.org/drugbank:DB00171
p3409
sg16
VAdenosine triphosphate [drugbank:DB00171]
p3410
sa(dp3411
g4
Vunknown
p3412
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00619_17
p3413
sg8
Vdrug-target interaction Imatinib and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB00619_17]
p3414
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:17
p3415
sg14
Vhttp://bio2rdf.org/drugbank:DB00619
p3416
sg16
VImatinib [drugbank:DB00619]
p3417
sa(dp3418
g4
Vyes
p3419
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01254_17
p3420
sg8
Vdrug-target interaction Dasatinib and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB01254_17]
p3421
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:17
p3422
sg14
Vhttp://bio2rdf.org/drugbank:DB01254
p3423
sg16
VDasatinib [drugbank:DB01254]
p3424
sa(dp3425
g4
Vunknown
p3426
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03878_17
p3427
sg8
Vdrug-target interaction N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB03878_17]
p3428
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:17
p3429
sg14
Vhttp://bio2rdf.org/drugbank:DB03878
p3430
sg16
VN-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide [drugbank:DB03878]
p3431
sa(dp3432
g4
Vyes
p3433
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04868_17
p3434
sg8
Vdrug-target interaction Nilotinib and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB04868_17]
p3435
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:17
p3436
sg14
Vhttp://bio2rdf.org/drugbank:DB04868
p3437
sg16
VNilotinib [drugbank:DB04868]
p3438
sa(dp3439
g4
Vunknown
p3440
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07831_17
p3441
sg8
Vdrug-target interaction 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB07831_17]
p3442
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:17
p3443
sg14
Vhttp://bio2rdf.org/drugbank:DB07831
p3444
sg16
V2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE [drugbank:DB07831]
p3445
sa(dp3446
g4
Vunknown
p3447
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08043_17
p3448
sg8
Vdrug-target interaction 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB08043_17]
p3449
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:17
p3450
sg14
Vhttp://bio2rdf.org/drugbank:DB08043
p3451
sg16
V1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA [drugbank:DB08043]
p3452
sa(dp3453
g4
Vunknown
p3454
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08339_17
p3455
sg8
Vdrug-target interaction 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB08339_17]
p3456
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:17
p3457
sg14
Vhttp://bio2rdf.org/drugbank:DB08339
p3458
sg16
V6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE [drugbank:DB08339]
p3459
sa(dp3460
g4
Vunknown
p3461
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08350_17
p3462
sg8
Vdrug-target interaction 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB08350_17]
p3463
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:17
p3464
sg14
Vhttp://bio2rdf.org/drugbank:DB08350
p3465
sg16
V5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE [drugbank:DB08350]
p3466
sa(dp3467
g4
Vunknown
p3468
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08583_17
p3469
sg8
Vdrug-target interaction 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB08583_17]
p3470
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:17
p3471
sg14
Vhttp://bio2rdf.org/drugbank:DB08583
p3472
sg16
V2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide [drugbank:DB08583]
p3473
sa(dp3474
g4
Vunknown
p3475
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08231_17
p3476
sg8
Vdrug-target interaction MYRISTIC ACID and Proto-oncogene tyrosine-protein kinase ABL1 [drugbank_resource:DB08231_17]
p3477
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:17
p3478
sg14
Vhttp://bio2rdf.org/drugbank:DB08231
p3479
sg16
VMYRISTIC ACID [drugbank:DB08231]
p3480
sasS'ITGB2'
p3481
(lp3482
(dp3483
g4
Vno
p3484
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00641_1630
p3485
sg8
Vdrug-target interaction Simvastatin and Integrin beta-2 [drugbank_resource:DB00641_1630]
p3486
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1630
p3487
sg14
Vhttp://bio2rdf.org/drugbank:DB00641
p3488
sg16
VSimvastatin [drugbank:DB00641]
p3489
sasS'EDNRA'
p3490
(lp3491
(dp3492
g4
Vyes
p3493
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00559_578
p3494
sg8
Vdrug-target interaction Bosentan and Endothelin-1 receptor [drugbank_resource:DB00559_578]
p3495
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:578
p3496
sg14
Vhttp://bio2rdf.org/drugbank:DB00559
p3497
sg16
VBosentan [drugbank:DB00559]
p3498
sa(dp3499
g4
Vunknown
p3500
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04674_578
p3501
sg8
Vdrug-target interaction 2-HYDROXY-3,5-DIIODOBENZOIC ACID and Endothelin-1 receptor [drugbank_resource:DB04674_578]
p3502
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:578
p3503
sg14
Vhttp://bio2rdf.org/drugbank:DB04674
p3504
sg16
V2-HYDROXY-3,5-DIIODOBENZOIC ACID [drugbank:DB04674]
p3505
sa(dp3506
g4
Vyes
p3507
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06268_578
p3508
sg8
Vdrug-target interaction Sitaxentan and Endothelin-1 receptor [drugbank_resource:DB06268_578]
p3509
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:578
p3510
sg14
Vhttp://bio2rdf.org/drugbank:DB06268
p3511
sg16
VSitaxentan [drugbank:DB06268]
p3512
sasS'GABBR2'
p3513
(lp3514
(dp3515
g4
Vyes
p3516
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00181_4094
p3517
sg8
Vdrug-target interaction Baclofen and Gamma-aminobutyric acid type B receptor, subunit 2 [drugbank_resource:DB00181_4094]
p3518
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4094
p3519
sg14
Vhttp://bio2rdf.org/drugbank:DB00181
p3520
sg16
VBaclofen [drugbank:DB00181]
p3521
sasS'KIT'
p3522
(lp3523
(dp3524
g4
Vyes
p3525
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00398_504
p3526
sg8
Vdrug-target interaction Sorafenib and Mast/stem cell growth factor receptor [drugbank_resource:DB00398_504]
p3527
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:504
p3528
sg14
Vhttp://bio2rdf.org/drugbank:DB00398
p3529
sg16
VSorafenib [drugbank:DB00398]
p3530
sa(dp3531
g4
Vyes
p3532
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00619_504
p3533
sg8
Vdrug-target interaction Imatinib and Mast/stem cell growth factor receptor [drugbank_resource:DB00619_504]
p3534
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:504
p3535
sg14
Vhttp://bio2rdf.org/drugbank:DB00619
p3536
sg16
VImatinib [drugbank:DB00619]
p3537
sa(dp3538
g4
Vunknown
p3539
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01254_504
p3540
sg8
Vdrug-target interaction Dasatinib and Mast/stem cell growth factor receptor [drugbank_resource:DB01254_504]
p3541
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:504
p3542
sg14
Vhttp://bio2rdf.org/drugbank:DB01254
p3543
sg16
VDasatinib [drugbank:DB01254]
p3544
sa(dp3545
g4
Vyes
p3546
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01268_504
p3547
sg8
Vdrug-target interaction Sunitinib and Mast/stem cell growth factor receptor [drugbank_resource:DB01268_504]
p3548
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:504
p3549
sg14
Vhttp://bio2rdf.org/drugbank:DB01268
p3550
sg16
VSunitinib [drugbank:DB01268]
p3551
sa(dp3552
g4
Vunknown
p3553
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01962_504
p3554
sg8
Vdrug-target interaction Phosphonotyrosine and Mast/stem cell growth factor receptor [drugbank_resource:DB01962_504]
p3555
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:504
p3556
sg14
Vhttp://bio2rdf.org/drugbank:DB01962
p3557
sg16
VPhosphonotyrosine [drugbank:DB01962]
p3558
sa(dp3559
g4
Vunknown
p3560
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03431_504
p3561
sg8
Vdrug-target interaction Adenosine-5'-Diphosphate and Mast/stem cell growth factor receptor [drugbank_resource:DB03431_504]
p3562
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:504
p3563
sg14
Vhttp://bio2rdf.org/drugbank:DB03431
p3564
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p3565
sa(dp3566
g4
Vunknown
p3567
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04868_504
p3568
sg8
Vdrug-target interaction Nilotinib and Mast/stem cell growth factor receptor [drugbank_resource:DB04868_504]
p3569
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:504
p3570
sg14
Vhttp://bio2rdf.org/drugbank:DB04868
p3571
sg16
VNilotinib [drugbank:DB04868]
p3572
sasS'SERPINE1'
p3573
(lp3574
(dp3575
g4
Vunknown
p3576
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00009_267
p3577
sg8
Vdrug-target interaction Alteplase and Plasminogen activator inhibitor 1 [drugbank_resource:DB00009_267]
p3578
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:267
p3579
sg14
Vhttp://bio2rdf.org/drugbank:DB00009
p3580
sg16
VAlteplase [drugbank:DB00009]
p3581
sa(dp3582
g4
Vunknown
p3583
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00015_267
p3584
sg8
Vdrug-target interaction Reteplase and Plasminogen activator inhibitor 1 [drugbank_resource:DB00015_267]
p3585
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:267
p3586
sg14
Vhttp://bio2rdf.org/drugbank:DB00015
p3587
sg16
VReteplase [drugbank:DB00015]
p3588
sa(dp3589
g4
Vunknown
p3590
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00197_267
p3591
sg8
Vdrug-target interaction Troglitazone and Plasminogen activator inhibitor 1 [drugbank_resource:DB00197_267]
p3592
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:267
p3593
sg14
Vhttp://bio2rdf.org/drugbank:DB00197
p3594
sg16
VTroglitazone [drugbank:DB00197]
p3595
sa(dp3596
g4
Vunknown
p3597
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00029_267
p3598
sg8
Vdrug-target interaction Anistreplase and Plasminogen activator inhibitor 1 [drugbank_resource:DB00029_267]
p3599
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:267
p3600
sg14
Vhttp://bio2rdf.org/drugbank:DB00029
p3601
sg16
VAnistreplase [drugbank:DB00029]
p3602
sa(dp3603
g4
Vyes
p3604
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00013_267
p3605
sg8
Vdrug-target interaction Urokinase and Plasminogen activator inhibitor 1 [drugbank_resource:DB00013_267]
p3606
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:267
p3607
sg14
Vhttp://bio2rdf.org/drugbank:DB00013
p3608
sg16
VUrokinase [drugbank:DB00013]
p3609
sa(dp3610
g4
Vunknown
p3611
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00031_267
p3612
sg8
Vdrug-target interaction Tenecteplase and Plasminogen activator inhibitor 1 [drugbank_resource:DB00031_267]
p3613
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:267
p3614
sg14
Vhttp://bio2rdf.org/drugbank:DB00031
p3615
sg16
VTenecteplase [drugbank:DB00031]
p3616
sa(dp3617
g4
Vunknown
p3618
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00055_267
p3619
sg8
Vdrug-target interaction Drotrecogin alfa and Plasminogen activator inhibitor 1 [drugbank_resource:DB00055_267]
p3620
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:267
p3621
sg14
Vhttp://bio2rdf.org/drugbank:DB00055
p3622
sg16
VDrotrecogin alfa [drugbank:DB00055]
p3623
sasS'CHD1'
p3624
(lp3625
(dp3626
g4
Vyes
p3627
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00445_588
p3628
sg8
Vdrug-target interaction Epirubicin and Chromodomain-helicase-DNA-binding protein 1 [drugbank_resource:DB00445_588]
p3629
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:588
p3630
sg14
Vhttp://bio2rdf.org/drugbank:DB00445
p3631
sg16
VEpirubicin [drugbank:DB00445]
p3632
sasS'AHR'
p3633
(lp3634
(dp3635
g4
Vunknown
p3636
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00393_6220
p3637
sg8
Vdrug-target interaction Nimodipine and Aryl hydrocarbon receptor [drugbank_resource:DB00393_6220]
p3638
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6220
p3639
sg14
Vhttp://bio2rdf.org/drugbank:DB00393
p3640
sg16
VNimodipine [drugbank:DB00393]
p3641
sa(dp3642
g4
Vunknown
p3643
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00379_6220
p3644
sg8
Vdrug-target interaction Mexiletine and Aryl hydrocarbon receptor [drugbank_resource:DB00379_6220]
p3645
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6220
p3646
sg14
Vhttp://bio2rdf.org/drugbank:DB00379
p3647
sg16
VMexiletine [drugbank:DB00379]
p3648
sa(dp3649
g4
Vunknown
p3650
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00499_6220
p3651
sg8
Vdrug-target interaction Flutamide and Aryl hydrocarbon receptor [drugbank_resource:DB00499_6220]
p3652
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6220
p3653
sg14
Vhttp://bio2rdf.org/drugbank:DB00499
p3654
sg16
VFlutamide [drugbank:DB00499]
p3655
sa(dp3656
g4
Vunknown
p3657
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01076_6220
p3658
sg8
Vdrug-target interaction Atorvastatin and Aryl hydrocarbon receptor [drugbank_resource:DB01076_6220]
p3659
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6220
p3660
sg14
Vhttp://bio2rdf.org/drugbank:DB01076
p3661
sg16
VAtorvastatin [drugbank:DB01076]
p3662
sa(dp3663
g4
Vunknown
p3664
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01097_6220
p3665
sg8
Vdrug-target interaction Leflunomide and Aryl hydrocarbon receptor [drugbank_resource:DB01097_6220]
p3666
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6220
p3667
sg14
Vhttp://bio2rdf.org/drugbank:DB01097
p3668
sg16
VLeflunomide [drugbank:DB01097]
p3669
sa(dp3670
g4
Vunknown
p3671
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01404_6220
p3672
sg8
Vdrug-target interaction Ginseng and Aryl hydrocarbon receptor [drugbank_resource:DB01404_6220]
p3673
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6220
p3674
sg14
Vhttp://bio2rdf.org/drugbank:DB01404
p3675
sg16
VGinseng [drugbank:DB01404]
p3676
sasS'KRT8'
p3677
(lp3678
(dp3679
g4
Vunknown
p3680
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00031_3826
p3681
sg8
Vdrug-target interaction Tenecteplase and Keratin, type II cytoskeletal 8 [drugbank_resource:DB00031_3826]
p3682
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3826
p3683
sg14
Vhttp://bio2rdf.org/drugbank:DB00031
p3684
sg16
VTenecteplase [drugbank:DB00031]
p3685
sasS'NEK2'
p3686
(lp3687
(dp3688
g4
Vunknown
p3689
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07180_6298
p3690
sg8
Vdrug-target interaction 5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE and Serine/threonine-protein kinase Nek2 [drugbank_resource:DB07180_6298]
p3691
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6298
p3692
sg14
Vhttp://bio2rdf.org/drugbank:DB07180
p3693
sg16
V5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE [drugbank:DB07180]
p3694
sasS'HMOX1'
p3695
(lp3696
(dp3697
g4
Vunknown
p3698
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00157_810
p3699
sg8
Vdrug-target interaction NADH and Heme oxygenase 1 [drugbank_resource:DB00157_810]
p3700
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:810
p3701
sg14
Vhttp://bio2rdf.org/drugbank:DB00157
p3702
sg16
VNADH [drugbank:DB00157]
p3703
sa(dp3704
g4
Vunknown
p3705
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02073_810
p3706
sg8
Vdrug-target interaction Biliverdine Ix Alpha and Heme oxygenase 1 [drugbank_resource:DB02073_810]
p3707
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:810
p3708
sg14
Vhttp://bio2rdf.org/drugbank:DB02073
p3709
sg16
VBiliverdine Ix Alpha [drugbank:DB02073]
p3710
sa(dp3711
g4
Vunknown
p3712
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01942_810
p3713
sg8
Vdrug-target interaction Formic Acid and Heme oxygenase 1 [drugbank_resource:DB01942_810]
p3714
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:810
p3715
sg14
Vhttp://bio2rdf.org/drugbank:DB01942
p3716
sg16
VFormic Acid [drugbank:DB01942]
p3717
sa(dp3718
g4
Vunknown
p3719
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02468_810
p3720
sg8
Vdrug-target interaction 12-Phenylheme and Heme oxygenase 1 [drugbank_resource:DB02468_810]
p3721
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:810
p3722
sg14
Vhttp://bio2rdf.org/drugbank:DB02468
p3723
sg16
V12-Phenylheme [drugbank:DB02468]
p3724
sa(dp3725
g4
Vunknown
p3726
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03014_810
p3727
sg8
Vdrug-target interaction Heme and Heme oxygenase 1 [drugbank_resource:DB03014_810]
p3728
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:810
p3729
sg14
Vhttp://bio2rdf.org/drugbank:DB03014
p3730
sg16
VHeme [drugbank:DB03014]
p3731
sa(dp3732
g4
Vunknown
p3733
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03906_810
p3734
sg8
Vdrug-target interaction 2-Phenylheme and Heme oxygenase 1 [drugbank_resource:DB03906_810]
p3735
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:810
p3736
sg14
Vhttp://bio2rdf.org/drugbank:DB03906
p3737
sg16
V2-Phenylheme [drugbank:DB03906]
p3738
sa(dp3739
g4
Vunknown
p3740
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04803_810
p3741
sg8
Vdrug-target interaction Verdoheme and Heme oxygenase 1 [drugbank_resource:DB04803_810]
p3742
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:810
p3743
sg14
Vhttp://bio2rdf.org/drugbank:DB04803
p3744
sg16
VVerdoheme [drugbank:DB04803]
p3745
sa(dp3746
g4
Vunknown
p3747
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06914_810
p3748
sg8
Vdrug-target interaction 1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE and Heme oxygenase 1 [drugbank_resource:DB06914_810]
p3749
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:810
p3750
sg14
Vhttp://bio2rdf.org/drugbank:DB06914
p3751
sg16
V1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE [drugbank:DB06914]
p3752
sa(dp3753
g4
Vunknown
p3754
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07342_810
p3755
sg8
Vdrug-target interaction 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone and Heme oxygenase 1 [drugbank_resource:DB07342_810]
p3756
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:810
p3757
sg14
Vhttp://bio2rdf.org/drugbank:DB07342
p3758
sg16
V1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone [drugbank:DB07342]
p3759
sasS'JUN'
p3760
(lp3761
(dp3762
g4
Vno
p3763
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00570_1629
p3764
sg8
Vdrug-target interaction Vinblastine and Transcription factor AP-1 [drugbank_resource:DB00570_1629]
p3765
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1629
p3766
sg14
Vhttp://bio2rdf.org/drugbank:DB00570
p3767
sg16
VVinblastine [drugbank:DB00570]
p3768
sa(dp3769
g4
Vunknown
p3770
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01029_1629
p3771
sg8
Vdrug-target interaction Irbesartan and Transcription factor AP-1 [drugbank_resource:DB01029_1629]
p3772
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1629
p3773
sg14
Vhttp://bio2rdf.org/drugbank:DB01029
p3774
sg16
VIrbesartan [drugbank:DB01029]
p3775
sa(dp3776
g4
Vyes
p3777
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01169_1629
p3778
sg8
Vdrug-target interaction Arsenic trioxide and Transcription factor AP-1 [drugbank_resource:DB01169_1629]
p3779
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1629
p3780
sg14
Vhttp://bio2rdf.org/drugbank:DB01169
p3781
sg16
VArsenic trioxide [drugbank:DB01169]
p3782
sasS'KCNMA1'
p3783
(lp3784
(dp3785
g4
Vyes
p3786
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00228_610
p3787
sg8
Vdrug-target interaction Enflurane and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB00228_610]
p3788
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:610
p3789
sg14
Vhttp://bio2rdf.org/drugbank:DB00228
p3790
sg16
VEnflurane [drugbank:DB00228]
p3791
sa(dp3792
g4
Vyes
p3793
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00436_610
p3794
sg8
Vdrug-target interaction Bendroflumethiazide and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB00436_610]
p3795
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:610
p3796
sg14
Vhttp://bio2rdf.org/drugbank:DB00436
p3797
sg16
VBendroflumethiazide [drugbank:DB00436]
p3798
sa(dp3799
g4
Vyes
p3800
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00356_610
p3801
sg8
Vdrug-target interaction Chlorzoxazone and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB00356_610]
p3802
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:610
p3803
sg14
Vhttp://bio2rdf.org/drugbank:DB00356
p3804
sg16
VChlorzoxazone [drugbank:DB00356]
p3805
sa(dp3806
g4
Vunknown
p3807
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00999_610
p3808
sg8
Vdrug-target interaction Hydrochlorothiazide and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB00999_610]
p3809
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:610
p3810
sg14
Vhttp://bio2rdf.org/drugbank:DB00999
p3811
sg16
VHydrochlorothiazide [drugbank:DB00999]
p3812
sa(dp3813
g4
Vyes
p3814
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01003_610
p3815
sg8
Vdrug-target interaction Cromoglicic acid and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB01003_610]
p3816
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:610
p3817
sg14
Vhttp://bio2rdf.org/drugbank:DB01003
p3818
sg16
VCromoglicic acid [drugbank:DB01003]
p3819
sa(dp3820
g4
Vunknown
p3821
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01110_610
p3822
sg8
Vdrug-target interaction Miconazole and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB01110_610]
p3823
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:610
p3824
sg14
Vhttp://bio2rdf.org/drugbank:DB01110
p3825
sg16
VMiconazole [drugbank:DB01110]
p3826
sa(dp3827
g4
Vunknown
p3828
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01159_610
p3829
sg8
Vdrug-target interaction Halothane and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB01159_610]
p3830
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:610
p3831
sg14
Vhttp://bio2rdf.org/drugbank:DB01159
p3832
sg16
VHalothane [drugbank:DB01159]
p3833
sa(dp3834
g4
Vunknown
p3835
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00774_610
p3836
sg8
Vdrug-target interaction Hydroflumethiazide and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB00774_610]
p3837
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:610
p3838
sg14
Vhttp://bio2rdf.org/drugbank:DB00774
p3839
sg16
VHydroflumethiazide [drugbank:DB00774]
p3840
sa(dp3841
g4
Vunknown
p3842
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01119_610
p3843
sg8
Vdrug-target interaction Diazoxide and Calcium-activated potassium channel subunit alpha 1 [drugbank_resource:DB01119_610]
p3844
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:610
p3845
sg14
Vhttp://bio2rdf.org/drugbank:DB01119
p3846
sg16
VDiazoxide [drugbank:DB01119]
p3847
sasS'TTK'
p3848
(lp3849
(dp3850
g4
Vunknown
p3851
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01782_6293
p3852
sg8
Vdrug-target interaction 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One and Dual specificity protein kinase TTK [drugbank_resource:DB01782_6293]
p3853
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6293
p3854
sg14
Vhttp://bio2rdf.org/drugbank:DB01782
p3855
sg16
V2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One [drugbank:DB01782]
p3856
sasS'NID1'
p3857
(lp3858
(dp3859
g4
Vunknown
p3860
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00013_3834
p3861
sg8
Vdrug-target interaction Urokinase and Nidogen-1 [drugbank_resource:DB00013_3834]
p3862
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3834
p3863
sg14
Vhttp://bio2rdf.org/drugbank:DB00013
p3864
sg16
VUrokinase [drugbank:DB00013]
p3865
sasS'HLA-DQB1'
p3866
(lp3867
(dp3868
g4
Vunknown
p3869
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00071_6976
p3870
sg8
Vdrug-target interaction Insulin, porcine and HLA class II histocompatibility antigen, DQ beta 1 chain [drugbank_resource:DB00071_6976]
p3871
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6976
p3872
sg14
Vhttp://bio2rdf.org/drugbank:DB00071
p3873
sg16
VInsulin, porcine [drugbank:DB00071]
p3874
sasS'FECH'
p3875
(lp3876
(dp3877
g4
Vunknown
p3878
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02659_1591
p3879
sg8
Vdrug-target interaction Cholic Acid and Ferrochelatase, mitochondrial [drugbank_resource:DB02659_1591]
p3880
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1591
p3881
sg14
Vhttp://bio2rdf.org/drugbank:DB02659
p3882
sg16
VCholic Acid [drugbank:DB02659]
p3883
sasS'HTR2C'
p3884
(lp3885
(dp3886
g4
Vunknown
p3887
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00246_590
p3888
sg8
Vdrug-target interaction Ziprasidone and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00246_590]
p3889
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3890
sg14
Vhttp://bio2rdf.org/drugbank:DB00246
p3891
sg16
VZiprasidone [drugbank:DB00246]
p3892
sa(dp3893
g4
Vyes
p3894
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00247_590
p3895
sg8
Vdrug-target interaction Methysergide and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00247_590]
p3896
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3897
sg14
Vhttp://bio2rdf.org/drugbank:DB00247
p3898
sg16
VMethysergide [drugbank:DB00247]
p3899
sa(dp3900
g4
Vunknown
p3901
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00248_590
p3902
sg8
Vdrug-target interaction Cabergoline and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00248_590]
p3903
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3904
sg14
Vhttp://bio2rdf.org/drugbank:DB00248
p3905
sg16
VCabergoline [drugbank:DB00248]
p3906
sa(dp3907
g4
Vunknown
p3908
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00268_590
p3909
sg8
Vdrug-target interaction Ropinirole and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00268_590]
p3910
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3911
sg14
Vhttp://bio2rdf.org/drugbank:DB00268
p3912
sg16
VRopinirole [drugbank:DB00268]
p3913
sa(dp3914
g4
Vunknown
p3915
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00193_590
p3916
sg8
Vdrug-target interaction Tramadol and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00193_590]
p3917
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3918
sg14
Vhttp://bio2rdf.org/drugbank:DB00193
p3919
sg16
VTramadol [drugbank:DB00193]
p3920
sa(dp3921
g4
Vunknown
p3922
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00413_590
p3923
sg8
Vdrug-target interaction Pramipexole and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00413_590]
p3924
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3925
sg14
Vhttp://bio2rdf.org/drugbank:DB00413
p3926
sg16
VPramipexole [drugbank:DB00413]
p3927
sa(dp3928
g4
Vyes
p3929
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00589_590
p3930
sg8
Vdrug-target interaction Lisuride and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00589_590]
p3931
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3932
sg14
Vhttp://bio2rdf.org/drugbank:DB00589
p3933
sg16
VLisuride [drugbank:DB00589]
p3934
sa(dp3935
g4
Vunknown
p3936
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00334_590
p3937
sg8
Vdrug-target interaction Olanzapine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00334_590]
p3938
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3939
sg14
Vhttp://bio2rdf.org/drugbank:DB00334
p3940
sg16
VOlanzapine [drugbank:DB00334]
p3941
sa(dp3942
g4
Vunknown
p3943
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00363_590
p3944
sg8
Vdrug-target interaction Clozapine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00363_590]
p3945
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3946
sg14
Vhttp://bio2rdf.org/drugbank:DB00363
p3947
sg16
VClozapine [drugbank:DB00363]
p3948
sa(dp3949
g4
Vunknown
p3950
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00408_590
p3951
sg8
Vdrug-target interaction Loxapine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00408_590]
p3952
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3953
sg14
Vhttp://bio2rdf.org/drugbank:DB00408
p3954
sg16
VLoxapine [drugbank:DB00408]
p3955
sa(dp3956
g4
Vyes
p3957
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00574_590
p3958
sg8
Vdrug-target interaction Fenfluramine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00574_590]
p3959
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3960
sg14
Vhttp://bio2rdf.org/drugbank:DB00574
p3961
sg16
VFenfluramine [drugbank:DB00574]
p3962
sa(dp3963
g4
Vunknown
p3964
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00370_590
p3965
sg8
Vdrug-target interaction Mirtazapine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00370_590]
p3966
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3967
sg14
Vhttp://bio2rdf.org/drugbank:DB00370
p3968
sg16
VMirtazapine [drugbank:DB00370]
p3969
sa(dp3970
g4
Vunknown
p3971
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00420_590
p3972
sg8
Vdrug-target interaction Promazine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00420_590]
p3973
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3974
sg14
Vhttp://bio2rdf.org/drugbank:DB00420
p3975
sg16
VPromazine [drugbank:DB00420]
p3976
sa(dp3977
g4
Vyes
p3978
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00434_590
p3979
sg8
Vdrug-target interaction Cyproheptadine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00434_590]
p3980
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3981
sg14
Vhttp://bio2rdf.org/drugbank:DB00434
p3982
sg16
VCyproheptadine [drugbank:DB00434]
p3983
sa(dp3984
g4
Vyes
p3985
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00656_590
p3986
sg8
Vdrug-target interaction Trazodone and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00656_590]
p3987
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3988
sg14
Vhttp://bio2rdf.org/drugbank:DB00656
p3989
sg16
VTrazodone [drugbank:DB00656]
p3990
sa(dp3991
g4
Vunknown
p3992
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00714_590
p3993
sg8
Vdrug-target interaction Apomorphine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00714_590]
p3994
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p3995
sg14
Vhttp://bio2rdf.org/drugbank:DB00714
p3996
sg16
VApomorphine [drugbank:DB00714]
p3997
sa(dp3998
g4
Vunknown
p3999
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00734_590
p4000
sg8
Vdrug-target interaction Risperidone and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00734_590]
p4001
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4002
sg14
Vhttp://bio2rdf.org/drugbank:DB00734
p4003
sg16
VRisperidone [drugbank:DB00734]
p4004
sa(dp4005
g4
Vunknown
p4006
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00777_590
p4007
sg8
Vdrug-target interaction Propiomazine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00777_590]
p4008
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4009
sg14
Vhttp://bio2rdf.org/drugbank:DB00777
p4010
sg16
VPropiomazine [drugbank:DB00777]
p4011
sa(dp4012
g4
Vunknown
p4013
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01079_590
p4014
sg8
Vdrug-target interaction Tegaserod and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01079_590]
p4015
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4016
sg14
Vhttp://bio2rdf.org/drugbank:DB01079
p4017
sg16
VTegaserod [drugbank:DB01079]
p4018
sa(dp4019
g4
Vyes
p4020
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00805_590
p4021
sg8
Vdrug-target interaction Minaprine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB00805_590]
p4022
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4023
sg14
Vhttp://bio2rdf.org/drugbank:DB00805
p4024
sg16
VMinaprine [drugbank:DB00805]
p4025
sa(dp4026
g4
Vyes
p4027
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01142_590
p4028
sg8
Vdrug-target interaction Doxepin and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01142_590]
p4029
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4030
sg14
Vhttp://bio2rdf.org/drugbank:DB01142
p4031
sg16
VDoxepin [drugbank:DB01142]
p4032
sa(dp4033
g4
Vyes
p4034
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01149_590
p4035
sg8
Vdrug-target interaction Nefazodone and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01149_590]
p4036
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4037
sg14
Vhttp://bio2rdf.org/drugbank:DB01149
p4038
sg16
VNefazodone [drugbank:DB01149]
p4039
sa(dp4040
g4
Vunknown
p4041
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01224_590
p4042
sg8
Vdrug-target interaction Quetiapine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01224_590]
p4043
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4044
sg14
Vhttp://bio2rdf.org/drugbank:DB01224
p4045
sg16
VQuetiapine [drugbank:DB01224]
p4046
sa(dp4047
g4
Vunknown
p4048
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01238_590
p4049
sg8
Vdrug-target interaction Aripiprazole and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01238_590]
p4050
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4051
sg14
Vhttp://bio2rdf.org/drugbank:DB01238
p4052
sg16
VAripiprazole [drugbank:DB01238]
p4053
sa(dp4054
g4
Vyes
p4055
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01239_590
p4056
sg8
Vdrug-target interaction Chlorprothixene and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01239_590]
p4057
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4058
sg14
Vhttp://bio2rdf.org/drugbank:DB01239
p4059
sg16
VChlorprothixene [drugbank:DB01239]
p4060
sa(dp4061
g4
Vyes
p4062
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01267_590
p4063
sg8
Vdrug-target interaction Paliperidone and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01267_590]
p4064
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4065
sg14
Vhttp://bio2rdf.org/drugbank:DB01267
p4066
sg16
VPaliperidone [drugbank:DB01267]
p4067
sa(dp4068
g4
Vunknown
p4069
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01454_590
p4070
sg8
Vdrug-target interaction 3,4-Methylenedioxymethamphetamine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01454_590]
p4071
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4072
sg14
Vhttp://bio2rdf.org/drugbank:DB01454
p4073
sg16
V3,4-Methylenedioxymethamphetamine [drugbank:DB01454]
p4074
sa(dp4075
g4
Vunknown
p4076
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01191_590
p4077
sg8
Vdrug-target interaction Dexfenfluramine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01191_590]
p4078
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4079
sg14
Vhttp://bio2rdf.org/drugbank:DB01191
p4080
sg16
VDexfenfluramine [drugbank:DB01191]
p4081
sa(dp4082
g4
Vyes
p4083
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01242_590
p4084
sg8
Vdrug-target interaction Clomipramine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01242_590]
p4085
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4086
sg14
Vhttp://bio2rdf.org/drugbank:DB01242
p4087
sg16
VClomipramine [drugbank:DB01242]
p4088
sa(dp4089
g4
Vunknown
p4090
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01392_590
p4091
sg8
Vdrug-target interaction Yohimbine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01392_590]
p4092
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4093
sg14
Vhttp://bio2rdf.org/drugbank:DB01392
p4094
sg16
VYohimbine [drugbank:DB01392]
p4095
sa(dp4096
g4
Vunknown
p4097
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01186_590
p4098
sg8
Vdrug-target interaction Pergolide and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01186_590]
p4099
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4100
sg14
Vhttp://bio2rdf.org/drugbank:DB01186
p4101
sg16
VPergolide [drugbank:DB01186]
p4102
sa(dp4103
g4
Vunknown
p4104
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01200_590
p4105
sg8
Vdrug-target interaction Bromocriptine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01200_590]
p4106
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4107
sg14
Vhttp://bio2rdf.org/drugbank:DB01200
p4108
sg16
VBromocriptine [drugbank:DB01200]
p4109
sa(dp4110
g4
Vunknown
p4111
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01403_590
p4112
sg8
Vdrug-target interaction Methotrimeprazine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB01403_590]
p4113
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4114
sg14
Vhttp://bio2rdf.org/drugbank:DB01403
p4115
sg16
VMethotrimeprazine [drugbank:DB01403]
p4116
sa(dp4117
g4
Vunknown
p4118
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06148_590
p4119
sg8
Vdrug-target interaction Mianserin and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB06148_590]
p4120
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4121
sg14
Vhttp://bio2rdf.org/drugbank:DB06148
p4122
sg16
VMianserin [drugbank:DB06148]
p4123
sa(dp4124
g4
Vunknown
p4125
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06594_590
p4126
sg8
Vdrug-target interaction Agomelatine and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB06594_590]
p4127
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4128
sg14
Vhttp://bio2rdf.org/drugbank:DB06594
p4129
sg16
VAgomelatine [drugbank:DB06594]
p4130
sa(dp4131
g4
Vyes
p4132
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06144_590
p4133
sg8
Vdrug-target interaction Sertindole and 5-hydroxytryptamine 2C receptor [drugbank_resource:DB06144_590]
p4134
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:590
p4135
sg14
Vhttp://bio2rdf.org/drugbank:DB06144
p4136
sg16
VSertindole [drugbank:DB06144]
p4137
sasS'JAK1'
p4138
(lp4139
(dp4140
g4
Vunknown
p4141
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04716_6649
p4142
sg8
Vdrug-target interaction 2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE and Tyrosine-protein kinase JAK1 [drugbank_resource:DB04716_6649]
p4143
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6649
p4144
sg14
Vhttp://bio2rdf.org/drugbank:DB04716
p4145
sg16
V2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE [drugbank:DB04716]
p4146
sa(dp4147
g4
Vunknown
p4148
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08183_6649
p4149
sg8
Vdrug-target interaction 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile and Tyrosine-protein kinase JAK1 [drugbank_resource:DB08183_6649]
p4150
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6649
p4151
sg14
Vhttp://bio2rdf.org/drugbank:DB08183
p4152
sg16
V3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile [drugbank:DB08183]
p4153
sasS'NR1H4'
p4154
(lp4155
(dp4156
g4
Vunknown
p4157
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02545_3233
p4158
sg8
Vdrug-target interaction Fexaramine and Bile acid receptor [drugbank_resource:DB02545_3233]
p4159
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3233
p4160
sg14
Vhttp://bio2rdf.org/drugbank:DB02545
p4161
sg16
VFexaramine [drugbank:DB02545]
p4162
sa(dp4163
g4
Vunknown
p4164
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06777_3233
p4165
sg8
Vdrug-target interaction Chenodeoxycholic acid and Bile acid receptor [drugbank_resource:DB06777_3233]
p4166
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3233
p4167
sg14
Vhttp://bio2rdf.org/drugbank:DB06777
p4168
sg16
VChenodeoxycholic acid [drugbank:DB06777]
p4169
sa(dp4170
g4
Vunknown
p4171
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08220_3233
p4172
sg8
Vdrug-target interaction (8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid and Bile acid receptor [drugbank_resource:DB08220_3233]
p4173
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3233
p4174
sg14
Vhttp://bio2rdf.org/drugbank:DB08220
p4175
sg16
V(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid [drugbank:DB08220]
p4176
sasS'COL1A2'
p4177
(lp4178
(dp4179
g4
Vunknown
p4180
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00048_3864
p4181
sg8
Vdrug-target interaction Collagenase and Collagen alpha-2(I) chain [drugbank_resource:DB00048_3864]
p4182
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3864
p4183
sg14
Vhttp://bio2rdf.org/drugbank:DB00048
p4184
sg16
VCollagenase [drugbank:DB00048]
p4185
sasS'GRM7'
p4186
(lp4187
(dp4188
g4
Vunknown
p4189
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00142_926
p4190
sg8
Vdrug-target interaction L-Glutamic Acid and Metabotropic glutamate receptor 7 [drugbank_resource:DB00142_926]
p4191
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:926
p4192
sg14
Vhttp://bio2rdf.org/drugbank:DB00142
p4193
sg16
VL-Glutamic Acid [drugbank:DB00142]
p4194
sasS'NR1H2'
p4195
(lp4196
(dp4197
g4
Vunknown
p4198
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03791_2907
p4199
sg8
Vdrug-target interaction (3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid and Oxysterols receptor LXR-beta [drugbank_resource:DB03791_2907]
p4200
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2907
p4201
sg14
Vhttp://bio2rdf.org/drugbank:DB03791
p4202
sg16
V(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid [drugbank:DB03791]
p4203
sa(dp4204
g4
Vunknown
p4205
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03848_2907
p4206
sg8
Vdrug-target interaction Benzenesulfonyl and Oxysterols receptor LXR-beta [drugbank_resource:DB03848_2907]
p4207
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2907
p4208
sg14
Vhttp://bio2rdf.org/drugbank:DB03848
p4209
sg16
VBenzenesulfonyl [drugbank:DB03848]
p4210
sa(dp4211
g4
Vunknown
p4212
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07080_2907
p4213
sg8
Vdrug-target interaction N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE and Oxysterols receptor LXR-beta [drugbank_resource:DB07080_2907]
p4214
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2907
p4215
sg14
Vhttp://bio2rdf.org/drugbank:DB07080
p4216
sg16
VN-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE [drugbank:DB07080]
p4217
sa(dp4218
g4
Vunknown
p4219
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07082_2907
p4220
sg8
Vdrug-target interaction 1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL and Oxysterols receptor LXR-beta [drugbank_resource:DB07082_2907]
p4221
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2907
p4222
sg14
Vhttp://bio2rdf.org/drugbank:DB07082
p4223
sg16
V1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL [drugbank:DB07082]
p4224
sasS'CHEK1'
p4225
(lp4226
(dp4227
g4
Vunknown
p4228
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06876_5790
p4229
sg8
Vdrug-target interaction N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB06876_5790]
p4230
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4231
sg14
Vhttp://bio2rdf.org/drugbank:DB06876
p4232
sg16
VN-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE [drugbank:DB06876]
p4233
sa(dp4234
g4
Vunknown
p4235
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07037_5790
p4236
sg8
Vdrug-target interaction (2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07037_5790]
p4237
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4238
sg14
Vhttp://bio2rdf.org/drugbank:DB07037
p4239
sg16
V(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL [drugbank:DB07037]
p4240
sa(dp4241
g4
Vunknown
p4242
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07038_5790
p4243
sg8
Vdrug-target interaction 2-(cyclohexylamino)benzoic acid and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07038_5790]
p4244
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4245
sg14
Vhttp://bio2rdf.org/drugbank:DB07038
p4246
sg16
V2-(cyclohexylamino)benzoic acid [drugbank:DB07038]
p4247
sa(dp4248
g4
Vunknown
p4249
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07228_5790
p4250
sg8
Vdrug-target interaction 1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07228_5790]
p4251
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4252
sg14
Vhttp://bio2rdf.org/drugbank:DB07228
p4253
sg16
V1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA [drugbank:DB07228]
p4254
sa(dp4255
g4
Vunknown
p4256
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07025_5790
p4257
sg8
Vdrug-target interaction 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07025_5790]
p4258
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4259
sg14
Vhttp://bio2rdf.org/drugbank:DB07025
p4260
sg16
V3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE [drugbank:DB07025]
p4261
sa(dp4262
g4
Vunknown
p4263
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07213_5790
p4264
sg8
Vdrug-target interaction (5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07213_5790]
p4265
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4266
sg14
Vhttp://bio2rdf.org/drugbank:DB07213
p4267
sg16
V(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL [drugbank:DB07213]
p4268
sa(dp4269
g4
Vunknown
p4270
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07243_5790
p4271
sg8
Vdrug-target interaction (3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07243_5790]
p4272
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4273
sg14
Vhttp://bio2rdf.org/drugbank:DB07243
p4274
sg16
V(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE [drugbank:DB07243]
p4275
sa(dp4276
g4
Vunknown
p4277
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07314_5790
p4278
sg8
Vdrug-target interaction 1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07314_5790]
p4279
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4280
sg14
Vhttp://bio2rdf.org/drugbank:DB07314
p4281
sg16
V1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA [drugbank:DB07314]
p4282
sa(dp4283
g4
Vunknown
p4284
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06852_5790
p4285
sg8
Vdrug-target interaction 4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB06852_5790]
p4286
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4287
sg14
Vhttp://bio2rdf.org/drugbank:DB06852
p4288
sg16
V4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE [drugbank:DB06852]
p4289
sa(dp4290
g4
Vunknown
p4291
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07034_5790
p4292
sg8
Vdrug-target interaction 2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07034_5790]
p4293
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4294
sg14
Vhttp://bio2rdf.org/drugbank:DB07034
p4295
sg16
V2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID [drugbank:DB07034]
p4296
sa(dp4297
g4
Vunknown
p4298
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07075_5790
p4299
sg8
Vdrug-target interaction 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07075_5790]
p4300
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4301
sg14
Vhttp://bio2rdf.org/drugbank:DB07075
p4302
sg16
V3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE [drugbank:DB07075]
p4303
sa(dp4304
g4
Vunknown
p4305
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07078_5790
p4306
sg8
Vdrug-target interaction (3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07078_5790]
p4307
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4308
sg14
Vhttp://bio2rdf.org/drugbank:DB07078
p4309
sg16
V(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE [drugbank:DB07078]
p4310
sa(dp4311
g4
Vunknown
p4312
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07158_5790
p4313
sg8
Vdrug-target interaction 5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07158_5790]
p4314
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4315
sg14
Vhttp://bio2rdf.org/drugbank:DB07158
p4316
sg16
V5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE [drugbank:DB07158]
p4317
sa(dp4318
g4
Vunknown
p4319
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07311_5790
p4320
sg8
Vdrug-target interaction 18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07311_5790]
p4321
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4322
sg14
Vhttp://bio2rdf.org/drugbank:DB07311
p4323
sg16
V18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE [drugbank:DB07311]
p4324
sa(dp4325
g4
Vunknown
p4326
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07320_5790
p4327
sg8
Vdrug-target interaction 4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07320_5790]
p4328
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4329
sg14
Vhttp://bio2rdf.org/drugbank:DB07320
p4330
sg16
V4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID [drugbank:DB07320]
p4331
sa(dp4332
g4
Vunknown
p4333
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07336_5790
p4334
sg8
Vdrug-target interaction 4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07336_5790]
p4335
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4336
sg14
Vhttp://bio2rdf.org/drugbank:DB07336
p4337
sg16
V4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL [drugbank:DB07336]
p4338
sa(dp4339
g4
Vunknown
p4340
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07653_5790
p4341
sg8
Vdrug-target interaction N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07653_5790]
p4342
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4343
sg14
Vhttp://bio2rdf.org/drugbank:DB07653
p4344
sg16
VN-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE [drugbank:DB07653]
p4345
sa(dp4346
g4
Vunknown
p4347
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08392_5790
p4348
sg8
Vdrug-target interaction 2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08392_5790]
p4349
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4350
sg14
Vhttp://bio2rdf.org/drugbank:DB08392
p4351
sg16
V2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL [drugbank:DB08392]
p4352
sa(dp4353
g4
Vunknown
p4354
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08393_5790
p4355
sg8
Vdrug-target interaction 2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08393_5790]
p4356
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4357
sg14
Vhttp://bio2rdf.org/drugbank:DB08393
p4358
sg16
V2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL [drugbank:DB08393]
p4359
sa(dp4360
g4
Vunknown
p4361
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07647_5790
p4362
sg8
Vdrug-target interaction (2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07647_5790]
p4363
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4364
sg14
Vhttp://bio2rdf.org/drugbank:DB07647
p4365
sg16
V(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL [drugbank:DB07647]
p4366
sa(dp4367
g4
Vunknown
p4368
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07648_5790
p4369
sg8
Vdrug-target interaction (2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07648_5790]
p4370
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4371
sg14
Vhttp://bio2rdf.org/drugbank:DB07648
p4372
sg16
V(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL [drugbank:DB07648]
p4373
sa(dp4374
g4
Vunknown
p4375
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07654_5790
p4376
sg8
Vdrug-target interaction (5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07654_5790]
p4377
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4378
sg14
Vhttp://bio2rdf.org/drugbank:DB07654
p4379
sg16
V(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC [drugbank:DB07654]
p4380
sa(dp4381
g4
Vunknown
p4382
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08774_5790
p4383
sg8
Vdrug-target interaction 1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08774_5790]
p4384
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4385
sg14
Vhttp://bio2rdf.org/drugbank:DB08774
p4386
sg16
V1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine [drugbank:DB08774]
p4387
sa(dp4388
g4
Vunknown
p4389
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07655_5790
p4390
sg8
Vdrug-target interaction 3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07655_5790]
p4391
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4392
sg14
Vhttp://bio2rdf.org/drugbank:DB07655
p4393
sg16
V3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE [drugbank:DB07655]
p4394
sa(dp4395
g4
Vunknown
p4396
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07959_5790
p4397
sg8
Vdrug-target interaction 3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB07959_5790]
p4398
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4399
sg14
Vhttp://bio2rdf.org/drugbank:DB07959
p4400
sg16
V3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE [drugbank:DB07959]
p4401
sa(dp4402
g4
Vunknown
p4403
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08683_5790
p4404
sg8
Vdrug-target interaction REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08683_5790]
p4405
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4406
sg14
Vhttp://bio2rdf.org/drugbank:DB08683
p4407
sg16
VREL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE [drugbank:DB08683]
p4408
sa(dp4409
g4
Vunknown
p4410
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08776_5790
p4411
sg8
Vdrug-target interaction N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08776_5790]
p4412
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4413
sg14
Vhttp://bio2rdf.org/drugbank:DB08776
p4414
sg16
VN-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE [drugbank:DB08776]
p4415
sa(dp4416
g4
Vunknown
p4417
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08777_5790
p4418
sg8
Vdrug-target interaction 5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08777_5790]
p4419
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4420
sg14
Vhttp://bio2rdf.org/drugbank:DB08777
p4421
sg16
V5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE [drugbank:DB08777]
p4422
sa(dp4423
g4
Vunknown
p4424
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08780_5790
p4425
sg8
Vdrug-target interaction 6-MORPHOLIN-4-YL-9H-PURINE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08780_5790]
p4426
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4427
sg14
Vhttp://bio2rdf.org/drugbank:DB08780
p4428
sg16
V6-MORPHOLIN-4-YL-9H-PURINE [drugbank:DB08780]
p4429
sa(dp4430
g4
Vunknown
p4431
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08778_5790
p4432
sg8
Vdrug-target interaction [4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08778_5790]
p4433
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4434
sg14
Vhttp://bio2rdf.org/drugbank:DB08778
p4435
sg16
V[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone [drugbank:DB08778]
p4436
sa(dp4437
g4
Vunknown
p4438
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08779_5790
p4439
sg8
Vdrug-target interaction 2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08779_5790]
p4440
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4441
sg14
Vhttp://bio2rdf.org/drugbank:DB08779
p4442
sg16
V2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol [drugbank:DB08779]
p4443
sa(dp4444
g4
Vunknown
p4445
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08781_5790
p4446
sg8
Vdrug-target interaction 1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE and Serine/threonine-protein kinase Chk1 [drugbank_resource:DB08781_5790]
p4447
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5790
p4448
sg14
Vhttp://bio2rdf.org/drugbank:DB08781
p4449
sg16
V1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE [drugbank:DB08781]
p4450
sasS'SLC12A5'
p4451
(lp4452
(dp4453
g4
Vunknown
p4454
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00761_53
p4455
sg8
Vdrug-target interaction Potassium Chloride and Solute carrier family 12 member 5 [drugbank_resource:DB00761_53]
p4456
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:53
p4457
sg14
Vhttp://bio2rdf.org/drugbank:DB00761
p4458
sg16
VPotassium Chloride [drugbank:DB00761]
p4459
sa(dp4460
g4
Vyes
p4461
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00887_53
p4462
sg8
Vdrug-target interaction Bumetanide and Solute carrier family 12 member 5 [drugbank_resource:DB00887_53]
p4463
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:53
p4464
sg14
Vhttp://bio2rdf.org/drugbank:DB00887
p4465
sg16
VBumetanide [drugbank:DB00887]
p4466
sasS'FOS'
p4467
(lp4468
(dp4469
g4
Vunknown
p4470
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08813_1953
p4471
sg8
Vdrug-target interaction Nadroparin and Proto-oncogene protein c-fos [drugbank_resource:DB08813_1953]
p4472
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1953
p4473
sg14
Vhttp://bio2rdf.org/drugbank:DB08813
p4474
sg16
VNadroparin [drugbank:DB08813]
p4475
sasS'CDC25B'
p4476
(lp4477
(dp4478
g4
Vunknown
p4479
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01769_3105
p4480
sg8
Vdrug-target interaction Double Oxidized Cysteine and M-phase inducer phosphatase 2 [drugbank_resource:DB01769_3105]
p4481
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3105
p4482
sg14
Vhttp://bio2rdf.org/drugbank:DB01769
p4483
sg16
VDouble Oxidized Cysteine [drugbank:DB01769]
p4484
sa(dp4485
g4
Vunknown
p4486
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03661_3105
p4487
sg8
Vdrug-target interaction Cysteinesulfonic Acid and M-phase inducer phosphatase 2 [drugbank_resource:DB03661_3105]
p4488
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3105
p4489
sg14
Vhttp://bio2rdf.org/drugbank:DB03661
p4490
sg16
VCysteinesulfonic Acid [drugbank:DB03661]
p4491
sa(dp4492
g4
Vunknown
p4493
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03674_3105
p4494
sg8
Vdrug-target interaction Methyl Mercury Ion and M-phase inducer phosphatase 2 [drugbank_resource:DB03674_3105]
p4495
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3105
p4496
sg14
Vhttp://bio2rdf.org/drugbank:DB03674
p4497
sg16
VMethyl Mercury Ion [drugbank:DB03674]
p4498
sasS'CDK7'
p4499
(lp4500
(dp4501
g4
Vunknown
p4502
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02482_3482
p4503
sg8
Vdrug-target interaction Phosphonothreonine and Cell division protein kinase 7 [drugbank_resource:DB02482_3482]
p4504
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3482
p4505
sg14
Vhttp://bio2rdf.org/drugbank:DB02482
p4506
sg16
VPhosphonothreonine [drugbank:DB02482]
p4507
sa(dp4508
g4
Vunknown
p4509
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03496_3482
p4510
sg8
Vdrug-target interaction Flavopiridol and Cell division protein kinase 7 [drugbank_resource:DB03496_3482]
p4511
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3482
p4512
sg14
Vhttp://bio2rdf.org/drugbank:DB03496
p4513
sg16
VFlavopiridol [drugbank:DB03496]
p4514
sasS'PARP1'
p4515
(lp4516
(dp4517
g4
Vunknown
p4518
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02690_3126
p4519
sg8
Vdrug-target interaction NU1025 and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB02690_3126]
p4520
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3126
p4521
sg14
Vhttp://bio2rdf.org/drugbank:DB02690
p4522
sg16
VNU1025 [drugbank:DB02690]
p4523
sa(dp4524
g4
Vunknown
p4525
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02498_3126
p4526
sg8
Vdrug-target interaction Carba-Nicotinamide-Adenine-Dinucleotide and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB02498_3126]
p4527
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3126
p4528
sg14
Vhttp://bio2rdf.org/drugbank:DB02498
p4529
sg16
VCarba-Nicotinamide-Adenine-Dinucleotide [drugbank:DB02498]
p4530
sa(dp4531
g4
Vunknown
p4532
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02701_3126
p4533
sg8
Vdrug-target interaction Nicotinamide and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB02701_3126]
p4534
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3126
p4535
sg14
Vhttp://bio2rdf.org/drugbank:DB02701
p4536
sg16
VNicotinamide [drugbank:DB02701]
p4537
sa(dp4538
g4
Vunknown
p4539
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03072_3126
p4540
sg8
Vdrug-target interaction 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB03072_3126]
p4541
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3126
p4542
sg14
Vhttp://bio2rdf.org/drugbank:DB03072
p4543
sg16
V2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone [drugbank:DB03072]
p4544
sa(dp4545
g4
Vunknown
p4546
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03073_3126
p4547
sg8
Vdrug-target interaction 3-Methoxybenzamide and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB03073_3126]
p4548
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3126
p4549
sg14
Vhttp://bio2rdf.org/drugbank:DB03073
p4550
sg16
V3-Methoxybenzamide [drugbank:DB03073]
p4551
sa(dp4552
g4
Vunknown
p4553
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03722_3126
p4554
sg8
Vdrug-target interaction 3,4-Dihydro-5-Methyl-Isoquinolinone and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB03722_3126]
p4555
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3126
p4556
sg14
Vhttp://bio2rdf.org/drugbank:DB03722
p4557
sg16
V3,4-Dihydro-5-Methyl-Isoquinolinone [drugbank:DB03722]
p4558
sa(dp4559
g4
Vunknown
p4560
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03509_3126
p4561
sg8
Vdrug-target interaction 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB03509_3126]
p4562
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3126
p4563
sg14
Vhttp://bio2rdf.org/drugbank:DB03509
p4564
sg16
V2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide [drugbank:DB03509]
p4565
sa(dp4566
g4
Vunknown
p4567
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04010_3126
p4568
sg8
Vdrug-target interaction 2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB04010_3126]
p4569
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3126
p4570
sg14
Vhttp://bio2rdf.org/drugbank:DB04010
p4571
sg16
V2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide [drugbank:DB04010]
p4572
sa(dp4573
g4
Vunknown
p4574
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07096_3126
p4575
sg8
Vdrug-target interaction 6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB07096_3126]
p4576
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3126
p4577
sg14
Vhttp://bio2rdf.org/drugbank:DB07096
p4578
sg16
V6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE [drugbank:DB07096]
p4579
sa(dp4580
g4
Vunknown
p4581
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07232_3126
p4582
sg8
Vdrug-target interaction (2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB07232_3126]
p4583
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3126
p4584
sg14
Vhttp://bio2rdf.org/drugbank:DB07232
p4585
sg16
V(2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium [drugbank:DB07232]
p4586
sa(dp4587
g4
Vunknown
p4588
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07330_3126
p4589
sg8
Vdrug-target interaction trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB07330_3126]
p4590
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3126
p4591
sg14
Vhttp://bio2rdf.org/drugbank:DB07330
p4592
sg16
Vtrans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium [drugbank:DB07330]
p4593
sa(dp4594
g4
Vunknown
p4595
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07787_3126
p4596
sg8
Vdrug-target interaction 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE and Poly [ADP-ribose] polymerase 1 [drugbank_resource:DB07787_3126]
p4597
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3126
p4598
sg14
Vhttp://bio2rdf.org/drugbank:DB07787
p4599
sg16
V5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE [drugbank:DB07787]
p4600
sasS'HIF1A'
p4601
(lp4602
(dp4603
g4
Vunknown
p4604
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08687_4130
p4605
sg8
Vdrug-target interaction N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE and Hypoxia-inducible factor 1 alpha [drugbank_resource:DB08687_4130]
p4606
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4130
p4607
sg14
Vhttp://bio2rdf.org/drugbank:DB08687
p4608
sg16
VN-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE [drugbank:DB08687]
p4609
sasS'GLRB'
p4610
(lp4611
(dp4612
g4
Vunknown
p4613
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00145_62
p4614
sg8
Vdrug-target interaction Glycine and Glycine receptor subunit beta [drugbank_resource:DB00145_62]
p4615
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:62
p4616
sg14
Vhttp://bio2rdf.org/drugbank:DB00145
p4617
sg16
VGlycine [drugbank:DB00145]
p4618
sa(dp4619
g4
Vunknown
p4620
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00431_62
p4621
sg8
Vdrug-target interaction Lindane and Glycine receptor subunit beta [drugbank_resource:DB00431_62]
p4622
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:62
p4623
sg14
Vhttp://bio2rdf.org/drugbank:DB00431
p4624
sg16
VLindane [drugbank:DB00431]
p4625
sasS'IGFBP3'
p4626
(lp4627
(dp4628
g4
Vunknown
p4629
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01277_1350
p4630
sg8
Vdrug-target interaction Mecasermin and Insulin-like growth factor-binding protein 3 [drugbank_resource:DB01277_1350]
p4631
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1350
p4632
sg14
Vhttp://bio2rdf.org/drugbank:DB01277
p4633
sg16
VMecasermin [drugbank:DB01277]
p4634
sasS'VEGFA'
p4635
(lp4636
(dp4637
g4
Vyes
p4638
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00112_183
p4639
sg8
Vdrug-target interaction Bevacizumab and Vascular endothelial growth factor A [drugbank_resource:DB00112_183]
p4640
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:183
p4641
sg14
Vhttp://bio2rdf.org/drugbank:DB00112
p4642
sg16
VBevacizumab [drugbank:DB00112]
p4643
sa(dp4644
g4
Vunknown
p4645
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01017_183
p4646
sg8
Vdrug-target interaction Minocycline and Vascular endothelial growth factor A [drugbank_resource:DB01017_183]
p4647
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:183
p4648
sg14
Vhttp://bio2rdf.org/drugbank:DB01017
p4649
sg16
VMinocycline [drugbank:DB01017]
p4650
sa(dp4651
g4
Vunknown
p4652
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01120_183
p4653
sg8
Vdrug-target interaction Gliclazide and Vascular endothelial growth factor A [drugbank_resource:DB01120_183]
p4654
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:183
p4655
sg14
Vhttp://bio2rdf.org/drugbank:DB01120
p4656
sg16
VGliclazide [drugbank:DB01120]
p4657
sa(dp4658
g4
Vunknown
p4659
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01136_183
p4660
sg8
Vdrug-target interaction Carvedilol and Vascular endothelial growth factor A [drugbank_resource:DB01136_183]
p4661
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:183
p4662
sg14
Vhttp://bio2rdf.org/drugbank:DB01136
p4663
sg16
VCarvedilol [drugbank:DB01136]
p4664
sa(dp4665
g4
Vyes
p4666
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01270_183
p4667
sg8
Vdrug-target interaction Ranibizumab and Vascular endothelial growth factor A [drugbank_resource:DB01270_183]
p4668
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:183
p4669
sg14
Vhttp://bio2rdf.org/drugbank:DB01270
p4670
sg16
VRanibizumab [drugbank:DB01270]
p4671
sa(dp4672
g4
Vunknown
p4673
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03088_183
p4674
sg8
Vdrug-target interaction Pyroglutamic Acid and Vascular endothelial growth factor A [drugbank_resource:DB03088_183]
p4675
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:183
p4676
sg14
Vhttp://bio2rdf.org/drugbank:DB03088
p4677
sg16
VPyroglutamic Acid [drugbank:DB03088]
p4678
sa(dp4679
g4
Vunknown
p4680
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03754_183
p4681
sg8
Vdrug-target interaction Tris(Hydroxymethyl)Aminomethane and Vascular endothelial growth factor A [drugbank_resource:DB03754_183]
p4682
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:183
p4683
sg14
Vhttp://bio2rdf.org/drugbank:DB03754
p4684
sg16
VTris(Hydroxymethyl)Aminomethane [drugbank:DB03754]
p4685
sa(dp4686
g4
Vyes
p4687
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06779_183
p4688
sg8
Vdrug-target interaction Dalteparin and Vascular endothelial growth factor A [drugbank_resource:DB06779_183]
p4689
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:183
p4690
sg14
Vhttp://bio2rdf.org/drugbank:DB06779
p4691
sg16
VDalteparin [drugbank:DB06779]
p4692
sasS'PLAU'
p4693
(lp4694
(dp4695
g4
Vyes
p4696
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00013_1074
p4697
sg8
Vdrug-target interaction Urokinase and Urokinase-type plasminogen activator [drugbank_resource:DB00013_1074]
p4698
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4699
sg14
Vhttp://bio2rdf.org/drugbank:DB00013
p4700
sg16
VUrokinase [drugbank:DB00013]
p4701
sa(dp4702
g4
Vunknown
p4703
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00594_1074
p4704
sg8
Vdrug-target interaction Amiloride and Urokinase-type plasminogen activator [drugbank_resource:DB00594_1074]
p4705
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4706
sg14
Vhttp://bio2rdf.org/drugbank:DB00594
p4707
sg16
VAmiloride [drugbank:DB00594]
p4708
sa(dp4709
g4
Vunknown
p4710
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01905_1074
p4711
sg8
Vdrug-target interaction 2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB01905_1074]
p4712
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4713
sg14
Vhttp://bio2rdf.org/drugbank:DB01905
p4714
sg16
V2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine [drugbank:DB01905]
p4715
sa(dp4716
g4
Vunknown
p4717
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01977_1074
p4718
sg8
Vdrug-target interaction 6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB01977_1074]
p4719
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4720
sg14
Vhttp://bio2rdf.org/drugbank:DB01977
p4721
sg16
V6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine [drugbank:DB01977]
p4722
sa(dp4723
g4
Vunknown
p4724
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02526_1074
p4725
sg8
Vdrug-target interaction CRA_10655 and Urokinase-type plasminogen activator [drugbank_resource:DB02526_1074]
p4726
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4727
sg14
Vhttp://bio2rdf.org/drugbank:DB02526
p4728
sg16
VCRA_10655 [drugbank:DB02526]
p4729
sa(dp4730
g4
Vunknown
p4731
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02551_1074
p4732
sg8
Vdrug-target interaction 6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB02551_1074]
p4733
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4734
sg14
Vhttp://bio2rdf.org/drugbank:DB02551
p4735
sg16
V6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine [drugbank:DB02551]
p4736
sa(dp4737
g4
Vunknown
p4738
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02193_1074
p4739
sg8
Vdrug-target interaction 2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB02193_1074]
p4740
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4741
sg14
Vhttp://bio2rdf.org/drugbank:DB02193
p4742
sg16
V2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine [drugbank:DB02193]
p4743
sa(dp4744
g4
Vunknown
p4745
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02705_1074
p4746
sg8
Vdrug-target interaction 6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB02705_1074]
p4747
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4748
sg14
Vhttp://bio2rdf.org/drugbank:DB02705
p4749
sg16
V6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine [drugbank:DB02705]
p4750
sa(dp4751
g4
Vunknown
p4752
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03046_1074
p4753
sg8
Vdrug-target interaction 7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide and Urokinase-type plasminogen activator [drugbank_resource:DB03046_1074]
p4754
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4755
sg14
Vhttp://bio2rdf.org/drugbank:DB03046
p4756
sg16
V7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide [drugbank:DB03046]
p4757
sa(dp4758
g4
Vunknown
p4759
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03127_1074
p4760
sg8
Vdrug-target interaction Benzamidine and Urokinase-type plasminogen activator [drugbank_resource:DB03127_1074]
p4761
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4762
sg14
Vhttp://bio2rdf.org/drugbank:DB03127
p4763
sg16
VBenzamidine [drugbank:DB03127]
p4764
sa(dp4765
g4
Vunknown
p4766
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03136_1074
p4767
sg8
Vdrug-target interaction 4-Iodobenzo[B]Thiophene-2-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB03136_1074]
p4768
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4769
sg14
Vhttp://bio2rdf.org/drugbank:DB03136
p4770
sg16
V4-Iodobenzo[B]Thiophene-2-Carboxamidine [drugbank:DB03136]
p4771
sa(dp4772
g4
Vunknown
p4773
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03159_1074
p4774
sg8
Vdrug-target interaction CRA_8696 and Urokinase-type plasminogen activator [drugbank_resource:DB03159_1074]
p4775
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4776
sg14
Vhttp://bio2rdf.org/drugbank:DB03159
p4777
sg16
VCRA_8696 [drugbank:DB03159]
p4778
sa(dp4779
g4
Vunknown
p4780
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02398_1074
p4781
sg8
Vdrug-target interaction 6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB02398_1074]
p4782
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4783
sg14
Vhttp://bio2rdf.org/drugbank:DB02398
p4784
sg16
V6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine [drugbank:DB02398]
p4785
sa(dp4786
g4
Vunknown
p4787
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02473_1074
p4788
sg8
Vdrug-target interaction 6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB02473_1074]
p4789
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4790
sg14
Vhttp://bio2rdf.org/drugbank:DB02473
p4791
sg16
V6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine [drugbank:DB02473]
p4792
sa(dp4793
g4
Vunknown
p4794
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03082_1074
p4795
sg8
Vdrug-target interaction 6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide and Urokinase-type plasminogen activator [drugbank_resource:DB03082_1074]
p4796
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4797
sg14
Vhttp://bio2rdf.org/drugbank:DB03082
p4798
sg16
V6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide [drugbank:DB03082]
p4799
sa(dp4800
g4
Vunknown
p4801
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03476_1074
p4802
sg8
Vdrug-target interaction Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB03476_1074]
p4803
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4804
sg14
Vhttp://bio2rdf.org/drugbank:DB03476
p4805
sg16
VTrans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine [drugbank:DB03476]
p4806
sa(dp4807
g4
Vunknown
p4808
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03782_1074
p4809
sg8
Vdrug-target interaction N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea and Urokinase-type plasminogen activator [drugbank_resource:DB03782_1074]
p4810
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4811
sg14
Vhttp://bio2rdf.org/drugbank:DB03782
p4812
sg16
VN-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea [drugbank:DB03782]
p4813
sa(dp4814
g4
Vunknown
p4815
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03876_1074
p4816
sg8
Vdrug-target interaction Thieno[2,3-B]Pyridine-2-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB03876_1074]
p4817
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4818
sg14
Vhttp://bio2rdf.org/drugbank:DB03876
p4819
sg16
VThieno[2,3-B]Pyridine-2-Carboxamidine [drugbank:DB03876]
p4820
sa(dp4821
g4
Vunknown
p4822
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03865_1074
p4823
sg8
Vdrug-target interaction 6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine and Urokinase-type plasminogen activator [drugbank_resource:DB03865_1074]
p4824
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4825
sg14
Vhttp://bio2rdf.org/drugbank:DB03865
p4826
sg16
V6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine [drugbank:DB03865]
p4827
sa(dp4828
g4
Vunknown
p4829
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04059_1074
p4830
sg8
Vdrug-target interaction 8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide and Urokinase-type plasminogen activator [drugbank_resource:DB04059_1074]
p4831
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4832
sg14
Vhttp://bio2rdf.org/drugbank:DB04059
p4833
sg16
V8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide [drugbank:DB04059]
p4834
sa(dp4835
g4
Vunknown
p4836
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03729_1074
p4837
sg8
Vdrug-target interaction 2-Amino-5-Hydroxy-Benzimidazole and Urokinase-type plasminogen activator [drugbank_resource:DB03729_1074]
p4838
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4839
sg14
Vhttp://bio2rdf.org/drugbank:DB03729
p4840
sg16
V2-Amino-5-Hydroxy-Benzimidazole [drugbank:DB03729]
p4841
sa(dp4842
g4
Vunknown
p4843
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04172_1074
p4844
sg8
Vdrug-target interaction [2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine and Urokinase-type plasminogen activator [drugbank_resource:DB04172_1074]
p4845
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4846
sg14
Vhttp://bio2rdf.org/drugbank:DB04172
p4847
sg16
V[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine [drugbank:DB04172]
p4848
sa(dp4849
g4
Vunknown
p4850
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06857_1074
p4851
sg8
Vdrug-target interaction N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE and Urokinase-type plasminogen activator [drugbank_resource:DB06857_1074]
p4852
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4853
sg14
Vhttp://bio2rdf.org/drugbank:DB06857
p4854
sg16
VN-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE [drugbank:DB06857]
p4855
sa(dp4856
g4
Vunknown
p4857
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07122_1074
p4858
sg8
Vdrug-target interaction 1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine and Urokinase-type plasminogen activator [drugbank_resource:DB07122_1074]
p4859
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4860
sg14
Vhttp://bio2rdf.org/drugbank:DB07122
p4861
sg16
V1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine [drugbank:DB07122]
p4862
sa(dp4863
g4
Vunknown
p4864
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06855_1074
p4865
sg8
Vdrug-target interaction 6-FLUORO-2-(2-HYDROXY-3-ISOBUTOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE and Urokinase-type plasminogen activator [drugbank_resource:DB06855_1074]
p4866
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4867
sg14
Vhttp://bio2rdf.org/drugbank:DB06855
p4868
sg16
V6-FLUORO-2-(2-HYDROXY-3-ISOBUTOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE [drugbank:DB06855]
p4869
sa(dp4870
g4
Vunknown
p4871
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06856_1074
p4872
sg8
Vdrug-target interaction 6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE and Urokinase-type plasminogen activator [drugbank_resource:DB06856_1074]
p4873
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4874
sg14
Vhttp://bio2rdf.org/drugbank:DB06856
p4875
sg16
V6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE [drugbank:DB06856]
p4876
sa(dp4877
g4
Vunknown
p4878
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07076_1074
p4879
sg8
Vdrug-target interaction 6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE and Urokinase-type plasminogen activator [drugbank_resource:DB07076_1074]
p4880
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4881
sg14
Vhttp://bio2rdf.org/drugbank:DB07076
p4882
sg16
V6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE [drugbank:DB07076]
p4883
sa(dp4884
g4
Vunknown
p4885
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06854_1074
p4886
sg8
Vdrug-target interaction 2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE and Urokinase-type plasminogen activator [drugbank_resource:DB06854_1074]
p4887
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4888
sg14
Vhttp://bio2rdf.org/drugbank:DB06854
p4889
sg16
V2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE [drugbank:DB06854]
p4890
sa(dp4891
g4
Vunknown
p4892
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07129_1074
p4893
sg8
Vdrug-target interaction (2R)-1-(2,6-dimethylphenoxy)propan-2-amine and Urokinase-type plasminogen activator [drugbank_resource:DB07129_1074]
p4894
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4895
sg14
Vhttp://bio2rdf.org/drugbank:DB07129
p4896
sg16
V(2R)-1-(2,6-dimethylphenoxy)propan-2-amine [drugbank:DB07129]
p4897
sa(dp4898
g4
Vunknown
p4899
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07625_1074
p4900
sg8
Vdrug-target interaction 4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide and Urokinase-type plasminogen activator [drugbank_resource:DB07625_1074]
p4901
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4902
sg14
Vhttp://bio2rdf.org/drugbank:DB07625
p4903
sg16
V4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide [drugbank:DB07625]
p4904
sa(dp4905
g4
Vunknown
p4906
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07626_1074
p4907
sg8
Vdrug-target interaction 4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide and Urokinase-type plasminogen activator [drugbank_resource:DB07626_1074]
p4908
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4909
sg14
Vhttp://bio2rdf.org/drugbank:DB07626
p4910
sg16
V4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide [drugbank:DB07626]
p4911
sa(dp4912
g4
Vunknown
p4913
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08072_1074
p4914
sg8
Vdrug-target interaction 4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE and Urokinase-type plasminogen activator [drugbank_resource:DB08072_1074]
p4915
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4916
sg14
Vhttp://bio2rdf.org/drugbank:DB08072
p4917
sg16
V4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE [drugbank:DB08072]
p4918
sa(dp4919
g4
Vunknown
p4920
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08697_1074
p4921
sg8
Vdrug-target interaction 4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide and Urokinase-type plasminogen activator [drugbank_resource:DB08697_1074]
p4922
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1074
p4923
sg14
Vhttp://bio2rdf.org/drugbank:DB08697
p4924
sg16
V4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide [drugbank:DB08697]
p4925
sasS'PPARA'
p4926
(lp4927
(dp4928
g4
Vyes
p4929
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00636_80
p4930
sg8
Vdrug-target interaction Clofibrate and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB00636_80]
p4931
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:80
p4932
sg14
Vhttp://bio2rdf.org/drugbank:DB00636
p4933
sg16
VClofibrate [drugbank:DB00636]
p4934
sa(dp4935
g4
Vyes
p4936
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01039_80
p4937
sg8
Vdrug-target interaction Fenofibrate and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB01039_80]
p4938
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:80
p4939
sg14
Vhttp://bio2rdf.org/drugbank:DB01039
p4940
sg16
VFenofibrate [drugbank:DB01039]
p4941
sa(dp4942
g4
Vyes
p4943
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01241_80
p4944
sg8
Vdrug-target interaction Gemfibrozil and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB01241_80]
p4945
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:80
p4946
sg14
Vhttp://bio2rdf.org/drugbank:DB01241
p4947
sg16
VGemfibrozil [drugbank:DB01241]
p4948
sa(dp4949
g4
Vyes
p4950
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01393_80
p4951
sg8
Vdrug-target interaction Bezafibrate and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB01393_80]
p4952
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:80
p4953
sg14
Vhttp://bio2rdf.org/drugbank:DB01393
p4954
sg16
VBezafibrate [drugbank:DB01393]
p4955
sa(dp4956
g4
Vunknown
p4957
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01890_80
p4958
sg8
Vdrug-target interaction Deoxy-Bigchap and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB01890_80]
p4959
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:80
p4960
sg14
Vhttp://bio2rdf.org/drugbank:DB01890
p4961
sg16
VDeoxy-Bigchap [drugbank:DB01890]
p4962
sa(dp4963
g4
Vunknown
p4964
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07215_80
p4965
sg8
Vdrug-target interaction 2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB07215_80]
p4966
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:80
p4967
sg14
Vhttp://bio2rdf.org/drugbank:DB07215
p4968
sg16
V2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID [drugbank:DB07215]
p4969
sa(dp4970
g4
Vunknown
p4971
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07724_80
p4972
sg8
Vdrug-target interaction 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB07724_80]
p4973
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:80
p4974
sg14
Vhttp://bio2rdf.org/drugbank:DB07724
p4975
sg16
V3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid [drugbank:DB07724]
p4976
sa(dp4977
g4
Vunknown
p4978
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08483_80
p4979
sg8
Vdrug-target interaction (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid and Peroxisome proliferator-activated receptor alpha [drugbank_resource:DB08483_80]
p4980
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:80
p4981
sg14
Vhttp://bio2rdf.org/drugbank:DB08483
p4982
sg16
V(2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid [drugbank:DB08483]
p4983
sasS'HCK'
p4984
(lp4985
(dp4986
g4
Vunknown
p4987
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01809_2599
p4988
sg8
Vdrug-target interaction 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine and Tyrosine-protein kinase HCK [drugbank_resource:DB01809_2599]
p4989
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2599
p4990
sg14
Vhttp://bio2rdf.org/drugbank:DB01809
p4991
sg16
V1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine [drugbank:DB01809]
p4992
sa(dp4993
g4
Vunknown
p4994
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01962_2599
p4995
sg8
Vdrug-target interaction Phosphonotyrosine and Tyrosine-protein kinase HCK [drugbank_resource:DB01962_2599]
p4996
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2599
p4997
sg14
Vhttp://bio2rdf.org/drugbank:DB01962
p4998
sg16
VPhosphonotyrosine [drugbank:DB01962]
p4999
sa(dp5000
g4
Vunknown
p5001
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04216_2599
p5002
sg8
Vdrug-target interaction Quercetin and Tyrosine-protein kinase HCK [drugbank_resource:DB04216_2599]
p5003
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2599
p5004
sg14
Vhttp://bio2rdf.org/drugbank:DB04216
p5005
sg16
VQuercetin [drugbank:DB04216]
p5006
sasS'RHOA'
p5007
(lp5008
(dp5009
g4
Vunknown
p5010
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04315_2170
p5011
sg8
Vdrug-target interaction Guanosine-5'-Diphosphate and Transforming protein RhoA [drugbank_resource:DB04315_2170]
p5012
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2170
p5013
sg14
Vhttp://bio2rdf.org/drugbank:DB04315
p5014
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p5015
sasS'ITPR1'
p5016
(lp5017
(dp5018
g4
Vunknown
p5019
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03401_7032
p5020
sg8
Vdrug-target interaction D-Myo-Inositol-1,4,5-Triphosphate and Inositol 1,4,5-trisphosphate receptor type 1 [drugbank_resource:DB03401_7032]
p5021
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7032
p5022
sg14
Vhttp://bio2rdf.org/drugbank:DB03401
p5023
sg16
VD-Myo-Inositol-1,4,5-Triphosphate [drugbank:DB03401]
p5024
sa(dp5025
g4
Vunknown
p5026
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04077_7032
p5027
sg8
Vdrug-target interaction Glycerol and Inositol 1,4,5-trisphosphate receptor type 1 [drugbank_resource:DB04077_7032]
p5028
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7032
p5029
sg14
Vhttp://bio2rdf.org/drugbank:DB04077
p5030
sg16
VGlycerol [drugbank:DB04077]
p5031
sasS'NR3C1'
p5032
(lp5033
(dp5034
g4
Vyes
p5035
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00180_871
p5036
sg8
Vdrug-target interaction Flunisolide and Glucocorticoid receptor [drugbank_resource:DB00180_871]
p5037
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5038
sg14
Vhttp://bio2rdf.org/drugbank:DB00180
p5039
sg16
VFlunisolide [drugbank:DB00180]
p5040
sa(dp5041
g4
Vyes
p5042
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00288_871
p5043
sg8
Vdrug-target interaction Amcinonide and Glucocorticoid receptor [drugbank_resource:DB00288_871]
p5044
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5045
sg14
Vhttp://bio2rdf.org/drugbank:DB00288
p5046
sg16
VAmcinonide [drugbank:DB00288]
p5047
sa(dp5048
g4
Vyes
p5049
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00223_871
p5050
sg8
Vdrug-target interaction Diflorasone and Glucocorticoid receptor [drugbank_resource:DB00223_871]
p5051
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5052
sg14
Vhttp://bio2rdf.org/drugbank:DB00223
p5053
sg16
VDiflorasone [drugbank:DB00223]
p5054
sa(dp5055
g4
Vyes
p5056
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00240_871
p5057
sg8
Vdrug-target interaction Alclometasone and Glucocorticoid receptor [drugbank_resource:DB00240_871]
p5058
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5059
sg14
Vhttp://bio2rdf.org/drugbank:DB00240
p5060
sg16
VAlclometasone [drugbank:DB00240]
p5061
sa(dp5062
g4
Vyes
p5063
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00253_871
p5064
sg8
Vdrug-target interaction Medrysone and Glucocorticoid receptor [drugbank_resource:DB00253_871]
p5065
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5066
sg14
Vhttp://bio2rdf.org/drugbank:DB00253
p5067
sg16
VMedrysone [drugbank:DB00253]
p5068
sa(dp5069
g4
Vyes
p5070
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00591_871
p5071
sg8
Vdrug-target interaction Fluocinolone Acetonide and Glucocorticoid receptor [drugbank_resource:DB00591_871]
p5072
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5073
sg14
Vhttp://bio2rdf.org/drugbank:DB00591
p5074
sg16
VFluocinolone Acetonide [drugbank:DB00591]
p5075
sa(dp5076
g4
Vunknown
p5077
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00351_871
p5078
sg8
Vdrug-target interaction Megestrol and Glucocorticoid receptor [drugbank_resource:DB00351_871]
p5079
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5080
sg14
Vhttp://bio2rdf.org/drugbank:DB00351
p5081
sg16
VMegestrol [drugbank:DB00351]
p5082
sa(dp5083
g4
Vyes
p5084
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00394_871
p5085
sg8
Vdrug-target interaction Beclometasone dipropionate and Glucocorticoid receptor [drugbank_resource:DB00394_871]
p5086
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5087
sg14
Vhttp://bio2rdf.org/drugbank:DB00394
p5088
sg16
VBeclometasone dipropionate [drugbank:DB00394]
p5089
sa(dp5090
g4
Vyes
p5091
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00443_871
p5092
sg8
Vdrug-target interaction Betamethasone and Glucocorticoid receptor [drugbank_resource:DB00443_871]
p5093
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5094
sg14
Vhttp://bio2rdf.org/drugbank:DB00443
p5095
sg16
VBetamethasone [drugbank:DB00443]
p5096
sa(dp5097
g4
Vyes
p5098
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00588_871
p5099
sg8
Vdrug-target interaction Fluticasone Propionate and Glucocorticoid receptor [drugbank_resource:DB00588_871]
p5100
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5101
sg14
Vhttp://bio2rdf.org/drugbank:DB00588
p5102
sg16
VFluticasone Propionate [drugbank:DB00588]
p5103
sa(dp5104
g4
Vyes
p5105
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00620_871
p5106
sg8
Vdrug-target interaction Triamcinolone and Glucocorticoid receptor [drugbank_resource:DB00620_871]
p5107
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5108
sg14
Vhttp://bio2rdf.org/drugbank:DB00620
p5109
sg16
VTriamcinolone [drugbank:DB00620]
p5110
sa(dp5111
g4
Vyes
p5112
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00635_871
p5113
sg8
Vdrug-target interaction Prednisone and Glucocorticoid receptor [drugbank_resource:DB00635_871]
p5114
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5115
sg14
Vhttp://bio2rdf.org/drugbank:DB00635
p5116
sg16
VPrednisone [drugbank:DB00635]
p5117
sa(dp5118
g4
Vyes
p5119
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00324_871
p5120
sg8
Vdrug-target interaction Fluorometholone and Glucocorticoid receptor [drugbank_resource:DB00324_871]
p5121
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5122
sg14
Vhttp://bio2rdf.org/drugbank:DB00324
p5123
sg16
VFluorometholone [drugbank:DB00324]
p5124
sa(dp5125
g4
Vyes
p5126
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00547_871
p5127
sg8
Vdrug-target interaction Desoximetasone and Glucocorticoid receptor [drugbank_resource:DB00547_871]
p5128
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5129
sg14
Vhttp://bio2rdf.org/drugbank:DB00547
p5130
sg16
VDesoximetasone [drugbank:DB00547]
p5131
sa(dp5132
g4
Vyes
p5133
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00596_871
p5134
sg8
Vdrug-target interaction Halobetasol Propionate and Glucocorticoid receptor [drugbank_resource:DB00596_871]
p5135
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5136
sg14
Vhttp://bio2rdf.org/drugbank:DB00596
p5137
sg16
VHalobetasol Propionate [drugbank:DB00596]
p5138
sa(dp5139
g4
Vyes
p5140
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00663_871
p5141
sg8
Vdrug-target interaction Flumethasone Pivalate and Glucocorticoid receptor [drugbank_resource:DB00663_871]
p5142
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5143
sg14
Vhttp://bio2rdf.org/drugbank:DB00663
p5144
sg16
VFlumethasone Pivalate [drugbank:DB00663]
p5145
sa(dp5146
g4
Vunknown
p5147
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00687_871
p5148
sg8
Vdrug-target interaction Fludrocortisone and Glucocorticoid receptor [drugbank_resource:DB00687_871]
p5149
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5150
sg14
Vhttp://bio2rdf.org/drugbank:DB00687
p5151
sg16
VFludrocortisone [drugbank:DB00687]
p5152
sa(dp5153
g4
Vyes
p5154
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00741_871
p5155
sg8
Vdrug-target interaction Hydrocortisone and Glucocorticoid receptor [drugbank_resource:DB00741_871]
p5156
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5157
sg14
Vhttp://bio2rdf.org/drugbank:DB00741
p5158
sg16
VHydrocortisone [drugbank:DB00741]
p5159
sa(dp5160
g4
Vyes
p5161
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00764_871
p5162
sg8
Vdrug-target interaction Mometasone and Glucocorticoid receptor [drugbank_resource:DB00764_871]
p5163
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5164
sg14
Vhttp://bio2rdf.org/drugbank:DB00764
p5165
sg16
VMometasone [drugbank:DB00764]
p5166
sa(dp5167
g4
Vyes
p5168
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00834_871
p5169
sg8
Vdrug-target interaction Mifepristone and Glucocorticoid receptor [drugbank_resource:DB00834_871]
p5170
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5171
sg14
Vhttp://bio2rdf.org/drugbank:DB00834
p5172
sg16
VMifepristone [drugbank:DB00834]
p5173
sa(dp5174
g4
Vyes
p5175
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00838_871
p5176
sg8
Vdrug-target interaction Clocortolone and Glucocorticoid receptor [drugbank_resource:DB00838_871]
p5177
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5178
sg14
Vhttp://bio2rdf.org/drugbank:DB00838
p5179
sg16
VClocortolone [drugbank:DB00838]
p5180
sa(dp5181
g4
Vyes
p5182
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00860_871
p5183
sg8
Vdrug-target interaction Prednisolone and Glucocorticoid receptor [drugbank_resource:DB00860_871]
p5184
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5185
sg14
Vhttp://bio2rdf.org/drugbank:DB00860
p5186
sg16
VPrednisolone [drugbank:DB00860]
p5187
sa(dp5188
g4
Vyes
p5189
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00873_871
p5190
sg8
Vdrug-target interaction Loteprednol and Glucocorticoid receptor [drugbank_resource:DB00873_871]
p5191
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5192
sg14
Vhttp://bio2rdf.org/drugbank:DB00873
p5193
sg16
VLoteprednol [drugbank:DB00873]
p5194
sa(dp5195
g4
Vyes
p5196
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00769_871
p5197
sg8
Vdrug-target interaction Hydrocortamate and Glucocorticoid receptor [drugbank_resource:DB00769_871]
p5198
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5199
sg14
Vhttp://bio2rdf.org/drugbank:DB00769
p5200
sg16
VHydrocortamate [drugbank:DB00769]
p5201
sa(dp5202
g4
Vyes
p5203
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00846_871
p5204
sg8
Vdrug-target interaction Flurandrenolide and Glucocorticoid receptor [drugbank_resource:DB00846_871]
p5205
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5206
sg14
Vhttp://bio2rdf.org/drugbank:DB00846
p5207
sg16
VFlurandrenolide [drugbank:DB00846]
p5208
sa(dp5209
g4
Vyes
p5210
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00896_871
p5211
sg8
Vdrug-target interaction Rimexolone and Glucocorticoid receptor [drugbank_resource:DB00896_871]
p5212
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5213
sg14
Vhttp://bio2rdf.org/drugbank:DB00896
p5214
sg16
VRimexolone [drugbank:DB00896]
p5215
sa(dp5216
g4
Vyes
p5217
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00959_871
p5218
sg8
Vdrug-target interaction Methylprednisolone and Glucocorticoid receptor [drugbank_resource:DB00959_871]
p5219
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5220
sg14
Vhttp://bio2rdf.org/drugbank:DB00959
p5221
sg16
VMethylprednisolone [drugbank:DB00959]
p5222
sa(dp5223
g4
Vyes
p5224
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01013_871
p5225
sg8
Vdrug-target interaction Clobetasol and Glucocorticoid receptor [drugbank_resource:DB01013_871]
p5226
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5227
sg14
Vhttp://bio2rdf.org/drugbank:DB01013
p5228
sg16
VClobetasol [drugbank:DB01013]
p5229
sa(dp5230
g4
Vyes
p5231
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01130_871
p5232
sg8
Vdrug-target interaction Prednicarbate and Glucocorticoid receptor [drugbank_resource:DB01130_871]
p5233
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5234
sg14
Vhttp://bio2rdf.org/drugbank:DB01130
p5235
sg16
VPrednicarbate [drugbank:DB01130]
p5236
sa(dp5237
g4
Vyes
p5238
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01047_871
p5239
sg8
Vdrug-target interaction Fluocinonide and Glucocorticoid receptor [drugbank_resource:DB01047_871]
p5240
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5241
sg14
Vhttp://bio2rdf.org/drugbank:DB01047
p5242
sg16
VFluocinonide [drugbank:DB01047]
p5243
sa(dp5244
g4
Vyes
p5245
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01260_871
p5246
sg8
Vdrug-target interaction Desonide and Glucocorticoid receptor [drugbank_resource:DB01260_871]
p5247
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5248
sg14
Vhttp://bio2rdf.org/drugbank:DB01260
p5249
sg16
VDesonide [drugbank:DB01260]
p5250
sa(dp5251
g4
Vyes
p5252
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01222_871
p5253
sg8
Vdrug-target interaction Budesonide and Glucocorticoid receptor [drugbank_resource:DB01222_871]
p5254
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5255
sg14
Vhttp://bio2rdf.org/drugbank:DB01222
p5256
sg16
VBudesonide [drugbank:DB01222]
p5257
sa(dp5258
g4
Vyes
p5259
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01234_871
p5260
sg8
Vdrug-target interaction Dexamethasone and Glucocorticoid receptor [drugbank_resource:DB01234_871]
p5261
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5262
sg14
Vhttp://bio2rdf.org/drugbank:DB01234
p5263
sg16
VDexamethasone [drugbank:DB01234]
p5264
sa(dp5265
g4
Vyes
p5266
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01380_871
p5267
sg8
Vdrug-target interaction Cortisone acetate and Glucocorticoid receptor [drugbank_resource:DB01380_871]
p5268
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5269
sg14
Vhttp://bio2rdf.org/drugbank:DB01380
p5270
sg16
VCortisone acetate [drugbank:DB01380]
p5271
sa(dp5272
g4
Vyes
p5273
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01384_871
p5274
sg8
Vdrug-target interaction Paramethasone and Glucocorticoid receptor [drugbank_resource:DB01384_871]
p5275
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5276
sg14
Vhttp://bio2rdf.org/drugbank:DB01384
p5277
sg16
VParamethasone [drugbank:DB01384]
p5278
sa(dp5279
g4
Vyes
p5280
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01410_871
p5281
sg8
Vdrug-target interaction Ciclesonide and Glucocorticoid receptor [drugbank_resource:DB01410_871]
p5282
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5283
sg14
Vhttp://bio2rdf.org/drugbank:DB01410
p5284
sg16
VCiclesonide [drugbank:DB01410]
p5285
sa(dp5286
g4
Vunknown
p5287
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01185_871
p5288
sg8
Vdrug-target interaction Fluoxymesterone and Glucocorticoid receptor [drugbank_resource:DB01185_871]
p5289
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5290
sg14
Vhttp://bio2rdf.org/drugbank:DB01185
p5291
sg16
VFluoxymesterone [drugbank:DB01185]
p5292
sa(dp5293
g4
Vunknown
p5294
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02210_871
p5295
sg8
Vdrug-target interaction Hexane-1,6-Diol and Glucocorticoid receptor [drugbank_resource:DB02210_871]
p5296
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5297
sg14
Vhttp://bio2rdf.org/drugbank:DB02210
p5298
sg16
VHexane-1,6-Diol [drugbank:DB02210]
p5299
sa(dp5300
g4
Vyes
p5301
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06781_871
p5302
sg8
Vdrug-target interaction Difluprednate and Glucocorticoid receptor [drugbank_resource:DB06781_871]
p5303
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:871
p5304
sg14
Vhttp://bio2rdf.org/drugbank:DB06781
p5305
sg16
VDifluprednate [drugbank:DB06781]
p5306
sasS'ANG'
p5307
(lp5308
(dp5309
g4
Vunknown
p5310
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02212_2149
p5311
sg8
Vdrug-target interaction Pyrophosphate 2- and Angiogenin [drugbank_resource:DB02212_2149]
p5312
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2149
p5313
sg14
Vhttp://bio2rdf.org/drugbank:DB02212
p5314
sg16
VPyrophosphate 2- [drugbank:DB02212]
p5315
sa(dp5316
g4
Vunknown
p5317
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03088_2149
p5318
sg8
Vdrug-target interaction Pyroglutamic Acid and Angiogenin [drugbank_resource:DB03088_2149]
p5319
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2149
p5320
sg14
Vhttp://bio2rdf.org/drugbank:DB03088
p5321
sg16
VPyroglutamic Acid [drugbank:DB03088]
p5322
sa(dp5323
g4
Vunknown
p5324
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04272_2149
p5325
sg8
Vdrug-target interaction Citric Acid and Angiogenin [drugbank_resource:DB04272_2149]
p5326
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2149
p5327
sg14
Vhttp://bio2rdf.org/drugbank:DB04272
p5328
sg16
VCitric Acid [drugbank:DB04272]
p5329
sasS'TP53'
p5330
(lp5331
(dp5332
g4
Vunknown
p5333
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08363_5788
p5334
sg8
Vdrug-target interaction 1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine and Cellular tumor antigen p53 [drugbank_resource:DB08363_5788]
p5335
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5788
p5336
sg14
Vhttp://bio2rdf.org/drugbank:DB08363
p5337
sg16
V1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine [drugbank:DB08363]
p5338
sasS'PPARG'
p5339
(lp5340
(dp5341
g4
Vyes
p5342
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00244_238
p5343
sg8
Vdrug-target interaction Mesalazine and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00244_238]
p5344
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5345
sg14
Vhttp://bio2rdf.org/drugbank:DB00244
p5346
sg16
VMesalazine [drugbank:DB00244]
p5347
sa(dp5348
g4
Vyes
p5349
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00159_238
p5350
sg8
Vdrug-target interaction Icosapent and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00159_238]
p5351
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5352
sg14
Vhttp://bio2rdf.org/drugbank:DB00159
p5353
sg16
VIcosapent [drugbank:DB00159]
p5354
sa(dp5355
g4
Vyes
p5356
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00197_238
p5357
sg8
Vdrug-target interaction Troglitazone and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00197_238]
p5358
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5359
sg14
Vhttp://bio2rdf.org/drugbank:DB00197
p5360
sg16
VTroglitazone [drugbank:DB00197]
p5361
sa(dp5362
g4
Vunknown
p5363
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00328_238
p5364
sg8
Vdrug-target interaction Indomethacin and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00328_238]
p5365
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5366
sg14
Vhttp://bio2rdf.org/drugbank:DB00328
p5367
sg16
VIndomethacin [drugbank:DB00328]
p5368
sa(dp5369
g4
Vyes
p5370
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00412_238
p5371
sg8
Vdrug-target interaction Rosiglitazone and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00412_238]
p5372
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5373
sg14
Vhttp://bio2rdf.org/drugbank:DB00412
p5374
sg16
VRosiglitazone [drugbank:DB00412]
p5375
sa(dp5376
g4
Vyes
p5377
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00795_238
p5378
sg8
Vdrug-target interaction Sulfasalazine and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00795_238]
p5379
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5380
sg14
Vhttp://bio2rdf.org/drugbank:DB00795
p5381
sg16
VSulfasalazine [drugbank:DB00795]
p5382
sa(dp5383
g4
Vunknown
p5384
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00912_238
p5385
sg8
Vdrug-target interaction Repaglinide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00912_238]
p5386
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5387
sg14
Vhttp://bio2rdf.org/drugbank:DB00912
p5388
sg16
VRepaglinide [drugbank:DB00912]
p5389
sa(dp5390
g4
Vunknown
p5391
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00731_238
p5392
sg8
Vdrug-target interaction Nateglinide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00731_238]
p5393
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5394
sg14
Vhttp://bio2rdf.org/drugbank:DB00731
p5395
sg16
VNateglinide [drugbank:DB00731]
p5396
sa(dp5397
g4
Vyes
p5398
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01014_238
p5399
sg8
Vdrug-target interaction Balsalazide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB01014_238]
p5400
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5401
sg14
Vhttp://bio2rdf.org/drugbank:DB01014
p5402
sg16
VBalsalazide [drugbank:DB01014]
p5403
sa(dp5404
g4
Vyes
p5405
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00966_238
p5406
sg8
Vdrug-target interaction Telmisartan and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB00966_238]
p5407
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5408
sg14
Vhttp://bio2rdf.org/drugbank:DB00966
p5409
sg16
VTelmisartan [drugbank:DB00966]
p5410
sa(dp5411
g4
Vunknown
p5412
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01067_238
p5413
sg8
Vdrug-target interaction Glipizide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB01067_238]
p5414
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5415
sg14
Vhttp://bio2rdf.org/drugbank:DB01067
p5416
sg16
VGlipizide [drugbank:DB01067]
p5417
sa(dp5418
g4
Vyes
p5419
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01132_238
p5420
sg8
Vdrug-target interaction Pioglitazone and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB01132_238]
p5421
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5422
sg14
Vhttp://bio2rdf.org/drugbank:DB01132
p5423
sg16
VPioglitazone [drugbank:DB01132]
p5424
sa(dp5425
g4
Vunknown
p5426
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01252_238
p5427
sg8
Vdrug-target interaction Mitiglinide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB01252_238]
p5428
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5429
sg14
Vhttp://bio2rdf.org/drugbank:DB01252
p5430
sg16
VMitiglinide [drugbank:DB01252]
p5431
sa(dp5432
g4
Vyes
p5433
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01393_238
p5434
sg8
Vdrug-target interaction Bezafibrate and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB01393_238]
p5435
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5436
sg14
Vhttp://bio2rdf.org/drugbank:DB01393
p5437
sg16
VBezafibrate [drugbank:DB01393]
p5438
sa(dp5439
g4
Vunknown
p5440
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04270_238
p5441
sg8
Vdrug-target interaction (S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB04270_238]
p5442
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5443
sg14
Vhttp://bio2rdf.org/drugbank:DB04270
p5444
sg16
V(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid [drugbank:DB04270]
p5445
sa(dp5446
g4
Vunknown
p5447
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06926_238
p5448
sg8
Vdrug-target interaction (9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB06926_238]
p5449
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5450
sg14
Vhttp://bio2rdf.org/drugbank:DB06926
p5451
sg16
V(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid [drugbank:DB06926]
p5452
sa(dp5453
g4
Vunknown
p5454
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07111_238
p5455
sg8
Vdrug-target interaction (4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07111_238]
p5456
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5457
sg14
Vhttp://bio2rdf.org/drugbank:DB07111
p5458
sg16
V(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid [drugbank:DB07111]
p5459
sa(dp5460
g4
Vunknown
p5461
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07172_238
p5462
sg8
Vdrug-target interaction (5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07172_238]
p5463
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5464
sg14
Vhttp://bio2rdf.org/drugbank:DB07172
p5465
sg16
V(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid [drugbank:DB07172]
p5466
sa(dp5467
g4
Vunknown
p5468
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07208_238
p5469
sg8
Vdrug-target interaction (8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07208_238]
p5470
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5471
sg14
Vhttp://bio2rdf.org/drugbank:DB07208
p5472
sg16
V(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid [drugbank:DB07208]
p5473
sa(dp5474
g4
Vunknown
p5475
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07209_238
p5476
sg8
Vdrug-target interaction (8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07209_238]
p5477
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5478
sg14
Vhttp://bio2rdf.org/drugbank:DB07209
p5479
sg16
V(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid [drugbank:DB07209]
p5480
sa(dp5481
g4
Vunknown
p5482
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06908_238
p5483
sg8
Vdrug-target interaction (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB06908_238]
p5484
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5485
sg14
Vhttp://bio2rdf.org/drugbank:DB06908
p5486
sg16
V(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID [drugbank:DB06908]
p5487
sa(dp5488
g4
Vunknown
p5489
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04689_238
p5490
sg8
Vdrug-target interaction 2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB04689_238]
p5491
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5492
sg14
Vhttp://bio2rdf.org/drugbank:DB04689
p5493
sg16
V2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID [drugbank:DB04689]
p5494
sa(dp5495
g4
Vunknown
p5496
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07053_238
p5497
sg8
Vdrug-target interaction 2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07053_238]
p5498
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5499
sg14
Vhttp://bio2rdf.org/drugbank:DB07053
p5500
sg16
V2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID [drugbank:DB07053]
p5501
sa(dp5502
g4
Vunknown
p5503
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07302_238
p5504
sg8
Vdrug-target interaction (9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07302_238]
p5505
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5506
sg14
Vhttp://bio2rdf.org/drugbank:DB07302
p5507
sg16
V(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid [drugbank:DB07302]
p5508
sa(dp5509
g4
Vunknown
p5510
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07509_238
p5511
sg8
Vdrug-target interaction difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07509_238]
p5512
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5513
sg14
Vhttp://bio2rdf.org/drugbank:DB07509
p5514
sg16
Vdifluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron [drugbank:DB07509]
p5515
sa(dp5516
g4
Vunknown
p5517
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07723_238
p5518
sg8
Vdrug-target interaction 3-(5-methoxy-1H-indol-3-yl)propanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07723_238]
p5519
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5520
sg14
Vhttp://bio2rdf.org/drugbank:DB07723
p5521
sg16
V3-(5-methoxy-1H-indol-3-yl)propanoic acid [drugbank:DB07723]
p5522
sa(dp5523
g4
Vunknown
p5524
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07724_238
p5525
sg8
Vdrug-target interaction 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07724_238]
p5526
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5527
sg14
Vhttp://bio2rdf.org/drugbank:DB07724
p5528
sg16
V3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid [drugbank:DB07724]
p5529
sa(dp5530
g4
Vunknown
p5531
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08302_238
p5532
sg8
Vdrug-target interaction 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08302_238]
p5533
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5534
sg14
Vhttp://bio2rdf.org/drugbank:DB08302
p5535
sg16
V3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid [drugbank:DB08302]
p5536
sa(dp5537
g4
Vunknown
p5538
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07842_238
p5539
sg8
Vdrug-target interaction (2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07842_238]
p5540
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5541
sg14
Vhttp://bio2rdf.org/drugbank:DB07842
p5542
sg16
V(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid [drugbank:DB07842]
p5543
sa(dp5544
g4
Vunknown
p5545
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07863_238
p5546
sg8
Vdrug-target interaction 2-chloro-5-nitro-N-phenylbenzamide and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07863_238]
p5547
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5548
sg14
Vhttp://bio2rdf.org/drugbank:DB07863
p5549
sg16
V2-chloro-5-nitro-N-phenylbenzamide [drugbank:DB07863]
p5550
sa(dp5551
g4
Vunknown
p5552
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08402_238
p5553
sg8
Vdrug-target interaction 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08402_238]
p5554
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5555
sg14
Vhttp://bio2rdf.org/drugbank:DB08402
p5556
sg16
V2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID [drugbank:DB08402]
p5557
sa(dp5558
g4
Vunknown
p5559
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08435_238
p5560
sg8
Vdrug-target interaction (5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08435_238]
p5561
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5562
sg14
Vhttp://bio2rdf.org/drugbank:DB08435
p5563
sg16
V(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid [drugbank:DB08435]
p5564
sa(dp5565
g4
Vunknown
p5566
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08560_238
p5567
sg8
Vdrug-target interaction 3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08560_238]
p5568
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5569
sg14
Vhttp://bio2rdf.org/drugbank:DB08560
p5570
sg16
V3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE [drugbank:DB08560]
p5571
sa(dp5572
g4
Vunknown
p5573
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08760_238
p5574
sg8
Vdrug-target interaction (2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08760_238]
p5575
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5576
sg14
Vhttp://bio2rdf.org/drugbank:DB08760
p5577
sg16
V(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid [drugbank:DB08760]
p5578
sa(dp5579
g4
Vunknown
p5580
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07675_238
p5581
sg8
Vdrug-target interaction (2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB07675_238]
p5582
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5583
sg14
Vhttp://bio2rdf.org/drugbank:DB07675
p5584
sg16
V(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID [drugbank:DB07675]
p5585
sa(dp5586
g4
Vunknown
p5587
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08121_238
p5588
sg8
Vdrug-target interaction (2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08121_238]
p5589
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5590
sg14
Vhttp://bio2rdf.org/drugbank:DB08121
p5591
sg16
V(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid [drugbank:DB08121]
p5592
sa(dp5593
g4
Vunknown
p5594
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08483_238
p5595
sg8
Vdrug-target interaction (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid and Peroxisome proliferator-activated receptor gamma [drugbank_resource:DB08483_238]
p5596
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:238
p5597
sg14
Vhttp://bio2rdf.org/drugbank:DB08483
p5598
sg16
V(2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid [drugbank:DB08483]
p5599
sasS'ABCA1'
p5600
(lp5601
(dp5602
g4
Vunknown
p5603
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00171_132
p5604
sg8
Vdrug-target interaction Adenosine triphosphate and ATP-binding cassette sub-family A member 1 [drugbank_resource:DB00171_132]
p5605
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:132
p5606
sg14
Vhttp://bio2rdf.org/drugbank:DB00171
p5607
sg16
VAdenosine triphosphate [drugbank:DB00171]
p5608
sa(dp5609
g4
Vunknown
p5610
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01016_132
p5611
sg8
Vdrug-target interaction Glyburide and ATP-binding cassette sub-family A member 1 [drugbank_resource:DB01016_132]
p5612
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:132
p5613
sg14
Vhttp://bio2rdf.org/drugbank:DB01016
p5614
sg16
VGlyburide [drugbank:DB01016]
p5615
sa(dp5616
g4
Vyes
p5617
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01599_132
p5618
sg8
Vdrug-target interaction Probucol and ATP-binding cassette sub-family A member 1 [drugbank_resource:DB01599_132]
p5619
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:132
p5620
sg14
Vhttp://bio2rdf.org/drugbank:DB01599
p5621
sg16
VProbucol [drugbank:DB01599]
p5622
sasS'SST'
p5623
(lp5624
(dp5625
g4
Vunknown
p5626
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00847_1736
p5627
sg8
Vdrug-target interaction Cysteamine and Somatostatin [drugbank_resource:DB00847_1736]
p5628
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1736
p5629
sg14
Vhttp://bio2rdf.org/drugbank:DB00847
p5630
sg16
VCysteamine [drugbank:DB00847]
p5631
sasS'DDR1'
p5632
(lp5633
(dp5634
g4
Vunknown
p5635
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00619_1950
p5636
sg8
Vdrug-target interaction Imatinib and Epithelial discoidin domain-containing receptor 1 [drugbank_resource:DB00619_1950]
p5637
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1950
p5638
sg14
Vhttp://bio2rdf.org/drugbank:DB00619
p5639
sg16
VImatinib [drugbank:DB00619]
p5640
sasS'HNF4A'
p5641
(lp5642
(dp5643
g4
Vunknown
p5644
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08231_6522
p5645
sg8
Vdrug-target interaction MYRISTIC ACID and Hepatocyte nuclear factor 4-alpha [drugbank_resource:DB08231_6522]
p5646
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6522
p5647
sg14
Vhttp://bio2rdf.org/drugbank:DB08231
p5648
sg16
VMYRISTIC ACID [drugbank:DB08231]
p5649
sasS'ITGAV'
p5650
(lp5651
(dp5652
g4
Vyes
p5653
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00098_6066
p5654
sg8
Vdrug-target interaction Antithymocyte globulin and Integrin alpha-V [drugbank_resource:DB00098_6066]
p5655
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6066
p5656
sg14
Vhttp://bio2rdf.org/drugbank:DB00098
p5657
sg16
VAntithymocyte globulin [drugbank:DB00098]
p5658
sasS'PRODH'
p5659
(lp5660
(dp5661
g4
Vunknown
p5662
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00172_4082
p5663
sg8
Vdrug-target interaction L-Proline and Proline oxidase, mitochondrial [drugbank_resource:DB00172_4082]
p5664
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4082
p5665
sg14
Vhttp://bio2rdf.org/drugbank:DB00172
p5666
sg16
VL-Proline [drugbank:DB00172]
p5667
sa(dp5668
g4
Vunknown
p5669
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00172_4082
p5670
sg8
Vdrug-enzyme interaction L-Proline and Proline oxidase, mitochondrial [drugbank_resource:DB00172_4082]
p5671
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4082
p5672
sg14
Vhttp://bio2rdf.org/drugbank:DB00172
p5673
sg16
VL-Proline [drugbank:DB00172]
p5674
sasS'NNMT'
p5675
(lp5676
(dp5677
g4
Vyes
p5678
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00627_860
p5679
sg8
Vdrug-target interaction Niacin and Nicotinamide N-methyltransferase [drugbank_resource:DB00627_860]
p5680
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:860
p5681
sg14
Vhttp://bio2rdf.org/drugbank:DB00627
p5682
sg16
VNiacin [drugbank:DB00627]
p5683
sasS'DTYMK'
p5684
(lp5685
(dp5686
g4
Vunknown
p5687
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01643_2254
p5688
sg8
Vdrug-target interaction Thymidine-5'-Phosphate and Thymidylate kinase [drugbank_resource:DB01643_2254]
p5689
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2254
p5690
sg14
Vhttp://bio2rdf.org/drugbank:DB01643
p5691
sg16
VThymidine-5'-Phosphate [drugbank:DB01643]
p5692
sa(dp5693
g4
Vunknown
p5694
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03195_2254
p5695
sg8
Vdrug-target interaction Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester and Thymidylate kinase [drugbank_resource:DB03195_2254]
p5696
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2254
p5697
sg14
Vhttp://bio2rdf.org/drugbank:DB03195
p5698
sg16
VPhosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester [drugbank:DB03195]
p5699
sa(dp5700
g4
Vunknown
p5701
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03280_2254
p5702
sg8
Vdrug-target interaction P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate and Thymidylate kinase [drugbank_resource:DB03280_2254]
p5703
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2254
p5704
sg14
Vhttp://bio2rdf.org/drugbank:DB03280
p5705
sg16
VP1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate [drugbank:DB03280]
p5706
sa(dp5707
g4
Vunknown
p5708
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03150_2254
p5709
sg8
Vdrug-target interaction 2',3'-Dideoxythymidine-5'-Monophosphate and Thymidylate kinase [drugbank_resource:DB03150_2254]
p5710
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2254
p5711
sg14
Vhttp://bio2rdf.org/drugbank:DB03150
p5712
sg16
V2',3'-Dideoxythymidine-5'-Monophosphate [drugbank:DB03150]
p5713
sa(dp5714
g4
Vunknown
p5715
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03233_2254
p5716
sg8
Vdrug-target interaction Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester and Thymidylate kinase [drugbank_resource:DB03233_2254]
p5717
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2254
p5718
sg14
Vhttp://bio2rdf.org/drugbank:DB03233
p5719
sg16
VPhosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester [drugbank:DB03233]
p5720
sa(dp5721
g4
Vunknown
p5722
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03431_2254
p5723
sg8
Vdrug-target interaction Adenosine-5'-Diphosphate and Thymidylate kinase [drugbank_resource:DB03431_2254]
p5724
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2254
p5725
sg14
Vhttp://bio2rdf.org/drugbank:DB03431
p5726
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p5727
sa(dp5728
g4
Vunknown
p5729
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03666_2254
p5730
sg8
Vdrug-target interaction 3'-Azido-3'-Deoxythymidine-5'-Monophosphate and Thymidylate kinase [drugbank_resource:DB03666_2254]
p5731
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2254
p5732
sg14
Vhttp://bio2rdf.org/drugbank:DB03666
p5733
sg16
V3'-Azido-3'-Deoxythymidine-5'-Monophosphate [drugbank:DB03666]
p5734
sa(dp5735
g4
Vunknown
p5736
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03845_2254
p5737
sg8
Vdrug-target interaction P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate and Thymidylate kinase [drugbank_resource:DB03845_2254]
p5738
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2254
p5739
sg14
Vhttp://bio2rdf.org/drugbank:DB03845
p5740
sg16
VP1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate [drugbank:DB03845]
p5741
sa(dp5742
g4
Vunknown
p5743
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04395_2254
p5744
sg8
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Thymidylate kinase [drugbank_resource:DB04395_2254]
p5745
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2254
p5746
sg14
Vhttp://bio2rdf.org/drugbank:DB04395
p5747
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p5748
sasS'POLE2'
p5749
(lp5750
(dp5751
g4
Vyes
p5752
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00242_6110
p5753
sg8
Vdrug-target interaction Cladribine and DNA polymerase epsilon subunit 2 [drugbank_resource:DB00242_6110]
p5754
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6110
p5755
sg14
Vhttp://bio2rdf.org/drugbank:DB00242
p5756
sg16
VCladribine [drugbank:DB00242]
p5757
sasS'CDK4'
p5758
(lp5759
(dp5760
g4
Vunknown
p5761
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02733_3959
p5762
sg8
Vdrug-target interaction Purvalanol and Cell division protein kinase 4 [drugbank_resource:DB02733_3959]
p5763
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3959
p5764
sg14
Vhttp://bio2rdf.org/drugbank:DB02733
p5765
sg16
VPurvalanol [drugbank:DB02733]
p5766
sa(dp5767
g4
Vunknown
p5768
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03496_3959
p5769
sg8
Vdrug-target interaction Flavopiridol and Cell division protein kinase 4 [drugbank_resource:DB03496_3959]
p5770
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3959
p5771
sg14
Vhttp://bio2rdf.org/drugbank:DB03496
p5772
sg16
VFlavopiridol [drugbank:DB03496]
p5773
sasS'VWF'
p5774
(lp5775
(dp5776
g4
Vyes
p5777
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00025_1635
p5778
sg8
Vdrug-target interaction Antihemophilic Factor and von Willebrand factor [drugbank_resource:DB00025_1635]
p5779
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1635
p5780
sg14
Vhttp://bio2rdf.org/drugbank:DB00025
p5781
sg16
VAntihemophilic Factor [drugbank:DB00025]
p5782
sasS'AIFM1'
p5783
(lp5784
(dp5785
g4
Vunknown
p5786
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03147_1329
p5787
sg8
Vdrug-target interaction Flavin-Adenine Dinucleotide and Apoptosis-inducing factor 1, mitochondrial [drugbank_resource:DB03147_1329]
p5788
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1329
p5789
sg14
Vhttp://bio2rdf.org/drugbank:DB03147
p5790
sg16
VFlavin-Adenine Dinucleotide [drugbank:DB03147]
p5791
sasS'AMY1A'
p5792
(lp5793
(dp5794
g4
Vunknown
p5795
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02379_3030
p5796
sg8
Vdrug-target interaction Beta-D-Glucose and Salivary alpha-amylase [drugbank_resource:DB02379_3030]
p5797
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3030
p5798
sg14
Vhttp://bio2rdf.org/drugbank:DB02379
p5799
sg16
VBeta-D-Glucose [drugbank:DB02379]
p5800
sa(dp5801
g4
Vunknown
p5802
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03088_3030
p5803
sg8
Vdrug-target interaction Pyroglutamic Acid and Salivary alpha-amylase [drugbank_resource:DB03088_3030]
p5804
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3030
p5805
sg14
Vhttp://bio2rdf.org/drugbank:DB03088
p5806
sg16
VPyroglutamic Acid [drugbank:DB03088]
p5807
sa(dp5808
g4
Vunknown
p5809
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03092_3030
p5810
sg8
Vdrug-target interaction 5-Hydroxymethyl-Chonduritol and Salivary alpha-amylase [drugbank_resource:DB03092_3030]
p5811
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3030
p5812
sg14
Vhttp://bio2rdf.org/drugbank:DB03092
p5813
sg16
V5-Hydroxymethyl-Chonduritol [drugbank:DB03092]
p5814
sa(dp5815
g4
Vunknown
p5816
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03439_3030
p5817
sg8
Vdrug-target interaction 4,6-Dideoxy-4-Amino-Alpha-D-Glucose and Salivary alpha-amylase [drugbank_resource:DB03439_3030]
p5818
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3030
p5819
sg14
Vhttp://bio2rdf.org/drugbank:DB03439
p5820
sg16
V4,6-Dideoxy-4-Amino-Alpha-D-Glucose [drugbank:DB03439]
p5821
sa(dp5822
g4
Vunknown
p5823
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04237_3030
p5824
sg8
Vdrug-target interaction Tris(Hydroxyethyl)Aminomethane and Salivary alpha-amylase [drugbank_resource:DB04237_3030]
p5825
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3030
p5826
sg14
Vhttp://bio2rdf.org/drugbank:DB04237
p5827
sg16
VTris(Hydroxyethyl)Aminomethane [drugbank:DB04237]
p5828
sasS'LCK'
p5829
(lp5830
(dp5831
g4
Vyes
p5832
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01254_937
p5833
sg8
Vdrug-target interaction Dasatinib and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB01254_937]
p5834
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:937
p5835
sg14
Vhttp://bio2rdf.org/drugbank:DB01254
p5836
sg16
VDasatinib [drugbank:DB01254]
p5837
sa(dp5838
g4
Vunknown
p5839
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01830_937
p5840
sg8
Vdrug-target interaction {4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB01830_937]
p5841
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:937
p5842
sg14
Vhttp://bio2rdf.org/drugbank:DB01830
p5843
sg16
V{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid [drugbank:DB01830]
p5844
sa(dp5845
g4
Vunknown
p5846
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02010_937
p5847
sg8
Vdrug-target interaction Staurosporine and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB02010_937]
p5848
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:937
p5849
sg14
Vhttp://bio2rdf.org/drugbank:DB02010
p5850
sg16
VStaurosporine [drugbank:DB02010]
p5851
sa(dp5852
g4
Vunknown
p5853
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03023_937
p5854
sg8
Vdrug-target interaction 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB03023_937]
p5855
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:937
p5856
sg14
Vhttp://bio2rdf.org/drugbank:DB03023
p5857
sg16
V1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine [drugbank:DB03023]
p5858
sa(dp5859
g4
Vunknown
p5860
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04395_937
p5861
sg8
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB04395_937]
p5862
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:937
p5863
sg14
Vhttp://bio2rdf.org/drugbank:DB04395
p5864
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p5865
sa(dp5866
g4
Vunknown
p5867
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04003_937
p5868
sg8
Vdrug-target interaction (4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB04003_937]
p5869
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:937
p5870
sg14
Vhttp://bio2rdf.org/drugbank:DB04003
p5871
sg16
V(4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid [drugbank:DB04003]
p5872
sa(dp5873
g4
Vunknown
p5874
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07146_937
p5875
sg8
Vdrug-target interaction 2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB07146_937]
p5876
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:937
p5877
sg14
Vhttp://bio2rdf.org/drugbank:DB07146
p5878
sg16
V2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE [drugbank:DB07146]
p5879
sa(dp5880
g4
Vunknown
p5881
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06925_937
p5882
sg8
Vdrug-target interaction 3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB06925_937]
p5883
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:937
p5884
sg14
Vhttp://bio2rdf.org/drugbank:DB06925
p5885
sg16
V3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE [drugbank:DB06925]
p5886
sa(dp5887
g4
Vunknown
p5888
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07297_937
p5889
sg8
Vdrug-target interaction 5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB07297_937]
p5890
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:937
p5891
sg14
Vhttp://bio2rdf.org/drugbank:DB07297
p5892
sg16
V5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE [drugbank:DB07297]
p5893
sa(dp5894
g4
Vunknown
p5895
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08055_937
p5896
sg8
Vdrug-target interaction N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB08055_937]
p5897
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:937
p5898
sg14
Vhttp://bio2rdf.org/drugbank:DB08055
p5899
sg16
VN-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine [drugbank:DB08055]
p5900
sa(dp5901
g4
Vunknown
p5902
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08056_937
p5903
sg8
Vdrug-target interaction N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB08056_937]
p5904
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:937
p5905
sg14
Vhttp://bio2rdf.org/drugbank:DB08056
p5906
sg16
VN-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine [drugbank:DB08056]
p5907
sa(dp5908
g4
Vunknown
p5909
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08057_937
p5910
sg8
Vdrug-target interaction N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine and Proto-oncogene tyrosine-protein kinase LCK [drugbank_resource:DB08057_937]
p5911
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:937
p5912
sg14
Vhttp://bio2rdf.org/drugbank:DB08057
p5913
sg16
VN-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine [drugbank:DB08057]
p5914
sasS'BTK'
p5915
(lp5916
(dp5917
g4
Vunknown
p5918
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01863_2355
p5919
sg8
Vdrug-target interaction Inositol 1,3,4,5-Tetrakisphosphate and Tyrosine-protein kinase BTK [drugbank_resource:DB01863_2355]
p5920
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2355
p5921
sg14
Vhttp://bio2rdf.org/drugbank:DB01863
p5922
sg16
VInositol 1,3,4,5-Tetrakisphosphate [drugbank:DB01863]
p5923
sasS'HDAC1'
p5924
(lp5925
(dp5926
g4
Vyes
p5927
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02546_4121
p5928
sg8
Vdrug-target interaction Vorinostat and Histone deacetylase 1 [drugbank_resource:DB02546_4121]
p5929
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4121
p5930
sg14
Vhttp://bio2rdf.org/drugbank:DB02546
p5931
sg16
VVorinostat [drugbank:DB02546]
p5932
sasS'PDGFRA'
p5933
(lp5934
(dp5935
g4
Vunknown
p5936
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00102_950
p5937
sg8
Vdrug-target interaction Becaplermin and Alpha platelet-derived growth factor receptor [drugbank_resource:DB00102_950]
p5938
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:950
p5939
sg14
Vhttp://bio2rdf.org/drugbank:DB00102
p5940
sg16
VBecaplermin [drugbank:DB00102]
p5941
sa(dp5942
g4
Vunknown
p5943
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00619_950
p5944
sg8
Vdrug-target interaction Imatinib and Alpha platelet-derived growth factor receptor [drugbank_resource:DB00619_950]
p5945
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:950
p5946
sg14
Vhttp://bio2rdf.org/drugbank:DB00619
p5947
sg16
VImatinib [drugbank:DB00619]
p5948
sa(dp5949
g4
Vunknown
p5950
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01268_950
p5951
sg8
Vdrug-target interaction Sunitinib and Alpha platelet-derived growth factor receptor [drugbank_resource:DB01268_950]
p5952
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:950
p5953
sg14
Vhttp://bio2rdf.org/drugbank:DB01268
p5954
sg16
VSunitinib [drugbank:DB01268]
p5955
sasS'HDAC2'
p5956
(lp5957
(dp5958
g4
Vno
p5959
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00227_4122
p5960
sg8
Vdrug-target interaction Lovastatin and Histone deacetylase 2 [drugbank_resource:DB00227_4122]
p5961
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4122
p5962
sg14
Vhttp://bio2rdf.org/drugbank:DB00227
p5963
sg16
VLovastatin [drugbank:DB00227]
p5964
sa(dp5965
g4
Vyes
p5966
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02546_4122
p5967
sg8
Vdrug-target interaction Vorinostat and Histone deacetylase 2 [drugbank_resource:DB02546_4122]
p5968
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4122
p5969
sg14
Vhttp://bio2rdf.org/drugbank:DB02546
p5970
sg16
VVorinostat [drugbank:DB02546]
p5971
sasS'HDAC4'
p5972
(lp5973
(dp5974
g4
Vunknown
p5975
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07879_6003
p5976
sg8
Vdrug-target interaction N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide and Histone deacetylase 4 [drugbank_resource:DB07879_6003]
p5977
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6003
p5978
sg14
Vhttp://bio2rdf.org/drugbank:DB07879
p5979
sg16
VN-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide [drugbank:DB07879]
p5980
sa(dp5981
g4
Vunknown
p5982
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08613_6003
p5983
sg8
Vdrug-target interaction 2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL and Histone deacetylase 4 [drugbank_resource:DB08613_6003]
p5984
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6003
p5985
sg14
Vhttp://bio2rdf.org/drugbank:DB08613
p5986
sg16
V2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL [drugbank:DB08613]
p5987
sasS'MAP2K1'
p5988
(lp5989
(dp5990
g4
Vunknown
p5991
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02152_990
p5992
sg8
Vdrug-target interaction K-252a and Dual specificity mitogen-activated protein kinase kinase 1 [drugbank_resource:DB02152_990]
p5993
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:990
p5994
sg14
Vhttp://bio2rdf.org/drugbank:DB02152
p5995
sg16
VK-252a [drugbank:DB02152]
p5996
sa(dp5997
g4
Vunknown
p5998
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03115_990
p5999
sg8
Vdrug-target interaction 5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide and Dual specificity mitogen-activated protein kinase kinase 1 [drugbank_resource:DB03115_990]
p6000
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:990
p6001
sg14
Vhttp://bio2rdf.org/drugbank:DB03115
p6002
sg16
V5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide [drugbank:DB03115]
p6003
sa(dp6004
g4
Vunknown
p6005
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07046_990
p6006
sg8
Vdrug-target interaction 2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide and Dual specificity mitogen-activated protein kinase kinase 1 [drugbank_resource:DB07046_990]
p6007
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:990
p6008
sg14
Vhttp://bio2rdf.org/drugbank:DB07046
p6009
sg16
V2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide [drugbank:DB07046]
p6010
sa(dp6011
g4
Vunknown
p6012
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07101_990
p6013
sg8
Vdrug-target interaction N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide and Dual specificity mitogen-activated protein kinase kinase 1 [drugbank_resource:DB07101_990]
p6014
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:990
p6015
sg14
Vhttp://bio2rdf.org/drugbank:DB07101
p6016
sg16
VN-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide [drugbank:DB07101]
p6017
sa(dp6018
g4
Vunknown
p6019
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06892_990
p6020
sg8
Vdrug-target interaction (5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide and Dual specificity mitogen-activated protein kinase kinase 1 [drugbank_resource:DB06892_990]
p6021
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:990
p6022
sg14
Vhttp://bio2rdf.org/drugbank:DB06892
p6023
sg16
V(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide [drugbank:DB06892]
p6024
sa(dp6025
g4
Vunknown
p6026
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08130_990
p6027
sg8
Vdrug-target interaction N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine and Dual specificity mitogen-activated protein kinase kinase 1 [drugbank_resource:DB08130_990]
p6028
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:990
p6029
sg14
Vhttp://bio2rdf.org/drugbank:DB08130
p6030
sg16
VN-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine [drugbank:DB08130]
p6031
sa(dp6032
g4
Vunknown
p6033
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08208_990
p6034
sg8
Vdrug-target interaction 2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE and Dual specificity mitogen-activated protein kinase kinase 1 [drugbank_resource:DB08208_990]
p6035
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:990
p6036
sg14
Vhttp://bio2rdf.org/drugbank:DB08208
p6037
sg16
V2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE [drugbank:DB08208]
p6038
sasS'HDAC6'
p6039
(lp6040
(dp6041
g4
Vyes
p6042
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02546_4124
p6043
sg8
Vdrug-target interaction Vorinostat and Histone deacetylase 6 [drugbank_resource:DB02546_4124]
p6044
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4124
p6045
sg14
Vhttp://bio2rdf.org/drugbank:DB02546
p6046
sg16
VVorinostat [drugbank:DB02546]
p6047
sasS'HDAC9'
p6048
(lp6049
(dp6050
g4
Vyes
p6051
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00313_1039
p6052
sg8
Vdrug-target interaction Valproic Acid and Histone deacetylase 9 [drugbank_resource:DB00313_1039]
p6053
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1039
p6054
sg14
Vhttp://bio2rdf.org/drugbank:DB00313
p6055
sg16
VValproic Acid [drugbank:DB00313]
p6056
sasS'MYO1D'
p6057
(lp6058
(dp6059
g4
Vunknown
p6060
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03431_7085
p6061
sg8
Vdrug-target interaction Adenosine-5'-Diphosphate and Myosin-Id [drugbank_resource:DB03431_7085]
p6062
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7085
p6063
sg14
Vhttp://bio2rdf.org/drugbank:DB03431
p6064
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p6065
sasS'SMAD2'
p6066
(lp6067
(dp6068
g4
Vunknown
p6069
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04522_6955
p6070
sg8
Vdrug-target interaction Phosphonoserine and Mothers against decapentaplegic homolog 2 [drugbank_resource:DB04522_6955]
p6071
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6955
p6072
sg14
Vhttp://bio2rdf.org/drugbank:DB04522
p6073
sg16
VPhosphonoserine [drugbank:DB04522]
p6074
sasS'PIK3R3'
p6075
(lp6076
(dp6077
g4
Vunknown
p6078
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01064_4146
p6079
sg8
Vdrug-target interaction Isoproterenol and Phosphatidylinositol 3-kinase regulatory subunit gamma [drugbank_resource:DB01064_4146]
p6080
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4146
p6081
sg14
Vhttp://bio2rdf.org/drugbank:DB01064
p6082
sg16
VIsoproterenol [drugbank:DB01064]
p6083
sasS'MAPK14'
p6084
(lp6085
(dp6086
g4
Vunknown
p6087
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01807_1540
p6088
sg8
Vdrug-target interaction N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea and Mitogen-activated protein kinase 14 [drugbank_resource:DB01807_1540]
p6089
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6090
sg14
Vhttp://bio2rdf.org/drugbank:DB01807
p6091
sg16
VN-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea [drugbank:DB01807]
p6092
sa(dp6093
g4
Vunknown
p6094
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01761_1540
p6095
sg8
Vdrug-target interaction 4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine and Mitogen-activated protein kinase 14 [drugbank_resource:DB01761_1540]
p6096
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6097
sg14
Vhttp://bio2rdf.org/drugbank:DB01761
p6098
sg16
V4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine [drugbank:DB01761]
p6099
sa(dp6100
g4
Vunknown
p6101
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01948_1540
p6102
sg8
Vdrug-target interaction 1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One and Mitogen-activated protein kinase 14 [drugbank_resource:DB01948_1540]
p6103
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6104
sg14
Vhttp://bio2rdf.org/drugbank:DB01948
p6105
sg16
V1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One [drugbank:DB01948]
p6106
sa(dp6107
g4
Vunknown
p6108
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01988_1540
p6109
sg8
Vdrug-target interaction 6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine and Mitogen-activated protein kinase 14 [drugbank_resource:DB01988_1540]
p6110
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6111
sg14
Vhttp://bio2rdf.org/drugbank:DB01988
p6112
sg16
V6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine [drugbank:DB01988]
p6113
sa(dp6114
g4
Vunknown
p6115
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02195_1540
p6116
sg8
Vdrug-target interaction 3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine and Mitogen-activated protein kinase 14 [drugbank_resource:DB02195_1540]
p6117
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6118
sg14
Vhttp://bio2rdf.org/drugbank:DB02195
p6119
sg16
V3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine [drugbank:DB02195]
p6120
sa(dp6121
g4
Vunknown
p6122
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01953_1540
p6123
sg8
Vdrug-target interaction Inhibitor of P38 Kinase and Mitogen-activated protein kinase 14 [drugbank_resource:DB01953_1540]
p6124
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6125
sg14
Vhttp://bio2rdf.org/drugbank:DB01953
p6126
sg16
VInhibitor of P38 Kinase [drugbank:DB01953]
p6127
sa(dp6128
g4
Vunknown
p6129
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02352_1540
p6130
sg8
Vdrug-target interaction 3-(Benzyloxy)Pyridin-2-Amine and Mitogen-activated protein kinase 14 [drugbank_resource:DB02352_1540]
p6131
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6132
sg14
Vhttp://bio2rdf.org/drugbank:DB02352
p6133
sg16
V3-(Benzyloxy)Pyridin-2-Amine [drugbank:DB02352]
p6134
sa(dp6135
g4
Vunknown
p6136
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02277_1540
p6137
sg8
Vdrug-target interaction 1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea and Mitogen-activated protein kinase 14 [drugbank_resource:DB02277_1540]
p6138
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6139
sg14
Vhttp://bio2rdf.org/drugbank:DB02277
p6140
sg16
V1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea [drugbank:DB02277]
p6141
sa(dp6142
g4
Vunknown
p6143
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02873_1540
p6144
sg8
Vdrug-target interaction 1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One and Mitogen-activated protein kinase 14 [drugbank_resource:DB02873_1540]
p6145
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6146
sg14
Vhttp://bio2rdf.org/drugbank:DB02873
p6147
sg16
V1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One [drugbank:DB02873]
p6148
sa(dp6149
g4
Vunknown
p6150
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03044_1540
p6151
sg8
Vdrug-target interaction 1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea and Mitogen-activated protein kinase 14 [drugbank_resource:DB03044_1540]
p6152
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6153
sg14
Vhttp://bio2rdf.org/drugbank:DB03044
p6154
sg16
V1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea [drugbank:DB03044]
p6155
sa(dp6156
g4
Vunknown
p6157
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02984_1540
p6158
sg8
Vdrug-target interaction 4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline and Mitogen-activated protein kinase 14 [drugbank_resource:DB02984_1540]
p6159
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6160
sg14
Vhttp://bio2rdf.org/drugbank:DB02984
p6161
sg16
V4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline [drugbank:DB02984]
p6162
sa(dp6163
g4
Vunknown
p6164
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03110_1540
p6165
sg8
Vdrug-target interaction 2-Chlorophenol and Mitogen-activated protein kinase 14 [drugbank_resource:DB03110_1540]
p6166
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6167
sg14
Vhttp://bio2rdf.org/drugbank:DB03110
p6168
sg16
V2-Chlorophenol [drugbank:DB03110]
p6169
sa(dp6170
g4
Vunknown
p6171
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03980_1540
p6172
sg8
Vdrug-target interaction 4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole and Mitogen-activated protein kinase 14 [drugbank_resource:DB03980_1540]
p6173
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6174
sg14
Vhttp://bio2rdf.org/drugbank:DB03980
p6175
sg16
V4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole [drugbank:DB03980]
p6176
sa(dp6177
g4
Vunknown
p6178
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04338_1540
p6179
sg8
Vdrug-target interaction SB220025 and Mitogen-activated protein kinase 14 [drugbank_resource:DB04338_1540]
p6180
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6181
sg14
Vhttp://bio2rdf.org/drugbank:DB04338
p6182
sg16
VSB220025 [drugbank:DB04338]
p6183
sa(dp6184
g4
Vunknown
p6185
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04797_1540
p6186
sg8
Vdrug-target interaction Triazolopyridine and Mitogen-activated protein kinase 14 [drugbank_resource:DB04797_1540]
p6187
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6188
sg14
Vhttp://bio2rdf.org/drugbank:DB04797
p6189
sg16
VTriazolopyridine [drugbank:DB04797]
p6190
sa(dp6191
g4
Vunknown
p6192
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06940_1540
p6193
sg8
Vdrug-target interaction N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB06940_1540]
p6194
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6195
sg14
Vhttp://bio2rdf.org/drugbank:DB06940
p6196
sg16
VN-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide [drugbank:DB06940]
p6197
sa(dp6198
g4
Vunknown
p6199
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04632_1540
p6200
sg8
Vdrug-target interaction 4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE and Mitogen-activated protein kinase 14 [drugbank_resource:DB04632_1540]
p6201
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6202
sg14
Vhttp://bio2rdf.org/drugbank:DB04632
p6203
sg16
V4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE [drugbank:DB04632]
p6204
sa(dp6205
g4
Vunknown
p6206
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06882_1540
p6207
sg8
Vdrug-target interaction 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea and Mitogen-activated protein kinase 14 [drugbank_resource:DB06882_1540]
p6208
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6209
sg14
Vhttp://bio2rdf.org/drugbank:DB06882
p6210
sg16
V1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea [drugbank:DB06882]
p6211
sa(dp6212
g4
Vunknown
p6213
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06991_1540
p6214
sg8
Vdrug-target interaction N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB06991_1540]
p6215
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6216
sg14
Vhttp://bio2rdf.org/drugbank:DB06991
p6217
sg16
VN-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide [drugbank:DB06991]
p6218
sa(dp6219
g4
Vunknown
p6220
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07138_1540
p6221
sg8
Vdrug-target interaction 5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]-6H-pyrimido[1,6-b]pyridazin-6-one and Mitogen-activated protein kinase 14 [drugbank_resource:DB07138_1540]
p6222
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6223
sg14
Vhttp://bio2rdf.org/drugbank:DB07138
p6224
sg16
V5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]-6H-pyrimido[1,6-b]pyridazin-6-one [drugbank:DB07138]
p6225
sa(dp6226
g4
Vunknown
p6227
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07307_1540
p6228
sg8
Vdrug-target interaction N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB07307_1540]
p6229
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6230
sg14
Vhttp://bio2rdf.org/drugbank:DB07307
p6231
sg16
VN-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide [drugbank:DB07307]
p6232
sa(dp6233
g4
Vunknown
p6234
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07459_1540
p6235
sg8
Vdrug-target interaction 4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE and Mitogen-activated protein kinase 14 [drugbank_resource:DB07459_1540]
p6236
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6237
sg14
Vhttp://bio2rdf.org/drugbank:DB07459
p6238
sg16
V4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE [drugbank:DB07459]
p6239
sa(dp6240
g4
Vunknown
p6241
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07607_1540
p6242
sg8
Vdrug-target interaction 4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE and Mitogen-activated protein kinase 14 [drugbank_resource:DB07607_1540]
p6243
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6244
sg14
Vhttp://bio2rdf.org/drugbank:DB07607
p6245
sg16
V4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE [drugbank:DB07607]
p6246
sa(dp6247
g4
Vunknown
p6248
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07811_1540
p6249
sg8
Vdrug-target interaction N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB07811_1540]
p6250
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6251
sg14
Vhttp://bio2rdf.org/drugbank:DB07811
p6252
sg16
VN-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide [drugbank:DB07811]
p6253
sa(dp6254
g4
Vunknown
p6255
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07829_1540
p6256
sg8
Vdrug-target interaction 4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE and Mitogen-activated protein kinase 14 [drugbank_resource:DB07829_1540]
p6257
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6258
sg14
Vhttp://bio2rdf.org/drugbank:DB07829
p6259
sg16
V4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE [drugbank:DB07829]
p6260
sa(dp6261
g4
Vunknown
p6262
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07832_1540
p6263
sg8
Vdrug-target interaction 4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde and Mitogen-activated protein kinase 14 [drugbank_resource:DB07832_1540]
p6264
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6265
sg14
Vhttp://bio2rdf.org/drugbank:DB07832
p6266
sg16
V4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde [drugbank:DB07832]
p6267
sa(dp6268
g4
Vunknown
p6269
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07833_1540
p6270
sg8
Vdrug-target interaction N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB07833_1540]
p6271
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6272
sg14
Vhttp://bio2rdf.org/drugbank:DB07833
p6273
sg16
VN-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide [drugbank:DB07833]
p6274
sa(dp6275
g4
Vunknown
p6276
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07834_1540
p6277
sg8
Vdrug-target interaction N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB07834_1540]
p6278
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6279
sg14
Vhttp://bio2rdf.org/drugbank:DB07834
p6280
sg16
VN-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide [drugbank:DB07834]
p6281
sa(dp6282
g4
Vunknown
p6283
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08092_1540
p6284
sg8
Vdrug-target interaction 3-FLUORO-N-1H-INDOL-5-YL-5-MORPHOLIN-4-YLBENZAMIDE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08092_1540]
p6285
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6286
sg14
Vhttp://bio2rdf.org/drugbank:DB08092
p6287
sg16
V3-FLUORO-N-1H-INDOL-5-YL-5-MORPHOLIN-4-YLBENZAMIDE [drugbank:DB08092]
p6288
sa(dp6289
g4
Vunknown
p6290
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08093_1540
p6291
sg8
Vdrug-target interaction 3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08093_1540]
p6292
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6293
sg14
Vhttp://bio2rdf.org/drugbank:DB08093
p6294
sg16
V3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE [drugbank:DB08093]
p6295
sa(dp6296
g4
Vunknown
p6297
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08097_1540
p6298
sg8
Vdrug-target interaction 2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08097_1540]
p6299
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6300
sg14
Vhttp://bio2rdf.org/drugbank:DB08097
p6301
sg16
V2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE [drugbank:DB08097]
p6302
sa(dp6303
g4
Vunknown
p6304
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08351_1540
p6305
sg8
Vdrug-target interaction N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB08351_1540]
p6306
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6307
sg14
Vhttp://bio2rdf.org/drugbank:DB08351
p6308
sg16
VN-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide [drugbank:DB08351]
p6309
sa(dp6310
g4
Vunknown
p6311
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08424_1540
p6312
sg8
Vdrug-target interaction [5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08424_1540]
p6313
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6314
sg14
Vhttp://bio2rdf.org/drugbank:DB08424
p6315
sg16
V[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE [drugbank:DB08424]
p6316
sa(dp6317
g4
Vunknown
p6318
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08730_1540
p6319
sg8
Vdrug-target interaction 3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08730_1540]
p6320
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6321
sg14
Vhttp://bio2rdf.org/drugbank:DB08730
p6322
sg16
V3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE [drugbank:DB08730]
p6323
sa(dp6324
g4
Vunknown
p6325
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07835_1540
p6326
sg8
Vdrug-target interaction N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB07835_1540]
p6327
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6328
sg14
Vhttp://bio2rdf.org/drugbank:DB07835
p6329
sg16
VN~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide [drugbank:DB07835]
p6330
sa(dp6331
g4
Vunknown
p6332
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08091_1540
p6333
sg8
Vdrug-target interaction 3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08091_1540]
p6334
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6335
sg14
Vhttp://bio2rdf.org/drugbank:DB08091
p6336
sg16
V3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE [drugbank:DB08091]
p6337
sa(dp6338
g4
Vunknown
p6339
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08096_1540
p6340
sg8
Vdrug-target interaction 8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM and Mitogen-activated protein kinase 14 [drugbank_resource:DB08096_1540]
p6341
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6342
sg14
Vhttp://bio2rdf.org/drugbank:DB08096
p6343
sg16
V8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM [drugbank:DB08096]
p6344
sa(dp6345
g4
Vunknown
p6346
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08242_1540
p6347
sg8
Vdrug-target interaction N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB08242_1540]
p6348
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6349
sg14
Vhttp://bio2rdf.org/drugbank:DB08242
p6350
sg16
VN,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide [drugbank:DB08242]
p6351
sa(dp6352
g4
Vunknown
p6353
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08352_1540
p6354
sg8
Vdrug-target interaction 6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine and Mitogen-activated protein kinase 14 [drugbank_resource:DB08352_1540]
p6355
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6356
sg14
Vhttp://bio2rdf.org/drugbank:DB08352
p6357
sg16
V6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine [drugbank:DB08352]
p6358
sa(dp6359
g4
Vunknown
p6360
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08522_1540
p6361
sg8
Vdrug-target interaction 4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08522_1540]
p6362
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6363
sg14
Vhttp://bio2rdf.org/drugbank:DB08522
p6364
sg16
V4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE [drugbank:DB08522]
p6365
sa(dp6366
g4
Vunknown
p6367
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07941_1540
p6368
sg8
Vdrug-target interaction 3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB07941_1540]
p6369
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6370
sg14
Vhttp://bio2rdf.org/drugbank:DB07941
p6371
sg16
V3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamide [drugbank:DB07941]
p6372
sa(dp6373
g4
Vunknown
p6374
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07942_1540
p6375
sg8
Vdrug-target interaction 2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine and Mitogen-activated protein kinase 14 [drugbank_resource:DB07942_1540]
p6376
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6377
sg14
Vhttp://bio2rdf.org/drugbank:DB07942
p6378
sg16
V2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine [drugbank:DB07942]
p6379
sa(dp6380
g4
Vunknown
p6381
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07943_1540
p6382
sg8
Vdrug-target interaction 2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol and Mitogen-activated protein kinase 14 [drugbank_resource:DB07943_1540]
p6383
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6384
sg14
Vhttp://bio2rdf.org/drugbank:DB07943
p6385
sg16
V2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol [drugbank:DB07943]
p6386
sa(dp6387
g4
Vunknown
p6388
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08064_1540
p6389
sg8
Vdrug-target interaction N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA and Mitogen-activated protein kinase 14 [drugbank_resource:DB08064_1540]
p6390
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6391
sg14
Vhttp://bio2rdf.org/drugbank:DB08064
p6392
sg16
VN-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA [drugbank:DB08064]
p6393
sa(dp6394
g4
Vunknown
p6395
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08068_1540
p6396
sg8
Vdrug-target interaction N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO- and Mitogen-activated protein kinase 14 [drugbank_resource:DB08068_1540]
p6397
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6398
sg14
Vhttp://bio2rdf.org/drugbank:DB08068
p6399
sg16
VN-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO- [drugbank:DB08068]
p6400
sa(dp6401
g4
Vunknown
p6402
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08095_1540
p6403
sg8
Vdrug-target interaction 3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA and Mitogen-activated protein kinase 14 [drugbank_resource:DB08095_1540]
p6404
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6405
sg14
Vhttp://bio2rdf.org/drugbank:DB08095
p6406
sg16
V3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA [drugbank:DB08095]
p6407
sa(dp6408
g4
Vunknown
p6409
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08349_1540
p6410
sg8
Vdrug-target interaction N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide and Mitogen-activated protein kinase 14 [drugbank_resource:DB08349_1540]
p6411
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6412
sg14
Vhttp://bio2rdf.org/drugbank:DB08349
p6413
sg16
VN-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide [drugbank:DB08349]
p6414
sa(dp6415
g4
Vunknown
p6416
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08395_1540
p6417
sg8
Vdrug-target interaction 2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08395_1540]
p6418
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6419
sg14
Vhttp://bio2rdf.org/drugbank:DB08395
p6420
sg16
V2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE [drugbank:DB08395]
p6421
sa(dp6422
g4
Vunknown
p6423
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08423_1540
p6424
sg8
Vdrug-target interaction [5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08423_1540]
p6425
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6426
sg14
Vhttp://bio2rdf.org/drugbank:DB08423
p6427
sg16
V[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE [drugbank:DB08423]
p6428
sa(dp6429
g4
Vunknown
p6430
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08521_1540
p6431
sg8
Vdrug-target interaction 4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE and Mitogen-activated protein kinase 14 [drugbank_resource:DB08521_1540]
p6432
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1540
p6433
sg14
Vhttp://bio2rdf.org/drugbank:DB08521
p6434
sg16
V4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE [drugbank:DB08521]
p6435
sasS'ISG20'
p6436
(lp6437
(dp6438
g4
Vunknown
p6439
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03685_3529
p6440
sg8
Vdrug-target interaction Uridine-5'-Monophosphate and Interferon-stimulated gene 20 kDa protein [drugbank_resource:DB03685_3529]
p6441
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3529
p6442
sg14
Vhttp://bio2rdf.org/drugbank:DB03685
p6443
sg16
VUridine-5'-Monophosphate [drugbank:DB03685]
p6444
sasS'SNAP25'
p6445
(lp6446
(dp6447
g4
Vyes
p6448
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00083_433
p6449
sg8
Vdrug-target interaction Botulinum Toxin Type A and Synaptosomal-associated protein 25 [drugbank_resource:DB00083_433]
p6450
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:433
p6451
sg14
Vhttp://bio2rdf.org/drugbank:DB00083
p6452
sg16
VBotulinum Toxin Type A [drugbank:DB00083]
p6453
sasS'PRKAR2B'
p6454
(lp6455
(dp6456
g4
Vunknown
p6457
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02527_7007
p6458
sg8
Vdrug-target interaction Cyclic Adenosine Monophosphate and cAMP-dependent protein kinase type II-beta regulatory subunit [drugbank_resource:DB02527_7007]
p6459
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7007
p6460
sg14
Vhttp://bio2rdf.org/drugbank:DB02527
p6461
sg16
VCyclic Adenosine Monophosphate [drugbank:DB02527]
p6462
sasS'KIF11'
p6463
(lp6464
(dp6465
g4
Vunknown
p6466
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03431_3379
p6467
sg8
Vdrug-target interaction Adenosine-5'-Diphosphate and Kinesin-like protein KIF11 [drugbank_resource:DB03431_3379]
p6468
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3379
p6469
sg14
Vhttp://bio2rdf.org/drugbank:DB03431
p6470
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p6471
sa(dp6472
g4
Vunknown
p6473
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04331_3379
p6474
sg8
Vdrug-target interaction Monastrol and Kinesin-like protein KIF11 [drugbank_resource:DB04331_3379]
p6475
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3379
p6476
sg14
Vhttp://bio2rdf.org/drugbank:DB04331
p6477
sg16
VMonastrol [drugbank:DB04331]
p6478
sa(dp6479
g4
Vunknown
p6480
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03996_3379
p6481
sg8
Vdrug-target interaction 3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol and Kinesin-like protein KIF11 [drugbank_resource:DB03996_3379]
p6482
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3379
p6483
sg14
Vhttp://bio2rdf.org/drugbank:DB03996
p6484
sg16
V3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol [drugbank:DB03996]
p6485
sa(dp6486
g4
Vunknown
p6487
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07064_3379
p6488
sg8
Vdrug-target interaction (4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB07064_3379]
p6489
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3379
p6490
sg14
Vhttp://bio2rdf.org/drugbank:DB07064
p6491
sg16
V(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE [drugbank:DB07064]
p6492
sa(dp6493
g4
Vunknown
p6494
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08033_3379
p6495
sg8
Vdrug-target interaction (5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB08033_3379]
p6496
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3379
p6497
sg14
Vhttp://bio2rdf.org/drugbank:DB08033
p6498
sg16
V(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE [drugbank:DB08033]
p6499
sa(dp6500
g4
Vunknown
p6501
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08037_3379
p6502
sg8
Vdrug-target interaction (2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide and Kinesin-like protein KIF11 [drugbank_resource:DB08037_3379]
p6503
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3379
p6504
sg14
Vhttp://bio2rdf.org/drugbank:DB08037
p6505
sg16
V(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide [drugbank:DB08037]
p6506
sa(dp6507
g4
Vunknown
p6508
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08246_3379
p6509
sg8
Vdrug-target interaction (2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB08246_3379]
p6510
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3379
p6511
sg14
Vhttp://bio2rdf.org/drugbank:DB08246
p6512
sg16
V(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE [drugbank:DB08246]
p6513
sa(dp6514
g4
Vunknown
p6515
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08032_3379
p6516
sg8
Vdrug-target interaction N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB08032_3379]
p6517
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3379
p6518
sg14
Vhttp://bio2rdf.org/drugbank:DB08032
p6519
sg16
VN,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE [drugbank:DB08032]
p6520
sa(dp6521
g4
Vunknown
p6522
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08198_3379
p6523
sg8
Vdrug-target interaction [(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE and Kinesin-like protein KIF11 [drugbank_resource:DB08198_3379]
p6524
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3379
p6525
sg14
Vhttp://bio2rdf.org/drugbank:DB08198
p6526
sg16
V[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE [drugbank:DB08198]
p6527
sa(dp6528
g4
Vunknown
p6529
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08244_3379
p6530
sg8
Vdrug-target interaction (1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE and Kinesin-like protein KIF11 [drugbank_resource:DB08244_3379]
p6531
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3379
p6532
sg14
Vhttp://bio2rdf.org/drugbank:DB08244
p6533
sg16
V(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE [drugbank:DB08244]
p6534
sa(dp6535
g4
Vunknown
p6536
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08239_3379
p6537
sg8
Vdrug-target interaction (2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB08239_3379]
p6538
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3379
p6539
sg14
Vhttp://bio2rdf.org/drugbank:DB08239
p6540
sg16
V(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE [drugbank:DB08239]
p6541
sa(dp6542
g4
Vunknown
p6543
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08250_3379
p6544
sg8
Vdrug-target interaction (5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE and Kinesin-like protein KIF11 [drugbank_resource:DB08250_3379]
p6545
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3379
p6546
sg14
Vhttp://bio2rdf.org/drugbank:DB08250
p6547
sg16
V(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE [drugbank:DB08250]
p6548
sasS'CD2'
p6549
(lp6550
(dp6551
g4
Vyes
p6552
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00092_793
p6553
sg8
Vdrug-target interaction Alefacept and T-cell surface antigen CD2 [drugbank_resource:DB00092_793]
p6554
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:793
p6555
sg14
Vhttp://bio2rdf.org/drugbank:DB00092
p6556
sg16
VAlefacept [drugbank:DB00092]
p6557
sa(dp6558
g4
Vunknown
p6559
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02944_793
p6560
sg8
Vdrug-target interaction Alpha-D-Mannose and T-cell surface antigen CD2 [drugbank_resource:DB02944_793]
p6561
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:793
p6562
sg14
Vhttp://bio2rdf.org/drugbank:DB02944
p6563
sg16
VAlpha-D-Mannose [drugbank:DB02944]
p6564
sasS'GABRA5'
p6565
(lp6566
(dp6567
g4
Vyes
p6568
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00237_523
p6569
sg8
Vdrug-target interaction Butabarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00237_523]
p6570
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6571
sg14
Vhttp://bio2rdf.org/drugbank:DB00237
p6572
sg16
VButabarbital [drugbank:DB00237]
p6573
sa(dp6574
g4
Vyes
p6575
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00241_523
p6576
sg8
Vdrug-target interaction Butalbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00241_523]
p6577
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6578
sg14
Vhttp://bio2rdf.org/drugbank:DB00241
p6579
sg16
VButalbital [drugbank:DB00241]
p6580
sa(dp6581
g4
Vyes
p6582
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00186_523
p6583
sg8
Vdrug-target interaction Lorazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00186_523]
p6584
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6585
sg14
Vhttp://bio2rdf.org/drugbank:DB00186
p6586
sg16
VLorazepam [drugbank:DB00186]
p6587
sa(dp6588
g4
Vunknown
p6589
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00189_523
p6590
sg8
Vdrug-target interaction Ethchlorvynol and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00189_523]
p6591
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6592
sg14
Vhttp://bio2rdf.org/drugbank:DB00189
p6593
sg16
VEthchlorvynol [drugbank:DB00189]
p6594
sa(dp6595
g4
Vyes
p6596
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00231_523
p6597
sg8
Vdrug-target interaction Temazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00231_523]
p6598
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6599
sg14
Vhttp://bio2rdf.org/drugbank:DB00231
p6600
sg16
VTemazepam [drugbank:DB00231]
p6601
sa(dp6602
g4
Vyes
p6603
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00312_523
p6604
sg8
Vdrug-target interaction Pentobarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00312_523]
p6605
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6606
sg14
Vhttp://bio2rdf.org/drugbank:DB00312
p6607
sg16
VPentobarbital [drugbank:DB00312]
p6608
sa(dp6609
g4
Vyes
p6610
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00418_523
p6611
sg8
Vdrug-target interaction Secobarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00418_523]
p6612
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6613
sg14
Vhttp://bio2rdf.org/drugbank:DB00418
p6614
sg16
VSecobarbital [drugbank:DB00418]
p6615
sa(dp6616
g4
Vyes
p6617
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00463_523
p6618
sg8
Vdrug-target interaction Metharbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00463_523]
p6619
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6620
sg14
Vhttp://bio2rdf.org/drugbank:DB00463
p6621
sg16
VMetharbital [drugbank:DB00463]
p6622
sa(dp6623
g4
Vyes
p6624
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00475_523
p6625
sg8
Vdrug-target interaction Chlordiazepoxide and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00475_523]
p6626
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6627
sg14
Vhttp://bio2rdf.org/drugbank:DB00475
p6628
sg16
VChlordiazepoxide [drugbank:DB00475]
p6629
sa(dp6630
g4
Vyes
p6631
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00546_523
p6632
sg8
Vdrug-target interaction Adinazolam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00546_523]
p6633
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6634
sg14
Vhttp://bio2rdf.org/drugbank:DB00546
p6635
sg16
VAdinazolam [drugbank:DB00546]
p6636
sa(dp6637
g4
Vyes
p6638
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00628_523
p6639
sg8
Vdrug-target interaction Clorazepate and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00628_523]
p6640
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6641
sg14
Vhttp://bio2rdf.org/drugbank:DB00628
p6642
sg16
VClorazepate [drugbank:DB00628]
p6643
sa(dp6644
g4
Vyes
p6645
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00306_523
p6646
sg8
Vdrug-target interaction Talbutal and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00306_523]
p6647
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6648
sg14
Vhttp://bio2rdf.org/drugbank:DB00306
p6649
sg16
VTalbutal [drugbank:DB00306]
p6650
sa(dp6651
g4
Vyes
p6652
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00349_523
p6653
sg8
Vdrug-target interaction Clobazam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00349_523]
p6654
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6655
sg14
Vhttp://bio2rdf.org/drugbank:DB00349
p6656
sg16
VClobazam [drugbank:DB00349]
p6657
sa(dp6658
g4
Vyes
p6659
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00371_523
p6660
sg8
Vdrug-target interaction Meprobamate and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00371_523]
p6661
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6662
sg14
Vhttp://bio2rdf.org/drugbank:DB00371
p6663
sg16
VMeprobamate [drugbank:DB00371]
p6664
sa(dp6665
g4
Vunknown
p6666
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00402_523
p6667
sg8
Vdrug-target interaction Eszopiclone and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00402_523]
p6668
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6669
sg14
Vhttp://bio2rdf.org/drugbank:DB00402
p6670
sg16
VEszopiclone [drugbank:DB00402]
p6671
sa(dp6672
g4
Vyes
p6673
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00404_523
p6674
sg8
Vdrug-target interaction Alprazolam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00404_523]
p6675
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6676
sg14
Vhttp://bio2rdf.org/drugbank:DB00404
p6677
sg16
VAlprazolam [drugbank:DB00404]
p6678
sa(dp6679
g4
Vyes
p6680
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00599_523
p6681
sg8
Vdrug-target interaction Thiopental and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00599_523]
p6682
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6683
sg14
Vhttp://bio2rdf.org/drugbank:DB00599
p6684
sg16
VThiopental [drugbank:DB00599]
p6685
sa(dp6686
g4
Vyes
p6687
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00683_523
p6688
sg8
Vdrug-target interaction Midazolam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00683_523]
p6689
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6690
sg14
Vhttp://bio2rdf.org/drugbank:DB00683
p6691
sg16
VMidazolam [drugbank:DB00683]
p6692
sa(dp6693
g4
Vyes
p6694
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00690_523
p6695
sg8
Vdrug-target interaction Flurazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00690_523]
p6696
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6697
sg14
Vhttp://bio2rdf.org/drugbank:DB00690
p6698
sg16
VFlurazepam [drugbank:DB00690]
p6699
sa(dp6700
g4
Vyes
p6701
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00794_523
p6702
sg8
Vdrug-target interaction Primidone and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00794_523]
p6703
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6704
sg14
Vhttp://bio2rdf.org/drugbank:DB00794
p6705
sg16
VPrimidone [drugbank:DB00794]
p6706
sa(dp6707
g4
Vyes
p6708
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00829_523
p6709
sg8
Vdrug-target interaction Diazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00829_523]
p6710
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6711
sg14
Vhttp://bio2rdf.org/drugbank:DB00829
p6712
sg16
VDiazepam [drugbank:DB00829]
p6713
sa(dp6714
g4
Vyes
p6715
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00842_523
p6716
sg8
Vdrug-target interaction Oxazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00842_523]
p6717
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6718
sg14
Vhttp://bio2rdf.org/drugbank:DB00842
p6719
sg16
VOxazepam [drugbank:DB00842]
p6720
sa(dp6721
g4
Vyes
p6722
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00801_523
p6723
sg8
Vdrug-target interaction Halazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00801_523]
p6724
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6725
sg14
Vhttp://bio2rdf.org/drugbank:DB00801
p6726
sg16
VHalazepam [drugbank:DB00801]
p6727
sa(dp6728
g4
Vyes
p6729
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00849_523
p6730
sg8
Vdrug-target interaction Methylphenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00849_523]
p6731
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6732
sg14
Vhttp://bio2rdf.org/drugbank:DB00849
p6733
sg16
VMethylphenobarbital [drugbank:DB00849]
p6734
sa(dp6735
g4
Vyes
p6736
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01068_523
p6737
sg8
Vdrug-target interaction Clonazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01068_523]
p6738
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6739
sg14
Vhttp://bio2rdf.org/drugbank:DB01068
p6740
sg16
VClonazepam [drugbank:DB01068]
p6741
sa(dp6742
g4
Vyes
p6743
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00897_523
p6744
sg8
Vdrug-target interaction Triazolam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB00897_523]
p6745
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6746
sg14
Vhttp://bio2rdf.org/drugbank:DB00897
p6747
sg16
VTriazolam [drugbank:DB00897]
p6748
sa(dp6749
g4
Vyes
p6750
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01215_523
p6751
sg8
Vdrug-target interaction Estazolam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01215_523]
p6752
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6753
sg14
Vhttp://bio2rdf.org/drugbank:DB01215
p6754
sg16
VEstazolam [drugbank:DB01215]
p6755
sa(dp6756
g4
Vyes
p6757
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01354_523
p6758
sg8
Vdrug-target interaction Heptabarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01354_523]
p6759
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6760
sg14
Vhttp://bio2rdf.org/drugbank:DB01354
p6761
sg16
VHeptabarbital [drugbank:DB01354]
p6762
sa(dp6763
g4
Vyes
p6764
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01558_523
p6765
sg8
Vdrug-target interaction Bromazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01558_523]
p6766
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6767
sg14
Vhttp://bio2rdf.org/drugbank:DB01558
p6768
sg16
VBromazepam [drugbank:DB01558]
p6769
sa(dp6770
g4
Vyes
p6771
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01588_523
p6772
sg8
Vdrug-target interaction Prazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01588_523]
p6773
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6774
sg14
Vhttp://bio2rdf.org/drugbank:DB01588
p6775
sg16
VPrazepam [drugbank:DB01588]
p6776
sa(dp6777
g4
Vyes
p6778
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01589_523
p6779
sg8
Vdrug-target interaction Quazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01589_523]
p6780
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6781
sg14
Vhttp://bio2rdf.org/drugbank:DB01589
p6782
sg16
VQuazepam [drugbank:DB01589]
p6783
sa(dp6784
g4
Vyes
p6785
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01174_523
p6786
sg8
Vdrug-target interaction Phenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01174_523]
p6787
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6788
sg14
Vhttp://bio2rdf.org/drugbank:DB01174
p6789
sg16
VPhenobarbital [drugbank:DB01174]
p6790
sa(dp6791
g4
Vyes
p6792
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01198_523
p6793
sg8
Vdrug-target interaction Zopiclone and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01198_523]
p6794
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6795
sg14
Vhttp://bio2rdf.org/drugbank:DB01198
p6796
sg16
VZopiclone [drugbank:DB01198]
p6797
sa(dp6798
g4
Vyes
p6799
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01352_523
p6800
sg8
Vdrug-target interaction Aprobarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01352_523]
p6801
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6802
sg14
Vhttp://bio2rdf.org/drugbank:DB01352
p6803
sg16
VAprobarbital [drugbank:DB01352]
p6804
sa(dp6805
g4
Vyes
p6806
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01355_523
p6807
sg8
Vdrug-target interaction Hexobarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01355_523]
p6808
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6809
sg14
Vhttp://bio2rdf.org/drugbank:DB01355
p6810
sg16
VHexobarbital [drugbank:DB01355]
p6811
sa(dp6812
g4
Vyes
p6813
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01544_523
p6814
sg8
Vdrug-target interaction Flunitrazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01544_523]
p6815
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6816
sg14
Vhttp://bio2rdf.org/drugbank:DB01544
p6817
sg16
VFlunitrazepam [drugbank:DB01544]
p6818
sa(dp6819
g4
Vyes
p6820
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01559_523
p6821
sg8
Vdrug-target interaction Clotiazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01559_523]
p6822
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6823
sg14
Vhttp://bio2rdf.org/drugbank:DB01559
p6824
sg16
VClotiazepam [drugbank:DB01559]
p6825
sa(dp6826
g4
Vyes
p6827
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01567_523
p6828
sg8
Vdrug-target interaction Fludiazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01567_523]
p6829
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6830
sg14
Vhttp://bio2rdf.org/drugbank:DB01567
p6831
sg16
VFludiazepam [drugbank:DB01567]
p6832
sa(dp6833
g4
Vyes
p6834
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01205_523
p6835
sg8
Vdrug-target interaction Flumazenil and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01205_523]
p6836
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6837
sg14
Vhttp://bio2rdf.org/drugbank:DB01205
p6838
sg16
VFlumazenil [drugbank:DB01205]
p6839
sa(dp6840
g4
Vyes
p6841
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01351_523
p6842
sg8
Vdrug-target interaction Amobarbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01351_523]
p6843
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6844
sg14
Vhttp://bio2rdf.org/drugbank:DB01351
p6845
sg16
VAmobarbital [drugbank:DB01351]
p6846
sa(dp6847
g4
Vyes
p6848
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01353_523
p6849
sg8
Vdrug-target interaction Butethal and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01353_523]
p6850
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6851
sg14
Vhttp://bio2rdf.org/drugbank:DB01353
p6852
sg16
VButethal [drugbank:DB01353]
p6853
sa(dp6854
g4
Vyes
p6855
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01483_523
p6856
sg8
Vdrug-target interaction Barbital and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01483_523]
p6857
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6858
sg14
Vhttp://bio2rdf.org/drugbank:DB01483
p6859
sg16
VBarbital [drugbank:DB01483]
p6860
sa(dp6861
g4
Vyes
p6862
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01496_523
p6863
sg8
Vdrug-target interaction Barbituric acid derivative and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01496_523]
p6864
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6865
sg14
Vhttp://bio2rdf.org/drugbank:DB01496
p6866
sg16
VBarbituric acid derivative [drugbank:DB01496]
p6867
sa(dp6868
g4
Vyes
p6869
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01594_523
p6870
sg8
Vdrug-target interaction Cinolazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01594_523]
p6871
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6872
sg14
Vhttp://bio2rdf.org/drugbank:DB01594
p6873
sg16
VCinolazepam [drugbank:DB01594]
p6874
sa(dp6875
g4
Vyes
p6876
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01595_523
p6877
sg8
Vdrug-target interaction Nitrazepam and Gamma-aminobutyric-acid receptor subunit alpha-5 [drugbank_resource:DB01595_523]
p6878
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:523
p6879
sg14
Vhttp://bio2rdf.org/drugbank:DB01595
p6880
sg16
VNitrazepam [drugbank:DB01595]
p6881
sasS'GABRA4'
p6882
(lp6883
(dp6884
g4
Vyes
p6885
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00186_530
p6886
sg8
Vdrug-target interaction Lorazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00186_530]
p6887
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6888
sg14
Vhttp://bio2rdf.org/drugbank:DB00186
p6889
sg16
VLorazepam [drugbank:DB00186]
p6890
sa(dp6891
g4
Vunknown
p6892
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00189_530
p6893
sg8
Vdrug-target interaction Ethchlorvynol and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00189_530]
p6894
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6895
sg14
Vhttp://bio2rdf.org/drugbank:DB00189
p6896
sg16
VEthchlorvynol [drugbank:DB00189]
p6897
sa(dp6898
g4
Vyes
p6899
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00231_530
p6900
sg8
Vdrug-target interaction Temazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00231_530]
p6901
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6902
sg14
Vhttp://bio2rdf.org/drugbank:DB00231
p6903
sg16
VTemazepam [drugbank:DB00231]
p6904
sa(dp6905
g4
Vyes
p6906
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00237_530
p6907
sg8
Vdrug-target interaction Butabarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00237_530]
p6908
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6909
sg14
Vhttp://bio2rdf.org/drugbank:DB00237
p6910
sg16
VButabarbital [drugbank:DB00237]
p6911
sa(dp6912
g4
Vyes
p6913
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00241_530
p6914
sg8
Vdrug-target interaction Butalbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00241_530]
p6915
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6916
sg14
Vhttp://bio2rdf.org/drugbank:DB00241
p6917
sg16
VButalbital [drugbank:DB00241]
p6918
sa(dp6919
g4
Vyes
p6920
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00306_530
p6921
sg8
Vdrug-target interaction Talbutal and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00306_530]
p6922
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6923
sg14
Vhttp://bio2rdf.org/drugbank:DB00306
p6924
sg16
VTalbutal [drugbank:DB00306]
p6925
sa(dp6926
g4
Vyes
p6927
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00349_530
p6928
sg8
Vdrug-target interaction Clobazam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00349_530]
p6929
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6930
sg14
Vhttp://bio2rdf.org/drugbank:DB00349
p6931
sg16
VClobazam [drugbank:DB00349]
p6932
sa(dp6933
g4
Vyes
p6934
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00371_530
p6935
sg8
Vdrug-target interaction Meprobamate and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00371_530]
p6936
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6937
sg14
Vhttp://bio2rdf.org/drugbank:DB00371
p6938
sg16
VMeprobamate [drugbank:DB00371]
p6939
sa(dp6940
g4
Vyes
p6941
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00418_530
p6942
sg8
Vdrug-target interaction Secobarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00418_530]
p6943
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6944
sg14
Vhttp://bio2rdf.org/drugbank:DB00418
p6945
sg16
VSecobarbital [drugbank:DB00418]
p6946
sa(dp6947
g4
Vyes
p6948
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00312_530
p6949
sg8
Vdrug-target interaction Pentobarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00312_530]
p6950
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6951
sg14
Vhttp://bio2rdf.org/drugbank:DB00312
p6952
sg16
VPentobarbital [drugbank:DB00312]
p6953
sa(dp6954
g4
Vyes
p6955
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00404_530
p6956
sg8
Vdrug-target interaction Alprazolam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00404_530]
p6957
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6958
sg14
Vhttp://bio2rdf.org/drugbank:DB00404
p6959
sg16
VAlprazolam [drugbank:DB00404]
p6960
sa(dp6961
g4
Vyes
p6962
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00463_530
p6963
sg8
Vdrug-target interaction Metharbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00463_530]
p6964
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6965
sg14
Vhttp://bio2rdf.org/drugbank:DB00463
p6966
sg16
VMetharbital [drugbank:DB00463]
p6967
sa(dp6968
g4
Vyes
p6969
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00475_530
p6970
sg8
Vdrug-target interaction Chlordiazepoxide and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00475_530]
p6971
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6972
sg14
Vhttp://bio2rdf.org/drugbank:DB00475
p6973
sg16
VChlordiazepoxide [drugbank:DB00475]
p6974
sa(dp6975
g4
Vyes
p6976
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00599_530
p6977
sg8
Vdrug-target interaction Thiopental and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00599_530]
p6978
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6979
sg14
Vhttp://bio2rdf.org/drugbank:DB00599
p6980
sg16
VThiopental [drugbank:DB00599]
p6981
sa(dp6982
g4
Vyes
p6983
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00628_530
p6984
sg8
Vdrug-target interaction Clorazepate and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00628_530]
p6985
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6986
sg14
Vhttp://bio2rdf.org/drugbank:DB00628
p6987
sg16
VClorazepate [drugbank:DB00628]
p6988
sa(dp6989
g4
Vyes
p6990
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00683_530
p6991
sg8
Vdrug-target interaction Midazolam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00683_530]
p6992
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p6993
sg14
Vhttp://bio2rdf.org/drugbank:DB00683
p6994
sg16
VMidazolam [drugbank:DB00683]
p6995
sa(dp6996
g4
Vyes
p6997
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00690_530
p6998
sg8
Vdrug-target interaction Flurazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00690_530]
p6999
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7000
sg14
Vhttp://bio2rdf.org/drugbank:DB00690
p7001
sg16
VFlurazepam [drugbank:DB00690]
p7002
sa(dp7003
g4
Vyes
p7004
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00794_530
p7005
sg8
Vdrug-target interaction Primidone and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00794_530]
p7006
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7007
sg14
Vhttp://bio2rdf.org/drugbank:DB00794
p7008
sg16
VPrimidone [drugbank:DB00794]
p7009
sa(dp7010
g4
Vyes
p7011
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00897_530
p7012
sg8
Vdrug-target interaction Triazolam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00897_530]
p7013
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7014
sg14
Vhttp://bio2rdf.org/drugbank:DB00897
p7015
sg16
VTriazolam [drugbank:DB00897]
p7016
sa(dp7017
g4
Vyes
p7018
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00842_530
p7019
sg8
Vdrug-target interaction Oxazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00842_530]
p7020
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7021
sg14
Vhttp://bio2rdf.org/drugbank:DB00842
p7022
sg16
VOxazepam [drugbank:DB00842]
p7023
sa(dp7024
g4
Vyes
p7025
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00849_530
p7026
sg8
Vdrug-target interaction Methylphenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB00849_530]
p7027
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7028
sg14
Vhttp://bio2rdf.org/drugbank:DB00849
p7029
sg16
VMethylphenobarbital [drugbank:DB00849]
p7030
sa(dp7031
g4
Vyes
p7032
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01068_530
p7033
sg8
Vdrug-target interaction Clonazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01068_530]
p7034
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7035
sg14
Vhttp://bio2rdf.org/drugbank:DB01068
p7036
sg16
VClonazepam [drugbank:DB01068]
p7037
sa(dp7038
g4
Vyes
p7039
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01352_530
p7040
sg8
Vdrug-target interaction Aprobarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01352_530]
p7041
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7042
sg14
Vhttp://bio2rdf.org/drugbank:DB01352
p7043
sg16
VAprobarbital [drugbank:DB01352]
p7044
sa(dp7045
g4
Vyes
p7046
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01355_530
p7047
sg8
Vdrug-target interaction Hexobarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01355_530]
p7048
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7049
sg14
Vhttp://bio2rdf.org/drugbank:DB01355
p7050
sg16
VHexobarbital [drugbank:DB01355]
p7051
sa(dp7052
g4
Vyes
p7053
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01544_530
p7054
sg8
Vdrug-target interaction Flunitrazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01544_530]
p7055
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7056
sg14
Vhttp://bio2rdf.org/drugbank:DB01544
p7057
sg16
VFlunitrazepam [drugbank:DB01544]
p7058
sa(dp7059
g4
Vyes
p7060
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01558_530
p7061
sg8
Vdrug-target interaction Bromazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01558_530]
p7062
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7063
sg14
Vhttp://bio2rdf.org/drugbank:DB01558
p7064
sg16
VBromazepam [drugbank:DB01558]
p7065
sa(dp7066
g4
Vyes
p7067
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01595_530
p7068
sg8
Vdrug-target interaction Nitrazepam and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01595_530]
p7069
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7070
sg14
Vhttp://bio2rdf.org/drugbank:DB01595
p7071
sg16
VNitrazepam [drugbank:DB01595]
p7072
sa(dp7073
g4
Vyes
p7074
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01174_530
p7075
sg8
Vdrug-target interaction Phenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01174_530]
p7076
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7077
sg14
Vhttp://bio2rdf.org/drugbank:DB01174
p7078
sg16
VPhenobarbital [drugbank:DB01174]
p7079
sa(dp7080
g4
Vyes
p7081
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01351_530
p7082
sg8
Vdrug-target interaction Amobarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01351_530]
p7083
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7084
sg14
Vhttp://bio2rdf.org/drugbank:DB01351
p7085
sg16
VAmobarbital [drugbank:DB01351]
p7086
sa(dp7087
g4
Vyes
p7088
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01353_530
p7089
sg8
Vdrug-target interaction Butethal and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01353_530]
p7090
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7091
sg14
Vhttp://bio2rdf.org/drugbank:DB01353
p7092
sg16
VButethal [drugbank:DB01353]
p7093
sa(dp7094
g4
Vyes
p7095
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01354_530
p7096
sg8
Vdrug-target interaction Heptabarbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01354_530]
p7097
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7098
sg14
Vhttp://bio2rdf.org/drugbank:DB01354
p7099
sg16
VHeptabarbital [drugbank:DB01354]
p7100
sa(dp7101
g4
Vyes
p7102
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01483_530
p7103
sg8
Vdrug-target interaction Barbital and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01483_530]
p7104
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7105
sg14
Vhttp://bio2rdf.org/drugbank:DB01483
p7106
sg16
VBarbital [drugbank:DB01483]
p7107
sa(dp7108
g4
Vyes
p7109
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01496_530
p7110
sg8
Vdrug-target interaction Barbituric acid derivative and Gamma-aminobutyric-acid receptor subunit alpha-4 [drugbank_resource:DB01496_530]
p7111
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:530
p7112
sg14
Vhttp://bio2rdf.org/drugbank:DB01496
p7113
sg16
VBarbituric acid derivative [drugbank:DB01496]
p7114
sasS'GLS'
p7115
(lp7116
(dp7117
g4
Vunknown
p7118
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00142_917
p7119
sg8
Vdrug-target interaction L-Glutamic Acid and Glutaminase kidney isoform, mitochondrial [drugbank_resource:DB00142_917]
p7120
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:917
p7121
sg14
Vhttp://bio2rdf.org/drugbank:DB00142
p7122
sg16
VL-Glutamic Acid [drugbank:DB00142]
p7123
sasS'GABRA1'
p7124
(lp7125
(dp7126
g4
Vyes
p7127
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00186_872
p7128
sg8
Vdrug-target interaction Lorazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00186_872]
p7129
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7130
sg14
Vhttp://bio2rdf.org/drugbank:DB00186
p7131
sg16
VLorazepam [drugbank:DB00186]
p7132
sa(dp7133
g4
Vyes
p7134
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00189_872
p7135
sg8
Vdrug-target interaction Ethchlorvynol and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00189_872]
p7136
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7137
sg14
Vhttp://bio2rdf.org/drugbank:DB00189
p7138
sg16
VEthchlorvynol [drugbank:DB00189]
p7139
sa(dp7140
g4
Vyes
p7141
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00228_872
p7142
sg8
Vdrug-target interaction Enflurane and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00228_872]
p7143
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7144
sg14
Vhttp://bio2rdf.org/drugbank:DB00228
p7145
sg16
VEnflurane [drugbank:DB00228]
p7146
sa(dp7147
g4
Vyes
p7148
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00237_872
p7149
sg8
Vdrug-target interaction Butabarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00237_872]
p7150
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7151
sg14
Vhttp://bio2rdf.org/drugbank:DB00237
p7152
sg16
VButabarbital [drugbank:DB00237]
p7153
sa(dp7154
g4
Vyes
p7155
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00312_872
p7156
sg8
Vdrug-target interaction Pentobarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00312_872]
p7157
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7158
sg14
Vhttp://bio2rdf.org/drugbank:DB00312
p7159
sg16
VPentobarbital [drugbank:DB00312]
p7160
sa(dp7161
g4
Vyes
p7162
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00231_872
p7163
sg8
Vdrug-target interaction Temazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00231_872]
p7164
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7165
sg14
Vhttp://bio2rdf.org/drugbank:DB00231
p7166
sg16
VTemazepam [drugbank:DB00231]
p7167
sa(dp7168
g4
Vyes
p7169
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00241_872
p7170
sg8
Vdrug-target interaction Butalbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00241_872]
p7171
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7172
sg14
Vhttp://bio2rdf.org/drugbank:DB00241
p7173
sg16
VButalbital [drugbank:DB00241]
p7174
sa(dp7175
g4
Vyes
p7176
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00273_872
p7177
sg8
Vdrug-target interaction Topiramate and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00273_872]
p7178
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7179
sg14
Vhttp://bio2rdf.org/drugbank:DB00273
p7180
sg16
VTopiramate [drugbank:DB00273]
p7181
sa(dp7182
g4
Vyes
p7183
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00292_872
p7184
sg8
Vdrug-target interaction Etomidate and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00292_872]
p7185
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7186
sg14
Vhttp://bio2rdf.org/drugbank:DB00292
p7187
sg16
VEtomidate [drugbank:DB00292]
p7188
sa(dp7189
g4
Vyes
p7190
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00306_872
p7191
sg8
Vdrug-target interaction Talbutal and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00306_872]
p7192
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7193
sg14
Vhttp://bio2rdf.org/drugbank:DB00306
p7194
sg16
VTalbutal [drugbank:DB00306]
p7195
sa(dp7196
g4
Vyes
p7197
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00371_872
p7198
sg8
Vdrug-target interaction Meprobamate and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00371_872]
p7199
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7200
sg14
Vhttp://bio2rdf.org/drugbank:DB00371
p7201
sg16
VMeprobamate [drugbank:DB00371]
p7202
sa(dp7203
g4
Vyes
p7204
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00402_872
p7205
sg8
Vdrug-target interaction Eszopiclone and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00402_872]
p7206
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7207
sg14
Vhttp://bio2rdf.org/drugbank:DB00402
p7208
sg16
VEszopiclone [drugbank:DB00402]
p7209
sa(dp7210
g4
Vyes
p7211
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00404_872
p7212
sg8
Vdrug-target interaction Alprazolam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00404_872]
p7213
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7214
sg14
Vhttp://bio2rdf.org/drugbank:DB00404
p7215
sg16
VAlprazolam [drugbank:DB00404]
p7216
sa(dp7217
g4
Vyes
p7218
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00418_872
p7219
sg8
Vdrug-target interaction Secobarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00418_872]
p7220
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7221
sg14
Vhttp://bio2rdf.org/drugbank:DB00418
p7222
sg16
VSecobarbital [drugbank:DB00418]
p7223
sa(dp7224
g4
Vyes
p7225
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00599_872
p7226
sg8
Vdrug-target interaction Thiopental and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00599_872]
p7227
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7228
sg14
Vhttp://bio2rdf.org/drugbank:DB00599
p7229
sg16
VThiopental [drugbank:DB00599]
p7230
sa(dp7231
g4
Vyes
p7232
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00425_872
p7233
sg8
Vdrug-target interaction Zolpidem and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00425_872]
p7234
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7235
sg14
Vhttp://bio2rdf.org/drugbank:DB00425
p7236
sg16
VZolpidem [drugbank:DB00425]
p7237
sa(dp7238
g4
Vyes
p7239
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00475_872
p7240
sg8
Vdrug-target interaction Chlordiazepoxide and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00475_872]
p7241
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7242
sg14
Vhttp://bio2rdf.org/drugbank:DB00475
p7243
sg16
VChlordiazepoxide [drugbank:DB00475]
p7244
sa(dp7245
g4
Vunknown
p7246
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00543_872
p7247
sg8
Vdrug-target interaction Amoxapine and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00543_872]
p7248
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7249
sg14
Vhttp://bio2rdf.org/drugbank:DB00543
p7250
sg16
VAmoxapine [drugbank:DB00543]
p7251
sa(dp7252
g4
Vyes
p7253
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00546_872
p7254
sg8
Vdrug-target interaction Adinazolam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00546_872]
p7255
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7256
sg14
Vhttp://bio2rdf.org/drugbank:DB00546
p7257
sg16
VAdinazolam [drugbank:DB00546]
p7258
sa(dp7259
g4
Vyes
p7260
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00349_872
p7261
sg8
Vdrug-target interaction Clobazam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00349_872]
p7262
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7263
sg14
Vhttp://bio2rdf.org/drugbank:DB00349
p7264
sg16
VClobazam [drugbank:DB00349]
p7265
sa(dp7266
g4
Vyes
p7267
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00463_872
p7268
sg8
Vdrug-target interaction Metharbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00463_872]
p7269
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7270
sg14
Vhttp://bio2rdf.org/drugbank:DB00463
p7271
sg16
VMetharbital [drugbank:DB00463]
p7272
sa(dp7273
g4
Vyes
p7274
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00466_872
p7275
sg8
Vdrug-target interaction Picrotoxin and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00466_872]
p7276
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7277
sg14
Vhttp://bio2rdf.org/drugbank:DB00466
p7278
sg16
VPicrotoxin [drugbank:DB00466]
p7279
sa(dp7280
g4
Vyes
p7281
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00474_872
p7282
sg8
Vdrug-target interaction Methohexital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00474_872]
p7283
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7284
sg14
Vhttp://bio2rdf.org/drugbank:DB00474
p7285
sg16
VMethohexital [drugbank:DB00474]
p7286
sa(dp7287
g4
Vyes
p7288
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00628_872
p7289
sg8
Vdrug-target interaction Clorazepate and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00628_872]
p7290
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7291
sg14
Vhttp://bio2rdf.org/drugbank:DB00628
p7292
sg16
VClorazepate [drugbank:DB00628]
p7293
sa(dp7294
g4
Vyes
p7295
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00829_872
p7296
sg8
Vdrug-target interaction Diazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00829_872]
p7297
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7298
sg14
Vhttp://bio2rdf.org/drugbank:DB00829
p7299
sg16
VDiazepam [drugbank:DB00829]
p7300
sa(dp7301
g4
Vyes
p7302
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00837_872
p7303
sg8
Vdrug-target interaction Progabide and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00837_872]
p7304
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7305
sg14
Vhttp://bio2rdf.org/drugbank:DB00837
p7306
sg16
VProgabide [drugbank:DB00837]
p7307
sa(dp7308
g4
Vyes
p7309
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00962_872
p7310
sg8
Vdrug-target interaction Zaleplon and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00962_872]
p7311
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7312
sg14
Vhttp://bio2rdf.org/drugbank:DB00962
p7313
sg16
VZaleplon [drugbank:DB00962]
p7314
sa(dp7315
g4
Vyes
p7316
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00683_872
p7317
sg8
Vdrug-target interaction Midazolam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00683_872]
p7318
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7319
sg14
Vhttp://bio2rdf.org/drugbank:DB00683
p7320
sg16
VMidazolam [drugbank:DB00683]
p7321
sa(dp7322
g4
Vyes
p7323
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00690_872
p7324
sg8
Vdrug-target interaction Flurazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00690_872]
p7325
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7326
sg14
Vhttp://bio2rdf.org/drugbank:DB00690
p7327
sg16
VFlurazepam [drugbank:DB00690]
p7328
sa(dp7329
g4
Vyes
p7330
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00794_872
p7331
sg8
Vdrug-target interaction Primidone and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00794_872]
p7332
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7333
sg14
Vhttp://bio2rdf.org/drugbank:DB00794
p7334
sg16
VPrimidone [drugbank:DB00794]
p7335
sa(dp7336
g4
Vyes
p7337
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00849_872
p7338
sg8
Vdrug-target interaction Methylphenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00849_872]
p7339
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7340
sg14
Vhttp://bio2rdf.org/drugbank:DB00849
p7341
sg16
VMethylphenobarbital [drugbank:DB00849]
p7342
sa(dp7343
g4
Vyes
p7344
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00897_872
p7345
sg8
Vdrug-target interaction Triazolam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00897_872]
p7346
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7347
sg14
Vhttp://bio2rdf.org/drugbank:DB00897
p7348
sg16
VTriazolam [drugbank:DB00897]
p7349
sa(dp7350
g4
Vyes
p7351
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01028_872
p7352
sg8
Vdrug-target interaction Methoxyflurane and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01028_872]
p7353
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7354
sg14
Vhttp://bio2rdf.org/drugbank:DB01028
p7355
sg16
VMethoxyflurane [drugbank:DB01028]
p7356
sa(dp7357
g4
Vyes
p7358
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00753_872
p7359
sg8
Vdrug-target interaction Isoflurane and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00753_872]
p7360
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7361
sg14
Vhttp://bio2rdf.org/drugbank:DB00753
p7362
sg16
VIsoflurane [drugbank:DB00753]
p7363
sa(dp7364
g4
Vyes
p7365
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00801_872
p7366
sg8
Vdrug-target interaction Halazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00801_872]
p7367
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7368
sg14
Vhttp://bio2rdf.org/drugbank:DB00801
p7369
sg16
VHalazepam [drugbank:DB00801]
p7370
sa(dp7371
g4
Vyes
p7372
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00842_872
p7373
sg8
Vdrug-target interaction Oxazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00842_872]
p7374
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7375
sg14
Vhttp://bio2rdf.org/drugbank:DB00842
p7376
sg16
VOxazepam [drugbank:DB00842]
p7377
sa(dp7378
g4
Vyes
p7379
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00898_872
p7380
sg8
Vdrug-target interaction Ethanol and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB00898_872]
p7381
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7382
sg14
Vhttp://bio2rdf.org/drugbank:DB00898
p7383
sg16
VEthanol [drugbank:DB00898]
p7384
sa(dp7385
g4
Vyes
p7386
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01068_872
p7387
sg8
Vdrug-target interaction Clonazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01068_872]
p7388
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7389
sg14
Vhttp://bio2rdf.org/drugbank:DB01068
p7390
sg16
VClonazepam [drugbank:DB01068]
p7391
sa(dp7392
g4
Vyes
p7393
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01107_872
p7394
sg8
Vdrug-target interaction Methyprylon and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01107_872]
p7395
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7396
sg14
Vhttp://bio2rdf.org/drugbank:DB01107
p7397
sg16
VMethyprylon [drugbank:DB01107]
p7398
sa(dp7399
g4
Vyes
p7400
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01154_872
p7401
sg8
Vdrug-target interaction Thiamylal and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01154_872]
p7402
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7403
sg14
Vhttp://bio2rdf.org/drugbank:DB01154
p7404
sg16
VThiamylal [drugbank:DB01154]
p7405
sa(dp7406
g4
Vyes
p7407
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01174_872
p7408
sg8
Vdrug-target interaction Phenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01174_872]
p7409
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7410
sg14
Vhttp://bio2rdf.org/drugbank:DB01174
p7411
sg16
VPhenobarbital [drugbank:DB01174]
p7412
sa(dp7413
g4
Vyes
p7414
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01205_872
p7415
sg8
Vdrug-target interaction Flumazenil and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01205_872]
p7416
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7417
sg14
Vhttp://bio2rdf.org/drugbank:DB01205
p7418
sg16
VFlumazenil [drugbank:DB01205]
p7419
sa(dp7420
g4
Vyes
p7421
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01341_872
p7422
sg8
Vdrug-target interaction Dihydroquinidine barbiturate and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01341_872]
p7423
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7424
sg14
Vhttp://bio2rdf.org/drugbank:DB01341
p7425
sg16
VDihydroquinidine barbiturate [drugbank:DB01341]
p7426
sa(dp7427
g4
Vyes
p7428
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01352_872
p7429
sg8
Vdrug-target interaction Aprobarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01352_872]
p7430
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7431
sg14
Vhttp://bio2rdf.org/drugbank:DB01352
p7432
sg16
VAprobarbital [drugbank:DB01352]
p7433
sa(dp7434
g4
Vyes
p7435
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01353_872
p7436
sg8
Vdrug-target interaction Butethal and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01353_872]
p7437
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7438
sg14
Vhttp://bio2rdf.org/drugbank:DB01353
p7439
sg16
VButethal [drugbank:DB01353]
p7440
sa(dp7441
g4
Vyes
p7442
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01354_872
p7443
sg8
Vdrug-target interaction Heptabarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01354_872]
p7444
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7445
sg14
Vhttp://bio2rdf.org/drugbank:DB01354
p7446
sg16
VHeptabarbital [drugbank:DB01354]
p7447
sa(dp7448
g4
Vyes
p7449
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01355_872
p7450
sg8
Vdrug-target interaction Hexobarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01355_872]
p7451
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7452
sg14
Vhttp://bio2rdf.org/drugbank:DB01355
p7453
sg16
VHexobarbital [drugbank:DB01355]
p7454
sa(dp7455
g4
Vyes
p7456
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01483_872
p7457
sg8
Vdrug-target interaction Barbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01483_872]
p7458
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7459
sg14
Vhttp://bio2rdf.org/drugbank:DB01483
p7460
sg16
VBarbital [drugbank:DB01483]
p7461
sa(dp7462
g4
Vyes
p7463
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01558_872
p7464
sg8
Vdrug-target interaction Bromazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01558_872]
p7465
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7466
sg14
Vhttp://bio2rdf.org/drugbank:DB01558
p7467
sg16
VBromazepam [drugbank:DB01558]
p7468
sa(dp7469
g4
Vyes
p7470
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01559_872
p7471
sg8
Vdrug-target interaction Clotiazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01559_872]
p7472
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7473
sg14
Vhttp://bio2rdf.org/drugbank:DB01559
p7474
sg16
VClotiazepam [drugbank:DB01559]
p7475
sa(dp7476
g4
Vyes
p7477
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01589_872
p7478
sg8
Vdrug-target interaction Quazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01589_872]
p7479
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7480
sg14
Vhttp://bio2rdf.org/drugbank:DB01589
p7481
sg16
VQuazepam [drugbank:DB01589]
p7482
sa(dp7483
g4
Vyes
p7484
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01594_872
p7485
sg8
Vdrug-target interaction Cinolazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01594_872]
p7486
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7487
sg14
Vhttp://bio2rdf.org/drugbank:DB01594
p7488
sg16
VCinolazepam [drugbank:DB01594]
p7489
sa(dp7490
g4
Vunknown
p7491
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01159_872
p7492
sg8
Vdrug-target interaction Halothane and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01159_872]
p7493
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7494
sg14
Vhttp://bio2rdf.org/drugbank:DB01159
p7495
sg16
VHalothane [drugbank:DB01159]
p7496
sa(dp7497
g4
Vyes
p7498
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01198_872
p7499
sg8
Vdrug-target interaction Zopiclone and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01198_872]
p7500
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7501
sg14
Vhttp://bio2rdf.org/drugbank:DB01198
p7502
sg16
VZopiclone [drugbank:DB01198]
p7503
sa(dp7504
g4
Vunknown
p7505
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01287_872
p7506
sg8
Vdrug-target interaction Dihydroergotoxine and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01287_872]
p7507
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7508
sg14
Vhttp://bio2rdf.org/drugbank:DB01287
p7509
sg16
VDihydroergotoxine [drugbank:DB01287]
p7510
sa(dp7511
g4
Vyes
p7512
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01346_872
p7513
sg8
Vdrug-target interaction Quinidine barbiturate and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01346_872]
p7514
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7515
sg14
Vhttp://bio2rdf.org/drugbank:DB01346
p7516
sg16
VQuinidine barbiturate [drugbank:DB01346]
p7517
sa(dp7518
g4
Vyes
p7519
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01496_872
p7520
sg8
Vdrug-target interaction Barbituric acid derivative and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01496_872]
p7521
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7522
sg14
Vhttp://bio2rdf.org/drugbank:DB01496
p7523
sg16
VBarbituric acid derivative [drugbank:DB01496]
p7524
sa(dp7525
g4
Vyes
p7526
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01567_872
p7527
sg8
Vdrug-target interaction Fludiazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01567_872]
p7528
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7529
sg14
Vhttp://bio2rdf.org/drugbank:DB01567
p7530
sg16
VFludiazepam [drugbank:DB01567]
p7531
sa(dp7532
g4
Vyes
p7533
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01588_872
p7534
sg8
Vdrug-target interaction Prazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01588_872]
p7535
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7536
sg14
Vhttp://bio2rdf.org/drugbank:DB01588
p7537
sg16
VPrazepam [drugbank:DB01588]
p7538
sa(dp7539
g4
Vyes
p7540
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01595_872
p7541
sg8
Vdrug-target interaction Nitrazepam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01595_872]
p7542
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7543
sg14
Vhttp://bio2rdf.org/drugbank:DB01595
p7544
sg16
VNitrazepam [drugbank:DB01595]
p7545
sa(dp7546
g4
Vyes
p7547
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01189_872
p7548
sg8
Vdrug-target interaction Desflurane and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01189_872]
p7549
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7550
sg14
Vhttp://bio2rdf.org/drugbank:DB01189
p7551
sg16
VDesflurane [drugbank:DB01189]
p7552
sa(dp7553
g4
Vyes
p7554
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01215_872
p7555
sg8
Vdrug-target interaction Estazolam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01215_872]
p7556
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7557
sg14
Vhttp://bio2rdf.org/drugbank:DB01215
p7558
sg16
VEstazolam [drugbank:DB01215]
p7559
sa(dp7560
g4
Vyes
p7561
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01236_872
p7562
sg8
Vdrug-target interaction Sevoflurane and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01236_872]
p7563
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7564
sg14
Vhttp://bio2rdf.org/drugbank:DB01236
p7565
sg16
VSevoflurane [drugbank:DB01236]
p7566
sa(dp7567
g4
Vyes
p7568
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01351_872
p7569
sg8
Vdrug-target interaction Amobarbital and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01351_872]
p7570
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7571
sg14
Vhttp://bio2rdf.org/drugbank:DB01351
p7572
sg16
VAmobarbital [drugbank:DB01351]
p7573
sa(dp7574
g4
Vunknown
p7575
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01381_872
p7576
sg8
Vdrug-target interaction Ginkgo biloba and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01381_872]
p7577
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7578
sg14
Vhttp://bio2rdf.org/drugbank:DB01381
p7579
sg16
VGinkgo biloba [drugbank:DB01381]
p7580
sa(dp7581
g4
Vyes
p7582
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01437_872
p7583
sg8
Vdrug-target interaction Glutethimide and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01437_872]
p7584
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7585
sg14
Vhttp://bio2rdf.org/drugbank:DB01437
p7586
sg16
VGlutethimide [drugbank:DB01437]
p7587
sa(dp7588
g4
Vyes
p7589
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01587_872
p7590
sg8
Vdrug-target interaction Ketazolam and Gamma-aminobutyric-acid receptor subunit alpha-1 [drugbank_resource:DB01587_872]
p7591
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:872
p7592
sg14
Vhttp://bio2rdf.org/drugbank:DB01587
p7593
sg16
VKetazolam [drugbank:DB01587]
p7594
sasS'GAD2'
p7595
(lp7596
(dp7597
g4
Vunknown
p7598
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00114_3890
p7599
sg8
Vdrug-target interaction Pyridoxal Phosphate and Glutamate decarboxylase 2 [drugbank_resource:DB00114_3890]
p7600
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3890
p7601
sg14
Vhttp://bio2rdf.org/drugbank:DB00114
p7602
sg16
VPyridoxal Phosphate [drugbank:DB00114]
p7603
sa(dp7604
g4
Vunknown
p7605
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00142_664
p7606
sg8
Vdrug-target interaction L-Glutamic Acid and Glutamate decarboxylase 2 [drugbank_resource:DB00142_664]
p7607
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:664
p7608
sg14
Vhttp://bio2rdf.org/drugbank:DB00142
p7609
sg16
VL-Glutamic Acid [drugbank:DB00142]
p7610
sasS'GABRA2'
p7611
(lp7612
(dp7613
g4
Vyes
p7614
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00186_423
p7615
sg8
Vdrug-target interaction Lorazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00186_423]
p7616
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7617
sg14
Vhttp://bio2rdf.org/drugbank:DB00186
p7618
sg16
VLorazepam [drugbank:DB00186]
p7619
sa(dp7620
g4
Vyes
p7621
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00189_423
p7622
sg8
Vdrug-target interaction Ethchlorvynol and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00189_423]
p7623
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7624
sg14
Vhttp://bio2rdf.org/drugbank:DB00189
p7625
sg16
VEthchlorvynol [drugbank:DB00189]
p7626
sa(dp7627
g4
Vyes
p7628
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00231_423
p7629
sg8
Vdrug-target interaction Temazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00231_423]
p7630
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7631
sg14
Vhttp://bio2rdf.org/drugbank:DB00231
p7632
sg16
VTemazepam [drugbank:DB00231]
p7633
sa(dp7634
g4
Vyes
p7635
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00237_423
p7636
sg8
Vdrug-target interaction Butabarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00237_423]
p7637
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7638
sg14
Vhttp://bio2rdf.org/drugbank:DB00237
p7639
sg16
VButabarbital [drugbank:DB00237]
p7640
sa(dp7641
g4
Vyes
p7642
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00241_423
p7643
sg8
Vdrug-target interaction Butalbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00241_423]
p7644
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7645
sg14
Vhttp://bio2rdf.org/drugbank:DB00241
p7646
sg16
VButalbital [drugbank:DB00241]
p7647
sa(dp7648
g4
Vunknown
p7649
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00402_423
p7650
sg8
Vdrug-target interaction Eszopiclone and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00402_423]
p7651
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7652
sg14
Vhttp://bio2rdf.org/drugbank:DB00402
p7653
sg16
VEszopiclone [drugbank:DB00402]
p7654
sa(dp7655
g4
Vyes
p7656
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00418_423
p7657
sg8
Vdrug-target interaction Secobarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00418_423]
p7658
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7659
sg14
Vhttp://bio2rdf.org/drugbank:DB00418
p7660
sg16
VSecobarbital [drugbank:DB00418]
p7661
sa(dp7662
g4
Vunknown
p7663
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00425_423
p7664
sg8
Vdrug-target interaction Zolpidem and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00425_423]
p7665
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7666
sg14
Vhttp://bio2rdf.org/drugbank:DB00425
p7667
sg16
VZolpidem [drugbank:DB00425]
p7668
sa(dp7669
g4
Vyes
p7670
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00463_423
p7671
sg8
Vdrug-target interaction Metharbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00463_423]
p7672
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7673
sg14
Vhttp://bio2rdf.org/drugbank:DB00463
p7674
sg16
VMetharbital [drugbank:DB00463]
p7675
sa(dp7676
g4
Vyes
p7677
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00546_423
p7678
sg8
Vdrug-target interaction Adinazolam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00546_423]
p7679
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7680
sg14
Vhttp://bio2rdf.org/drugbank:DB00546
p7681
sg16
VAdinazolam [drugbank:DB00546]
p7682
sa(dp7683
g4
Vyes
p7684
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00599_423
p7685
sg8
Vdrug-target interaction Thiopental and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00599_423]
p7686
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7687
sg14
Vhttp://bio2rdf.org/drugbank:DB00599
p7688
sg16
VThiopental [drugbank:DB00599]
p7689
sa(dp7690
g4
Vyes
p7691
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00628_423
p7692
sg8
Vdrug-target interaction Clorazepate and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00628_423]
p7693
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7694
sg14
Vhttp://bio2rdf.org/drugbank:DB00628
p7695
sg16
VClorazepate [drugbank:DB00628]
p7696
sa(dp7697
g4
Vyes
p7698
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00306_423
p7699
sg8
Vdrug-target interaction Talbutal and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00306_423]
p7700
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7701
sg14
Vhttp://bio2rdf.org/drugbank:DB00306
p7702
sg16
VTalbutal [drugbank:DB00306]
p7703
sa(dp7704
g4
Vyes
p7705
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00312_423
p7706
sg8
Vdrug-target interaction Pentobarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00312_423]
p7707
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7708
sg14
Vhttp://bio2rdf.org/drugbank:DB00312
p7709
sg16
VPentobarbital [drugbank:DB00312]
p7710
sa(dp7711
g4
Vyes
p7712
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00371_423
p7713
sg8
Vdrug-target interaction Meprobamate and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00371_423]
p7714
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7715
sg14
Vhttp://bio2rdf.org/drugbank:DB00371
p7716
sg16
VMeprobamate [drugbank:DB00371]
p7717
sa(dp7718
g4
Vyes
p7719
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00404_423
p7720
sg8
Vdrug-target interaction Alprazolam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00404_423]
p7721
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7722
sg14
Vhttp://bio2rdf.org/drugbank:DB00404
p7723
sg16
VAlprazolam [drugbank:DB00404]
p7724
sa(dp7725
g4
Vyes
p7726
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00475_423
p7727
sg8
Vdrug-target interaction Chlordiazepoxide and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00475_423]
p7728
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7729
sg14
Vhttp://bio2rdf.org/drugbank:DB00475
p7730
sg16
VChlordiazepoxide [drugbank:DB00475]
p7731
sa(dp7732
g4
Vyes
p7733
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00349_423
p7734
sg8
Vdrug-target interaction Clobazam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00349_423]
p7735
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7736
sg14
Vhttp://bio2rdf.org/drugbank:DB00349
p7737
sg16
VClobazam [drugbank:DB00349]
p7738
sa(dp7739
g4
Vyes
p7740
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00683_423
p7741
sg8
Vdrug-target interaction Midazolam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00683_423]
p7742
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7743
sg14
Vhttp://bio2rdf.org/drugbank:DB00683
p7744
sg16
VMidazolam [drugbank:DB00683]
p7745
sa(dp7746
g4
Vyes
p7747
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00801_423
p7748
sg8
Vdrug-target interaction Halazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00801_423]
p7749
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7750
sg14
Vhttp://bio2rdf.org/drugbank:DB00801
p7751
sg16
VHalazepam [drugbank:DB00801]
p7752
sa(dp7753
g4
Vyes
p7754
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00842_423
p7755
sg8
Vdrug-target interaction Oxazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00842_423]
p7756
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7757
sg14
Vhttp://bio2rdf.org/drugbank:DB00842
p7758
sg16
VOxazepam [drugbank:DB00842]
p7759
sa(dp7760
g4
Vyes
p7761
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00690_423
p7762
sg8
Vdrug-target interaction Flurazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00690_423]
p7763
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7764
sg14
Vhttp://bio2rdf.org/drugbank:DB00690
p7765
sg16
VFlurazepam [drugbank:DB00690]
p7766
sa(dp7767
g4
Vyes
p7768
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00829_423
p7769
sg8
Vdrug-target interaction Diazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00829_423]
p7770
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7771
sg14
Vhttp://bio2rdf.org/drugbank:DB00829
p7772
sg16
VDiazepam [drugbank:DB00829]
p7773
sa(dp7774
g4
Vyes
p7775
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00849_423
p7776
sg8
Vdrug-target interaction Methylphenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00849_423]
p7777
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7778
sg14
Vhttp://bio2rdf.org/drugbank:DB00849
p7779
sg16
VMethylphenobarbital [drugbank:DB00849]
p7780
sa(dp7781
g4
Vyes
p7782
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00794_423
p7783
sg8
Vdrug-target interaction Primidone and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00794_423]
p7784
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7785
sg14
Vhttp://bio2rdf.org/drugbank:DB00794
p7786
sg16
VPrimidone [drugbank:DB00794]
p7787
sa(dp7788
g4
Vyes
p7789
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00897_423
p7790
sg8
Vdrug-target interaction Triazolam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB00897_423]
p7791
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7792
sg14
Vhttp://bio2rdf.org/drugbank:DB00897
p7793
sg16
VTriazolam [drugbank:DB00897]
p7794
sa(dp7795
g4
Vyes
p7796
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01068_423
p7797
sg8
Vdrug-target interaction Clonazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01068_423]
p7798
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7799
sg14
Vhttp://bio2rdf.org/drugbank:DB01068
p7800
sg16
VClonazepam [drugbank:DB01068]
p7801
sa(dp7802
g4
Vyes
p7803
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01174_423
p7804
sg8
Vdrug-target interaction Phenobarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01174_423]
p7805
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7806
sg14
Vhttp://bio2rdf.org/drugbank:DB01174
p7807
sg16
VPhenobarbital [drugbank:DB01174]
p7808
sa(dp7809
g4
Vyes
p7810
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01346_423
p7811
sg8
Vdrug-target interaction Quinidine barbiturate and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01346_423]
p7812
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7813
sg14
Vhttp://bio2rdf.org/drugbank:DB01346
p7814
sg16
VQuinidine barbiturate [drugbank:DB01346]
p7815
sa(dp7816
g4
Vyes
p7817
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01352_423
p7818
sg8
Vdrug-target interaction Aprobarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01352_423]
p7819
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7820
sg14
Vhttp://bio2rdf.org/drugbank:DB01352
p7821
sg16
VAprobarbital [drugbank:DB01352]
p7822
sa(dp7823
g4
Vyes
p7824
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01483_423
p7825
sg8
Vdrug-target interaction Barbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01483_423]
p7826
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7827
sg14
Vhttp://bio2rdf.org/drugbank:DB01483
p7828
sg16
VBarbital [drugbank:DB01483]
p7829
sa(dp7830
g4
Vyes
p7831
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01544_423
p7832
sg8
Vdrug-target interaction Flunitrazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01544_423]
p7833
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7834
sg14
Vhttp://bio2rdf.org/drugbank:DB01544
p7835
sg16
VFlunitrazepam [drugbank:DB01544]
p7836
sa(dp7837
g4
Vyes
p7838
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01558_423
p7839
sg8
Vdrug-target interaction Bromazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01558_423]
p7840
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7841
sg14
Vhttp://bio2rdf.org/drugbank:DB01558
p7842
sg16
VBromazepam [drugbank:DB01558]
p7843
sa(dp7844
g4
Vyes
p7845
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01567_423
p7846
sg8
Vdrug-target interaction Fludiazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01567_423]
p7847
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7848
sg14
Vhttp://bio2rdf.org/drugbank:DB01567
p7849
sg16
VFludiazepam [drugbank:DB01567]
p7850
sa(dp7851
g4
Vyes
p7852
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01588_423
p7853
sg8
Vdrug-target interaction Prazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01588_423]
p7854
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7855
sg14
Vhttp://bio2rdf.org/drugbank:DB01588
p7856
sg16
VPrazepam [drugbank:DB01588]
p7857
sa(dp7858
g4
Vyes
p7859
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01205_423
p7860
sg8
Vdrug-target interaction Flumazenil and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01205_423]
p7861
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7862
sg14
Vhttp://bio2rdf.org/drugbank:DB01205
p7863
sg16
VFlumazenil [drugbank:DB01205]
p7864
sa(dp7865
g4
Vyes
p7866
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01215_423
p7867
sg8
Vdrug-target interaction Estazolam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01215_423]
p7868
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7869
sg14
Vhttp://bio2rdf.org/drugbank:DB01215
p7870
sg16
VEstazolam [drugbank:DB01215]
p7871
sa(dp7872
g4
Vyes
p7873
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01559_423
p7874
sg8
Vdrug-target interaction Clotiazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01559_423]
p7875
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7876
sg14
Vhttp://bio2rdf.org/drugbank:DB01559
p7877
sg16
VClotiazepam [drugbank:DB01559]
p7878
sa(dp7879
g4
Vyes
p7880
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01589_423
p7881
sg8
Vdrug-target interaction Quazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01589_423]
p7882
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7883
sg14
Vhttp://bio2rdf.org/drugbank:DB01589
p7884
sg16
VQuazepam [drugbank:DB01589]
p7885
sa(dp7886
g4
Vyes
p7887
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01594_423
p7888
sg8
Vdrug-target interaction Cinolazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01594_423]
p7889
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7890
sg14
Vhttp://bio2rdf.org/drugbank:DB01594
p7891
sg16
VCinolazepam [drugbank:DB01594]
p7892
sa(dp7893
g4
Vyes
p7894
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01595_423
p7895
sg8
Vdrug-target interaction Nitrazepam and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01595_423]
p7896
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7897
sg14
Vhttp://bio2rdf.org/drugbank:DB01595
p7898
sg16
VNitrazepam [drugbank:DB01595]
p7899
sa(dp7900
g4
Vyes
p7901
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01198_423
p7902
sg8
Vdrug-target interaction Zopiclone and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01198_423]
p7903
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7904
sg14
Vhttp://bio2rdf.org/drugbank:DB01198
p7905
sg16
VZopiclone [drugbank:DB01198]
p7906
sa(dp7907
g4
Vyes
p7908
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01351_423
p7909
sg8
Vdrug-target interaction Amobarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01351_423]
p7910
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7911
sg14
Vhttp://bio2rdf.org/drugbank:DB01351
p7912
sg16
VAmobarbital [drugbank:DB01351]
p7913
sa(dp7914
g4
Vyes
p7915
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01353_423
p7916
sg8
Vdrug-target interaction Butethal and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01353_423]
p7917
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7918
sg14
Vhttp://bio2rdf.org/drugbank:DB01353
p7919
sg16
VButethal [drugbank:DB01353]
p7920
sa(dp7921
g4
Vyes
p7922
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01354_423
p7923
sg8
Vdrug-target interaction Heptabarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01354_423]
p7924
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7925
sg14
Vhttp://bio2rdf.org/drugbank:DB01354
p7926
sg16
VHeptabarbital [drugbank:DB01354]
p7927
sa(dp7928
g4
Vyes
p7929
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01355_423
p7930
sg8
Vdrug-target interaction Hexobarbital and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01355_423]
p7931
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7932
sg14
Vhttp://bio2rdf.org/drugbank:DB01355
p7933
sg16
VHexobarbital [drugbank:DB01355]
p7934
sa(dp7935
g4
Vyes
p7936
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01496_423
p7937
sg8
Vdrug-target interaction Barbituric acid derivative and Gamma-aminobutyric-acid receptor subunit alpha-2 [drugbank_resource:DB01496_423]
p7938
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:423
p7939
sg14
Vhttp://bio2rdf.org/drugbank:DB01496
p7940
sg16
VBarbituric acid derivative [drugbank:DB01496]
p7941
sasS'ENPEP'
p7942
(lp7943
(dp7944
g4
Vunknown
p7945
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00142_4020
p7946
sg8
Vdrug-target interaction L-Glutamic Acid and Glutamyl aminopeptidase [drugbank_resource:DB00142_4020]
p7947
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4020
p7948
sg14
Vhttp://bio2rdf.org/drugbank:DB00142
p7949
sg16
VL-Glutamic Acid [drugbank:DB00142]
p7950
sasS'FCER1G'
p7951
(lp7952
(dp7953
g4
Vyes
p7954
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00895_55
p7955
sg8
Vdrug-target interaction Benzylpenicilloyl Polylysine and High affinity immunoglobulin epsilon receptor gamma-subunit [drugbank_resource:DB00895_55]
p7956
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:55
p7957
sg14
Vhttp://bio2rdf.org/drugbank:DB00895
p7958
sg16
VBenzylpenicilloyl Polylysine [drugbank:DB00895]
p7959
sasS'NCOA1'
p7960
(lp7961
(dp7962
g4
Vunknown
p7963
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01645_6228
p7964
sg8
Vdrug-target interaction Genistein and Nuclear receptor coactivator 1 [drugbank_resource:DB01645_6228]
p7965
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p7966
sg14
Vhttp://bio2rdf.org/drugbank:DB01645
p7967
sg16
VGenistein [drugbank:DB01645]
p7968
sa(dp7969
g4
Vunknown
p7970
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06875_6228
p7971
sg8
Vdrug-target interaction 3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE and Nuclear receptor coactivator 1 [drugbank_resource:DB06875_6228]
p7972
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p7973
sg14
Vhttp://bio2rdf.org/drugbank:DB06875
p7974
sg16
V3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE [drugbank:DB06875]
p7975
sa(dp7976
g4
Vunknown
p7977
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07009_6228
p7978
sg8
Vdrug-target interaction 2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL and Nuclear receptor coactivator 1 [drugbank_resource:DB07009_6228]
p7979
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p7980
sg14
Vhttp://bio2rdf.org/drugbank:DB07009
p7981
sg16
V2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL [drugbank:DB07009]
p7982
sa(dp7983
g4
Vunknown
p7984
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07119_6228
p7985
sg8
Vdrug-target interaction 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL and Nuclear receptor coactivator 1 [drugbank_resource:DB07119_6228]
p7986
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p7987
sg14
Vhttp://bio2rdf.org/drugbank:DB07119
p7988
sg16
V1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL [drugbank:DB07119]
p7989
sa(dp7990
g4
Vunknown
p7991
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07150_6228
p7992
sg8
Vdrug-target interaction 4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME and Nuclear receptor coactivator 1 [drugbank_resource:DB07150_6228]
p7993
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p7994
sg14
Vhttp://bio2rdf.org/drugbank:DB07150
p7995
sg16
V4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME [drugbank:DB07150]
p7996
sa(dp7997
g4
Vunknown
p7998
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07230_6228
p7999
sg8
Vdrug-target interaction 3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE and Nuclear receptor coactivator 1 [drugbank_resource:DB07230_6228]
p8000
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8001
sg14
Vhttp://bio2rdf.org/drugbank:DB07230
p8002
sg16
V3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE [drugbank:DB07230]
p8003
sa(dp8004
g4
Vunknown
p8005
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06832_6228
p8006
sg8
Vdrug-target interaction 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL and Nuclear receptor coactivator 1 [drugbank_resource:DB06832_6228]
p8007
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8008
sg14
Vhttp://bio2rdf.org/drugbank:DB06832
p8009
sg16
V2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL [drugbank:DB06832]
p8010
sa(dp8011
g4
Vunknown
p8012
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06908_6228
p8013
sg8
Vdrug-target interaction (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID and Nuclear receptor coactivator 1 [drugbank_resource:DB06908_6228]
p8014
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8015
sg14
Vhttp://bio2rdf.org/drugbank:DB06908
p8016
sg16
V(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID [drugbank:DB06908]
p8017
sa(dp8018
g4
Vunknown
p8019
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07215_6228
p8020
sg8
Vdrug-target interaction 2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID and Nuclear receptor coactivator 1 [drugbank_resource:DB07215_6228]
p8021
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8022
sg14
Vhttp://bio2rdf.org/drugbank:DB07215
p8023
sg16
V2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID [drugbank:DB07215]
p8024
sa(dp8025
g4
Vunknown
p8026
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07236_6228
p8027
sg8
Vdrug-target interaction 3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL and Nuclear receptor coactivator 1 [drugbank_resource:DB07236_6228]
p8028
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8029
sg14
Vhttp://bio2rdf.org/drugbank:DB07236
p8030
sg16
V3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL [drugbank:DB07236]
p8031
sa(dp8032
g4
Vunknown
p8033
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04652_6228
p8034
sg8
Vdrug-target interaction (11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE and Nuclear receptor coactivator 1 [drugbank_resource:DB04652_6228]
p8035
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8036
sg14
Vhttp://bio2rdf.org/drugbank:DB04652
p8037
sg16
V(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE [drugbank:DB04652]
p8038
sa(dp8039
g4
Vunknown
p8040
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06927_6228
p8041
sg8
Vdrug-target interaction [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE and Nuclear receptor coactivator 1 [drugbank_resource:DB06927_6228]
p8042
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8043
sg14
Vhttp://bio2rdf.org/drugbank:DB06927
p8044
sg16
V[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE [drugbank:DB06927]
p8045
sa(dp8046
g4
Vunknown
p8047
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07080_6228
p8048
sg8
Vdrug-target interaction N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE and Nuclear receptor coactivator 1 [drugbank_resource:DB07080_6228]
p8049
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8050
sg14
Vhttp://bio2rdf.org/drugbank:DB07080
p8051
sg16
VN-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE [drugbank:DB07080]
p8052
sa(dp8053
g4
Vunknown
p8054
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07198_6228
p8055
sg8
Vdrug-target interaction 5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE and Nuclear receptor coactivator 1 [drugbank_resource:DB07198_6228]
p8056
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8057
sg14
Vhttp://bio2rdf.org/drugbank:DB07198
p8058
sg16
V5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE [drugbank:DB07198]
p8059
sa(dp8060
g4
Vunknown
p8061
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07530_6228
p8062
sg8
Vdrug-target interaction (1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol and Nuclear receptor coactivator 1 [drugbank_resource:DB07530_6228]
p8063
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8064
sg14
Vhttp://bio2rdf.org/drugbank:DB07530
p8065
sg16
V(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol [drugbank:DB07530]
p8066
sa(dp8067
g4
Vunknown
p8068
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08231_6228
p8069
sg8
Vdrug-target interaction MYRISTIC ACID and Nuclear receptor coactivator 1 [drugbank_resource:DB08231_6228]
p8070
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8071
sg14
Vhttp://bio2rdf.org/drugbank:DB08231
p8072
sg16
VMYRISTIC ACID [drugbank:DB08231]
p8073
sa(dp8074
g4
Vunknown
p8075
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07557_6228
p8076
sg8
Vdrug-target interaction (5BETA)-PREGNANE-3,20-DIONE and Nuclear receptor coactivator 1 [drugbank_resource:DB07557_6228]
p8077
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8078
sg14
Vhttp://bio2rdf.org/drugbank:DB07557
p8079
sg16
V(5BETA)-PREGNANE-3,20-DIONE [drugbank:DB07557]
p8080
sa(dp8081
g4
Vunknown
p8082
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07724_6228
p8083
sg8
Vdrug-target interaction 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid and Nuclear receptor coactivator 1 [drugbank_resource:DB07724_6228]
p8084
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8085
sg14
Vhttp://bio2rdf.org/drugbank:DB07724
p8086
sg16
V3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid [drugbank:DB07724]
p8087
sa(dp8088
g4
Vunknown
p8089
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08220_6228
p8090
sg8
Vdrug-target interaction (8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid and Nuclear receptor coactivator 1 [drugbank_resource:DB08220_6228]
p8091
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8092
sg14
Vhttp://bio2rdf.org/drugbank:DB08220
p8093
sg16
V(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid [drugbank:DB08220]
p8094
sa(dp8095
g4
Vunknown
p8096
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08483_6228
p8097
sg8
Vdrug-target interaction (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid and Nuclear receptor coactivator 1 [drugbank_resource:DB08483_6228]
p8098
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8099
sg14
Vhttp://bio2rdf.org/drugbank:DB08483
p8100
sg16
V(2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid [drugbank:DB08483]
p8101
sa(dp8102
g4
Vunknown
p8103
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08742_6228
p8104
sg8
Vdrug-target interaction 1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z) and Nuclear receptor coactivator 1 [drugbank_resource:DB08742_6228]
p8105
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6228
p8106
sg14
Vhttp://bio2rdf.org/drugbank:DB08742
p8107
sg16
V1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z) [drugbank:DB08742]
p8108
sasS'SKP1'
p8109
(lp8110
(dp8111
g4
Vunknown
p8112
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01750_6269
p8113
sg8
Vdrug-target interaction Naphthalen-1-Yl-Acetic Acid and S-phase kinase-associated protein 1 [drugbank_resource:DB01750_6269]
p8114
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6269
p8115
sg14
Vhttp://bio2rdf.org/drugbank:DB01750
p8116
sg16
VNaphthalen-1-Yl-Acetic Acid [drugbank:DB01750]
p8117
sa(dp8118
g4
Vunknown
p8119
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06980_6269
p8120
sg8
Vdrug-target interaction (2S)-2-(1H-indol-3-yl)hexanoic acid and S-phase kinase-associated protein 1 [drugbank_resource:DB06980_6269]
p8121
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6269
p8122
sg14
Vhttp://bio2rdf.org/drugbank:DB06980
p8123
sg16
V(2S)-2-(1H-indol-3-yl)hexanoic acid [drugbank:DB06980]
p8124
sa(dp8125
g4
Vunknown
p8126
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06981_6269
p8127
sg8
Vdrug-target interaction (2S)-2-(1H-indol-3-yl)pentanoic acid and S-phase kinase-associated protein 1 [drugbank_resource:DB06981_6269]
p8128
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6269
p8129
sg14
Vhttp://bio2rdf.org/drugbank:DB06981
p8130
sg16
V(2S)-2-(1H-indol-3-yl)pentanoic acid [drugbank:DB06981]
p8131
sa(dp8132
g4
Vunknown
p8133
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06982_6269
p8134
sg8
Vdrug-target interaction (2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid and S-phase kinase-associated protein 1 [drugbank_resource:DB06982_6269]
p8135
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6269
p8136
sg14
Vhttp://bio2rdf.org/drugbank:DB06982
p8137
sg16
V(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid [drugbank:DB06982]
p8138
sa(dp8139
g4
Vunknown
p8140
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07950_6269
p8141
sg8
Vdrug-target interaction 1H-INDOL-3-YLACETIC ACID and S-phase kinase-associated protein 1 [drugbank_resource:DB07950_6269]
p8142
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6269
p8143
sg14
Vhttp://bio2rdf.org/drugbank:DB07950
p8144
sg16
V1H-INDOL-3-YLACETIC ACID [drugbank:DB07950]
p8145
sasS'CACNB3'
p8146
(lp8147
(dp8148
g4
Vyes
p8149
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00393_4114
p8150
sg8
Vdrug-target interaction Nimodipine and Voltage-dependent L-type calcium channel subunit beta-3 [drugbank_resource:DB00393_4114]
p8151
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4114
p8152
sg14
Vhttp://bio2rdf.org/drugbank:DB00393
p8153
sg16
VNimodipine [drugbank:DB00393]
p8154
sa(dp8155
g4
Vyes
p8156
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00661_4114
p8157
sg8
Vdrug-target interaction Verapamil and Voltage-dependent L-type calcium channel subunit beta-3 [drugbank_resource:DB00661_4114]
p8158
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4114
p8159
sg14
Vhttp://bio2rdf.org/drugbank:DB00661
p8160
sg16
VVerapamil [drugbank:DB00661]
p8161
sa(dp8162
g4
Vyes
p8163
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01388_4114
p8164
sg8
Vdrug-target interaction Mibefradil and Voltage-dependent L-type calcium channel subunit beta-3 [drugbank_resource:DB01388_4114]
p8165
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4114
p8166
sg14
Vhttp://bio2rdf.org/drugbank:DB01388
p8167
sg16
VMibefradil [drugbank:DB01388]
p8168
sasS'CACNB2'
p8169
(lp8170
(dp8171
g4
Vyes
p8172
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00270_4110
p8173
sg8
Vdrug-target interaction Isradipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB00270_4110]
p8174
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4110
p8175
sg14
Vhttp://bio2rdf.org/drugbank:DB00270
p8176
sg16
VIsradipine [drugbank:DB00270]
p8177
sa(dp8178
g4
Vyes
p8179
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00393_4110
p8180
sg8
Vdrug-target interaction Nimodipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB00393_4110]
p8181
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4110
p8182
sg14
Vhttp://bio2rdf.org/drugbank:DB00393
p8183
sg16
VNimodipine [drugbank:DB00393]
p8184
sa(dp8185
g4
Vyes
p8186
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00381_4110
p8187
sg8
Vdrug-target interaction Amlodipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB00381_4110]
p8188
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4110
p8189
sg14
Vhttp://bio2rdf.org/drugbank:DB00381
p8190
sg16
VAmlodipine [drugbank:DB00381]
p8191
sa(dp8192
g4
Vyes
p8193
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00401_4110
p8194
sg8
Vdrug-target interaction Nisoldipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB00401_4110]
p8195
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4110
p8196
sg14
Vhttp://bio2rdf.org/drugbank:DB00401
p8197
sg16
VNisoldipine [drugbank:DB00401]
p8198
sa(dp8199
g4
Vyes
p8200
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00622_4110
p8201
sg8
Vdrug-target interaction Nicardipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB00622_4110]
p8202
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4110
p8203
sg14
Vhttp://bio2rdf.org/drugbank:DB00622
p8204
sg16
VNicardipine [drugbank:DB00622]
p8205
sa(dp8206
g4
Vyes
p8207
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00661_4110
p8208
sg8
Vdrug-target interaction Verapamil and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB00661_4110]
p8209
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4110
p8210
sg14
Vhttp://bio2rdf.org/drugbank:DB00661
p8211
sg16
VVerapamil [drugbank:DB00661]
p8212
sa(dp8213
g4
Vunknown
p8214
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00653_4110
p8215
sg8
Vdrug-target interaction Magnesium Sulfate and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB00653_4110]
p8216
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4110
p8217
sg14
Vhttp://bio2rdf.org/drugbank:DB00653
p8218
sg16
VMagnesium Sulfate [drugbank:DB00653]
p8219
sa(dp8220
g4
Vyes
p8221
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01023_4110
p8222
sg8
Vdrug-target interaction Felodipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB01023_4110]
p8223
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4110
p8224
sg14
Vhttp://bio2rdf.org/drugbank:DB01023
p8225
sg16
VFelodipine [drugbank:DB01023]
p8226
sa(dp8227
g4
Vyes
p8228
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01054_4110
p8229
sg8
Vdrug-target interaction Nitrendipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB01054_4110]
p8230
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4110
p8231
sg14
Vhttp://bio2rdf.org/drugbank:DB01054
p8232
sg16
VNitrendipine [drugbank:DB01054]
p8233
sa(dp8234
g4
Vyes
p8235
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01115_4110
p8236
sg8
Vdrug-target interaction Nifedipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB01115_4110]
p8237
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4110
p8238
sg14
Vhttp://bio2rdf.org/drugbank:DB01115
p8239
sg16
VNifedipine [drugbank:DB01115]
p8240
sa(dp8241
g4
Vyes
p8242
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01388_4110
p8243
sg8
Vdrug-target interaction Mibefradil and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB01388_4110]
p8244
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4110
p8245
sg14
Vhttp://bio2rdf.org/drugbank:DB01388
p8246
sg16
VMibefradil [drugbank:DB01388]
p8247
sa(dp8248
g4
Vyes
p8249
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06712_4110
p8250
sg8
Vdrug-target interaction Nilvadipine and Voltage-dependent L-type calcium channel subunit beta-2 [drugbank_resource:DB06712_4110]
p8251
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4110
p8252
sg14
Vhttp://bio2rdf.org/drugbank:DB06712
p8253
sg16
VNilvadipine [drugbank:DB06712]
p8254
sasS'HPRT1'
p8255
(lp8256
(dp8257
g4
Vyes
p8258
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00993_87
p8259
sg8
Vdrug-target interaction Azathioprine and Hypoxanthine-guanine phosphoribosyltransferase [drugbank_resource:DB00993_87]
p8260
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:87
p8261
sg14
Vhttp://bio2rdf.org/drugbank:DB00993
p8262
sg16
VAzathioprine [drugbank:DB00993]
p8263
sa(dp8264
g4
Vyes
p8265
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01033_87
p8266
sg8
Vdrug-target interaction Mercaptopurine and Hypoxanthine-guanine phosphoribosyltransferase [drugbank_resource:DB01033_87]
p8267
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:87
p8268
sg14
Vhttp://bio2rdf.org/drugbank:DB01033
p8269
sg16
VMercaptopurine [drugbank:DB01033]
p8270
sa(dp8271
g4
Vunknown
p8272
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01632_87
p8273
sg8
Vdrug-target interaction Alpha-Phosphoribosylpyrophosphoric Acid and Hypoxanthine-guanine phosphoribosyltransferase [drugbank_resource:DB01632_87]
p8274
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:87
p8275
sg14
Vhttp://bio2rdf.org/drugbank:DB01632
p8276
sg16
VAlpha-Phosphoribosylpyrophosphoric Acid [drugbank:DB01632]
p8277
sa(dp8278
g4
Vunknown
p8279
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02212_87
p8280
sg8
Vdrug-target interaction Pyrophosphate 2- and Hypoxanthine-guanine phosphoribosyltransferase [drugbank_resource:DB02212_87]
p8281
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:87
p8282
sg14
Vhttp://bio2rdf.org/drugbank:DB02212
p8283
sg16
VPyrophosphate 2- [drugbank:DB02212]
p8284
sa(dp8285
g4
Vunknown
p8286
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02309_87
p8287
sg8
Vdrug-target interaction 5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine and Hypoxanthine-guanine phosphoribosyltransferase [drugbank_resource:DB02309_87]
p8288
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:87
p8289
sg14
Vhttp://bio2rdf.org/drugbank:DB02309
p8290
sg16
V5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine [drugbank:DB02309]
p8291
sa(dp8292
g4
Vunknown
p8293
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03153_87
p8294
sg8
Vdrug-target interaction 3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol and Hypoxanthine-guanine phosphoribosyltransferase [drugbank_resource:DB03153_87]
p8295
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:87
p8296
sg14
Vhttp://bio2rdf.org/drugbank:DB03153
p8297
sg16
V3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol [drugbank:DB03153]
p8298
sa(dp8299
g4
Vunknown
p8300
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04356_87
p8301
sg8
Vdrug-target interaction 9-Deazaguanine and Hypoxanthine-guanine phosphoribosyltransferase [drugbank_resource:DB04356_87]
p8302
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:87
p8303
sg14
Vhttp://bio2rdf.org/drugbank:DB04356
p8304
sg16
V9-Deazaguanine [drugbank:DB04356]
p8305
sasS'CACNA2D3'
p8306
(lp8307
(dp8308
g4
Vunknown
p8309
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00381_6045
p8310
sg8
Vdrug-target interaction Amlodipine and Voltage-dependent calcium channel subunit alpha-2/delta-3 [drugbank_resource:DB00381_6045]
p8311
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6045
p8312
sg14
Vhttp://bio2rdf.org/drugbank:DB00381
p8313
sg16
VAmlodipine [drugbank:DB00381]
p8314
sa(dp8315
g4
Vunknown
p8316
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06712_6045
p8317
sg8
Vdrug-target interaction Nilvadipine and Voltage-dependent calcium channel subunit alpha-2/delta-3 [drugbank_resource:DB06712_6045]
p8318
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6045
p8319
sg14
Vhttp://bio2rdf.org/drugbank:DB06712
p8320
sg16
VNilvadipine [drugbank:DB06712]
p8321
sasS'CD86'
p8322
(lp8323
(dp8324
g4
Vyes
p8325
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00098_942
p8326
sg8
Vdrug-target interaction Antithymocyte globulin and T-lymphocyte activation antigen CD86 [drugbank_resource:DB00098_942]
p8327
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:942
p8328
sg14
Vhttp://bio2rdf.org/drugbank:DB00098
p8329
sg16
VAntithymocyte globulin [drugbank:DB00098]
p8330
sa(dp8331
g4
Vyes
p8332
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01281_942
p8333
sg8
Vdrug-target interaction Abatacept and T-lymphocyte activation antigen CD86 [drugbank_resource:DB01281_942]
p8334
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:942
p8335
sg14
Vhttp://bio2rdf.org/drugbank:DB01281
p8336
sg16
VAbatacept [drugbank:DB01281]
p8337
sasS'MAPK3'
p8338
(lp8339
(dp8340
g4
Vunknown
p8341
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00605_1714
p8342
sg8
Vdrug-target interaction Sulindac and Mitogen-activated protein kinase 3 [drugbank_resource:DB00605_1714]
p8343
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1714
p8344
sg14
Vhttp://bio2rdf.org/drugbank:DB00605
p8345
sg16
VSulindac [drugbank:DB00605]
p8346
sa(dp8347
g4
Vyes
p8348
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01169_1714
p8349
sg8
Vdrug-target interaction Arsenic trioxide and Mitogen-activated protein kinase 3 [drugbank_resource:DB01169_1714]
p8350
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1714
p8351
sg14
Vhttp://bio2rdf.org/drugbank:DB01169
p8352
sg16
VArsenic trioxide [drugbank:DB01169]
p8353
sa(dp8354
g4
Vunknown
p8355
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02733_1714
p8356
sg8
Vdrug-target interaction Purvalanol and Mitogen-activated protein kinase 3 [drugbank_resource:DB02733_1714]
p8357
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1714
p8358
sg14
Vhttp://bio2rdf.org/drugbank:DB02733
p8359
sg16
VPurvalanol [drugbank:DB02733]
p8360
sa(dp8361
g4
Vunknown
p8362
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04604_1714
p8363
sg8
Vdrug-target interaction 5-iodotubercidin and Mitogen-activated protein kinase 3 [drugbank_resource:DB04604_1714]
p8364
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1714
p8365
sg14
Vhttp://bio2rdf.org/drugbank:DB04604
p8366
sg16
V5-iodotubercidin [drugbank:DB04604]
p8367
sasS'MAPK1'
p8368
(lp8369
(dp8370
g4
Vunknown
p8371
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01064_1176
p8372
sg8
Vdrug-target interaction Isoproterenol and Mitogen-activated protein kinase 1 [drugbank_resource:DB01064_1176]
p8373
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1176
p8374
sg14
Vhttp://bio2rdf.org/drugbank:DB01064
p8375
sg16
VIsoproterenol [drugbank:DB01064]
p8376
sa(dp8377
g4
Vunknown
p8378
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02116_1176
p8379
sg8
Vdrug-target interaction Olomoucine and Mitogen-activated protein kinase 1 [drugbank_resource:DB02116_1176]
p8380
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1176
p8381
sg14
Vhttp://bio2rdf.org/drugbank:DB02116
p8382
sg16
VOlomoucine [drugbank:DB02116]
p8383
sa(dp8384
g4
Vyes
p8385
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01169_1176
p8386
sg8
Vdrug-target interaction Arsenic trioxide and Mitogen-activated protein kinase 1 [drugbank_resource:DB01169_1176]
p8387
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1176
p8388
sg14
Vhttp://bio2rdf.org/drugbank:DB01169
p8389
sg16
VArsenic trioxide [drugbank:DB01169]
p8390
sa(dp8391
g4
Vunknown
p8392
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02482_1176
p8393
sg8
Vdrug-target interaction Phosphonothreonine and Mitogen-activated protein kinase 1 [drugbank_resource:DB02482_1176]
p8394
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1176
p8395
sg14
Vhttp://bio2rdf.org/drugbank:DB02482
p8396
sg16
VPhosphonothreonine [drugbank:DB02482]
p8397
sa(dp8398
g4
Vunknown
p8399
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02733_1176
p8400
sg8
Vdrug-target interaction Purvalanol and Mitogen-activated protein kinase 1 [drugbank_resource:DB02733_1176]
p8401
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1176
p8402
sg14
Vhttp://bio2rdf.org/drugbank:DB02733
p8403
sg16
VPurvalanol [drugbank:DB02733]
p8404
sa(dp8405
g4
Vunknown
p8406
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04338_1176
p8407
sg8
Vdrug-target interaction SB220025 and Mitogen-activated protein kinase 1 [drugbank_resource:DB04338_1176]
p8408
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1176
p8409
sg14
Vhttp://bio2rdf.org/drugbank:DB04338
p8410
sg16
VSB220025 [drugbank:DB04338]
p8411
sa(dp8412
g4
Vunknown
p8413
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06877_1176
p8414
sg8
Vdrug-target interaction N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE and Mitogen-activated protein kinase 1 [drugbank_resource:DB06877_1176]
p8415
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1176
p8416
sg14
Vhttp://bio2rdf.org/drugbank:DB06877
p8417
sg16
VN,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE [drugbank:DB06877]
p8418
sa(dp8419
g4
Vunknown
p8420
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07010_1176
p8421
sg8
Vdrug-target interaction N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE and Mitogen-activated protein kinase 1 [drugbank_resource:DB07010_1176]
p8422
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1176
p8423
sg14
Vhttp://bio2rdf.org/drugbank:DB07010
p8424
sg16
VN-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE [drugbank:DB07010]
p8425
sa(dp8426
g4
Vunknown
p8427
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07264_1176
p8428
sg8
Vdrug-target interaction (S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE and Mitogen-activated protein kinase 1 [drugbank_resource:DB07264_1176]
p8429
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1176
p8430
sg14
Vhttp://bio2rdf.org/drugbank:DB07264
p8431
sg16
V(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE [drugbank:DB07264]
p8432
sa(dp8433
g4
Vunknown
p8434
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07788_1176
p8435
sg8
Vdrug-target interaction (3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE and Mitogen-activated protein kinase 1 [drugbank_resource:DB07788_1176]
p8436
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1176
p8437
sg14
Vhttp://bio2rdf.org/drugbank:DB07788
p8438
sg16
V(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE [drugbank:DB07788]
p8439
sa(dp8440
g4
Vunknown
p8441
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07794_1176
p8442
sg8
Vdrug-target interaction 5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE and Mitogen-activated protein kinase 1 [drugbank_resource:DB07794_1176]
p8443
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1176
p8444
sg14
Vhttp://bio2rdf.org/drugbank:DB07794
p8445
sg16
V5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE [drugbank:DB07794]
p8446
sa(dp8447
g4
Vunknown
p8448
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08513_1176
p8449
sg8
Vdrug-target interaction [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID and Mitogen-activated protein kinase 1 [drugbank_resource:DB08513_1176]
p8450
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1176
p8451
sg14
Vhttp://bio2rdf.org/drugbank:DB08513
p8452
sg16
V[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID [drugbank:DB08513]
p8453
sa(dp8454
g4
Vunknown
p8455
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07905_1176
p8456
sg8
Vdrug-target interaction (1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione and Mitogen-activated protein kinase 1 [drugbank_resource:DB07905_1176]
p8457
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1176
p8458
sg14
Vhttp://bio2rdf.org/drugbank:DB07905
p8459
sg16
V(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione [drugbank:DB07905]
p8460
sa(dp8461
g4
Vunknown
p8462
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08521_1176
p8463
sg8
Vdrug-target interaction 4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE and Mitogen-activated protein kinase 1 [drugbank_resource:DB08521_1176]
p8464
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1176
p8465
sg14
Vhttp://bio2rdf.org/drugbank:DB08521
p8466
sg16
V4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE [drugbank:DB08521]
p8467
sasS'PLAUR'
p8468
(lp8469
(dp8470
g4
Vunknown
p8471
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00031_791
p8472
sg8
Vdrug-target interaction Tenecteplase and Urokinase plasminogen activator surface receptor [drugbank_resource:DB00031_791]
p8473
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:791
p8474
sg14
Vhttp://bio2rdf.org/drugbank:DB00031
p8475
sg16
VTenecteplase [drugbank:DB00031]
p8476
sa(dp8477
g4
Vunknown
p8478
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00009_791
p8479
sg8
Vdrug-target interaction Alteplase and Urokinase plasminogen activator surface receptor [drugbank_resource:DB00009_791]
p8480
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:791
p8481
sg14
Vhttp://bio2rdf.org/drugbank:DB00009
p8482
sg16
VAlteplase [drugbank:DB00009]
p8483
sa(dp8484
g4
Vyes
p8485
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00013_791
p8486
sg8
Vdrug-target interaction Urokinase and Urokinase plasminogen activator surface receptor [drugbank_resource:DB00013_791]
p8487
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:791
p8488
sg14
Vhttp://bio2rdf.org/drugbank:DB00013
p8489
sg16
VUrokinase [drugbank:DB00013]
p8490
sa(dp8491
g4
Vunknown
p8492
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00015_791
p8493
sg8
Vdrug-target interaction Reteplase and Urokinase plasminogen activator surface receptor [drugbank_resource:DB00015_791]
p8494
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:791
p8495
sg14
Vhttp://bio2rdf.org/drugbank:DB00015
p8496
sg16
VReteplase [drugbank:DB00015]
p8497
sa(dp8498
g4
Vunknown
p8499
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00029_791
p8500
sg8
Vdrug-target interaction Anistreplase and Urokinase plasminogen activator surface receptor [drugbank_resource:DB00029_791]
p8501
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:791
p8502
sg14
Vhttp://bio2rdf.org/drugbank:DB00029
p8503
sg16
VAnistreplase [drugbank:DB00029]
p8504
sasS'C3'
p8505
(lp8506
(dp8507
g4
Vunknown
p8508
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01907_2683
p8509
sg8
Vdrug-target interaction Nicotinamide-Adenine-Dinucleotide and Mono-ADP-ribosyltransferase C3 [drugbank_resource:DB01907_2683]
p8510
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2683
p8511
sg14
Vhttp://bio2rdf.org/drugbank:DB01907
p8512
sg16
VNicotinamide-Adenine-Dinucleotide [drugbank:DB01907]
p8513
sa(dp8514
g4
Vunknown
p8515
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02147_2683
p8516
sg8
Vdrug-target interaction Cyclo-Tetrametavanadate and Mono-ADP-ribosyltransferase C3 [drugbank_resource:DB02147_2683]
p8517
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2683
p8518
sg14
Vhttp://bio2rdf.org/drugbank:DB02147
p8519
sg16
VCyclo-Tetrametavanadate [drugbank:DB02147]
p8520
sa(dp8521
g4
Vunknown
p8522
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03431_2683
p8523
sg8
Vdrug-target interaction Adenosine-5'-Diphosphate and Mono-ADP-ribosyltransferase C3 [drugbank_resource:DB03431_2683]
p8524
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2683
p8525
sg14
Vhttp://bio2rdf.org/drugbank:DB03431
p8526
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p8527
sa(dp8528
g4
Vyes
p8529
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00028_5898
p8530
sg8
Vdrug-target interaction Intravenous Immunoglobulin and Complement C3 [drugbank_resource:DB00028_5898]
p8531
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5898
p8532
sg14
Vhttp://bio2rdf.org/drugbank:DB00028
p8533
sg16
VIntravenous Immunoglobulin [drugbank:DB00028]
p8534
sa(dp8535
g4
Vunknown
p8536
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01915_5898
p8537
sg8
Vdrug-target interaction S-Hydroxycysteine and Complement C3 [drugbank_resource:DB01915_5898]
p8538
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5898
p8539
sg14
Vhttp://bio2rdf.org/drugbank:DB01915
p8540
sg16
VS-Hydroxycysteine [drugbank:DB01915]
p8541
sasS'NFKB1'
p8542
(lp8543
(dp8544
g4
Vyes
p8545
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01041_1787
p8546
sg8
Vdrug-target interaction Thalidomide and Nuclear factor NF-kappa-B p105 subunit [drugbank_resource:DB01041_1787]
p8547
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1787
p8548
sg14
Vhttp://bio2rdf.org/drugbank:DB01041
p8549
sg16
VThalidomide [drugbank:DB01041]
p8550
sa(dp8551
g4
Vunknown
p8552
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01411_1787
p8553
sg8
Vdrug-target interaction Pranlukast and Nuclear factor NF-kappa-B p105 subunit [drugbank_resource:DB01411_1787]
p8554
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1787
p8555
sg14
Vhttp://bio2rdf.org/drugbank:DB01411
p8556
sg16
VPranlukast [drugbank:DB01411]
p8557
sa(dp8558
g4
Vyes
p8559
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08814_1787
p8560
sg8
Vdrug-target interaction Triflusal and Nuclear factor NF-kappa-B p105 subunit [drugbank_resource:DB08814_1787]
p8561
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1787
p8562
sg14
Vhttp://bio2rdf.org/drugbank:DB08814
p8563
sg16
VTriflusal [drugbank:DB08814]
p8564
sasS'NFKB2'
p8565
(lp8566
(dp8567
g4
Vunknown
p8568
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01296_4149
p8569
sg8
Vdrug-target interaction Glucosamine and Nuclear factor NF-kappa-B p100 subunit [drugbank_resource:DB01296_4149]
p8570
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4149
p8571
sg14
Vhttp://bio2rdf.org/drugbank:DB01296
p8572
sg16
VGlucosamine [drugbank:DB01296]
p8573
sasS'KDR'
p8574
(lp8575
(dp8576
g4
Vyes
p8577
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00398_407
p8578
sg8
Vdrug-target interaction Sorafenib and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB00398_407]
p8579
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:407
p8580
sg14
Vhttp://bio2rdf.org/drugbank:DB00398
p8581
sg16
VSorafenib [drugbank:DB00398]
p8582
sa(dp8583
g4
Vunknown
p8584
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01268_407
p8585
sg8
Vdrug-target interaction Sunitinib and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB01268_407]
p8586
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:407
p8587
sg14
Vhttp://bio2rdf.org/drugbank:DB01268
p8588
sg16
VSunitinib [drugbank:DB01268]
p8589
sa(dp8590
g4
Vunknown
p8591
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06938_407
p8592
sg8
Vdrug-target interaction 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB06938_407]
p8593
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:407
p8594
sg14
Vhttp://bio2rdf.org/drugbank:DB06938
p8595
sg16
V4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide [drugbank:DB06938]
p8596
sa(dp8597
g4
Vunknown
p8598
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07183_407
p8599
sg8
Vdrug-target interaction N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07183_407]
p8600
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:407
p8601
sg14
Vhttp://bio2rdf.org/drugbank:DB07183
p8602
sg16
VN-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide [drugbank:DB07183]
p8603
sa(dp8604
g4
Vunknown
p8605
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07274_407
p8606
sg8
Vdrug-target interaction N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07274_407]
p8607
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:407
p8608
sg14
Vhttp://bio2rdf.org/drugbank:DB07274
p8609
sg16
VN-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide [drugbank:DB07274]
p8610
sa(dp8611
g4
Vunknown
p8612
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07326_407
p8613
sg8
Vdrug-target interaction 6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07326_407]
p8614
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:407
p8615
sg14
Vhttp://bio2rdf.org/drugbank:DB07326
p8616
sg16
V6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide [drugbank:DB07326]
p8617
sa(dp8618
g4
Vunknown
p8619
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04727_407
p8620
sg8
Vdrug-target interaction N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB04727_407]
p8621
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:407
p8622
sg14
Vhttp://bio2rdf.org/drugbank:DB04727
p8623
sg16
VN-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA [drugbank:DB04727]
p8624
sa(dp8625
g4
Vunknown
p8626
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07333_407
p8627
sg8
Vdrug-target interaction N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07333_407]
p8628
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:407
p8629
sg14
Vhttp://bio2rdf.org/drugbank:DB07333
p8630
sg16
VN-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE [drugbank:DB07333]
p8631
sa(dp8632
g4
Vunknown
p8633
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07334_407
p8634
sg8
Vdrug-target interaction N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07334_407]
p8635
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:407
p8636
sg14
Vhttp://bio2rdf.org/drugbank:DB07334
p8637
sg16
VN-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE [drugbank:DB07334]
p8638
sa(dp8639
g4
Vunknown
p8640
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07514_407
p8641
sg8
Vdrug-target interaction 3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07514_407]
p8642
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:407
p8643
sg14
Vhttp://bio2rdf.org/drugbank:DB07514
p8644
sg16
V3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one [drugbank:DB07514]
p8645
sa(dp8646
g4
Vunknown
p8647
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07528_407
p8648
sg8
Vdrug-target interaction 3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07528_407]
p8649
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:407
p8650
sg14
Vhttp://bio2rdf.org/drugbank:DB07528
p8651
sg16
V3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one [drugbank:DB07528]
p8652
sa(dp8653
g4
Vunknown
p8654
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07537_407
p8655
sg8
Vdrug-target interaction N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB07537_407]
p8656
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:407
p8657
sg14
Vhttp://bio2rdf.org/drugbank:DB07537
p8658
sg16
VN'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide [drugbank:DB07537]
p8659
sa(dp8660
g4
Vunknown
p8661
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08042_407
p8662
sg8
Vdrug-target interaction N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB08042_407]
p8663
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:407
p8664
sg14
Vhttp://bio2rdf.org/drugbank:DB08042
p8665
sg16
VN~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine [drugbank:DB08042]
p8666
sa(dp8667
g4
Vunknown
p8668
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08519_407
p8669
sg8
Vdrug-target interaction N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine and Vascular endothelial growth factor receptor 2 [drugbank_resource:DB08519_407]
p8670
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:407
p8671
sg14
Vhttp://bio2rdf.org/drugbank:DB08519
p8672
sg16
VN~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine [drugbank:DB08519]
p8673
sasS'SRC'
p8674
(lp8675
(dp8676
g4
Vunknown
p8677
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01678_933
p8678
sg8
Vdrug-target interaction RU84687 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB01678_933]
p8679
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8680
sg14
Vhttp://bio2rdf.org/drugbank:DB01678
p8681
sg16
VRU84687 [drugbank:DB01678]
p8682
sa(dp8683
g4
Vunknown
p8684
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01908_933
p8685
sg8
Vdrug-target interaction RU85493 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB01908_933]
p8686
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8687
sg14
Vhttp://bio2rdf.org/drugbank:DB01908
p8688
sg16
VRU85493 [drugbank:DB01908]
p8689
sa(dp8690
g4
Vunknown
p8691
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01962_933
p8692
sg8
Vdrug-target interaction Phosphonotyrosine and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB01962_933]
p8693
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8694
sg14
Vhttp://bio2rdf.org/drugbank:DB01962
p8695
sg16
VPhosphonotyrosine [drugbank:DB01962]
p8696
sa(dp8697
g4
Vyes
p8698
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01254_933
p8699
sg8
Vdrug-target interaction Dasatinib and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB01254_933]
p8700
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8701
sg14
Vhttp://bio2rdf.org/drugbank:DB01254
p8702
sg16
VDasatinib [drugbank:DB01254]
p8703
sa(dp8704
g4
Vunknown
p8705
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01866_933
p8706
sg8
Vdrug-target interaction RU79256 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB01866_933]
p8707
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8708
sg14
Vhttp://bio2rdf.org/drugbank:DB01866
p8709
sg16
VRU79256 [drugbank:DB01866]
p8710
sa(dp8711
g4
Vunknown
p8712
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01893_933
p8713
sg8
Vdrug-target interaction N6-Benzyl Adenosine-5'-Diphosphate and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB01893_933]
p8714
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8715
sg14
Vhttp://bio2rdf.org/drugbank:DB01893
p8716
sg16
VN6-Benzyl Adenosine-5'-Diphosphate [drugbank:DB01893]
p8717
sa(dp8718
g4
Vunknown
p8719
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01947_933
p8720
sg8
Vdrug-target interaction RU78262 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB01947_933]
p8721
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8722
sg14
Vhttp://bio2rdf.org/drugbank:DB01947
p8723
sg16
VRU78262 [drugbank:DB01947]
p8724
sa(dp8725
g4
Vunknown
p8726
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02336_933
p8727
sg8
Vdrug-target interaction RU83876 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB02336_933]
p8728
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8729
sg14
Vhttp://bio2rdf.org/drugbank:DB02336
p8730
sg16
VRU83876 [drugbank:DB02336]
p8731
sa(dp8732
g4
Vunknown
p8733
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02175_933
p8734
sg8
Vdrug-target interaction Malonic acid and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB02175_933]
p8735
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8736
sg14
Vhttp://bio2rdf.org/drugbank:DB02175
p8737
sg16
VMalonic acid [drugbank:DB02175]
p8738
sa(dp8739
g4
Vunknown
p8740
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02432_933
p8741
sg8
Vdrug-target interaction RU90395 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB02432_933]
p8742
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8743
sg14
Vhttp://bio2rdf.org/drugbank:DB02432
p8744
sg16
VRU90395 [drugbank:DB02432]
p8745
sa(dp8746
g4
Vunknown
p8747
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02762_933
p8748
sg8
Vdrug-target interaction RU79072 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB02762_933]
p8749
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8750
sg14
Vhttp://bio2rdf.org/drugbank:DB02762
p8751
sg16
VRU79072 [drugbank:DB02762]
p8752
sa(dp8753
g4
Vunknown
p8754
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03268_933
p8755
sg8
Vdrug-target interaction RU82197 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03268_933]
p8756
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8757
sg14
Vhttp://bio2rdf.org/drugbank:DB03268
p8758
sg16
VRU82197 [drugbank:DB03268]
p8759
sa(dp8760
g4
Vunknown
p8761
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03023_933
p8762
sg8
Vdrug-target interaction 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03023_933]
p8763
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8764
sg14
Vhttp://bio2rdf.org/drugbank:DB03023
p8765
sg16
V1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine [drugbank:DB03023]
p8766
sa(dp8767
g4
Vunknown
p8768
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03114_933
p8769
sg8
Vdrug-target interaction PAS219 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03114_933]
p8770
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8771
sg14
Vhttp://bio2rdf.org/drugbank:DB03114
p8772
sg16
VPAS219 [drugbank:DB03114]
p8773
sa(dp8774
g4
Vunknown
p8775
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03217_933
p8776
sg8
Vdrug-target interaction DPI59 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03217_933]
p8777
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8778
sg14
Vhttp://bio2rdf.org/drugbank:DB03217
p8779
sg16
VDPI59 [drugbank:DB03217]
p8780
sa(dp8781
g4
Vunknown
p8782
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02908_933
p8783
sg8
Vdrug-target interaction RU78783 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB02908_933]
p8784
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8785
sg14
Vhttp://bio2rdf.org/drugbank:DB02908
p8786
sg16
VRU78783 [drugbank:DB02908]
p8787
sa(dp8788
g4
Vunknown
p8789
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03078_933
p8790
sg8
Vdrug-target interaction PASBN and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03078_933]
p8791
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8792
sg14
Vhttp://bio2rdf.org/drugbank:DB03078
p8793
sg16
VPASBN [drugbank:DB03078]
p8794
sa(dp8795
g4
Vunknown
p8796
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03104_933
p8797
sg8
Vdrug-target interaction RU82129 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03104_933]
p8798
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8799
sg14
Vhttp://bio2rdf.org/drugbank:DB03104
p8800
sg16
VRU82129 [drugbank:DB03104]
p8801
sa(dp8802
g4
Vunknown
p8803
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03298_933
p8804
sg8
Vdrug-target interaction Phenylphosphate and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03298_933]
p8805
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8806
sg14
Vhttp://bio2rdf.org/drugbank:DB03298
p8807
sg16
VPhenylphosphate [drugbank:DB03298]
p8808
sa(dp8809
g4
Vunknown
p8810
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03306_933
p8811
sg8
Vdrug-target interaction RU78300 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03306_933]
p8812
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8813
sg14
Vhttp://bio2rdf.org/drugbank:DB03306
p8814
sg16
VRU78300 [drugbank:DB03306]
p8815
sa(dp8816
g4
Vunknown
p8817
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03525_933
p8818
sg8
Vdrug-target interaction RU79073 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03525_933]
p8819
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8820
sg14
Vhttp://bio2rdf.org/drugbank:DB03525
p8821
sg16
VRU79073 [drugbank:DB03525]
p8822
sa(dp8823
g4
Vunknown
p8824
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03712_933
p8825
sg8
Vdrug-target interaction RU85053 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03712_933]
p8826
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8827
sg14
Vhttp://bio2rdf.org/drugbank:DB03712
p8828
sg16
VRU85053 [drugbank:DB03712]
p8829
sa(dp8830
g4
Vunknown
p8831
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03591_933
p8832
sg8
Vdrug-target interaction RU82209 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03591_933]
p8833
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8834
sg14
Vhttp://bio2rdf.org/drugbank:DB03591
p8835
sg16
VRU82209 [drugbank:DB03591]
p8836
sa(dp8837
g4
Vunknown
p8838
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03628_933
p8839
sg8
Vdrug-target interaction ISO24 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03628_933]
p8840
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8841
sg14
Vhttp://bio2rdf.org/drugbank:DB03628
p8842
sg16
VISO24 [drugbank:DB03628]
p8843
sa(dp8844
g4
Vunknown
p8845
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03902_933
p8846
sg8
Vdrug-target interaction Oxalic Acid and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03902_933]
p8847
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8848
sg14
Vhttp://bio2rdf.org/drugbank:DB03902
p8849
sg16
VOxalic Acid [drugbank:DB03902]
p8850
sa(dp8851
g4
Vunknown
p8852
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03828_933
p8853
sg8
Vdrug-target interaction RU78299 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB03828_933]
p8854
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8855
sg14
Vhttp://bio2rdf.org/drugbank:DB03828
p8856
sg16
VRU78299 [drugbank:DB03828]
p8857
sa(dp8858
g4
Vunknown
p8859
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04495_933
p8860
sg8
Vdrug-target interaction RU81843 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB04495_933]
p8861
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8862
sg14
Vhttp://bio2rdf.org/drugbank:DB04495
p8863
sg16
VRU81843 [drugbank:DB04495]
p8864
sa(dp8865
g4
Vunknown
p8866
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04080_933
p8867
sg8
Vdrug-target interaction RU78191 and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB04080_933]
p8868
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8869
sg14
Vhttp://bio2rdf.org/drugbank:DB04080
p8870
sg16
VRU78191 [drugbank:DB04080]
p8871
sa(dp8872
g4
Vunknown
p8873
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04272_933
p8874
sg8
Vdrug-target interaction Citric Acid and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB04272_933]
p8875
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8876
sg14
Vhttp://bio2rdf.org/drugbank:DB04272
p8877
sg16
VCitric Acid [drugbank:DB04272]
p8878
sa(dp8879
g4
Vunknown
p8880
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04739_933
p8881
sg8
Vdrug-target interaction 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB04739_933]
p8882
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8883
sg14
Vhttp://bio2rdf.org/drugbank:DB04739
p8884
sg16
V4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE [drugbank:DB04739]
p8885
sa(dp8886
g4
Vunknown
p8887
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04751_933
p8888
sg8
Vdrug-target interaction Purvalanol A and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB04751_933]
p8889
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8890
sg14
Vhttp://bio2rdf.org/drugbank:DB04751
p8891
sg16
VPurvalanol A [drugbank:DB04751]
p8892
sa(dp8893
g4
Vunknown
p8894
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07335_933
p8895
sg8
Vdrug-target interaction 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB07335_933]
p8896
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8897
sg14
Vhttp://bio2rdf.org/drugbank:DB07335
p8898
sg16
V3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL [drugbank:DB07335]
p8899
sa(dp8900
g4
Vunknown
p8901
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06882_933
p8902
sg8
Vdrug-target interaction 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB06882_933]
p8903
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8904
sg14
Vhttp://bio2rdf.org/drugbank:DB06882
p8905
sg16
V1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea [drugbank:DB06882]
p8906
sa(dp8907
g4
Vunknown
p8908
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06883_933
p8909
sg8
Vdrug-target interaction 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB06883_933]
p8910
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8911
sg14
Vhttp://bio2rdf.org/drugbank:DB06883
p8912
sg16
V1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea [drugbank:DB06883]
p8913
sa(dp8914
g4
Vunknown
p8915
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08462_933
p8916
sg8
Vdrug-target interaction N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB08462_933]
p8917
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8918
sg14
Vhttp://bio2rdf.org/drugbank:DB08462
p8919
sg16
VN-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE [drugbank:DB08462]
p8920
sa(dp8921
g4
Vunknown
p8922
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08564_933
p8923
sg8
Vdrug-target interaction (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB08564_933]
p8924
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8925
sg14
Vhttp://bio2rdf.org/drugbank:DB08564
p8926
sg16
V(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide [drugbank:DB08564]
p8927
sa(dp8928
g4
Vunknown
p8929
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07662_933
p8930
sg8
Vdrug-target interaction N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB07662_933]
p8931
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8932
sg14
Vhttp://bio2rdf.org/drugbank:DB07662
p8933
sg16
VN-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE [drugbank:DB07662]
p8934
sa(dp8935
g4
Vunknown
p8936
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07966_933
p8937
sg8
Vdrug-target interaction [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB07966_933]
p8938
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8939
sg14
Vhttp://bio2rdf.org/drugbank:DB07966
p8940
sg16
V[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile [drugbank:DB07966]
p8941
sa(dp8942
g4
Vunknown
p8943
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08054_933
p8944
sg8
Vdrug-target interaction 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB08054_933]
p8945
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8946
sg14
Vhttp://bio2rdf.org/drugbank:DB08054
p8947
sg16
V1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine [drugbank:DB08054]
p8948
sa(dp8949
g4
Vunknown
p8950
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08052_933
p8951
sg8
Vdrug-target interaction 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB08052_933]
p8952
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8953
sg14
Vhttp://bio2rdf.org/drugbank:DB08052
p8954
sg16
V1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine [drugbank:DB08052]
p8955
sa(dp8956
g4
Vunknown
p8957
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08053_933
p8958
sg8
Vdrug-target interaction 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB08053_933]
p8959
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8960
sg14
Vhttp://bio2rdf.org/drugbank:DB08053
p8961
sg16
V1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine [drugbank:DB08053]
p8962
sa(dp8963
g4
Vunknown
p8964
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08192_933
p8965
sg8
Vdrug-target interaction 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE and Proto-oncogene tyrosine-protein kinase Src [drugbank_resource:DB08192_933]
p8966
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:933
p8967
sg14
Vhttp://bio2rdf.org/drugbank:DB08192
p8968
sg16
V2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE [drugbank:DB08192]
p8969
sasS'TGFBR1'
p8970
(lp8971
(dp8972
g4
Vunknown
p8973
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03921_6284
p8974
sg8
Vdrug-target interaction 4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline and TGF-beta receptor type-1 [drugbank_resource:DB03921_6284]
p8975
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6284
p8976
sg14
Vhttp://bio2rdf.org/drugbank:DB03921
p8977
sg16
V4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline [drugbank:DB03921]
p8978
sa(dp8979
g4
Vunknown
p8980
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04434_6284
p8981
sg8
Vdrug-target interaction Naphthyridine Inhibitor and TGF-beta receptor type-1 [drugbank_resource:DB04434_6284]
p8982
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6284
p8983
sg14
Vhttp://bio2rdf.org/drugbank:DB04434
p8984
sg16
VNaphthyridine Inhibitor [drugbank:DB04434]
p8985
sa(dp8986
g4
Vunknown
p8987
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04480_6284
p8988
sg8
Vdrug-target interaction 3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole and TGF-beta receptor type-1 [drugbank_resource:DB04480_6284]
p8989
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6284
p8990
sg14
Vhttp://bio2rdf.org/drugbank:DB04480
p8991
sg16
V3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole [drugbank:DB04480]
p8992
sa(dp8993
g4
Vunknown
p8994
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07152_6284
p8995
sg8
Vdrug-target interaction N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide and TGF-beta receptor type-1 [drugbank_resource:DB07152_6284]
p8996
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6284
p8997
sg14
Vhttp://bio2rdf.org/drugbank:DB07152
p8998
sg16
VN-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide [drugbank:DB07152]
p8999
sa(dp9000
g4
Vunknown
p9001
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07267_6284
p9002
sg8
Vdrug-target interaction 2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine and TGF-beta receptor type-1 [drugbank_resource:DB07267_6284]
p9003
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6284
p9004
sg14
Vhttp://bio2rdf.org/drugbank:DB07267
p9005
sg16
V2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine [drugbank:DB07267]
p9006
sa(dp9007
g4
Vunknown
p9008
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08450_6284
p9009
sg8
Vdrug-target interaction N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine and TGF-beta receptor type-1 [drugbank_resource:DB08450_6284]
p9010
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6284
p9011
sg14
Vhttp://bio2rdf.org/drugbank:DB08450
p9012
sg16
VN-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine [drugbank:DB08450]
p9013
sasS'NTSR2'
p9014
(lp9015
(dp9016
g4
Vyes
p9017
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01106_516
p9018
sg8
Vdrug-target interaction Levocabastine and Neurotensin receptor type 2 [drugbank_resource:DB01106_516]
p9019
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:516
p9020
sg14
Vhttp://bio2rdf.org/drugbank:DB01106
p9021
sg16
VLevocabastine [drugbank:DB01106]
p9022
sasS'MAPK8'
p9023
(lp9024
(dp9025
g4
Vunknown
p9026
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01782_6292
p9027
sg8
Vdrug-target interaction 2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One and Mitogen-activated protein kinase 8 [drugbank_resource:DB01782_6292]
p9028
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6292
p9029
sg14
Vhttp://bio2rdf.org/drugbank:DB01782
p9030
sg16
V2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One [drugbank:DB01782]
p9031
sa(dp9032
g4
Vunknown
p9033
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07268_6292
p9034
sg8
Vdrug-target interaction 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE and Mitogen-activated protein kinase 8 [drugbank_resource:DB07268_6292]
p9035
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6292
p9036
sg14
Vhttp://bio2rdf.org/drugbank:DB07268
p9037
sg16
V2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE [drugbank:DB07268]
p9038
sa(dp9039
g4
Vunknown
p9040
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07218_6292
p9041
sg8
Vdrug-target interaction 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE and Mitogen-activated protein kinase 8 [drugbank_resource:DB07218_6292]
p9042
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6292
p9043
sg14
Vhttp://bio2rdf.org/drugbank:DB07218
p9044
sg16
V6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE [drugbank:DB07218]
p9045
sa(dp9046
g4
Vunknown
p9047
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07272_6292
p9048
sg8
Vdrug-target interaction N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE and Mitogen-activated protein kinase 8 [drugbank_resource:DB07272_6292]
p9049
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6292
p9050
sg14
Vhttp://bio2rdf.org/drugbank:DB07272
p9051
sg16
VN-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE [drugbank:DB07272]
p9052
sa(dp9053
g4
Vunknown
p9054
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07276_6292
p9055
sg8
Vdrug-target interaction 5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE and Mitogen-activated protein kinase 8 [drugbank_resource:DB07276_6292]
p9056
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6292
p9057
sg14
Vhttp://bio2rdf.org/drugbank:DB07276
p9058
sg16
V5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE [drugbank:DB07276]
p9059
sa(dp9060
g4
Vunknown
p9061
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07845_6292
p9062
sg8
Vdrug-target interaction 2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide and Mitogen-activated protein kinase 8 [drugbank_resource:DB07845_6292]
p9063
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6292
p9064
sg14
Vhttp://bio2rdf.org/drugbank:DB07845
p9065
sg16
V2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide [drugbank:DB07845]
p9066
sasS'RXRA'
p9067
(lp9068
(dp9069
g4
Vno
p9070
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00210_459
p9071
sg8
Vdrug-target interaction Adapalene and Retinoic acid receptor RXR-alpha [drugbank_resource:DB00210_459]
p9072
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:459
p9073
sg14
Vhttp://bio2rdf.org/drugbank:DB00210
p9074
sg16
VAdapalene [drugbank:DB00210]
p9075
sa(dp9076
g4
Vyes
p9077
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00459_459
p9078
sg8
Vdrug-target interaction Acitretin and Retinoic acid receptor RXR-alpha [drugbank_resource:DB00459_459]
p9079
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:459
p9080
sg14
Vhttp://bio2rdf.org/drugbank:DB00459
p9081
sg16
VAcitretin [drugbank:DB00459]
p9082
sa(dp9083
g4
Vyes
p9084
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00523_459
p9085
sg8
Vdrug-target interaction Alitretinoin and Retinoic acid receptor RXR-alpha [drugbank_resource:DB00523_459]
p9086
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:459
p9087
sg14
Vhttp://bio2rdf.org/drugbank:DB00523
p9088
sg16
VAlitretinoin [drugbank:DB00523]
p9089
sa(dp9090
g4
Vyes
p9091
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00307_459
p9092
sg8
Vdrug-target interaction Bexarotene and Retinoic acid receptor RXR-alpha [drugbank_resource:DB00307_459]
p9093
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:459
p9094
sg14
Vhttp://bio2rdf.org/drugbank:DB00307
p9095
sg16
VBexarotene [drugbank:DB00307]
p9096
sa(dp9097
g4
Vyes
p9098
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00926_459
p9099
sg8
Vdrug-target interaction Etretinate and Retinoic acid receptor RXR-alpha [drugbank_resource:DB00926_459]
p9100
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:459
p9101
sg14
Vhttp://bio2rdf.org/drugbank:DB00926
p9102
sg16
VEtretinate [drugbank:DB00926]
p9103
sa(dp9104
g4
Vunknown
p9105
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00749_459
p9106
sg8
Vdrug-target interaction Etodolac and Retinoic acid receptor RXR-alpha [drugbank_resource:DB00749_459]
p9107
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:459
p9108
sg14
Vhttp://bio2rdf.org/drugbank:DB00749
p9109
sg16
VEtodolac [drugbank:DB00749]
p9110
sa(dp9111
g4
Vunknown
p9112
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07863_459
p9113
sg8
Vdrug-target interaction 2-chloro-5-nitro-N-phenylbenzamide and Retinoic acid receptor RXR-alpha [drugbank_resource:DB07863_459]
p9114
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:459
p9115
sg14
Vhttp://bio2rdf.org/drugbank:DB07863
p9116
sg16
V2-chloro-5-nitro-N-phenylbenzamide [drugbank:DB07863]
p9117
sa(dp9118
g4
Vunknown
p9119
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08063_459
p9120
sg8
Vdrug-target interaction 1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE and Retinoic acid receptor RXR-alpha [drugbank_resource:DB08063_459]
p9121
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:459
p9122
sg14
Vhttp://bio2rdf.org/drugbank:DB08063
p9123
sg16
V1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE [drugbank:DB08063]
p9124
sa(dp9125
g4
Vunknown
p9126
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07557_459
p9127
sg8
Vdrug-target interaction (5BETA)-PREGNANE-3,20-DIONE and Retinoic acid receptor RXR-alpha [drugbank_resource:DB07557_459]
p9128
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:459
p9129
sg14
Vhttp://bio2rdf.org/drugbank:DB07557
p9130
sg16
V(5BETA)-PREGNANE-3,20-DIONE [drugbank:DB07557]
p9131
sa(dp9132
g4
Vunknown
p9133
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08402_459
p9134
sg8
Vdrug-target interaction 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID and Retinoic acid receptor RXR-alpha [drugbank_resource:DB08402_459]
p9135
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:459
p9136
sg14
Vhttp://bio2rdf.org/drugbank:DB08402
p9137
sg16
V2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID [drugbank:DB08402]
p9138
sa(dp9139
g4
Vunknown
p9140
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08601_459
p9141
sg8
Vdrug-target interaction tributylstannanyl and Retinoic acid receptor RXR-alpha [drugbank_resource:DB08601_459]
p9142
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:459
p9143
sg14
Vhttp://bio2rdf.org/drugbank:DB08601
p9144
sg16
Vtributylstannanyl [drugbank:DB08601]
p9145
sasS'KAT2B'
p9146
(lp9147
(dp9148
g4
Vunknown
p9149
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01992_4573
p9150
sg8
Vdrug-target interaction Coenzyme A and Histone acetyltransferase PCAF [drugbank_resource:DB01992_4573]
p9151
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4573
p9152
sg14
Vhttp://bio2rdf.org/drugbank:DB01992
p9153
sg16
VCoenzyme A [drugbank:DB01992]
p9154
sa(dp9155
g4
Vunknown
p9156
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08186_4573
p9157
sg8
Vdrug-target interaction (3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE and Histone acetyltransferase PCAF [drugbank_resource:DB08186_4573]
p9158
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4573
p9159
sg14
Vhttp://bio2rdf.org/drugbank:DB08186
p9160
sg16
V(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE [drugbank:DB08186]
p9161
sa(dp9162
g4
Vunknown
p9163
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08291_4573
p9164
sg8
Vdrug-target interaction N-(3-AMINOPROPYL)-2-NITROBENZENAMINE and Histone acetyltransferase PCAF [drugbank_resource:DB08291_4573]
p9165
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4573
p9166
sg14
Vhttp://bio2rdf.org/drugbank:DB08291
p9167
sg16
VN-(3-AMINOPROPYL)-2-NITROBENZENAMINE [drugbank:DB08291]
p9168
sasS'MTOR'
p9169
(lp9170
(dp9171
g4
Vyes
p9172
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00337_4148
p9173
sg8
Vdrug-target interaction Pimecrolimus and Serine/threonine-protein kinase mTOR [drugbank_resource:DB00337_4148]
p9174
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4148
p9175
sg14
Vhttp://bio2rdf.org/drugbank:DB00337
p9176
sg16
VPimecrolimus [drugbank:DB00337]
p9177
sa(dp9178
g4
Vyes
p9179
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00877_4148
p9180
sg8
Vdrug-target interaction Sirolimus and Serine/threonine-protein kinase mTOR [drugbank_resource:DB00877_4148]
p9181
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4148
p9182
sg14
Vhttp://bio2rdf.org/drugbank:DB00877
p9183
sg16
VSirolimus [drugbank:DB00877]
p9184
sa(dp9185
g4
Vyes
p9186
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01590_4148
p9187
sg8
Vdrug-target interaction Everolimus and Serine/threonine-protein kinase mTOR [drugbank_resource:DB01590_4148]
p9188
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4148
p9189
sg14
Vhttp://bio2rdf.org/drugbank:DB01590
p9190
sg16
VEverolimus [drugbank:DB01590]
p9191
sa(dp9192
g4
Vyes
p9193
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06287_4148
p9194
sg8
Vdrug-target interaction Temsirolimus and Serine/threonine-protein kinase mTOR [drugbank_resource:DB06287_4148]
p9195
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4148
p9196
sg14
Vhttp://bio2rdf.org/drugbank:DB06287
p9197
sg16
VTemsirolimus [drugbank:DB06287]
p9198
sasS'LTF'
p9199
(lp9200
(dp9201
g4
Vunknown
p9202
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01811_1439
p9203
sg8
Vdrug-target interaction 3h-Indole-5,6-Diol and Lactotransferrin [drugbank_resource:DB01811_1439]
p9204
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1439
p9205
sg14
Vhttp://bio2rdf.org/drugbank:DB01811
p9206
sg16
V3h-Indole-5,6-Diol [drugbank:DB01811]
p9207
sa(dp9208
g4
Vunknown
p9209
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02944_1439
p9210
sg8
Vdrug-target interaction Alpha-D-Mannose and Lactotransferrin [drugbank_resource:DB02944_1439]
p9211
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1439
p9212
sg14
Vhttp://bio2rdf.org/drugbank:DB02944
p9213
sg16
VAlpha-D-Mannose [drugbank:DB02944]
p9214
sa(dp9215
g4
Vunknown
p9216
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03040_1439
p9217
sg8
Vdrug-target interaction Nitrilotriacetic Acid and Lactotransferrin [drugbank_resource:DB03040_1439]
p9218
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1439
p9219
sg14
Vhttp://bio2rdf.org/drugbank:DB03040
p9220
sg16
VNitrilotriacetic Acid [drugbank:DB03040]
p9221
sa(dp9222
g4
Vunknown
p9223
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03485_1439
p9224
sg8
Vdrug-target interaction Alpha-D-Fucose and Lactotransferrin [drugbank_resource:DB03485_1439]
p9225
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1439
p9226
sg14
Vhttp://bio2rdf.org/drugbank:DB03485
p9227
sg16
VAlpha-D-Fucose [drugbank:DB03485]
p9228
sa(dp9229
g4
Vunknown
p9230
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04743_1439
p9231
sg8
Vdrug-target interaction Nimesulide and Lactotransferrin [drugbank_resource:DB04743_1439]
p9232
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1439
p9233
sg14
Vhttp://bio2rdf.org/drugbank:DB04743
p9234
sg16
VNimesulide [drugbank:DB04743]
p9235
sa(dp9236
g4
Vunknown
p9237
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06987_1439
p9238
sg8
Vdrug-target interaction 2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE and Lactotransferrin [drugbank_resource:DB06987_1439]
p9239
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1439
p9240
sg14
Vhttp://bio2rdf.org/drugbank:DB06987
p9241
sg16
V2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE [drugbank:DB06987]
p9242
sa(dp9243
g4
Vunknown
p9244
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08439_1439
p9245
sg8
Vdrug-target interaction parecoxib and Lactotransferrin [drugbank_resource:DB08439_1439]
p9246
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1439
p9247
sg14
Vhttp://bio2rdf.org/drugbank:DB08439
p9248
sg16
Vparecoxib [drugbank:DB08439]
p9249
sasS'S100A4'
p9250
(lp9251
(dp9252
g4
Vunknown
p9253
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00831_6859
p9254
sg8
Vdrug-target interaction Trifluoperazine and Protein S100-A4 [drugbank_resource:DB00831_6859]
p9255
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6859
p9256
sg14
Vhttp://bio2rdf.org/drugbank:DB00831
p9257
sg16
VTrifluoperazine [drugbank:DB00831]
p9258
sasS'LGALS3'
p9259
(lp9260
(dp9261
g4
Vunknown
p9262
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01827_2467
p9263
sg8
Vdrug-target interaction 2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide and Galectin-3 [drugbank_resource:DB01827_2467]
p9264
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2467
p9265
sg14
Vhttp://bio2rdf.org/drugbank:DB01827
p9266
sg16
V2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide [drugbank:DB01827]
p9267
sasS'ESR2'
p9268
(lp9269
(dp9270
g4
Vyes
p9271
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00255_869
p9272
sg8
Vdrug-target interaction Diethylstilbestrol and Estrogen receptor beta [drugbank_resource:DB00255_869]
p9273
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9274
sg14
Vhttp://bio2rdf.org/drugbank:DB00255
p9275
sg16
VDiethylstilbestrol [drugbank:DB00255]
p9276
sa(dp9277
g4
Vyes
p9278
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00481_869
p9279
sg8
Vdrug-target interaction Raloxifene and Estrogen receptor beta [drugbank_resource:DB00481_869]
p9280
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9281
sg14
Vhttp://bio2rdf.org/drugbank:DB00481
p9282
sg16
VRaloxifene [drugbank:DB00481]
p9283
sa(dp9284
g4
Vyes
p9285
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00675_869
p9286
sg8
Vdrug-target interaction Tamoxifen and Estrogen receptor beta [drugbank_resource:DB00675_869]
p9287
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9288
sg14
Vhttp://bio2rdf.org/drugbank:DB00675
p9289
sg16
VTamoxifen [drugbank:DB00675]
p9290
sa(dp9291
g4
Vyes
p9292
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01108_869
p9293
sg8
Vdrug-target interaction Trilostane and Estrogen receptor beta [drugbank_resource:DB01108_869]
p9294
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9295
sg14
Vhttp://bio2rdf.org/drugbank:DB01108
p9296
sg16
VTrilostane [drugbank:DB01108]
p9297
sa(dp9298
g4
Vyes
p9299
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00783_869
p9300
sg8
Vdrug-target interaction Estradiol and Estrogen receptor beta [drugbank_resource:DB00783_869]
p9301
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9302
sg14
Vhttp://bio2rdf.org/drugbank:DB00783
p9303
sg16
VEstradiol [drugbank:DB00783]
p9304
sa(dp9305
g4
Vyes
p9306
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01196_869
p9307
sg8
Vdrug-target interaction Estramustine and Estrogen receptor beta [drugbank_resource:DB01196_869]
p9308
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9309
sg14
Vhttp://bio2rdf.org/drugbank:DB01196
p9310
sg16
VEstramustine [drugbank:DB01196]
p9311
sa(dp9312
g4
Vunknown
p9313
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01645_869
p9314
sg8
Vdrug-target interaction Genistein and Estrogen receptor beta [drugbank_resource:DB01645_869]
p9315
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9316
sg14
Vhttp://bio2rdf.org/drugbank:DB01645
p9317
sg16
VGenistein [drugbank:DB01645]
p9318
sa(dp9319
g4
Vunknown
p9320
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02983_869
p9321
sg8
Vdrug-target interaction Para-Mercury-Benzenesulfonic Acid and Estrogen receptor beta [drugbank_resource:DB02983_869]
p9322
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9323
sg14
Vhttp://bio2rdf.org/drugbank:DB02983
p9324
sg16
VPara-Mercury-Benzenesulfonic Acid [drugbank:DB02983]
p9325
sa(dp9326
g4
Vunknown
p9327
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03860_869
p9328
sg8
Vdrug-target interaction N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide and Estrogen receptor beta [drugbank_resource:DB03860_869]
p9329
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9330
sg14
Vhttp://bio2rdf.org/drugbank:DB03860
p9331
sg16
VN-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide [drugbank:DB03860]
p9332
sa(dp9333
g4
Vunknown
p9334
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03882_869
p9335
sg8
Vdrug-target interaction 5-Alpha-Androstane-3-Beta,17beta-Diol and Estrogen receptor beta [drugbank_resource:DB03882_869]
p9336
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9337
sg14
Vhttp://bio2rdf.org/drugbank:DB03882
p9338
sg16
V5-Alpha-Androstane-3-Beta,17beta-Diol [drugbank:DB03882]
p9339
sa(dp9340
g4
Vunknown
p9341
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04020_869
p9342
sg8
Vdrug-target interaction 4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol and Estrogen receptor beta [drugbank_resource:DB04020_869]
p9343
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9344
sg14
Vhttp://bio2rdf.org/drugbank:DB04020
p9345
sg16
V4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol [drugbank:DB04020]
p9346
sa(dp9347
g4
Vunknown
p9348
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06832_869
p9349
sg8
Vdrug-target interaction 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL and Estrogen receptor beta [drugbank_resource:DB06832_869]
p9350
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9351
sg14
Vhttp://bio2rdf.org/drugbank:DB06832
p9352
sg16
V2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL [drugbank:DB06832]
p9353
sa(dp9354
g4
Vunknown
p9355
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07009_869
p9356
sg8
Vdrug-target interaction 2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL and Estrogen receptor beta [drugbank_resource:DB07009_869]
p9357
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9358
sg14
Vhttp://bio2rdf.org/drugbank:DB07009
p9359
sg16
V2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL [drugbank:DB07009]
p9360
sa(dp9361
g4
Vunknown
p9362
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07036_869
p9363
sg8
Vdrug-target interaction (3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol and Estrogen receptor beta [drugbank_resource:DB07036_869]
p9364
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9365
sg14
Vhttp://bio2rdf.org/drugbank:DB07036
p9366
sg16
V(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol [drugbank:DB07036]
p9367
sa(dp9368
g4
Vunknown
p9369
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07150_869
p9370
sg8
Vdrug-target interaction 4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME and Estrogen receptor beta [drugbank_resource:DB07150_869]
p9371
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9372
sg14
Vhttp://bio2rdf.org/drugbank:DB07150
p9373
sg16
V4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME [drugbank:DB07150]
p9374
sa(dp9375
g4
Vunknown
p9376
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07230_869
p9377
sg8
Vdrug-target interaction 3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE and Estrogen receptor beta [drugbank_resource:DB07230_869]
p9378
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9379
sg14
Vhttp://bio2rdf.org/drugbank:DB07230
p9380
sg16
V3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE [drugbank:DB07230]
p9381
sa(dp9382
g4
Vunknown
p9383
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04573_869
p9384
sg8
Vdrug-target interaction Estriol and Estrogen receptor beta [drugbank_resource:DB04573_869]
p9385
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9386
sg14
Vhttp://bio2rdf.org/drugbank:DB04573
p9387
sg16
VEstriol [drugbank:DB04573]
p9388
sa(dp9389
g4
Vunknown
p9390
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04574_869
p9391
sg8
Vdrug-target interaction Estropipate and Estrogen receptor beta [drugbank_resource:DB04574_869]
p9392
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9393
sg14
Vhttp://bio2rdf.org/drugbank:DB04574
p9394
sg16
VEstropipate [drugbank:DB04574]
p9395
sa(dp9396
g4
Vunknown
p9397
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06875_869
p9398
sg8
Vdrug-target interaction 3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE and Estrogen receptor beta [drugbank_resource:DB06875_869]
p9399
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9400
sg14
Vhttp://bio2rdf.org/drugbank:DB06875
p9401
sg16
V3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE [drugbank:DB06875]
p9402
sa(dp9403
g4
Vunknown
p9404
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06927_869
p9405
sg8
Vdrug-target interaction [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE and Estrogen receptor beta [drugbank_resource:DB06927_869]
p9406
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9407
sg14
Vhttp://bio2rdf.org/drugbank:DB06927
p9408
sg16
V[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE [drugbank:DB06927]
p9409
sa(dp9410
g4
Vunknown
p9411
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06937_869
p9412
sg8
Vdrug-target interaction 4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL and Estrogen receptor beta [drugbank_resource:DB06937_869]
p9413
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9414
sg14
Vhttp://bio2rdf.org/drugbank:DB06937
p9415
sg16
V4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL [drugbank:DB06937]
p9416
sa(dp9417
g4
Vunknown
p9418
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07032_869
p9419
sg8
Vdrug-target interaction 2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL and Estrogen receptor beta [drugbank_resource:DB07032_869]
p9420
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9421
sg14
Vhttp://bio2rdf.org/drugbank:DB07032
p9422
sg16
V2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL [drugbank:DB07032]
p9423
sa(dp9424
g4
Vunknown
p9425
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07119_869
p9426
sg8
Vdrug-target interaction 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL and Estrogen receptor beta [drugbank_resource:DB07119_869]
p9427
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9428
sg14
Vhttp://bio2rdf.org/drugbank:DB07119
p9429
sg16
V1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL [drugbank:DB07119]
p9430
sa(dp9431
g4
Vunknown
p9432
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07198_869
p9433
sg8
Vdrug-target interaction 5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE and Estrogen receptor beta [drugbank_resource:DB07198_869]
p9434
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9435
sg14
Vhttp://bio2rdf.org/drugbank:DB07198
p9436
sg16
V5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE [drugbank:DB07198]
p9437
sa(dp9438
g4
Vunknown
p9439
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07236_869
p9440
sg8
Vdrug-target interaction 3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL and Estrogen receptor beta [drugbank_resource:DB07236_869]
p9441
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9442
sg14
Vhttp://bio2rdf.org/drugbank:DB07236
p9443
sg16
V3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL [drugbank:DB07236]
p9444
sa(dp9445
g4
Vunknown
p9446
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08020_869
p9447
sg8
Vdrug-target interaction (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL and Estrogen receptor beta [drugbank_resource:DB08020_869]
p9448
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9449
sg14
Vhttp://bio2rdf.org/drugbank:DB08020
p9450
sg16
V(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL [drugbank:DB08020]
p9451
sa(dp9452
g4
Vunknown
p9453
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07757_869
p9454
sg8
Vdrug-target interaction (9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one and Estrogen receptor beta [drugbank_resource:DB07757_869]
p9455
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9456
sg14
Vhttp://bio2rdf.org/drugbank:DB07757
p9457
sg16
V(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one [drugbank:DB07757]
p9458
sa(dp9459
g4
Vunknown
p9460
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07933_869
p9461
sg8
Vdrug-target interaction (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL and Estrogen receptor beta [drugbank_resource:DB07933_869]
p9462
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9463
sg14
Vhttp://bio2rdf.org/drugbank:DB07933
p9464
sg16
V(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL [drugbank:DB07933]
p9465
sa(dp9466
g4
Vunknown
p9467
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07638_869
p9468
sg8
Vdrug-target interaction (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL and Estrogen receptor beta [drugbank_resource:DB07638_869]
p9469
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9470
sg14
Vhttp://bio2rdf.org/drugbank:DB07638
p9471
sg16
V(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL [drugbank:DB07638]
p9472
sa(dp9473
g4
Vunknown
p9474
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07702_869
p9475
sg8
Vdrug-target interaction (16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL and Estrogen receptor beta [drugbank_resource:DB07702_869]
p9476
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:869
p9477
sg14
Vhttp://bio2rdf.org/drugbank:DB07702
p9478
sg16
V(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL [drugbank:DB07702]
p9479
sasS'GABRB3'
p9480
(lp9481
(dp9482
g4
Vyes
p9483
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00231_4099
p9484
sg8
Vdrug-target interaction Temazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00231_4099]
p9485
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9486
sg14
Vhttp://bio2rdf.org/drugbank:DB00231
p9487
sg16
VTemazepam [drugbank:DB00231]
p9488
sa(dp9489
g4
Vyes
p9490
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00189_4099
p9491
sg8
Vdrug-target interaction Ethchlorvynol and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00189_4099]
p9492
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9493
sg14
Vhttp://bio2rdf.org/drugbank:DB00189
p9494
sg16
VEthchlorvynol [drugbank:DB00189]
p9495
sa(dp9496
g4
Vyes
p9497
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00186_4099
p9498
sg8
Vdrug-target interaction Lorazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00186_4099]
p9499
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9500
sg14
Vhttp://bio2rdf.org/drugbank:DB00186
p9501
sg16
VLorazepam [drugbank:DB00186]
p9502
sa(dp9503
g4
Vyes
p9504
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00546_4099
p9505
sg8
Vdrug-target interaction Adinazolam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00546_4099]
p9506
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9507
sg14
Vhttp://bio2rdf.org/drugbank:DB00546
p9508
sg16
VAdinazolam [drugbank:DB00546]
p9509
sa(dp9510
g4
Vyes
p9511
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00592_4099
p9512
sg8
Vdrug-target interaction Piperazine and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00592_4099]
p9513
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9514
sg14
Vhttp://bio2rdf.org/drugbank:DB00592
p9515
sg16
VPiperazine [drugbank:DB00592]
p9516
sa(dp9517
g4
Vyes
p9518
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00349_4099
p9519
sg8
Vdrug-target interaction Clobazam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00349_4099]
p9520
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9521
sg14
Vhttp://bio2rdf.org/drugbank:DB00349
p9522
sg16
VClobazam [drugbank:DB00349]
p9523
sa(dp9524
g4
Vyes
p9525
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00404_4099
p9526
sg8
Vdrug-target interaction Alprazolam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00404_4099]
p9527
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9528
sg14
Vhttp://bio2rdf.org/drugbank:DB00404
p9529
sg16
VAlprazolam [drugbank:DB00404]
p9530
sa(dp9531
g4
Vyes
p9532
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00475_4099
p9533
sg8
Vdrug-target interaction Chlordiazepoxide and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00475_4099]
p9534
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9535
sg14
Vhttp://bio2rdf.org/drugbank:DB00475
p9536
sg16
VChlordiazepoxide [drugbank:DB00475]
p9537
sa(dp9538
g4
Vunknown
p9539
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00602_4099
p9540
sg8
Vdrug-target interaction Ivermectin and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00602_4099]
p9541
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9542
sg14
Vhttp://bio2rdf.org/drugbank:DB00602
p9543
sg16
VIvermectin [drugbank:DB00602]
p9544
sa(dp9545
g4
Vyes
p9546
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00628_4099
p9547
sg8
Vdrug-target interaction Clorazepate and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00628_4099]
p9548
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9549
sg14
Vhttp://bio2rdf.org/drugbank:DB00628
p9550
sg16
VClorazepate [drugbank:DB00628]
p9551
sa(dp9552
g4
Vyes
p9553
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00683_4099
p9554
sg8
Vdrug-target interaction Midazolam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00683_4099]
p9555
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9556
sg14
Vhttp://bio2rdf.org/drugbank:DB00683
p9557
sg16
VMidazolam [drugbank:DB00683]
p9558
sa(dp9559
g4
Vyes
p9560
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00690_4099
p9561
sg8
Vdrug-target interaction Flurazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00690_4099]
p9562
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9563
sg14
Vhttp://bio2rdf.org/drugbank:DB00690
p9564
sg16
VFlurazepam [drugbank:DB00690]
p9565
sa(dp9566
g4
Vyes
p9567
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00801_4099
p9568
sg8
Vdrug-target interaction Halazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00801_4099]
p9569
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9570
sg14
Vhttp://bio2rdf.org/drugbank:DB00801
p9571
sg16
VHalazepam [drugbank:DB00801]
p9572
sa(dp9573
g4
Vyes
p9574
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00818_4099
p9575
sg8
Vdrug-target interaction Propofol and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00818_4099]
p9576
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9577
sg14
Vhttp://bio2rdf.org/drugbank:DB00818
p9578
sg16
VPropofol [drugbank:DB00818]
p9579
sa(dp9580
g4
Vyes
p9581
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00897_4099
p9582
sg8
Vdrug-target interaction Triazolam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00897_4099]
p9583
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9584
sg14
Vhttp://bio2rdf.org/drugbank:DB00897
p9585
sg16
VTriazolam [drugbank:DB00897]
p9586
sa(dp9587
g4
Vyes
p9588
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00829_4099
p9589
sg8
Vdrug-target interaction Diazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00829_4099]
p9590
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9591
sg14
Vhttp://bio2rdf.org/drugbank:DB00829
p9592
sg16
VDiazepam [drugbank:DB00829]
p9593
sa(dp9594
g4
Vyes
p9595
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00842_4099
p9596
sg8
Vdrug-target interaction Oxazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB00842_4099]
p9597
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9598
sg14
Vhttp://bio2rdf.org/drugbank:DB00842
p9599
sg16
VOxazepam [drugbank:DB00842]
p9600
sa(dp9601
g4
Vyes
p9602
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01068_4099
p9603
sg8
Vdrug-target interaction Clonazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01068_4099]
p9604
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9605
sg14
Vhttp://bio2rdf.org/drugbank:DB01068
p9606
sg16
VClonazepam [drugbank:DB01068]
p9607
sa(dp9608
g4
Vyes
p9609
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01215_4099
p9610
sg8
Vdrug-target interaction Estazolam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01215_4099]
p9611
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9612
sg14
Vhttp://bio2rdf.org/drugbank:DB01215
p9613
sg16
VEstazolam [drugbank:DB01215]
p9614
sa(dp9615
g4
Vyes
p9616
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01559_4099
p9617
sg8
Vdrug-target interaction Clotiazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01559_4099]
p9618
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9619
sg14
Vhttp://bio2rdf.org/drugbank:DB01559
p9620
sg16
VClotiazepam [drugbank:DB01559]
p9621
sa(dp9622
g4
Vyes
p9623
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01567_4099
p9624
sg8
Vdrug-target interaction Fludiazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01567_4099]
p9625
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9626
sg14
Vhttp://bio2rdf.org/drugbank:DB01567
p9627
sg16
VFludiazepam [drugbank:DB01567]
p9628
sa(dp9629
g4
Vyes
p9630
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01594_4099
p9631
sg8
Vdrug-target interaction Cinolazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01594_4099]
p9632
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9633
sg14
Vhttp://bio2rdf.org/drugbank:DB01594
p9634
sg16
VCinolazepam [drugbank:DB01594]
p9635
sa(dp9636
g4
Vyes
p9637
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01558_4099
p9638
sg8
Vdrug-target interaction Bromazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01558_4099]
p9639
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9640
sg14
Vhttp://bio2rdf.org/drugbank:DB01558
p9641
sg16
VBromazepam [drugbank:DB01558]
p9642
sa(dp9643
g4
Vyes
p9644
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01588_4099
p9645
sg8
Vdrug-target interaction Prazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01588_4099]
p9646
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9647
sg14
Vhttp://bio2rdf.org/drugbank:DB01588
p9648
sg16
VPrazepam [drugbank:DB01588]
p9649
sa(dp9650
g4
Vyes
p9651
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01589_4099
p9652
sg8
Vdrug-target interaction Quazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01589_4099]
p9653
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9654
sg14
Vhttp://bio2rdf.org/drugbank:DB01589
p9655
sg16
VQuazepam [drugbank:DB01589]
p9656
sa(dp9657
g4
Vyes
p9658
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01595_4099
p9659
sg8
Vdrug-target interaction Nitrazepam and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB01595_4099]
p9660
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9661
sg14
Vhttp://bio2rdf.org/drugbank:DB01595
p9662
sg16
VNitrazepam [drugbank:DB01595]
p9663
sa(dp9664
g4
Vyes
p9665
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06716_4099
p9666
sg8
Vdrug-target interaction Fospropofol and Gamma-aminobutyric-acid receptor subunit beta-3 [drugbank_resource:DB06716_4099]
p9667
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4099
p9668
sg14
Vhttp://bio2rdf.org/drugbank:DB06716
p9669
sg16
VFospropofol [drugbank:DB06716]
p9670
sasS'WAS'
p9671
(lp9672
(dp9673
g4
Vunknown
p9674
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01731_4304
p9675
sg8
Vdrug-target interaction (S)-Wiskostatin and Wiskott-Aldrich syndrome protein [drugbank_resource:DB01731_4304]
p9676
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4304
p9677
sg14
Vhttp://bio2rdf.org/drugbank:DB01731
p9678
sg16
V(S)-Wiskostatin [drugbank:DB01731]
p9679
sasS'WEE1'
p9680
(lp9681
(dp9682
g4
Vunknown
p9683
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07226_5717
p9684
sg8
Vdrug-target interaction N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE and Wee1-like protein kinase [drugbank_resource:DB07226_5717]
p9685
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5717
p9686
sg14
Vhttp://bio2rdf.org/drugbank:DB07226
p9687
sg16
VN-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE [drugbank:DB07226]
p9688
sa(dp9689
g4
Vunknown
p9690
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07257_5717
p9691
sg8
Vdrug-target interaction 4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione and Wee1-like protein kinase [drugbank_resource:DB07257_5717]
p9692
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5717
p9693
sg14
Vhttp://bio2rdf.org/drugbank:DB07257
p9694
sg16
V4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione [drugbank:DB07257]
p9695
sa(dp9696
g4
Vunknown
p9697
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07265_5717
p9698
sg8
Vdrug-target interaction 3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID and Wee1-like protein kinase [drugbank_resource:DB07265_5717]
p9699
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5717
p9700
sg14
Vhttp://bio2rdf.org/drugbank:DB07265
p9701
sg16
V3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID [drugbank:DB07265]
p9702
sa(dp9703
g4
Vunknown
p9704
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04608_5717
p9705
sg8
Vdrug-target interaction 9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE and Wee1-like protein kinase [drugbank_resource:DB04608_5717]
p9706
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5717
p9707
sg14
Vhttp://bio2rdf.org/drugbank:DB04608
p9708
sg16
V9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE [drugbank:DB04608]
p9709
sa(dp9710
g4
Vunknown
p9711
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07006_5717
p9712
sg8
Vdrug-target interaction 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE and Wee1-like protein kinase [drugbank_resource:DB07006_5717]
p9713
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5717
p9714
sg14
Vhttp://bio2rdf.org/drugbank:DB07006
p9715
sg16
V9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE [drugbank:DB07006]
p9716
sa(dp9717
g4
Vunknown
p9718
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08365_5717
p9719
sg8
Vdrug-target interaction 8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide and Wee1-like protein kinase [drugbank_resource:DB08365_5717]
p9720
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5717
p9721
sg14
Vhttp://bio2rdf.org/drugbank:DB08365
p9722
sg16
V8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide [drugbank:DB08365]
p9723
sasS'KCNJ3'
p9724
(lp9725
(dp9726
g4
Vunknown
p9727
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01159_1571
p9728
sg8
Vdrug-target interaction Halothane and G protein-activated inward rectifier potassium channel 1 [drugbank_resource:DB01159_1571]
p9729
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1571
p9730
sg14
Vhttp://bio2rdf.org/drugbank:DB01159
p9731
sg16
VHalothane [drugbank:DB01159]
p9732
sasS'CTNNB1'
p9733
(lp9734
(dp9735
g4
Vunknown
p9736
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03904_1392
p9737
sg8
Vdrug-target interaction Urea and Catenin beta-1 [drugbank_resource:DB03904_1392]
p9738
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1392
p9739
sg14
Vhttp://bio2rdf.org/drugbank:DB03904
p9740
sg16
VUrea [drugbank:DB03904]
p9741
sasS'HSP90AA1'
p9742
(lp9743
(dp9744
g4
Vno
p9745
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00615_1939
p9746
sg8
Vdrug-target interaction Rifabutin and Heat shock protein HSP 90-alpha [drugbank_resource:DB00615_1939]
p9747
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9748
sg14
Vhttp://bio2rdf.org/drugbank:DB00615
p9749
sg16
VRifabutin [drugbank:DB00615]
p9750
sa(dp9751
g4
Vunknown
p9752
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00716_1939
p9753
sg8
Vdrug-target interaction Nedocromil and Heat shock protein HSP 90-alpha [drugbank_resource:DB00716_1939]
p9754
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9755
sg14
Vhttp://bio2rdf.org/drugbank:DB00716
p9756
sg16
VNedocromil [drugbank:DB00716]
p9757
sa(dp9758
g4
Vunknown
p9759
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02359_1939
p9760
sg8
Vdrug-target interaction 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB02359_1939]
p9761
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9762
sg14
Vhttp://bio2rdf.org/drugbank:DB02359
p9763
sg16
V9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine [drugbank:DB02359]
p9764
sa(dp9765
g4
Vunknown
p9766
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02754_1939
p9767
sg8
Vdrug-target interaction 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB02754_1939]
p9768
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9769
sg14
Vhttp://bio2rdf.org/drugbank:DB02754
p9770
sg16
V9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine [drugbank:DB02754]
p9771
sa(dp9772
g4
Vunknown
p9773
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02424_1939
p9774
sg8
Vdrug-target interaction Geldanamycin and Heat shock protein HSP 90-alpha [drugbank_resource:DB02424_1939]
p9775
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9776
sg14
Vhttp://bio2rdf.org/drugbank:DB02424
p9777
sg16
VGeldanamycin [drugbank:DB02424]
p9778
sa(dp9779
g4
Vunknown
p9780
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02550_1939
p9781
sg8
Vdrug-target interaction 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB02550_1939]
p9782
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9783
sg14
Vhttp://bio2rdf.org/drugbank:DB02550
p9784
sg16
V8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine [drugbank:DB02550]
p9785
sa(dp9786
g4
Vunknown
p9787
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02840_1939
p9788
sg8
Vdrug-target interaction 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid and Heat shock protein HSP 90-alpha [drugbank_resource:DB02840_1939]
p9789
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9790
sg14
Vhttp://bio2rdf.org/drugbank:DB02840
p9791
sg16
V4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid [drugbank:DB02840]
p9792
sa(dp9793
g4
Vunknown
p9794
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03137_1939
p9795
sg8
Vdrug-target interaction 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB03137_1939]
p9796
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9797
sg14
Vhttp://bio2rdf.org/drugbank:DB03137
p9798
sg16
V8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine [drugbank:DB03137]
p9799
sa(dp9800
g4
Vunknown
p9801
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03080_1939
p9802
sg8
Vdrug-target interaction 17-Dmag and Heat shock protein HSP 90-alpha [drugbank_resource:DB03080_1939]
p9803
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9804
sg14
Vhttp://bio2rdf.org/drugbank:DB03080
p9805
sg16
V17-Dmag [drugbank:DB03080]
p9806
sa(dp9807
g4
Vunknown
p9808
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03093_1939
p9809
sg8
Vdrug-target interaction 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB03093_1939]
p9810
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9811
sg14
Vhttp://bio2rdf.org/drugbank:DB03093
p9812
sg16
V8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine [drugbank:DB03093]
p9813
sa(dp9814
g4
Vunknown
p9815
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03504_1939
p9816
sg8
Vdrug-target interaction 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB03504_1939]
p9817
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9818
sg14
Vhttp://bio2rdf.org/drugbank:DB03504
p9819
sg16
V9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine [drugbank:DB03504]
p9820
sa(dp9821
g4
Vunknown
p9822
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03749_1939
p9823
sg8
Vdrug-target interaction 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole and Heat shock protein HSP 90-alpha [drugbank_resource:DB03749_1939]
p9824
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9825
sg14
Vhttp://bio2rdf.org/drugbank:DB03749
p9826
sg16
V4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole [drugbank:DB03749]
p9827
sa(dp9828
g4
Vunknown
p9829
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03809_1939
p9830
sg8
Vdrug-target interaction 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB03809_1939]
p9831
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9832
sg14
Vhttp://bio2rdf.org/drugbank:DB03809
p9833
sg16
V9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine [drugbank:DB03809]
p9834
sa(dp9835
g4
Vunknown
p9836
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03899_1939
p9837
sg8
Vdrug-target interaction 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB03899_1939]
p9838
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9839
sg14
Vhttp://bio2rdf.org/drugbank:DB03899
p9840
sg16
V9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine [drugbank:DB03899]
p9841
sa(dp9842
g4
Vunknown
p9843
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04054_1939
p9844
sg8
Vdrug-target interaction 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB04054_1939]
p9845
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9846
sg14
Vhttp://bio2rdf.org/drugbank:DB04054
p9847
sg16
V9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine [drugbank:DB04054]
p9848
sa(dp9849
g4
Vunknown
p9850
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03431_1939
p9851
sg8
Vdrug-target interaction Adenosine-5'-Diphosphate and Heat shock protein HSP 90-alpha [drugbank_resource:DB03431_1939]
p9852
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9853
sg14
Vhttp://bio2rdf.org/drugbank:DB03431
p9854
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p9855
sa(dp9856
g4
Vunknown
p9857
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04254_1939
p9858
sg8
Vdrug-target interaction 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB04254_1939]
p9859
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9860
sg14
Vhttp://bio2rdf.org/drugbank:DB04254
p9861
sg16
V8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine [drugbank:DB04254]
p9862
sa(dp9863
g4
Vunknown
p9864
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04588_1939
p9865
sg8
Vdrug-target interaction N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB04588_1939]
p9866
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9867
sg14
Vhttp://bio2rdf.org/drugbank:DB04588
p9868
sg16
VN-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE [drugbank:DB04588]
p9869
sa(dp9870
g4
Vunknown
p9871
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06956_1939
p9872
sg8
Vdrug-target interaction N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB06956_1939]
p9873
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9874
sg14
Vhttp://bio2rdf.org/drugbank:DB06956
p9875
sg16
VN-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE [drugbank:DB06956]
p9876
sa(dp9877
g4
Vunknown
p9878
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06958_1939
p9879
sg8
Vdrug-target interaction 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB06958_1939]
p9880
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9881
sg14
Vhttp://bio2rdf.org/drugbank:DB06958
p9882
sg16
V5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE [drugbank:DB06958]
p9883
sa(dp9884
g4
Vunknown
p9885
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06961_1939
p9886
sg8
Vdrug-target interaction 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide and Heat shock protein HSP 90-alpha [drugbank_resource:DB06961_1939]
p9887
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9888
sg14
Vhttp://bio2rdf.org/drugbank:DB06961
p9889
sg16
V5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide [drugbank:DB06961]
p9890
sa(dp9891
g4
Vunknown
p9892
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06969_1939
p9893
sg8
Vdrug-target interaction 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide and Heat shock protein HSP 90-alpha [drugbank_resource:DB06969_1939]
p9894
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9895
sg14
Vhttp://bio2rdf.org/drugbank:DB06969
p9896
sg16
V2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide [drugbank:DB06969]
p9897
sa(dp9898
g4
Vunknown
p9899
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04505_1939
p9900
sg8
Vdrug-target interaction 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine and Heat shock protein HSP 90-alpha [drugbank_resource:DB04505_1939]
p9901
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9902
sg14
Vhttp://bio2rdf.org/drugbank:DB04505
p9903
sg16
V8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine [drugbank:DB04505]
p9904
sa(dp9905
g4
Vunknown
p9906
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07324_1939
p9907
sg8
Vdrug-target interaction 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE and Heat shock protein HSP 90-alpha [drugbank_resource:DB07324_1939]
p9908
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9909
sg14
Vhttp://bio2rdf.org/drugbank:DB07324
p9910
sg16
V3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE [drugbank:DB07324]
p9911
sa(dp9912
g4
Vunknown
p9913
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07325_1939
p9914
sg8
Vdrug-target interaction N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB07325_1939]
p9915
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9916
sg14
Vhttp://bio2rdf.org/drugbank:DB07325
p9917
sg16
VN-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE [drugbank:DB07325]
p9918
sa(dp9919
g4
Vunknown
p9920
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06957_1939
p9921
sg8
Vdrug-target interaction 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL and Heat shock protein HSP 90-alpha [drugbank_resource:DB06957_1939]
p9922
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9923
sg14
Vhttp://bio2rdf.org/drugbank:DB06957
p9924
sg16
V4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL [drugbank:DB06957]
p9925
sa(dp9926
g4
Vunknown
p9927
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06964_1939
p9928
sg8
Vdrug-target interaction 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB06964_1939]
p9929
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9930
sg14
Vhttp://bio2rdf.org/drugbank:DB06964
p9931
sg16
V5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE [drugbank:DB06964]
p9932
sa(dp9933
g4
Vunknown
p9934
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07100_1939
p9935
sg8
Vdrug-target interaction 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL and Heat shock protein HSP 90-alpha [drugbank_resource:DB07100_1939]
p9936
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9937
sg14
Vhttp://bio2rdf.org/drugbank:DB07100
p9938
sg16
V4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL [drugbank:DB07100]
p9939
sa(dp9940
g4
Vunknown
p9941
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07317_1939
p9942
sg8
Vdrug-target interaction (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one and Heat shock protein HSP 90-alpha [drugbank_resource:DB07317_1939]
p9943
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9944
sg14
Vhttp://bio2rdf.org/drugbank:DB07317
p9945
sg16
V(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one [drugbank:DB07317]
p9946
sa(dp9947
g4
Vunknown
p9948
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07319_1939
p9949
sg8
Vdrug-target interaction 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE and Heat shock protein HSP 90-alpha [drugbank_resource:DB07319_1939]
p9950
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9951
sg14
Vhttp://bio2rdf.org/drugbank:DB07319
p9952
sg16
V6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE [drugbank:DB07319]
p9953
sa(dp9954
g4
Vunknown
p9955
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07495_1939
p9956
sg8
Vdrug-target interaction 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB07495_1939]
p9957
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9958
sg14
Vhttp://bio2rdf.org/drugbank:DB07495
p9959
sg16
V5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE [drugbank:DB07495]
p9960
sa(dp9961
g4
Vunknown
p9962
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07502_1939
p9963
sg8
Vdrug-target interaction 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol and Heat shock protein HSP 90-alpha [drugbank_resource:DB07502_1939]
p9964
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9965
sg14
Vhttp://bio2rdf.org/drugbank:DB07502
p9966
sg16
V4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol [drugbank:DB07502]
p9967
sa(dp9968
g4
Vunknown
p9969
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08197_1939
p9970
sg8
Vdrug-target interaction (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime and Heat shock protein HSP 90-alpha [drugbank_resource:DB08197_1939]
p9971
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9972
sg14
Vhttp://bio2rdf.org/drugbank:DB08197
p9973
sg16
V(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime [drugbank:DB08197]
p9974
sa(dp9975
g4
Vunknown
p9976
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08442_1939
p9977
sg8
Vdrug-target interaction 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol and Heat shock protein HSP 90-alpha [drugbank_resource:DB08442_1939]
p9978
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9979
sg14
Vhttp://bio2rdf.org/drugbank:DB08442
p9980
sg16
V4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol [drugbank:DB08442]
p9981
sa(dp9982
g4
Vunknown
p9983
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07594_1939
p9984
sg8
Vdrug-target interaction 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL and Heat shock protein HSP 90-alpha [drugbank_resource:DB07594_1939]
p9985
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9986
sg14
Vhttp://bio2rdf.org/drugbank:DB07594
p9987
sg16
V4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL [drugbank:DB07594]
p9988
sa(dp9989
g4
Vunknown
p9990
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07877_1939
p9991
sg8
Vdrug-target interaction 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE and Heat shock protein HSP 90-alpha [drugbank_resource:DB07877_1939]
p9992
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p9993
sg14
Vhttp://bio2rdf.org/drugbank:DB07877
p9994
sg16
V8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE [drugbank:DB07877]
p9995
sa(dp9996
g4
Vunknown
p9997
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08194_1939
p9998
sg8
Vdrug-target interaction 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB08194_1939]
p9999
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p10000
sg14
Vhttp://bio2rdf.org/drugbank:DB08194
p10001
sg16
V4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine [drugbank:DB08194]
p10002
sa(dp10003
g4
Vunknown
p10004
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08436_1939
p10005
sg8
Vdrug-target interaction 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H- and Heat shock protein HSP 90-alpha [drugbank_resource:DB08436_1939]
p10006
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p10007
sg14
Vhttp://bio2rdf.org/drugbank:DB08436
p10008
sg16
V8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H- [drugbank:DB08436]
p10009
sa(dp10010
g4
Vunknown
p10011
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08443_1939
p10012
sg8
Vdrug-target interaction 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol and Heat shock protein HSP 90-alpha [drugbank_resource:DB08443_1939]
p10013
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p10014
sg14
Vhttp://bio2rdf.org/drugbank:DB08443
p10015
sg16
V2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol [drugbank:DB08443]
p10016
sa(dp10017
g4
Vunknown
p10018
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08786_1939
p10019
sg8
Vdrug-target interaction 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB08786_1939]
p10020
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p10021
sg14
Vhttp://bio2rdf.org/drugbank:DB08786
p10022
sg16
V4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine [drugbank:DB08786]
p10023
sa(dp10024
g4
Vunknown
p10025
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08787_1939
p10026
sg8
Vdrug-target interaction 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine and Heat shock protein HSP 90-alpha [drugbank_resource:DB08787_1939]
p10027
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p10028
sg14
Vhttp://bio2rdf.org/drugbank:DB08787
p10029
sg16
V4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine [drugbank:DB08787]
p10030
sa(dp10031
g4
Vunknown
p10032
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08789_1939
p10033
sg8
Vdrug-target interaction 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB08789_1939]
p10034
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p10035
sg14
Vhttp://bio2rdf.org/drugbank:DB08789
p10036
sg16
V2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE [drugbank:DB08789]
p10037
sa(dp10038
g4
Vunknown
p10039
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07601_1939
p10040
sg8
Vdrug-target interaction 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol and Heat shock protein HSP 90-alpha [drugbank_resource:DB07601_1939]
p10041
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p10042
sg14
Vhttp://bio2rdf.org/drugbank:DB07601
p10043
sg16
V4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol [drugbank:DB07601]
p10044
sa(dp10045
g4
Vunknown
p10046
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08557_1939
p10047
sg8
Vdrug-target interaction 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide and Heat shock protein HSP 90-alpha [drugbank_resource:DB08557_1939]
p10048
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p10049
sg14
Vhttp://bio2rdf.org/drugbank:DB08557
p10050
sg16
V2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide [drugbank:DB08557]
p10051
sa(dp10052
g4
Vunknown
p10053
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08788_1939
p10054
sg8
Vdrug-target interaction 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE and Heat shock protein HSP 90-alpha [drugbank_resource:DB08788_1939]
p10055
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1939
p10056
sg14
Vhttp://bio2rdf.org/drugbank:DB08788
p10057
sg16
V3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE [drugbank:DB08788]
p10058
sasS'F5'
p10059
(lp10060
(dp10061
g4
Vyes
p10062
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00055_46
p10063
sg8
Vdrug-target interaction Drotrecogin alfa and Coagulation factor V [drugbank_resource:DB00055_46]
p10064
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:46
p10065
sg14
Vhttp://bio2rdf.org/drugbank:DB00055
p10066
sg16
VDrotrecogin alfa [drugbank:DB00055]
p10067
sa(dp10068
g4
Vunknown
p10069
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04558_46
p10070
sg8
Vdrug-target interaction Phenylmercury and Coagulation factor V [drugbank_resource:DB04558_46]
p10071
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:46
p10072
sg14
Vhttp://bio2rdf.org/drugbank:DB04558
p10073
sg16
VPhenylmercury [drugbank:DB04558]
p10074
sasS'TRPA1'
p10075
(lp10076
(dp10077
g4
Vyes
p10078
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00825_1944
p10079
sg8
Vdrug-target interaction Menthol and Transient receptor potential cation channel subfamily A member 1 [drugbank_resource:DB00825_1944]
p10080
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1944
p10081
sg14
Vhttp://bio2rdf.org/drugbank:DB00825
p10082
sg16
VMenthol [drugbank:DB00825]
p10083
sasS'ESR1'
p10084
(lp10085
(dp10086
g4
Vyes
p10087
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00255_136
p10088
sg8
Vdrug-target interaction Diethylstilbestrol and Estrogen receptor [drugbank_resource:DB00255_136]
p10089
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10090
sg14
Vhttp://bio2rdf.org/drugbank:DB00255
p10091
sg16
VDiethylstilbestrol [drugbank:DB00255]
p10092
sa(dp10093
g4
Vyes
p10094
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00269_136
p10095
sg8
Vdrug-target interaction Chlorotrianisene and Estrogen receptor [drugbank_resource:DB00269_136]
p10096
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10097
sg14
Vhttp://bio2rdf.org/drugbank:DB00269
p10098
sg16
VChlorotrianisene [drugbank:DB00269]
p10099
sa(dp10100
g4
Vyes
p10101
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00304_136
p10102
sg8
Vdrug-target interaction Desogestrel and Estrogen receptor [drugbank_resource:DB00304_136]
p10103
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10104
sg14
Vhttp://bio2rdf.org/drugbank:DB00304
p10105
sg16
VDesogestrel [drugbank:DB00304]
p10106
sa(dp10107
g4
Vyes
p10108
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00286_136
p10109
sg8
Vdrug-target interaction Conjugated Estrogens and Estrogen receptor [drugbank_resource:DB00286_136]
p10110
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10111
sg14
Vhttp://bio2rdf.org/drugbank:DB00286
p10112
sg16
VConjugated Estrogens [drugbank:DB00286]
p10113
sa(dp10114
g4
Vyes
p10115
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00294_136
p10116
sg8
Vdrug-target interaction Etonogestrel and Estrogen receptor [drugbank_resource:DB00294_136]
p10117
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10118
sg14
Vhttp://bio2rdf.org/drugbank:DB00294
p10119
sg16
VEtonogestrel [drugbank:DB00294]
p10120
sa(dp10121
g4
Vyes
p10122
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00396_136
p10123
sg8
Vdrug-target interaction Progesterone and Estrogen receptor [drugbank_resource:DB00396_136]
p10124
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10125
sg14
Vhttp://bio2rdf.org/drugbank:DB00396
p10126
sg16
VProgesterone [drugbank:DB00396]
p10127
sa(dp10128
g4
Vyes
p10129
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00481_136
p10130
sg8
Vdrug-target interaction Raloxifene and Estrogen receptor [drugbank_resource:DB00481_136]
p10131
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10132
sg14
Vhttp://bio2rdf.org/drugbank:DB00481
p10133
sg16
VRaloxifene [drugbank:DB00481]
p10134
sa(dp10135
g4
Vyes
p10136
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00539_136
p10137
sg8
Vdrug-target interaction Toremifene and Estrogen receptor [drugbank_resource:DB00539_136]
p10138
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10139
sg14
Vhttp://bio2rdf.org/drugbank:DB00539
p10140
sg16
VToremifene [drugbank:DB00539]
p10141
sa(dp10142
g4
Vyes
p10143
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00603_136
p10144
sg8
Vdrug-target interaction Medroxyprogesterone and Estrogen receptor [drugbank_resource:DB00603_136]
p10145
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10146
sg14
Vhttp://bio2rdf.org/drugbank:DB00603
p10147
sg16
VMedroxyprogesterone [drugbank:DB00603]
p10148
sa(dp10149
g4
Vyes
p10150
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00367_136
p10151
sg8
Vdrug-target interaction Levonorgestrel and Estrogen receptor [drugbank_resource:DB00367_136]
p10152
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10153
sg14
Vhttp://bio2rdf.org/drugbank:DB00367
p10154
sg16
VLevonorgestrel [drugbank:DB00367]
p10155
sa(dp10156
g4
Vyes
p10157
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00655_136
p10158
sg8
Vdrug-target interaction Estrone and Estrogen receptor [drugbank_resource:DB00655_136]
p10159
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10160
sg14
Vhttp://bio2rdf.org/drugbank:DB00655
p10161
sg16
VEstrone [drugbank:DB00655]
p10162
sa(dp10163
g4
Vyes
p10164
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00783_136
p10165
sg8
Vdrug-target interaction Estradiol and Estrogen receptor [drugbank_resource:DB00783_136]
p10166
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10167
sg14
Vhttp://bio2rdf.org/drugbank:DB00783
p10168
sg16
VEstradiol [drugbank:DB00783]
p10169
sa(dp10170
g4
Vyes
p10171
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00823_136
p10172
sg8
Vdrug-target interaction Ethynodiol Diacetate and Estrogen receptor [drugbank_resource:DB00823_136]
p10173
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10174
sg14
Vhttp://bio2rdf.org/drugbank:DB00823
p10175
sg16
VEthynodiol Diacetate [drugbank:DB00823]
p10176
sa(dp10177
g4
Vyes
p10178
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00957_136
p10179
sg8
Vdrug-target interaction Norgestimate and Estrogen receptor [drugbank_resource:DB00957_136]
p10180
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10181
sg14
Vhttp://bio2rdf.org/drugbank:DB00957
p10182
sg16
VNorgestimate [drugbank:DB00957]
p10183
sa(dp10184
g4
Vyes
p10185
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00675_136
p10186
sg8
Vdrug-target interaction Tamoxifen and Estrogen receptor [drugbank_resource:DB00675_136]
p10187
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10188
sg14
Vhttp://bio2rdf.org/drugbank:DB00675
p10189
sg16
VTamoxifen [drugbank:DB00675]
p10190
sa(dp10191
g4
Vyes
p10192
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00882_136
p10193
sg8
Vdrug-target interaction Clomifene and Estrogen receptor [drugbank_resource:DB00882_136]
p10194
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10195
sg14
Vhttp://bio2rdf.org/drugbank:DB00882
p10196
sg16
VClomifene [drugbank:DB00882]
p10197
sa(dp10198
g4
Vyes
p10199
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00947_136
p10200
sg8
Vdrug-target interaction Fulvestrant and Estrogen receptor [drugbank_resource:DB00947_136]
p10201
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10202
sg14
Vhttp://bio2rdf.org/drugbank:DB00947
p10203
sg16
VFulvestrant [drugbank:DB00947]
p10204
sa(dp10205
g4
Vyes
p10206
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00890_136
p10207
sg8
Vdrug-target interaction Dienestrol and Estrogen receptor [drugbank_resource:DB00890_136]
p10208
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10209
sg14
Vhttp://bio2rdf.org/drugbank:DB00890
p10210
sg16
VDienestrol [drugbank:DB00890]
p10211
sa(dp10212
g4
Vyes
p10213
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00977_136
p10214
sg8
Vdrug-target interaction Ethinyl Estradiol and Estrogen receptor [drugbank_resource:DB00977_136]
p10215
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10216
sg14
Vhttp://bio2rdf.org/drugbank:DB00977
p10217
sg16
VEthinyl Estradiol [drugbank:DB00977]
p10218
sa(dp10219
g4
Vunknown
p10220
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01065_136
p10221
sg8
Vdrug-target interaction Melatonin and Estrogen receptor [drugbank_resource:DB01065_136]
p10222
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10223
sg14
Vhttp://bio2rdf.org/drugbank:DB01065
p10224
sg16
VMelatonin [drugbank:DB01065]
p10225
sa(dp10226
g4
Vyes
p10227
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01108_136
p10228
sg8
Vdrug-target interaction Trilostane and Estrogen receptor [drugbank_resource:DB01108_136]
p10229
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10230
sg14
Vhttp://bio2rdf.org/drugbank:DB01108
p10231
sg16
VTrilostane [drugbank:DB01108]
p10232
sa(dp10233
g4
Vunknown
p10234
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01431_136
p10235
sg8
Vdrug-target interaction Allylestrenol and Estrogen receptor [drugbank_resource:DB01431_136]
p10236
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10237
sg14
Vhttp://bio2rdf.org/drugbank:DB01431
p10238
sg16
VAllylestrenol [drugbank:DB01431]
p10239
sa(dp10240
g4
Vunknown
p10241
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01645_136
p10242
sg8
Vdrug-target interaction Genistein and Estrogen receptor [drugbank_resource:DB01645_136]
p10243
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10244
sg14
Vhttp://bio2rdf.org/drugbank:DB01645
p10245
sg16
VGenistein [drugbank:DB01645]
p10246
sa(dp10247
g4
Vyes
p10248
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01196_136
p10249
sg8
Vdrug-target interaction Estramustine and Estrogen receptor [drugbank_resource:DB01196_136]
p10250
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10251
sg14
Vhttp://bio2rdf.org/drugbank:DB01196
p10252
sg16
VEstramustine [drugbank:DB01196]
p10253
sa(dp10254
g4
Vyes
p10255
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01406_136
p10256
sg8
Vdrug-target interaction Danazol and Estrogen receptor [drugbank_resource:DB01406_136]
p10257
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10258
sg14
Vhttp://bio2rdf.org/drugbank:DB01406
p10259
sg16
VDanazol [drugbank:DB01406]
p10260
sa(dp10261
g4
Vno
p10262
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01183_136
p10263
sg8
Vdrug-target interaction Naloxone and Estrogen receptor [drugbank_resource:DB01183_136]
p10264
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10265
sg14
Vhttp://bio2rdf.org/drugbank:DB01183
p10266
sg16
VNaloxone [drugbank:DB01183]
p10267
sa(dp10268
g4
Vyes
p10269
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01185_136
p10270
sg8
Vdrug-target interaction Fluoxymesterone and Estrogen receptor [drugbank_resource:DB01185_136]
p10271
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10272
sg14
Vhttp://bio2rdf.org/drugbank:DB01185
p10273
sg16
VFluoxymesterone [drugbank:DB01185]
p10274
sa(dp10275
g4
Vyes
p10276
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01357_136
p10277
sg8
Vdrug-target interaction Mestranol and Estrogen receptor [drugbank_resource:DB01357_136]
p10278
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10279
sg14
Vhttp://bio2rdf.org/drugbank:DB01357
p10280
sg16
VMestranol [drugbank:DB01357]
p10281
sa(dp10282
g4
Vunknown
p10283
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02715_136
p10284
sg8
Vdrug-target interaction Compound 18 and Estrogen receptor [drugbank_resource:DB02715_136]
p10285
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10286
sg14
Vhttp://bio2rdf.org/drugbank:DB02715
p10287
sg16
VCompound 18 [drugbank:DB02715]
p10288
sa(dp10289
g4
Vunknown
p10290
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02615_136
p10291
sg8
Vdrug-target interaction Compound 19 and Estrogen receptor [drugbank_resource:DB02615_136]
p10292
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10293
sg14
Vhttp://bio2rdf.org/drugbank:DB02615
p10294
sg16
VCompound 19 [drugbank:DB02615]
p10295
sa(dp10296
g4
Vunknown
p10297
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03742_136
p10298
sg8
Vdrug-target interaction Compound 4-D and Estrogen receptor [drugbank_resource:DB03742_136]
p10299
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10300
sg14
Vhttp://bio2rdf.org/drugbank:DB03742
p10301
sg16
VCompound 4-D [drugbank:DB03742]
p10302
sa(dp10303
g4
Vunknown
p10304
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03802_136
p10305
sg8
Vdrug-target interaction 1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol and Estrogen receptor [drugbank_resource:DB03802_136]
p10306
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10307
sg14
Vhttp://bio2rdf.org/drugbank:DB03802
p10308
sg16
V1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol [drugbank:DB03802]
p10309
sa(dp10310
g4
Vunknown
p10311
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04471_136
p10312
sg8
Vdrug-target interaction 2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol and Estrogen receptor [drugbank_resource:DB04471_136]
p10313
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10314
sg14
Vhttp://bio2rdf.org/drugbank:DB04471
p10315
sg16
V2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol [drugbank:DB04471]
p10316
sa(dp10317
g4
Vyes
p10318
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04574_136
p10319
sg8
Vdrug-target interaction Estropipate and Estrogen receptor [drugbank_resource:DB04574_136]
p10320
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10321
sg14
Vhttp://bio2rdf.org/drugbank:DB04574
p10322
sg16
VEstropipate [drugbank:DB04574]
p10323
sa(dp10324
g4
Vyes
p10325
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06713_136
p10326
sg8
Vdrug-target interaction Norelgestromin and Estrogen receptor [drugbank_resource:DB06713_136]
p10327
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10328
sg14
Vhttp://bio2rdf.org/drugbank:DB06713
p10329
sg16
VNorelgestromin [drugbank:DB06713]
p10330
sa(dp10331
g4
Vunknown
p10332
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06927_136
p10333
sg8
Vdrug-target interaction [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE and Estrogen receptor [drugbank_resource:DB06927_136]
p10334
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10335
sg14
Vhttp://bio2rdf.org/drugbank:DB06927
p10336
sg16
V[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE [drugbank:DB06927]
p10337
sa(dp10338
g4
Vunknown
p10339
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07087_136
p10340
sg8
Vdrug-target interaction 4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Estrogen receptor [drugbank_resource:DB07087_136]
p10341
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10342
sg14
Vhttp://bio2rdf.org/drugbank:DB07087
p10343
sg16
V4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB07087]
p10344
sa(dp10345
g4
Vunknown
p10346
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07195_136
p10347
sg8
Vdrug-target interaction 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Estrogen receptor [drugbank_resource:DB07195_136]
p10348
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10349
sg14
Vhttp://bio2rdf.org/drugbank:DB07195
p10350
sg16
V4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB07195]
p10351
sa(dp10352
g4
Vyes
p10353
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04573_136
p10354
sg8
Vdrug-target interaction Estriol and Estrogen receptor [drugbank_resource:DB04573_136]
p10355
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10356
sg14
Vhttp://bio2rdf.org/drugbank:DB04573
p10357
sg16
VEstriol [drugbank:DB04573]
p10358
sa(dp10359
g4
Vyes
p10360
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04575_136
p10361
sg8
Vdrug-target interaction Quinestrol and Estrogen receptor [drugbank_resource:DB04575_136]
p10362
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10363
sg14
Vhttp://bio2rdf.org/drugbank:DB04575
p10364
sg16
VQuinestrol [drugbank:DB04575]
p10365
sa(dp10366
g4
Vunknown
p10367
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06898_136
p10368
sg8
Vdrug-target interaction 4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol and Estrogen receptor [drugbank_resource:DB06898_136]
p10369
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10370
sg14
Vhttp://bio2rdf.org/drugbank:DB06898
p10371
sg16
V4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol [drugbank:DB06898]
p10372
sa(dp10373
g4
Vunknown
p10374
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06871_136
p10375
sg8
Vdrug-target interaction 17-METHYL-17-ALPHA-DIHYDROEQUILENIN and Estrogen receptor [drugbank_resource:DB06871_136]
p10376
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10377
sg14
Vhttp://bio2rdf.org/drugbank:DB06871
p10378
sg16
V17-METHYL-17-ALPHA-DIHYDROEQUILENIN [drugbank:DB06871]
p10379
sa(dp10380
g4
Vunknown
p10381
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07086_136
p10382
sg8
Vdrug-target interaction 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Estrogen receptor [drugbank_resource:DB07086_136]
p10383
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10384
sg14
Vhttp://bio2rdf.org/drugbank:DB07086
p10385
sg16
V4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB07086]
p10386
sa(dp10387
g4
Vunknown
p10388
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07567_136
p10389
sg8
Vdrug-target interaction (2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL and Estrogen receptor [drugbank_resource:DB07567_136]
p10390
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10391
sg14
Vhttp://bio2rdf.org/drugbank:DB07567
p10392
sg16
V(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL [drugbank:DB07567]
p10393
sa(dp10394
g4
Vunknown
p10395
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07638_136
p10396
sg8
Vdrug-target interaction (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL and Estrogen receptor [drugbank_resource:DB07638_136]
p10397
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10398
sg14
Vhttp://bio2rdf.org/drugbank:DB07638
p10399
sg16
V(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL [drugbank:DB07638]
p10400
sa(dp10401
g4
Vunknown
p10402
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07712_136
p10403
sg8
Vdrug-target interaction 3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL and Estrogen receptor [drugbank_resource:DB07712_136]
p10404
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10405
sg14
Vhttp://bio2rdf.org/drugbank:DB07712
p10406
sg16
V3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL [drugbank:DB07712]
p10407
sa(dp10408
g4
Vunknown
p10409
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07991_136
p10410
sg8
Vdrug-target interaction N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE and Estrogen receptor [drugbank_resource:DB07991_136]
p10411
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10412
sg14
Vhttp://bio2rdf.org/drugbank:DB07991
p10413
sg16
VN-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE [drugbank:DB07991]
p10414
sa(dp10415
g4
Vunknown
p10416
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08020_136
p10417
sg8
Vdrug-target interaction (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL and Estrogen receptor [drugbank_resource:DB08020_136]
p10418
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10419
sg14
Vhttp://bio2rdf.org/drugbank:DB08020
p10420
sg16
V(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL [drugbank:DB08020]
p10421
sa(dp10422
g4
Vunknown
p10423
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08048_136
p10424
sg8
Vdrug-target interaction 4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL and Estrogen receptor [drugbank_resource:DB08048_136]
p10425
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10426
sg14
Vhttp://bio2rdf.org/drugbank:DB08048
p10427
sg16
V4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL [drugbank:DB08048]
p10428
sa(dp10429
g4
Vunknown
p10430
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07678_136
p10431
sg8
Vdrug-target interaction (9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL and Estrogen receptor [drugbank_resource:DB07678_136]
p10432
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10433
sg14
Vhttp://bio2rdf.org/drugbank:DB07678
p10434
sg16
V(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL [drugbank:DB07678]
p10435
sa(dp10436
g4
Vunknown
p10437
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07708_136
p10438
sg8
Vdrug-target interaction 3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL and Estrogen receptor [drugbank_resource:DB07708_136]
p10439
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10440
sg14
Vhttp://bio2rdf.org/drugbank:DB07708
p10441
sg16
V3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL [drugbank:DB07708]
p10442
sa(dp10443
g4
Vunknown
p10444
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07707_136
p10445
sg8
Vdrug-target interaction (9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL and Estrogen receptor [drugbank_resource:DB07707_136]
p10446
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10447
sg14
Vhttp://bio2rdf.org/drugbank:DB07707
p10448
sg16
V(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL [drugbank:DB07707]
p10449
sa(dp10450
g4
Vunknown
p10451
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07932_136
p10452
sg8
Vdrug-target interaction dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate and Estrogen receptor [drugbank_resource:DB07932_136]
p10453
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10454
sg14
Vhttp://bio2rdf.org/drugbank:DB07932
p10455
sg16
Vdimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate [drugbank:DB07932]
p10456
sa(dp10457
g4
Vunknown
p10458
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07933_136
p10459
sg8
Vdrug-target interaction (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL and Estrogen receptor [drugbank_resource:DB07933_136]
p10460
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10461
sg14
Vhttp://bio2rdf.org/drugbank:DB07933
p10462
sg16
V(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL [drugbank:DB07933]
p10463
sa(dp10464
g4
Vunknown
p10465
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08047_136
p10466
sg8
Vdrug-target interaction 4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol and Estrogen receptor [drugbank_resource:DB08047_136]
p10467
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10468
sg14
Vhttp://bio2rdf.org/drugbank:DB08047
p10469
sg16
V4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol [drugbank:DB08047]
p10470
sa(dp10471
g4
Vunknown
p10472
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08320_136
p10473
sg8
Vdrug-target interaction DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE and Estrogen receptor [drugbank_resource:DB08320_136]
p10474
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10475
sg14
Vhttp://bio2rdf.org/drugbank:DB08320
p10476
sg16
VDIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE [drugbank:DB08320]
p10477
sa(dp10478
g4
Vunknown
p10479
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08398_136
p10480
sg8
Vdrug-target interaction 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE and Estrogen receptor [drugbank_resource:DB08398_136]
p10481
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10482
sg14
Vhttp://bio2rdf.org/drugbank:DB08398
p10483
sg16
V2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE [drugbank:DB08398]
p10484
sa(dp10485
g4
Vunknown
p10486
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08595_136
p10487
sg8
Vdrug-target interaction 4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL and Estrogen receptor [drugbank_resource:DB08595_136]
p10488
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10489
sg14
Vhttp://bio2rdf.org/drugbank:DB08595
p10490
sg16
V4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL [drugbank:DB08595]
p10491
sa(dp10492
g4
Vunknown
p10493
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08737_136
p10494
sg8
Vdrug-target interaction (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL and Estrogen receptor [drugbank_resource:DB08737_136]
p10495
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10496
sg14
Vhttp://bio2rdf.org/drugbank:DB08737
p10497
sg16
V(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL [drugbank:DB08737]
p10498
sa(dp10499
g4
Vunknown
p10500
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08773_136
p10501
sg8
Vdrug-target interaction RALOXIFENE CORE and Estrogen receptor [drugbank_resource:DB08773_136]
p10502
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:136
p10503
sg14
Vhttp://bio2rdf.org/drugbank:DB08773
p10504
sg16
VRALOXIFENE CORE [drugbank:DB08773]
p10505
sasS'IRS1'
p10506
(lp10507
(dp10508
g4
Vunknown
p10509
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08513_1372
p10510
sg8
Vdrug-target interaction [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID and Insulin receptor substrate 1 [drugbank_resource:DB08513_1372]
p10511
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1372
p10512
sg14
Vhttp://bio2rdf.org/drugbank:DB08513
p10513
sg16
V[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID [drugbank:DB08513]
p10514
sasS'IL6'
p10515
(lp10516
(dp10517
g4
Vunknown
p10518
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01404_1159
p10519
sg8
Vdrug-target interaction Ginseng and Interleukin-6 [drugbank_resource:DB01404_1159]
p10520
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1159
p10521
sg14
Vhttp://bio2rdf.org/drugbank:DB01404
p10522
sg16
VGinseng [drugbank:DB01404]
p10523
sasS'MET'
p10524
(lp10525
(dp10526
g4
Vunknown
p10527
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02152_1144
p10528
sg8
Vdrug-target interaction K-252a and Hepatocyte growth factor receptor [drugbank_resource:DB02152_1144]
p10529
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1144
p10530
sg14
Vhttp://bio2rdf.org/drugbank:DB02152
p10531
sg16
VK-252a [drugbank:DB02152]
p10532
sa(dp10533
g4
Vunknown
p10534
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06896_1144
p10535
sg8
Vdrug-target interaction 1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide and Hepatocyte growth factor receptor [drugbank_resource:DB06896_1144]
p10536
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1144
p10537
sg14
Vhttp://bio2rdf.org/drugbank:DB06896
p10538
sg16
V1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide [drugbank:DB06896]
p10539
sa(dp10540
g4
Vunknown
p10541
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06995_1144
p10542
sg8
Vdrug-target interaction N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide and Hepatocyte growth factor receptor [drugbank_resource:DB06995_1144]
p10543
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1144
p10544
sg14
Vhttp://bio2rdf.org/drugbank:DB06995
p10545
sg16
VN-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide [drugbank:DB06995]
p10546
sa(dp10547
g4
Vunknown
p10548
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06997_1144
p10549
sg8
Vdrug-target interaction 2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide and Hepatocyte growth factor receptor [drugbank_resource:DB06997_1144]
p10550
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1144
p10551
sg14
Vhttp://bio2rdf.org/drugbank:DB06997
p10552
sg16
V2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide [drugbank:DB06997]
p10553
sa(dp10554
g4
Vunknown
p10555
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07369_1144
p10556
sg8
Vdrug-target interaction N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide and Hepatocyte growth factor receptor [drugbank_resource:DB07369_1144]
p10557
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1144
p10558
sg14
Vhttp://bio2rdf.org/drugbank:DB07369
p10559
sg16
VN-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide [drugbank:DB07369]
p10560
sa(dp10561
g4
Vunknown
p10562
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07969_1144
p10563
sg8
Vdrug-target interaction 3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol and Hepatocyte growth factor receptor [drugbank_resource:DB07969_1144]
p10564
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1144
p10565
sg14
Vhttp://bio2rdf.org/drugbank:DB07969
p10566
sg16
V3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol [drugbank:DB07969]
p10567
sa(dp10568
g4
Vunknown
p10569
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08584_1144
p10570
sg8
Vdrug-target interaction 6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline and Hepatocyte growth factor receptor [drugbank_resource:DB08584_1144]
p10571
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1144
p10572
sg14
Vhttp://bio2rdf.org/drugbank:DB08584
p10573
sg16
V6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline [drugbank:DB08584]
p10574
sa(dp10575
g4
Vunknown
p10576
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08700_1144
p10577
sg8
Vdrug-target interaction 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine and Hepatocyte growth factor receptor [drugbank_resource:DB08700_1144]
p10578
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1144
p10579
sg14
Vhttp://bio2rdf.org/drugbank:DB08700
p10580
sg16
V3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine [drugbank:DB08700]
p10581
sa(dp10582
g4
Vunknown
p10583
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08791_1144
p10584
sg8
Vdrug-target interaction 1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE and Hepatocyte growth factor receptor [drugbank_resource:DB08791_1144]
p10585
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1144
p10586
sg14
Vhttp://bio2rdf.org/drugbank:DB08791
p10587
sg16
V1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE [drugbank:DB08791]
p10588
sasS'CDK2'
p10589
(lp10590
(dp10591
g4
Vunknown
p10592
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01769_2240
p10593
sg8
Vdrug-target interaction Double Oxidized Cysteine and Cell division protein kinase 2 [drugbank_resource:DB01769_2240]
p10594
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10595
sg14
Vhttp://bio2rdf.org/drugbank:DB01769
p10596
sg16
VDouble Oxidized Cysteine [drugbank:DB01769]
p10597
sa(dp10598
g4
Vunknown
p10599
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01888_2240
p10600
sg8
Vdrug-target interaction 4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide and Cell division protein kinase 2 [drugbank_resource:DB01888_2240]
p10601
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10602
sg14
Vhttp://bio2rdf.org/drugbank:DB01888
p10603
sg16
V4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide [drugbank:DB01888]
p10604
sa(dp10605
g4
Vunknown
p10606
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02091_2240
p10607
sg8
Vdrug-target interaction 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine and Cell division protein kinase 2 [drugbank_resource:DB02091_2240]
p10608
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10609
sg14
Vhttp://bio2rdf.org/drugbank:DB02091
p10610
sg16
V4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine [drugbank:DB02091]
p10611
sa(dp10612
g4
Vunknown
p10613
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02116_2240
p10614
sg8
Vdrug-target interaction Olomoucine and Cell division protein kinase 2 [drugbank_resource:DB02116_2240]
p10615
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10616
sg14
Vhttp://bio2rdf.org/drugbank:DB02116
p10617
sg16
VOlomoucine [drugbank:DB02116]
p10618
sa(dp10619
g4
Vunknown
p10620
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02197_2240
p10621
sg8
Vdrug-target interaction 4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide and Cell division protein kinase 2 [drugbank_resource:DB02197_2240]
p10622
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10623
sg14
Vhttp://bio2rdf.org/drugbank:DB02197
p10624
sg16
V4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide [drugbank:DB02197]
p10625
sa(dp10626
g4
Vunknown
p10627
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02010_2240
p10628
sg8
Vdrug-target interaction Staurosporine and Cell division protein kinase 2 [drugbank_resource:DB02010_2240]
p10629
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10630
sg14
Vhttp://bio2rdf.org/drugbank:DB02010
p10631
sg16
VStaurosporine [drugbank:DB02010]
p10632
sa(dp10633
g4
Vunknown
p10634
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02052_2240
p10635
sg8
Vdrug-target interaction Indirubin-3'-Monoxime and Cell division protein kinase 2 [drugbank_resource:DB02052_2240]
p10636
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10637
sg14
Vhttp://bio2rdf.org/drugbank:DB02052
p10638
sg16
VIndirubin-3'-Monoxime [drugbank:DB02052]
p10639
sa(dp10640
g4
Vunknown
p10641
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02538_2240
p10642
sg8
Vdrug-target interaction N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide and Cell division protein kinase 2 [drugbank_resource:DB02538_2240]
p10643
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10644
sg14
Vhttp://bio2rdf.org/drugbank:DB02538
p10645
sg16
VN-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide [drugbank:DB02538]
p10646
sa(dp10647
g4
Vunknown
p10648
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02297_2240
p10649
sg8
Vdrug-target interaction 2-Amino-6-Chloropyrazine and Cell division protein kinase 2 [drugbank_resource:DB02297_2240]
p10650
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10651
sg14
Vhttp://bio2rdf.org/drugbank:DB02297
p10652
sg16
V2-Amino-6-Chloropyrazine [drugbank:DB02297]
p10653
sa(dp10654
g4
Vunknown
p10655
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02407_2240
p10656
sg8
Vdrug-target interaction 6-O-Cyclohexylmethyl Guanine and Cell division protein kinase 2 [drugbank_resource:DB02407_2240]
p10657
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10658
sg14
Vhttp://bio2rdf.org/drugbank:DB02407
p10659
sg16
V6-O-Cyclohexylmethyl Guanine [drugbank:DB02407]
p10660
sa(dp10661
g4
Vunknown
p10662
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02833_2240
p10663
sg8
Vdrug-target interaction [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine and Cell division protein kinase 2 [drugbank_resource:DB02833_2240]
p10664
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10665
sg14
Vhttp://bio2rdf.org/drugbank:DB02833
p10666
sg16
V[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine [drugbank:DB02833]
p10667
sa(dp10668
g4
Vunknown
p10669
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02898_2240
p10670
sg8
Vdrug-target interaction 5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone and Cell division protein kinase 2 [drugbank_resource:DB02898_2240]
p10671
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10672
sg14
Vhttp://bio2rdf.org/drugbank:DB02898
p10673
sg16
V5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone [drugbank:DB02898]
p10674
sa(dp10675
g4
Vunknown
p10676
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02915_2240
p10677
sg8
Vdrug-target interaction 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine and Cell division protein kinase 2 [drugbank_resource:DB02915_2240]
p10678
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10679
sg14
Vhttp://bio2rdf.org/drugbank:DB02915
p10680
sg16
V4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine [drugbank:DB02915]
p10681
sa(dp10682
g4
Vunknown
p10683
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02950_2240
p10684
sg8
Vdrug-target interaction Hymenialdisine and Cell division protein kinase 2 [drugbank_resource:DB02950_2240]
p10685
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10686
sg14
Vhttp://bio2rdf.org/drugbank:DB02950
p10687
sg16
VHymenialdisine [drugbank:DB02950]
p10688
sa(dp10689
g4
Vunknown
p10690
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03019_2240
p10691
sg8
Vdrug-target interaction 4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine and Cell division protein kinase 2 [drugbank_resource:DB03019_2240]
p10692
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10693
sg14
Vhttp://bio2rdf.org/drugbank:DB03019
p10694
sg16
V4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine [drugbank:DB03019]
p10695
sa(dp10696
g4
Vunknown
p10697
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02603_2240
p10698
sg8
Vdrug-target interaction 1-Amino-6-Cyclohex-3-Enylmethyloxypurine and Cell division protein kinase 2 [drugbank_resource:DB02603_2240]
p10699
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10700
sg14
Vhttp://bio2rdf.org/drugbank:DB02603
p10701
sg16
V1-Amino-6-Cyclohex-3-Enylmethyloxypurine [drugbank:DB02603]
p10702
sa(dp10703
g4
Vunknown
p10704
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02647_2240
p10705
sg8
Vdrug-target interaction N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide and Cell division protein kinase 2 [drugbank_resource:DB02647_2240]
p10706
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10707
sg14
Vhttp://bio2rdf.org/drugbank:DB02647
p10708
sg16
VN-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide [drugbank:DB02647]
p10709
sa(dp10710
g4
Vunknown
p10711
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02733_2240
p10712
sg8
Vdrug-target interaction Purvalanol and Cell division protein kinase 2 [drugbank_resource:DB02733_2240]
p10713
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10714
sg14
Vhttp://bio2rdf.org/drugbank:DB02733
p10715
sg16
VPurvalanol [drugbank:DB02733]
p10716
sa(dp10717
g4
Vunknown
p10718
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03307_2240
p10719
sg8
Vdrug-target interaction 4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide and Cell division protein kinase 2 [drugbank_resource:DB03307_2240]
p10720
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10721
sg14
Vhttp://bio2rdf.org/drugbank:DB03307
p10722
sg16
V4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide [drugbank:DB03307]
p10723
sa(dp10724
g4
Vunknown
p10725
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02963_2240
p10726
sg8
Vdrug-target interaction (5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine and Cell division protein kinase 2 [drugbank_resource:DB02963_2240]
p10727
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10728
sg14
Vhttp://bio2rdf.org/drugbank:DB02963
p10729
sg16
V(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine [drugbank:DB02963]
p10730
sa(dp10731
g4
Vunknown
p10732
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02973_2240
p10733
sg8
Vdrug-target interaction 4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide and Cell division protein kinase 2 [drugbank_resource:DB02973_2240]
p10734
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10735
sg14
Vhttp://bio2rdf.org/drugbank:DB02973
p10736
sg16
V4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide [drugbank:DB02973]
p10737
sa(dp10738
g4
Vunknown
p10739
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03428_2240
p10740
sg8
Vdrug-target interaction SU9516 and Cell division protein kinase 2 [drugbank_resource:DB03428_2240]
p10741
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10742
sg14
Vhttp://bio2rdf.org/drugbank:DB03428
p10743
sg16
VSU9516 [drugbank:DB03428]
p10744
sa(dp10745
g4
Vunknown
p10746
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03737_2240
p10747
sg8
Vdrug-target interaction 4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One and Cell division protein kinase 2 [drugbank_resource:DB03737_2240]
p10748
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10749
sg14
Vhttp://bio2rdf.org/drugbank:DB03737
p10750
sg16
V4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One [drugbank:DB03737]
p10751
sa(dp10752
g4
Vunknown
p10753
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03365_2240
p10754
sg8
Vdrug-target interaction 4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline and Cell division protein kinase 2 [drugbank_resource:DB03365_2240]
p10755
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10756
sg14
Vhttp://bio2rdf.org/drugbank:DB03365
p10757
sg16
V4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline [drugbank:DB03365]
p10758
sa(dp10759
g4
Vunknown
p10760
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03496_2240
p10761
sg8
Vdrug-target interaction Flavopiridol and Cell division protein kinase 2 [drugbank_resource:DB03496_2240]
p10762
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10763
sg14
Vhttp://bio2rdf.org/drugbank:DB03496
p10764
sg16
VFlavopiridol [drugbank:DB03496]
p10765
sa(dp10766
g4
Vunknown
p10767
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03583_2240
p10768
sg8
Vdrug-target interaction (2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One and Cell division protein kinase 2 [drugbank_resource:DB03583_2240]
p10769
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10770
sg14
Vhttp://bio2rdf.org/drugbank:DB03583
p10771
sg16
V(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One [drugbank:DB03583]
p10772
sa(dp10773
g4
Vunknown
p10774
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03801_2240
p10775
sg8
Vdrug-target interaction Lysine Nz-Carboxylic Acid and Cell division protein kinase 2 [drugbank_resource:DB03801_2240]
p10776
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10777
sg14
Vhttp://bio2rdf.org/drugbank:DB03801
p10778
sg16
VLysine Nz-Carboxylic Acid [drugbank:DB03801]
p10779
sa(dp10780
g4
Vunknown
p10781
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04006_2240
p10782
sg8
Vdrug-target interaction [2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone and Cell division protein kinase 2 [drugbank_resource:DB04006_2240]
p10783
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10784
sg14
Vhttp://bio2rdf.org/drugbank:DB04006
p10785
sg16
V[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone [drugbank:DB04006]
p10786
sa(dp10787
g4
Vunknown
p10788
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03490_2240
p10789
sg8
Vdrug-target interaction 3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole and Cell division protein kinase 2 [drugbank_resource:DB03490_2240]
p10790
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10791
sg14
Vhttp://bio2rdf.org/drugbank:DB03490
p10792
sg16
V3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole [drugbank:DB03490]
p10793
sa(dp10794
g4
Vunknown
p10795
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03663_2240
p10796
sg8
Vdrug-target interaction 1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol and Cell division protein kinase 2 [drugbank_resource:DB03663_2240]
p10797
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10798
sg14
Vhttp://bio2rdf.org/drugbank:DB03663
p10799
sg16
V1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol [drugbank:DB03663]
p10800
sa(dp10801
g4
Vunknown
p10802
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04186_2240
p10803
sg8
Vdrug-target interaction N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea and Cell division protein kinase 2 [drugbank_resource:DB04186_2240]
p10804
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10805
sg14
Vhttp://bio2rdf.org/drugbank:DB04186
p10806
sg16
VN'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea [drugbank:DB04186]
p10807
sa(dp10808
g4
Vunknown
p10809
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04288_2240
p10810
sg8
Vdrug-target interaction 2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine and Cell division protein kinase 2 [drugbank_resource:DB04288_2240]
p10811
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10812
sg14
Vhttp://bio2rdf.org/drugbank:DB04288
p10813
sg16
V2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine [drugbank:DB04288]
p10814
sa(dp10815
g4
Vunknown
p10816
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04407_2240
p10817
sg8
Vdrug-target interaction 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol and Cell division protein kinase 2 [drugbank_resource:DB04407_2240]
p10818
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10819
sg14
Vhttp://bio2rdf.org/drugbank:DB04407
p10820
sg16
V4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol [drugbank:DB04407]
p10821
sa(dp10822
g4
Vunknown
p10823
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04101_2240
p10824
sg8
Vdrug-target interaction N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide and Cell division protein kinase 2 [drugbank_resource:DB04101_2240]
p10825
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10826
sg14
Vhttp://bio2rdf.org/drugbank:DB04101
p10827
sg16
VN-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide [drugbank:DB04101]
p10828
sa(dp10829
g4
Vunknown
p10830
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04662_2240
p10831
sg8
Vdrug-target interaction OLOMOUCINE II and Cell division protein kinase 2 [drugbank_resource:DB04662_2240]
p10832
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10833
sg14
Vhttp://bio2rdf.org/drugbank:DB04662
p10834
sg16
VOLOMOUCINE II [drugbank:DB04662]
p10835
sa(dp10836
g4
Vunknown
p10837
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04669_2240
p10838
sg8
Vdrug-target interaction TRIAZOLOPYRIMIDINE and Cell division protein kinase 2 [drugbank_resource:DB04669_2240]
p10839
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10840
sg14
Vhttp://bio2rdf.org/drugbank:DB04669
p10841
sg16
VTRIAZOLOPYRIMIDINE [drugbank:DB04669]
p10842
sa(dp10843
g4
Vunknown
p10844
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06844_2240
p10845
sg8
Vdrug-target interaction 4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB06844_2240]
p10846
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10847
sg14
Vhttp://bio2rdf.org/drugbank:DB06844
p10848
sg16
V4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE [drugbank:DB06844]
p10849
sa(dp10850
g4
Vunknown
p10851
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06976_2240
p10852
sg8
Vdrug-target interaction 1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA and Cell division protein kinase 2 [drugbank_resource:DB06976_2240]
p10853
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10854
sg14
Vhttp://bio2rdf.org/drugbank:DB06976
p10855
sg16
V1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA [drugbank:DB06976]
p10856
sa(dp10857
g4
Vunknown
p10858
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06983_2240
p10859
sg8
Vdrug-target interaction (5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol and Cell division protein kinase 2 [drugbank_resource:DB06983_2240]
p10860
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10861
sg14
Vhttp://bio2rdf.org/drugbank:DB06983
p10862
sg16
V(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol [drugbank:DB06983]
p10863
sa(dp10864
g4
Vunknown
p10865
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07065_2240
p10866
sg8
Vdrug-target interaction 5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB07065_2240]
p10867
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10868
sg14
Vhttp://bio2rdf.org/drugbank:DB07065
p10869
sg16
V5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB07065]
p10870
sa(dp10871
g4
Vunknown
p10872
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07203_2240
p10873
sg8
Vdrug-target interaction 6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE and Cell division protein kinase 2 [drugbank_resource:DB07203_2240]
p10874
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10875
sg14
Vhttp://bio2rdf.org/drugbank:DB07203
p10876
sg16
V6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE [drugbank:DB07203]
p10877
sa(dp10878
g4
Vunknown
p10879
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04518_2240
p10880
sg8
Vdrug-target interaction 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol and Cell division protein kinase 2 [drugbank_resource:DB04518_2240]
p10881
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10882
sg14
Vhttp://bio2rdf.org/drugbank:DB04518
p10883
sg16
V3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol [drugbank:DB04518]
p10884
sa(dp10885
g4
Vunknown
p10886
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04607_2240
p10887
sg8
Vdrug-target interaction PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE and Cell division protein kinase 2 [drugbank_resource:DB04607_2240]
p10888
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10889
sg14
Vhttp://bio2rdf.org/drugbank:DB04607
p10890
sg16
VPHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE [drugbank:DB04607]
p10891
sa(dp10892
g4
Vunknown
p10893
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06888_2240
p10894
sg8
Vdrug-target interaction (13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE and Cell division protein kinase 2 [drugbank_resource:DB06888_2240]
p10895
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10896
sg14
Vhttp://bio2rdf.org/drugbank:DB06888
p10897
sg16
V(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE [drugbank:DB06888]
p10898
sa(dp10899
g4
Vunknown
p10900
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07024_2240
p10901
sg8
Vdrug-target interaction 2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE and Cell division protein kinase 2 [drugbank_resource:DB07024_2240]
p10902
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10903
sg14
Vhttp://bio2rdf.org/drugbank:DB07024
p10904
sg16
V2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE [drugbank:DB07024]
p10905
sa(dp10906
g4
Vunknown
p10907
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07054_2240
p10908
sg8
Vdrug-target interaction (2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07054_2240]
p10909
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10910
sg14
Vhttp://bio2rdf.org/drugbank:DB07054
p10911
sg16
V(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL [drugbank:DB07054]
p10912
sa(dp10913
g4
Vunknown
p10914
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07137_2240
p10915
sg8
Vdrug-target interaction (2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07137_2240]
p10916
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10917
sg14
Vhttp://bio2rdf.org/drugbank:DB07137
p10918
sg16
V(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE [drugbank:DB07137]
p10919
sa(dp10920
g4
Vunknown
p10921
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07163_2240
p10922
sg8
Vdrug-target interaction 5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE and Cell division protein kinase 2 [drugbank_resource:DB07163_2240]
p10923
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10924
sg14
Vhttp://bio2rdf.org/drugbank:DB07163
p10925
sg16
V5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE [drugbank:DB07163]
p10926
sa(dp10927
g4
Vunknown
p10928
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07164_2240
p10929
sg8
Vdrug-target interaction N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine and Cell division protein kinase 2 [drugbank_resource:DB07164_2240]
p10930
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10931
sg14
Vhttp://bio2rdf.org/drugbank:DB07164
p10932
sg16
VN-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine [drugbank:DB07164]
p10933
sa(dp10934
g4
Vunknown
p10935
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07179_2240
p10936
sg8
Vdrug-target interaction 3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide and Cell division protein kinase 2 [drugbank_resource:DB07179_2240]
p10937
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10938
sg14
Vhttp://bio2rdf.org/drugbank:DB07179
p10939
sg16
V3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide [drugbank:DB07179]
p10940
sa(dp10941
g4
Vunknown
p10942
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07210_2240
p10943
sg8
Vdrug-target interaction 3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB07210_2240]
p10944
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10945
sg14
Vhttp://bio2rdf.org/drugbank:DB07210
p10946
sg16
V3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB07210]
p10947
sa(dp10948
g4
Vunknown
p10949
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07220_2240
p10950
sg8
Vdrug-target interaction N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07220_2240]
p10951
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10952
sg14
Vhttp://bio2rdf.org/drugbank:DB07220
p10953
sg16
VN-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE [drugbank:DB07220]
p10954
sa(dp10955
g4
Vunknown
p10956
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07431_2240
p10957
sg8
Vdrug-target interaction (3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one and Cell division protein kinase 2 [drugbank_resource:DB07431_2240]
p10958
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10959
sg14
Vhttp://bio2rdf.org/drugbank:DB07431
p10960
sg16
V(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one [drugbank:DB07431]
p10961
sa(dp10962
g4
Vunknown
p10963
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06944_2240
p10964
sg8
Vdrug-target interaction N-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE and Cell division protein kinase 2 [drugbank_resource:DB06944_2240]
p10965
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10966
sg14
Vhttp://bio2rdf.org/drugbank:DB06944
p10967
sg16
VN-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE [drugbank:DB06944]
p10968
sa(dp10969
g4
Vunknown
p10970
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06948_2240
p10971
sg8
Vdrug-target interaction 2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE and Cell division protein kinase 2 [drugbank_resource:DB06948_2240]
p10972
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10973
sg14
Vhttp://bio2rdf.org/drugbank:DB06948
p10974
sg16
V2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE [drugbank:DB06948]
p10975
sa(dp10976
g4
Vunknown
p10977
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07126_2240
p10978
sg8
Vdrug-target interaction O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE and Cell division protein kinase 2 [drugbank_resource:DB07126_2240]
p10979
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10980
sg14
Vhttp://bio2rdf.org/drugbank:DB07126
p10981
sg16
VO6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE [drugbank:DB07126]
p10982
sa(dp10983
g4
Vunknown
p10984
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07493_2240
p10985
sg8
Vdrug-target interaction (2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE and Cell division protein kinase 2 [drugbank_resource:DB07493_2240]
p10986
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10987
sg14
Vhttp://bio2rdf.org/drugbank:DB07493
p10988
sg16
V(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE [drugbank:DB07493]
p10989
sa(dp10990
g4
Vunknown
p10991
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07504_2240
p10992
sg8
Vdrug-target interaction (2R)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07504_2240]
p10993
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p10994
sg14
Vhttp://bio2rdf.org/drugbank:DB07504
p10995
sg16
V(2R)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07504]
p10996
sa(dp10997
g4
Vunknown
p10998
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07529_2240
p10999
sg8
Vdrug-target interaction 2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE and Cell division protein kinase 2 [drugbank_resource:DB07529_2240]
p11000
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11001
sg14
Vhttp://bio2rdf.org/drugbank:DB07529
p11002
sg16
V2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE [drugbank:DB07529]
p11003
sa(dp11004
g4
Vunknown
p11005
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07471_2240
p11006
sg8
Vdrug-target interaction 5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07471_2240]
p11007
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11008
sg14
Vhttp://bio2rdf.org/drugbank:DB07471
p11009
sg16
V5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE [drugbank:DB07471]
p11010
sa(dp11011
g4
Vunknown
p11012
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07501_2240
p11013
sg8
Vdrug-target interaction (2S)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07501_2240]
p11014
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11015
sg14
Vhttp://bio2rdf.org/drugbank:DB07501
p11016
sg16
V(2S)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07501]
p11017
sa(dp11018
g4
Vunknown
p11019
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07531_2240
p11020
sg8
Vdrug-target interaction 4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07531_2240]
p11021
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11022
sg14
Vhttp://bio2rdf.org/drugbank:DB07531
p11023
sg16
V4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE [drugbank:DB07531]
p11024
sa(dp11025
g4
Vunknown
p11026
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07538_2240
p11027
sg8
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07538_2240]
p11028
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11029
sg14
Vhttp://bio2rdf.org/drugbank:DB07538
p11030
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE [drugbank:DB07538]
p11031
sa(dp11032
g4
Vunknown
p11033
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07540_2240
p11034
sg8
Vdrug-target interaction 4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07540_2240]
p11035
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11036
sg14
Vhttp://bio2rdf.org/drugbank:DB07540
p11037
sg16
V4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE [drugbank:DB07540]
p11038
sa(dp11039
g4
Vunknown
p11040
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07562_2240
p11041
sg8
Vdrug-target interaction N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE and Cell division protein kinase 2 [drugbank_resource:DB07562_2240]
p11042
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11043
sg14
Vhttp://bio2rdf.org/drugbank:DB07562
p11044
sg16
VN-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE [drugbank:DB07562]
p11045
sa(dp11046
g4
Vunknown
p11047
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07612_2240
p11048
sg8
Vdrug-target interaction 6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE and Cell division protein kinase 2 [drugbank_resource:DB07612_2240]
p11049
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11050
sg14
Vhttp://bio2rdf.org/drugbank:DB07612
p11051
sg16
V6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE [drugbank:DB07612]
p11052
sa(dp11053
g4
Vunknown
p11054
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07618_2240
p11055
sg8
Vdrug-target interaction 2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07618_2240]
p11056
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11057
sg14
Vhttp://bio2rdf.org/drugbank:DB07618
p11058
sg16
V2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE [drugbank:DB07618]
p11059
sa(dp11060
g4
Vunknown
p11061
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07685_2240
p11062
sg8
Vdrug-target interaction 4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07685_2240]
p11063
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11064
sg14
Vhttp://bio2rdf.org/drugbank:DB07685
p11065
sg16
V4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE [drugbank:DB07685]
p11066
sa(dp11067
g4
Vunknown
p11068
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07687_2240
p11069
sg8
Vdrug-target interaction 4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07687_2240]
p11070
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11071
sg14
Vhttp://bio2rdf.org/drugbank:DB07687
p11072
sg16
V4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE [drugbank:DB07687]
p11073
sa(dp11074
g4
Vunknown
p11075
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07688_2240
p11076
sg8
Vdrug-target interaction 4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07688_2240]
p11077
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11078
sg14
Vhttp://bio2rdf.org/drugbank:DB07688
p11079
sg16
V4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE [drugbank:DB07688]
p11080
sa(dp11081
g4
Vunknown
p11082
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07750_2240
p11083
sg8
Vdrug-target interaction (2R)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07750_2240]
p11084
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11085
sg14
Vhttp://bio2rdf.org/drugbank:DB07750
p11086
sg16
V(2R)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07750]
p11087
sa(dp11088
g4
Vunknown
p11089
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07755_2240
p11090
sg8
Vdrug-target interaction (2S)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07755_2240]
p11091
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11092
sg14
Vhttp://bio2rdf.org/drugbank:DB07755
p11093
sg16
V(2S)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07755]
p11094
sa(dp11095
g4
Vunknown
p11096
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07761_2240
p11097
sg8
Vdrug-target interaction (2R)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07761_2240]
p11098
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11099
sg14
Vhttp://bio2rdf.org/drugbank:DB07761
p11100
sg16
V(2R)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07761]
p11101
sa(dp11102
g4
Vunknown
p11103
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07790_2240
p11104
sg8
Vdrug-target interaction N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07790_2240]
p11105
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11106
sg14
Vhttp://bio2rdf.org/drugbank:DB07790
p11107
sg16
VN-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE [drugbank:DB07790]
p11108
sa(dp11109
g4
Vunknown
p11110
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08132_2240
p11111
sg8
Vdrug-target interaction 5-hydroxynaphthalene-1-sulfonamide and Cell division protein kinase 2 [drugbank_resource:DB08132_2240]
p11112
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11113
sg14
Vhttp://bio2rdf.org/drugbank:DB08132
p11114
sg16
V5-hydroxynaphthalene-1-sulfonamide [drugbank:DB08132]
p11115
sa(dp11116
g4
Vunknown
p11117
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08133_2240
p11118
sg8
Vdrug-target interaction N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08133_2240]
p11119
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11120
sg14
Vhttp://bio2rdf.org/drugbank:DB08133
p11121
sg16
VN-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide [drugbank:DB08133]
p11122
sa(dp11123
g4
Vunknown
p11124
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08139_2240
p11125
sg8
Vdrug-target interaction 5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile and Cell division protein kinase 2 [drugbank_resource:DB08139_2240]
p11126
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11127
sg14
Vhttp://bio2rdf.org/drugbank:DB08139
p11128
sg16
V5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile [drugbank:DB08139]
p11129
sa(dp11130
g4
Vunknown
p11131
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08141_2240
p11132
sg8
Vdrug-target interaction 4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08141_2240]
p11133
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11134
sg14
Vhttp://bio2rdf.org/drugbank:DB08141
p11135
sg16
V4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide [drugbank:DB08141]
p11136
sa(dp11137
g4
Vunknown
p11138
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08247_2240
p11139
sg8
Vdrug-target interaction 6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE and Cell division protein kinase 2 [drugbank_resource:DB08247_2240]
p11140
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11141
sg14
Vhttp://bio2rdf.org/drugbank:DB08247
p11142
sg16
V6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE [drugbank:DB08247]
p11143
sa(dp11144
g4
Vunknown
p11145
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08248_2240
p11146
sg8
Vdrug-target interaction 3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08248_2240]
p11147
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11148
sg14
Vhttp://bio2rdf.org/drugbank:DB08248
p11149
sg16
V3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE [drugbank:DB08248]
p11150
sa(dp11151
g4
Vunknown
p11152
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08312_2240
p11153
sg8
Vdrug-target interaction 6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE and Cell division protein kinase 2 [drugbank_resource:DB08312_2240]
p11154
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11155
sg14
Vhttp://bio2rdf.org/drugbank:DB08312
p11156
sg16
V6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE [drugbank:DB08312]
p11157
sa(dp11158
g4
Vunknown
p11159
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08355_2240
p11160
sg8
Vdrug-target interaction 1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid and Cell division protein kinase 2 [drugbank_resource:DB08355_2240]
p11161
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11162
sg14
Vhttp://bio2rdf.org/drugbank:DB08355
p11163
sg16
V1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid [drugbank:DB08355]
p11164
sa(dp11165
g4
Vunknown
p11166
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08533_2240
p11167
sg8
Vdrug-target interaction 3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine and Cell division protein kinase 2 [drugbank_resource:DB08533_2240]
p11168
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11169
sg14
Vhttp://bio2rdf.org/drugbank:DB08533
p11170
sg16
V3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine [drugbank:DB08533]
p11171
sa(dp11172
g4
Vunknown
p11173
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08534_2240
p11174
sg8
Vdrug-target interaction 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08534_2240]
p11175
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11176
sg14
Vhttp://bio2rdf.org/drugbank:DB08534
p11177
sg16
V5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB08534]
p11178
sa(dp11179
g4
Vunknown
p11180
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08539_2240
p11181
sg8
Vdrug-target interaction 3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08539_2240]
p11182
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11183
sg14
Vhttp://bio2rdf.org/drugbank:DB08539
p11184
sg16
V3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB08539]
p11185
sa(dp11186
g4
Vunknown
p11187
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08572_2240
p11188
sg8
Vdrug-target interaction 4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08572_2240]
p11189
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11190
sg14
Vhttp://bio2rdf.org/drugbank:DB08572
p11191
sg16
V4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE [drugbank:DB08572]
p11192
sa(dp11193
g4
Vunknown
p11194
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08673_2240
p11195
sg8
Vdrug-target interaction 4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08673_2240]
p11196
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11197
sg14
Vhttp://bio2rdf.org/drugbank:DB08673
p11198
sg16
V4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE [drugbank:DB08673]
p11199
sa(dp11200
g4
Vunknown
p11201
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08677_2240
p11202
sg8
Vdrug-target interaction N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08677_2240]
p11203
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11204
sg14
Vhttp://bio2rdf.org/drugbank:DB08677
p11205
sg16
VN-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE [drugbank:DB08677]
p11206
sa(dp11207
g4
Vunknown
p11208
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08694_2240
p11209
sg8
Vdrug-target interaction 9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol and Cell division protein kinase 2 [drugbank_resource:DB08694_2240]
p11210
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11211
sg14
Vhttp://bio2rdf.org/drugbank:DB08694
p11212
sg16
V9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol [drugbank:DB08694]
p11213
sa(dp11214
g4
Vunknown
p11215
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07533_2240
p11216
sg8
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07533_2240]
p11217
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11218
sg14
Vhttp://bio2rdf.org/drugbank:DB07533
p11219
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE [drugbank:DB07533]
p11220
sa(dp11221
g4
Vunknown
p11222
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07534_2240
p11223
sg8
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07534_2240]
p11224
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11225
sg14
Vhttp://bio2rdf.org/drugbank:DB07534
p11226
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE [drugbank:DB07534]
p11227
sa(dp11228
g4
Vunknown
p11229
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07539_2240
p11230
sg8
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID and Cell division protein kinase 2 [drugbank_resource:DB07539_2240]
p11231
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11232
sg14
Vhttp://bio2rdf.org/drugbank:DB07539
p11233
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID [drugbank:DB07539]
p11234
sa(dp11235
g4
Vunknown
p11236
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07606_2240
p11237
sg8
Vdrug-target interaction 6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE and Cell division protein kinase 2 [drugbank_resource:DB07606_2240]
p11238
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11239
sg14
Vhttp://bio2rdf.org/drugbank:DB07606
p11240
sg16
V6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE [drugbank:DB07606]
p11241
sa(dp11242
g4
Vunknown
p11243
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07622_2240
p11244
sg8
Vdrug-target interaction 1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA and Cell division protein kinase 2 [drugbank_resource:DB07622_2240]
p11245
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11246
sg14
Vhttp://bio2rdf.org/drugbank:DB07622
p11247
sg16
V1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA [drugbank:DB07622]
p11248
sa(dp11249
g4
Vunknown
p11250
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07751_2240
p11251
sg8
Vdrug-target interaction (2S)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07751_2240]
p11252
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11253
sg14
Vhttp://bio2rdf.org/drugbank:DB07751
p11254
sg16
V(2S)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL [drugbank:DB07751]
p11255
sa(dp11256
g4
Vunknown
p11257
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07791_2240
p11258
sg8
Vdrug-target interaction 4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07791_2240]
p11259
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11260
sg14
Vhttp://bio2rdf.org/drugbank:DB07791
p11261
sg16
V4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE [drugbank:DB07791]
p11262
sa(dp11263
g4
Vunknown
p11264
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07852_2240
p11265
sg8
Vdrug-target interaction 1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID and Cell division protein kinase 2 [drugbank_resource:DB07852_2240]
p11266
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11267
sg14
Vhttp://bio2rdf.org/drugbank:DB07852
p11268
sg16
V1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID [drugbank:DB07852]
p11269
sa(dp11270
g4
Vunknown
p11271
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07982_2240
p11272
sg8
Vdrug-target interaction 2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol and Cell division protein kinase 2 [drugbank_resource:DB07982_2240]
p11273
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11274
sg14
Vhttp://bio2rdf.org/drugbank:DB07982
p11275
sg16
V2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol [drugbank:DB07982]
p11276
sa(dp11277
g4
Vunknown
p11278
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08094_2240
p11279
sg8
Vdrug-target interaction (4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE and Cell division protein kinase 2 [drugbank_resource:DB08094_2240]
p11280
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11281
sg14
Vhttp://bio2rdf.org/drugbank:DB08094
p11282
sg16
V(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE [drugbank:DB08094]
p11283
sa(dp11284
g4
Vunknown
p11285
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08122_2240
p11286
sg8
Vdrug-target interaction N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08122_2240]
p11287
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11288
sg14
Vhttp://bio2rdf.org/drugbank:DB08122
p11289
sg16
VN-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE [drugbank:DB08122]
p11290
sa(dp11291
g4
Vunknown
p11292
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08123_2240
p11293
sg8
Vdrug-target interaction N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08123_2240]
p11294
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11295
sg14
Vhttp://bio2rdf.org/drugbank:DB08123
p11296
sg16
VN-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE [drugbank:DB08123]
p11297
sa(dp11298
g4
Vunknown
p11299
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08125_2240
p11300
sg8
Vdrug-target interaction 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08125_2240]
p11301
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11302
sg14
Vhttp://bio2rdf.org/drugbank:DB08125
p11303
sg16
V4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE [drugbank:DB08125]
p11304
sa(dp11305
g4
Vunknown
p11306
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08126_2240
p11307
sg8
Vdrug-target interaction 3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE and Cell division protein kinase 2 [drugbank_resource:DB08126_2240]
p11308
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11309
sg14
Vhttp://bio2rdf.org/drugbank:DB08126
p11310
sg16
V3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE [drugbank:DB08126]
p11311
sa(dp11312
g4
Vunknown
p11313
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08134_2240
p11314
sg8
Vdrug-target interaction 4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide and Cell division protein kinase 2 [drugbank_resource:DB08134_2240]
p11315
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11316
sg14
Vhttp://bio2rdf.org/drugbank:DB08134
p11317
sg16
V4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide [drugbank:DB08134]
p11318
sa(dp11319
g4
Vunknown
p11320
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08135_2240
p11321
sg8
Vdrug-target interaction N-phenyl-1H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08135_2240]
p11322
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11323
sg14
Vhttp://bio2rdf.org/drugbank:DB08135
p11324
sg16
VN-phenyl-1H-pyrazole-3-carboxamide [drugbank:DB08135]
p11325
sa(dp11326
g4
Vunknown
p11327
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08137_2240
p11328
sg8
Vdrug-target interaction (4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08137_2240]
p11329
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11330
sg14
Vhttp://bio2rdf.org/drugbank:DB08137
p11331
sg16
V(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide [drugbank:DB08137]
p11332
sa(dp11333
g4
Vunknown
p11334
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08178_2240
p11335
sg8
Vdrug-target interaction 4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine and Cell division protein kinase 2 [drugbank_resource:DB08178_2240]
p11336
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11337
sg14
Vhttp://bio2rdf.org/drugbank:DB08178
p11338
sg16
V4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine [drugbank:DB08178]
p11339
sa(dp11340
g4
Vunknown
p11341
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08309_2240
p11342
sg8
Vdrug-target interaction 3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL and Cell division protein kinase 2 [drugbank_resource:DB08309_2240]
p11343
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11344
sg14
Vhttp://bio2rdf.org/drugbank:DB08309
p11345
sg16
V3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL [drugbank:DB08309]
p11346
sa(dp11347
g4
Vunknown
p11348
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08441_2240
p11349
sg8
Vdrug-target interaction 6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE and Cell division protein kinase 2 [drugbank_resource:DB08441_2240]
p11350
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11351
sg14
Vhttp://bio2rdf.org/drugbank:DB08441
p11352
sg16
V6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE [drugbank:DB08441]
p11353
sa(dp11354
g4
Vunknown
p11355
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08532_2240
p11356
sg8
Vdrug-target interaction 6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine and Cell division protein kinase 2 [drugbank_resource:DB08532_2240]
p11357
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11358
sg14
Vhttp://bio2rdf.org/drugbank:DB08532
p11359
sg16
V6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine [drugbank:DB08532]
p11360
sa(dp11361
g4
Vunknown
p11362
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08536_2240
p11363
sg8
Vdrug-target interaction 3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08536_2240]
p11364
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11365
sg14
Vhttp://bio2rdf.org/drugbank:DB08536
p11366
sg16
V3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine [drugbank:DB08536]
p11367
sa(dp11368
g4
Vunknown
p11369
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08537_2240
p11370
sg8
Vdrug-target interaction 3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine and Cell division protein kinase 2 [drugbank_resource:DB08537_2240]
p11371
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11372
sg14
Vhttp://bio2rdf.org/drugbank:DB08537
p11373
sg16
V3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine [drugbank:DB08537]
p11374
sa(dp11375
g4
Vunknown
p11376
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08768_2240
p11377
sg8
Vdrug-target interaction N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE and Cell division protein kinase 2 [drugbank_resource:DB08768_2240]
p11378
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11379
sg14
Vhttp://bio2rdf.org/drugbank:DB08768
p11380
sg16
VN-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE [drugbank:DB08768]
p11381
sa(dp11382
g4
Vunknown
p11383
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07595_2240
p11384
sg8
Vdrug-target interaction (5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE and Cell division protein kinase 2 [drugbank_resource:DB07595_2240]
p11385
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11386
sg14
Vhttp://bio2rdf.org/drugbank:DB07595
p11387
sg16
V(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE [drugbank:DB07595]
p11388
sa(dp11389
g4
Vunknown
p11390
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07686_2240
p11391
sg8
Vdrug-target interaction 4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE and Cell division protein kinase 2 [drugbank_resource:DB07686_2240]
p11392
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11393
sg14
Vhttp://bio2rdf.org/drugbank:DB07686
p11394
sg16
V4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE [drugbank:DB07686]
p11395
sa(dp11396
g4
Vunknown
p11397
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07731_2240
p11398
sg8
Vdrug-target interaction 4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL and Cell division protein kinase 2 [drugbank_resource:DB07731_2240]
p11399
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11400
sg14
Vhttp://bio2rdf.org/drugbank:DB07731
p11401
sg16
V4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL [drugbank:DB07731]
p11402
sa(dp11403
g4
Vunknown
p11404
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07889_2240
p11405
sg8
Vdrug-target interaction 1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}PHENOXY)PROPAN-2-OL and Cell division protein kinase 2 [drugbank_resource:DB07889_2240]
p11406
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11407
sg14
Vhttp://bio2rdf.org/drugbank:DB07889
p11408
sg16
V1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}PHENOXY)PROPAN-2-OL [drugbank:DB07889]
p11409
sa(dp11410
g4
Vunknown
p11411
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07936_2240
p11412
sg8
Vdrug-target interaction N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine and Cell division protein kinase 2 [drugbank_resource:DB07936_2240]
p11413
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11414
sg14
Vhttp://bio2rdf.org/drugbank:DB07936
p11415
sg16
VN-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine [drugbank:DB07936]
p11416
sa(dp11417
g4
Vunknown
p11418
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08066_2240
p11419
sg8
Vdrug-target interaction N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08066_2240]
p11420
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11421
sg14
Vhttp://bio2rdf.org/drugbank:DB08066
p11422
sg16
VN-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE [drugbank:DB08066]
p11423
sa(dp11424
g4
Vunknown
p11425
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08124_2240
p11426
sg8
Vdrug-target interaction 3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE and Cell division protein kinase 2 [drugbank_resource:DB08124_2240]
p11427
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11428
sg14
Vhttp://bio2rdf.org/drugbank:DB08124
p11429
sg16
V3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE [drugbank:DB08124]
p11430
sa(dp11431
g4
Vunknown
p11432
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08136_2240
p11433
sg8
Vdrug-target interaction 4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08136_2240]
p11434
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11435
sg14
Vhttp://bio2rdf.org/drugbank:DB08136
p11436
sg16
V4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide [drugbank:DB08136]
p11437
sa(dp11438
g4
Vunknown
p11439
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08138_2240
p11440
sg8
Vdrug-target interaction {[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08138_2240]
p11441
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11442
sg14
Vhttp://bio2rdf.org/drugbank:DB08138
p11443
sg16
V{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide [drugbank:DB08138]
p11444
sa(dp11445
g4
Vunknown
p11446
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08140_2240
p11447
sg8
Vdrug-target interaction 5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE and Cell division protein kinase 2 [drugbank_resource:DB08140_2240]
p11448
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11449
sg14
Vhttp://bio2rdf.org/drugbank:DB08140
p11450
sg16
V5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE [drugbank:DB08140]
p11451
sa(dp11452
g4
Vunknown
p11453
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08142_2240
p11454
sg8
Vdrug-target interaction 4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide and Cell division protein kinase 2 [drugbank_resource:DB08142_2240]
p11455
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11456
sg14
Vhttp://bio2rdf.org/drugbank:DB08142
p11457
sg16
V4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide [drugbank:DB08142]
p11458
sa(dp11459
g4
Vunknown
p11460
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08182_2240
p11461
sg8
Vdrug-target interaction 4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine and Cell division protein kinase 2 [drugbank_resource:DB08182_2240]
p11462
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11463
sg14
Vhttp://bio2rdf.org/drugbank:DB08182
p11464
sg16
V4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine [drugbank:DB08182]
p11465
sa(dp11466
g4
Vunknown
p11467
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08218_2240
p11468
sg8
Vdrug-target interaction HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM and Cell division protein kinase 2 [drugbank_resource:DB08218_2240]
p11469
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11470
sg14
Vhttp://bio2rdf.org/drugbank:DB08218
p11471
sg16
VHYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM [drugbank:DB08218]
p11472
sa(dp11473
g4
Vunknown
p11474
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08219_2240
p11475
sg8
Vdrug-target interaction 4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE and Cell division protein kinase 2 [drugbank_resource:DB08219_2240]
p11476
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11477
sg14
Vhttp://bio2rdf.org/drugbank:DB08219
p11478
sg16
V4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE [drugbank:DB08219]
p11479
sa(dp11480
g4
Vunknown
p11481
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08233_2240
p11482
sg8
Vdrug-target interaction 6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE and Cell division protein kinase 2 [drugbank_resource:DB08233_2240]
p11483
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11484
sg14
Vhttp://bio2rdf.org/drugbank:DB08233
p11485
sg16
V6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE [drugbank:DB08233]
p11486
sa(dp11487
g4
Vunknown
p11488
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08241_2240
p11489
sg8
Vdrug-target interaction 4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08241_2240]
p11490
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11491
sg14
Vhttp://bio2rdf.org/drugbank:DB08241
p11492
sg16
V4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE [drugbank:DB08241]
p11493
sa(dp11494
g4
Vunknown
p11495
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08285_2240
p11496
sg8
Vdrug-target interaction (2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol and Cell division protein kinase 2 [drugbank_resource:DB08285_2240]
p11497
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11498
sg14
Vhttp://bio2rdf.org/drugbank:DB08285
p11499
sg16
V(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol [drugbank:DB08285]
p11500
sa(dp11501
g4
Vunknown
p11502
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08463_2240
p11503
sg8
Vdrug-target interaction (2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol and Cell division protein kinase 2 [drugbank_resource:DB08463_2240]
p11504
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11505
sg14
Vhttp://bio2rdf.org/drugbank:DB08463
p11506
sg16
V(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol [drugbank:DB08463]
p11507
sa(dp11508
g4
Vunknown
p11509
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08527_2240
p11510
sg8
Vdrug-target interaction 1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE and Cell division protein kinase 2 [drugbank_resource:DB08527_2240]
p11511
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11512
sg14
Vhttp://bio2rdf.org/drugbank:DB08527
p11513
sg16
V1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE [drugbank:DB08527]
p11514
sa(dp11515
g4
Vunknown
p11516
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08531_2240
p11517
sg8
Vdrug-target interaction 5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08531_2240]
p11518
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11519
sg14
Vhttp://bio2rdf.org/drugbank:DB08531
p11520
sg16
V5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB08531]
p11521
sa(dp11522
g4
Vunknown
p11523
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08535_2240
p11524
sg8
Vdrug-target interaction 3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08535_2240]
p11525
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11526
sg14
Vhttp://bio2rdf.org/drugbank:DB08535
p11527
sg16
V3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB08535]
p11528
sa(dp11529
g4
Vunknown
p11530
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08538_2240
p11531
sg8
Vdrug-target interaction N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine and Cell division protein kinase 2 [drugbank_resource:DB08538_2240]
p11532
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2240
p11533
sg14
Vhttp://bio2rdf.org/drugbank:DB08538
p11534
sg16
VN-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine [drugbank:DB08538]
p11535
sasS'SSTR2'
p11536
(lp11537
(dp11538
g4
Vyes
p11539
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00104_6008
p11540
sg8
Vdrug-target interaction Octreotide and Somatostatin receptor type 2 [drugbank_resource:DB00104_6008]
p11541
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6008
p11542
sg14
Vhttp://bio2rdf.org/drugbank:DB00104
p11543
sg16
VOctreotide [drugbank:DB00104]
p11544
sa(dp11545
g4
Vyes
p11546
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04894_6008
p11547
sg8
Vdrug-target interaction Vapreotide and Somatostatin receptor type 2 [drugbank_resource:DB04894_6008]
p11548
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6008
p11549
sg14
Vhttp://bio2rdf.org/drugbank:DB04894
p11550
sg16
VVapreotide [drugbank:DB04894]
p11551
sasS'PRKACA'
p11552
(lp11553
(dp11554
g4
Vunknown
p11555
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01940_6263
p11556
sg8
Vdrug-target interaction Balanol Analog 2 and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB01940_6263]
p11557
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11558
sg14
Vhttp://bio2rdf.org/drugbank:DB01940
p11559
sg16
VBalanol Analog 2 [drugbank:DB01940]
p11560
sa(dp11561
g4
Vunknown
p11562
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01919_6263
p11563
sg8
Vdrug-target interaction Pentanal and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB01919_6263]
p11564
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11565
sg14
Vhttp://bio2rdf.org/drugbank:DB01919
p11566
sg16
VPentanal [drugbank:DB01919]
p11567
sa(dp11568
g4
Vunknown
p11569
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02440_6263
p11570
sg8
Vdrug-target interaction N-Octane and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB02440_6263]
p11571
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11572
sg14
Vhttp://bio2rdf.org/drugbank:DB02440
p11573
sg16
VN-Octane [drugbank:DB02440]
p11574
sa(dp11575
g4
Vunknown
p11576
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02155_6263
p11577
sg8
Vdrug-target interaction Balanol Analog 8 and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB02155_6263]
p11578
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11579
sg14
Vhttp://bio2rdf.org/drugbank:DB02155
p11580
sg16
VBalanol Analog 8 [drugbank:DB02155]
p11581
sa(dp11582
g4
Vunknown
p11583
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02482_6263
p11584
sg8
Vdrug-target interaction Phosphonothreonine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB02482_6263]
p11585
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11586
sg14
Vhttp://bio2rdf.org/drugbank:DB02482
p11587
sg16
VPhosphonothreonine [drugbank:DB02482]
p11588
sa(dp11589
g4
Vunknown
p11590
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02611_6263
p11591
sg8
Vdrug-target interaction Balanol Analog 1 and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB02611_6263]
p11592
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11593
sg14
Vhttp://bio2rdf.org/drugbank:DB02611
p11594
sg16
VBalanol Analog 1 [drugbank:DB02611]
p11595
sa(dp11596
g4
Vunknown
p11597
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03374_6263
p11598
sg8
Vdrug-target interaction 3,5-Diiodotyrosine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB03374_6263]
p11599
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11600
sg14
Vhttp://bio2rdf.org/drugbank:DB03374
p11601
sg16
V3,5-Diiodotyrosine [drugbank:DB03374]
p11602
sa(dp11603
g4
Vunknown
p11604
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04098_6263
p11605
sg8
Vdrug-target interaction Balanol and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB04098_6263]
p11606
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11607
sg14
Vhttp://bio2rdf.org/drugbank:DB04098
p11608
sg16
VBalanol [drugbank:DB04098]
p11609
sa(dp11610
g4
Vunknown
p11611
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04707_6263
p11612
sg8
Vdrug-target interaction HYDROXYFASUDIL and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB04707_6263]
p11613
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11614
sg14
Vhttp://bio2rdf.org/drugbank:DB04707
p11615
sg16
VHYDROXYFASUDIL [drugbank:DB04707]
p11616
sa(dp11617
g4
Vunknown
p11618
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06959_6263
p11619
sg8
Vdrug-target interaction (1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB06959_6263]
p11620
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11621
sg14
Vhttp://bio2rdf.org/drugbank:DB06959
p11622
sg16
V(1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE [drugbank:DB06959]
p11623
sa(dp11624
g4
Vunknown
p11625
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06977_6263
p11626
sg8
Vdrug-target interaction (2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-[(7AS)-7AH-INDOL-3-YL]PROPAN-2-AMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB06977_6263]
p11627
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11628
sg14
Vhttp://bio2rdf.org/drugbank:DB06977
p11629
sg16
V(2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-[(7AS)-7AH-INDOL-3-YL]PROPAN-2-AMINE [drugbank:DB06977]
p11630
sa(dp11631
g4
Vunknown
p11632
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07124_6263
p11633
sg8
Vdrug-target interaction (2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07124_6263]
p11634
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11635
sg14
Vhttp://bio2rdf.org/drugbank:DB07124
p11636
sg16
V(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE [drugbank:DB07124]
p11637
sa(dp11638
g4
Vunknown
p11639
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04522_6263
p11640
sg8
Vdrug-target interaction Phosphonoserine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB04522_6263]
p11641
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11642
sg14
Vhttp://bio2rdf.org/drugbank:DB04522
p11643
sg16
VPhosphonoserine [drugbank:DB04522]
p11644
sa(dp11645
g4
Vunknown
p11646
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07107_6263
p11647
sg8
Vdrug-target interaction (1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07107_6263]
p11648
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11649
sg14
Vhttp://bio2rdf.org/drugbank:DB07107
p11650
sg16
V(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE [drugbank:DB07107]
p11651
sa(dp11652
g4
Vunknown
p11653
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07458_6263
p11654
sg8
Vdrug-target interaction 3-(1H-INDOL-3-YL)-4-{1-[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]-1H-INDOL-3-YL}-1H-PYRROLE-2,5-DIONE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07458_6263]
p11655
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11656
sg14
Vhttp://bio2rdf.org/drugbank:DB07458
p11657
sg16
V3-(1H-INDOL-3-YL)-4-{1-[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]-1H-INDOL-3-YL}-1H-PYRROLE-2,5-DIONE [drugbank:DB07458]
p11658
sa(dp11659
g4
Vunknown
p11660
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04530_6263
p11661
sg8
Vdrug-target interaction S,S-(2-Hydroxyethyl)Thiocysteine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB04530_6263]
p11662
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11663
sg14
Vhttp://bio2rdf.org/drugbank:DB04530
p11664
sg16
VS,S-(2-Hydroxyethyl)Thiocysteine [drugbank:DB04530]
p11665
sa(dp11666
g4
Vunknown
p11667
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07204_6263
p11668
sg8
Vdrug-target interaction (1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07204_6263]
p11669
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11670
sg14
Vhttp://bio2rdf.org/drugbank:DB07204
p11671
sg16
V(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE [drugbank:DB07204]
p11672
sa(dp11673
g4
Vunknown
p11674
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07235_6263
p11675
sg8
Vdrug-target interaction N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07235_6263]
p11676
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11677
sg14
Vhttp://bio2rdf.org/drugbank:DB07235
p11678
sg16
VN-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE [drugbank:DB07235]
p11679
sa(dp11680
g4
Vunknown
p11681
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07857_6263
p11682
sg8
Vdrug-target interaction (2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07857_6263]
p11683
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11684
sg14
Vhttp://bio2rdf.org/drugbank:DB07857
p11685
sg16
V(2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE [drugbank:DB07857]
p11686
sa(dp11687
g4
Vunknown
p11688
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07858_6263
p11689
sg8
Vdrug-target interaction (2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07858_6263]
p11690
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11691
sg14
Vhttp://bio2rdf.org/drugbank:DB07858
p11692
sg16
V(2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE [drugbank:DB07858]
p11693
sa(dp11694
g4
Vunknown
p11695
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07947_6263
p11696
sg8
Vdrug-target interaction ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07947_6263]
p11697
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11698
sg14
Vhttp://bio2rdf.org/drugbank:DB07947
p11699
sg16
VISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE [drugbank:DB07947]
p11700
sa(dp11701
g4
Vunknown
p11702
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08070_6263
p11703
sg8
Vdrug-target interaction 2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08070_6263]
p11704
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11705
sg14
Vhttp://bio2rdf.org/drugbank:DB08070
p11706
sg16
V2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE [drugbank:DB08070]
p11707
sa(dp11708
g4
Vunknown
p11709
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08162_6263
p11710
sg8
Vdrug-target interaction 5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08162_6263]
p11711
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11712
sg14
Vhttp://bio2rdf.org/drugbank:DB08162
p11713
sg16
V5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE [drugbank:DB08162]
p11714
sa(dp11715
g4
Vunknown
p11716
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08568_6263
p11717
sg8
Vdrug-target interaction (2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08568_6263]
p11718
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11719
sg14
Vhttp://bio2rdf.org/drugbank:DB08568
p11720
sg16
V(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE [drugbank:DB08568]
p11721
sa(dp11722
g4
Vunknown
p11723
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07855_6263
p11724
sg8
Vdrug-target interaction (S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07855_6263]
p11725
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11726
sg14
Vhttp://bio2rdf.org/drugbank:DB07855
p11727
sg16
V(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE [drugbank:DB07855]
p11728
sa(dp11729
g4
Vunknown
p11730
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07996_6263
p11731
sg8
Vdrug-target interaction 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07996_6263]
p11732
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11733
sg14
Vhttp://bio2rdf.org/drugbank:DB07996
p11734
sg16
V1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE [drugbank:DB07996]
p11735
sa(dp11736
g4
Vunknown
p11737
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08073_6263
p11738
sg8
Vdrug-target interaction (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08073_6263]
p11739
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11740
sg14
Vhttp://bio2rdf.org/drugbank:DB08073
p11741
sg16
V(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE [drugbank:DB08073]
p11742
sa(dp11743
g4
Vunknown
p11744
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08114_6263
p11745
sg8
Vdrug-target interaction 5-benzyl-1,3-thiazol-2-amine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08114_6263]
p11746
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11747
sg14
Vhttp://bio2rdf.org/drugbank:DB08114
p11748
sg16
V5-benzyl-1,3-thiazol-2-amine [drugbank:DB08114]
p11749
sa(dp11750
g4
Vunknown
p11751
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08149_6263
p11752
sg8
Vdrug-target interaction 1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08149_6263]
p11753
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11754
sg14
Vhttp://bio2rdf.org/drugbank:DB08149
p11755
sg16
V1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine [drugbank:DB08149]
p11756
sa(dp11757
g4
Vunknown
p11758
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08150_6263
p11759
sg8
Vdrug-target interaction 4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08150_6263]
p11760
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11761
sg14
Vhttp://bio2rdf.org/drugbank:DB08150
p11762
sg16
V4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium [drugbank:DB08150]
p11763
sa(dp11764
g4
Vunknown
p11765
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08569_6263
p11766
sg8
Vdrug-target interaction 3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08569_6263]
p11767
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11768
sg14
Vhttp://bio2rdf.org/drugbank:DB08569
p11769
sg16
V3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE [drugbank:DB08569]
p11770
sa(dp11771
g4
Vunknown
p11772
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07583_6263
p11773
sg8
Vdrug-target interaction (4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07583_6263]
p11774
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11775
sg14
Vhttp://bio2rdf.org/drugbank:DB07583
p11776
sg16
V(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE [drugbank:DB07583]
p11777
sa(dp11778
g4
Vunknown
p11779
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07854_6263
p11780
sg8
Vdrug-target interaction N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07854_6263]
p11781
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11782
sg14
Vhttp://bio2rdf.org/drugbank:DB07854
p11783
sg16
VN-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE [drugbank:DB07854]
p11784
sa(dp11785
g4
Vunknown
p11786
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07856_6263
p11787
sg8
Vdrug-target interaction 6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07856_6263]
p11788
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11789
sg14
Vhttp://bio2rdf.org/drugbank:DB07856
p11790
sg16
V6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE [drugbank:DB07856]
p11791
sa(dp11792
g4
Vunknown
p11793
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07859_6263
p11794
sg8
Vdrug-target interaction 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07859_6263]
p11795
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11796
sg14
Vhttp://bio2rdf.org/drugbank:DB07859
p11797
sg16
V4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE [drugbank:DB07859]
p11798
sa(dp11799
g4
Vunknown
p11800
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07860_6263
p11801
sg8
Vdrug-target interaction (2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07860_6263]
p11802
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11803
sg14
Vhttp://bio2rdf.org/drugbank:DB07860
p11804
sg16
V(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE [drugbank:DB07860]
p11805
sa(dp11806
g4
Vunknown
p11807
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07876_6263
p11808
sg8
Vdrug-target interaction (S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07876_6263]
p11809
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11810
sg14
Vhttp://bio2rdf.org/drugbank:DB07876
p11811
sg16
V(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE [drugbank:DB07876]
p11812
sa(dp11813
g4
Vunknown
p11814
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07995_6263
p11815
sg8
Vdrug-target interaction N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07995_6263]
p11816
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11817
sg14
Vhttp://bio2rdf.org/drugbank:DB07995
p11818
sg16
VN-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE [drugbank:DB07995]
p11819
sa(dp11820
g4
Vunknown
p11821
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07997_6263
p11822
sg8
Vdrug-target interaction N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB07997_6263]
p11823
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11824
sg14
Vhttp://bio2rdf.org/drugbank:DB07997
p11825
sg16
VN-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE [drugbank:DB07997]
p11826
sa(dp11827
g4
Vunknown
p11828
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08113_6263
p11829
sg8
Vdrug-target interaction 3-pyridin-4-yl-1H-indazole and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08113_6263]
p11830
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11831
sg14
Vhttp://bio2rdf.org/drugbank:DB08113
p11832
sg16
V3-pyridin-4-yl-1H-indazole [drugbank:DB08113]
p11833
sa(dp11834
g4
Vunknown
p11835
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08148_6263
p11836
sg8
Vdrug-target interaction 1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08148_6263]
p11837
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11838
sg14
Vhttp://bio2rdf.org/drugbank:DB08148
p11839
sg16
V1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine [drugbank:DB08148]
p11840
sa(dp11841
g4
Vunknown
p11842
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08231_6263
p11843
sg8
Vdrug-target interaction MYRISTIC ACID and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08231_6263]
p11844
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11845
sg14
Vhttp://bio2rdf.org/drugbank:DB08231
p11846
sg16
VMYRISTIC ACID [drugbank:DB08231]
p11847
sa(dp11848
g4
Vunknown
p11849
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08756_6263
p11850
sg8
Vdrug-target interaction (R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE and cAMP-dependent protein kinase catalytic subunit alpha [drugbank_resource:DB08756_6263]
p11851
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6263
p11852
sg14
Vhttp://bio2rdf.org/drugbank:DB08756
p11853
sg16
V(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE [drugbank:DB08756]
p11854
sasS'CDK5'
p11855
(lp11856
(dp11857
g4
Vunknown
p11858
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02052_1058
p11859
sg8
Vdrug-target interaction Indirubin-3'-Monoxime and Cell division protein kinase 5 [drugbank_resource:DB02052_1058]
p11860
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1058
p11861
sg14
Vhttp://bio2rdf.org/drugbank:DB02052
p11862
sg16
VIndirubin-3'-Monoxime [drugbank:DB02052]
p11863
sa(dp11864
g4
Vunknown
p11865
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02116_1058
p11866
sg8
Vdrug-target interaction Olomoucine and Cell division protein kinase 5 [drugbank_resource:DB02116_1058]
p11867
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1058
p11868
sg14
Vhttp://bio2rdf.org/drugbank:DB02116
p11869
sg16
VOlomoucine [drugbank:DB02116]
p11870
sa(dp11871
g4
Vunknown
p11872
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02950_1058
p11873
sg8
Vdrug-target interaction Hymenialdisine and Cell division protein kinase 5 [drugbank_resource:DB02950_1058]
p11874
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1058
p11875
sg14
Vhttp://bio2rdf.org/drugbank:DB02950
p11876
sg16
VHymenialdisine [drugbank:DB02950]
p11877
sa(dp11878
g4
Vunknown
p11879
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03428_1058
p11880
sg8
Vdrug-target interaction SU9516 and Cell division protein kinase 5 [drugbank_resource:DB03428_1058]
p11881
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1058
p11882
sg14
Vhttp://bio2rdf.org/drugbank:DB03428
p11883
sg16
VSU9516 [drugbank:DB03428]
p11884
sa(dp11885
g4
Vunknown
p11886
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03496_1058
p11887
sg8
Vdrug-target interaction Flavopiridol and Cell division protein kinase 5 [drugbank_resource:DB03496_1058]
p11888
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1058
p11889
sg14
Vhttp://bio2rdf.org/drugbank:DB03496
p11890
sg16
VFlavopiridol [drugbank:DB03496]
p11891
sa(dp11892
g4
Vunknown
p11893
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04014_1058
p11894
sg8
Vdrug-target interaction Alsterpaullone and Cell division protein kinase 5 [drugbank_resource:DB04014_1058]
p11895
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1058
p11896
sg14
Vhttp://bio2rdf.org/drugbank:DB04014
p11897
sg16
VAlsterpaullone [drugbank:DB04014]
p11898
sa(dp11899
g4
Vunknown
p11900
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07364_1058
p11901
sg8
Vdrug-target interaction 6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE and Cell division protein kinase 5 [drugbank_resource:DB07364_1058]
p11902
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1058
p11903
sg14
Vhttp://bio2rdf.org/drugbank:DB07364
p11904
sg16
V6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE [drugbank:DB07364]
p11905
sasS'COL1A1'
p11906
(lp11907
(dp11908
g4
Vunknown
p11909
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00048_28
p11910
sg8
Vdrug-target interaction Collagenase and Collagen alpha-1(I) chain [drugbank_resource:DB00048_28]
p11911
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:28
p11912
sg14
Vhttp://bio2rdf.org/drugbank:DB00048
p11913
sg16
VCollagenase [drugbank:DB00048]
p11914
sasS'CDK8'
p11915
(lp11916
(dp11917
g4
Vunknown
p11918
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03496_3968
p11919
sg8
Vdrug-target interaction Flavopiridol and Cell division protein kinase 8 [drugbank_resource:DB03496_3968]
p11920
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3968
p11921
sg14
Vhttp://bio2rdf.org/drugbank:DB03496
p11922
sg16
VFlavopiridol [drugbank:DB03496]
p11923
sasS'CDK9'
p11924
(lp11925
(dp11926
g4
Vunknown
p11927
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03496_3950
p11928
sg8
Vdrug-target interaction Flavopiridol and Cell division protein kinase 9 [drugbank_resource:DB03496_3950]
p11929
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3950
p11930
sg14
Vhttp://bio2rdf.org/drugbank:DB03496
p11931
sg16
VFlavopiridol [drugbank:DB03496]
p11932
sasS'PPIC'
p11933
(lp11934
(dp11935
g4
Vunknown
p11936
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00172_4085
p11937
sg8
Vdrug-target interaction L-Proline and Peptidyl-prolyl cis-trans isomerase C [drugbank_resource:DB00172_4085]
p11938
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4085
p11939
sg14
Vhttp://bio2rdf.org/drugbank:DB00172
p11940
sg16
VL-Proline [drugbank:DB00172]
p11941
sasS'CALR'
p11942
(lp11943
(dp11944
g4
Vunknown
p11945
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00025_3830
p11946
sg8
Vdrug-target interaction Antihemophilic Factor and Calreticulin [drugbank_resource:DB00025_3830]
p11947
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3830
p11948
sg14
Vhttp://bio2rdf.org/drugbank:DB00025
p11949
sg16
VAntihemophilic Factor [drugbank:DB00025]
p11950
sa(dp11951
g4
Vunknown
p11952
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00031_3830
p11953
sg8
Vdrug-target interaction Tenecteplase and Calreticulin [drugbank_resource:DB00031_3830]
p11954
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3830
p11955
sg14
Vhttp://bio2rdf.org/drugbank:DB00031
p11956
sg16
VTenecteplase [drugbank:DB00031]
p11957
sa(dp11958
g4
Vunknown
p11959
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01065_3830
p11960
sg8
Vdrug-target interaction Melatonin and Calreticulin [drugbank_resource:DB01065_3830]
p11961
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3830
p11962
sg14
Vhttp://bio2rdf.org/drugbank:DB01065
p11963
sg16
VMelatonin [drugbank:DB01065]
p11964
sasS'GLS2'
p11965
(lp11966
(dp11967
g4
Vunknown
p11968
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00142_5
p11969
sg8
Vdrug-target interaction L-Glutamic Acid and Glutaminase liver isoform, mitochondrial [drugbank_resource:DB00142_5]
p11970
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5
p11971
sg14
Vhttp://bio2rdf.org/drugbank:DB00142
p11972
sg16
VL-Glutamic Acid [drugbank:DB00142]
p11973
sasS'CDC42'
p11974
(lp11975
(dp11976
g4
Vunknown
p11977
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02623_7128
p11978
sg8
Vdrug-target interaction Aminophosphonic Acid-Guanylate Ester and Cell division control protein 42 homolog [drugbank_resource:DB02623_7128]
p11979
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7128
p11980
sg14
Vhttp://bio2rdf.org/drugbank:DB02623
p11981
sg16
VAminophosphonic Acid-Guanylate Ester [drugbank:DB02623]
p11982
sa(dp11983
g4
Vunknown
p11984
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04315_7128
p11985
sg8
Vdrug-target interaction Guanosine-5'-Diphosphate and Cell division control protein 42 homolog [drugbank_resource:DB04315_7128]
p11986
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7128
p11987
sg14
Vhttp://bio2rdf.org/drugbank:DB04315
p11988
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p11989
sasS'SAT1'
p11990
(lp11991
(dp11992
g4
Vunknown
p11993
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04633_123
p11994
sg8
Vdrug-target interaction N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine and Diamine acetyltransferase 1 [drugbank_resource:DB04633_123]
p11995
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:123
p11996
sg14
Vhttp://bio2rdf.org/drugbank:DB04633
p11997
sg16
VN-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine [drugbank:DB04633]
p11998
sasS'POLA1'
p11999
(lp12000
(dp12001
g4
Vyes
p12002
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00242_603
p12003
sg8
Vdrug-target interaction Cladribine and DNA polymerase alpha catalytic subunit [drugbank_resource:DB00242_603]
p12004
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:603
p12005
sg14
Vhttp://bio2rdf.org/drugbank:DB00242
p12006
sg16
VCladribine [drugbank:DB00242]
p12007
sa(dp12008
g4
Vyes
p12009
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00631_603
p12010
sg8
Vdrug-target interaction Clofarabine and DNA polymerase alpha catalytic subunit [drugbank_resource:DB00631_603]
p12011
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:603
p12012
sg14
Vhttp://bio2rdf.org/drugbank:DB00631
p12013
sg16
VClofarabine [drugbank:DB00631]
p12014
sa(dp12015
g4
Vyes
p12016
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01073_603
p12017
sg8
Vdrug-target interaction Fludarabine and DNA polymerase alpha catalytic subunit [drugbank_resource:DB01073_603]
p12018
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:603
p12019
sg14
Vhttp://bio2rdf.org/drugbank:DB01073
p12020
sg16
VFludarabine [drugbank:DB01073]
p12021
sa(dp12022
g4
Vunknown
p12023
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01280_603
p12024
sg8
Vdrug-target interaction Nelarabine and DNA polymerase alpha catalytic subunit [drugbank_resource:DB01280_603]
p12025
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:603
p12026
sg14
Vhttp://bio2rdf.org/drugbank:DB01280
p12027
sg16
VNelarabine [drugbank:DB01280]
p12028
sasS'CAMK1D'
p12029
(lp12030
(dp12031
g4
Vunknown
p12032
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08454_6833
p12033
sg8
Vdrug-target interaction N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE and Calcium/calmodulin-dependent protein kinase type 1D [drugbank_resource:DB08454_6833]
p12034
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6833
p12035
sg14
Vhttp://bio2rdf.org/drugbank:DB08454
p12036
sg16
VN-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE [drugbank:DB08454]
p12037
sasS'HLA-B'
p12038
(lp12039
(dp12040
g4
Vunknown
p12041
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04464_6585
p12042
sg8
Vdrug-target interaction N-Formylmethionine and HLA class I histocompatibility antigen, B-27 alpha chain [drugbank_resource:DB04464_6585]
p12043
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6585
p12044
sg14
Vhttp://bio2rdf.org/drugbank:DB04464
p12045
sg16
VN-Formylmethionine [drugbank:DB04464]
p12046
sasS'EEF1A1'
p12047
(lp12048
(dp12049
g4
Vunknown
p12050
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04315_7038
p12051
sg8
Vdrug-target interaction Guanosine-5'-Diphosphate and Elongation factor 1-alpha 1 [drugbank_resource:DB04315_7038]
p12052
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7038
p12053
sg14
Vhttp://bio2rdf.org/drugbank:DB04315
p12054
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p12055
sasS'EGFR'
p12056
(lp12057
(dp12058
g4
Vunknown
p12059
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00072_844
p12060
sg8
Vdrug-target interaction Trastuzumab and Epidermal growth factor receptor [drugbank_resource:DB00072_844]
p12061
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:844
p12062
sg14
Vhttp://bio2rdf.org/drugbank:DB00072
p12063
sg16
VTrastuzumab [drugbank:DB00072]
p12064
sa(dp12065
g4
Vyes
p12066
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00002_844
p12067
sg8
Vdrug-target interaction Cetuximab and Epidermal growth factor receptor [drugbank_resource:DB00002_844]
p12068
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:844
p12069
sg14
Vhttp://bio2rdf.org/drugbank:DB00002
p12070
sg16
VCetuximab [drugbank:DB00002]
p12071
sa(dp12072
g4
Vunknown
p12073
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00281_844
p12074
sg8
Vdrug-target interaction Lidocaine and Epidermal growth factor receptor [drugbank_resource:DB00281_844]
p12075
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:844
p12076
sg14
Vhttp://bio2rdf.org/drugbank:DB00281
p12077
sg16
VLidocaine [drugbank:DB00281]
p12078
sa(dp12079
g4
Vyes
p12080
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00317_844
p12081
sg8
Vdrug-target interaction Gefitinib and Epidermal growth factor receptor [drugbank_resource:DB00317_844]
p12082
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:844
p12083
sg14
Vhttp://bio2rdf.org/drugbank:DB00317
p12084
sg16
VGefitinib [drugbank:DB00317]
p12085
sa(dp12086
g4
Vyes
p12087
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00530_844
p12088
sg8
Vdrug-target interaction Erlotinib and Epidermal growth factor receptor [drugbank_resource:DB00530_844]
p12089
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:844
p12090
sg14
Vhttp://bio2rdf.org/drugbank:DB00530
p12091
sg16
VErlotinib [drugbank:DB00530]
p12092
sa(dp12093
g4
Vyes
p12094
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01259_844
p12095
sg8
Vdrug-target interaction Lapatinib and Epidermal growth factor receptor [drugbank_resource:DB01259_844]
p12096
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:844
p12097
sg14
Vhttp://bio2rdf.org/drugbank:DB01259
p12098
sg16
VLapatinib [drugbank:DB01259]
p12099
sa(dp12100
g4
Vyes
p12101
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01269_844
p12102
sg8
Vdrug-target interaction Panitumumab and Epidermal growth factor receptor [drugbank_resource:DB01269_844]
p12103
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:844
p12104
sg14
Vhttp://bio2rdf.org/drugbank:DB01269
p12105
sg16
VPanitumumab [drugbank:DB01269]
p12106
sa(dp12107
g4
Vunknown
p12108
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03496_844
p12109
sg8
Vdrug-target interaction Flavopiridol and Epidermal growth factor receptor [drugbank_resource:DB03496_844]
p12110
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:844
p12111
sg14
Vhttp://bio2rdf.org/drugbank:DB03496
p12112
sg16
VFlavopiridol [drugbank:DB03496]
p12113
sa(dp12114
g4
Vunknown
p12115
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07602_844
p12116
sg8
Vdrug-target interaction S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE and Epidermal growth factor receptor [drugbank_resource:DB07602_844]
p12117
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:844
p12118
sg14
Vhttp://bio2rdf.org/drugbank:DB07602
p12119
sg16
VS-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE [drugbank:DB07602]
p12120
sa(dp12121
g4
Vunknown
p12122
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07662_844
p12123
sg8
Vdrug-target interaction N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE and Epidermal growth factor receptor [drugbank_resource:DB07662_844]
p12124
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:844
p12125
sg14
Vhttp://bio2rdf.org/drugbank:DB07662
p12126
sg16
VN-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE [drugbank:DB07662]
p12127
sasS'PRKAA1'
p12128
(lp12129
(dp12130
g4
Vunknown
p12131
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00131_748
p12132
sg8
Vdrug-target interaction Adenosine monophosphate and 5'-AMP-activated protein kinase catalytic subunit alpha-1 [drugbank_resource:DB00131_748]
p12133
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:748
p12134
sg14
Vhttp://bio2rdf.org/drugbank:DB00131
p12135
sg16
VAdenosine monophosphate [drugbank:DB00131]
p12136
sa(dp12137
g4
Vunknown
p12138
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00171_748
p12139
sg8
Vdrug-target interaction Adenosine triphosphate and 5'-AMP-activated protein kinase catalytic subunit alpha-1 [drugbank_resource:DB00171_748]
p12140
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:748
p12141
sg14
Vhttp://bio2rdf.org/drugbank:DB00171
p12142
sg16
VAdenosine triphosphate [drugbank:DB00171]
p12143
sa(dp12144
g4
Vyes
p12145
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00914_748
p12146
sg8
Vdrug-target interaction Phenformin and 5'-AMP-activated protein kinase catalytic subunit alpha-1 [drugbank_resource:DB00914_748]
p12147
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:748
p12148
sg14
Vhttp://bio2rdf.org/drugbank:DB00914
p12149
sg16
VPhenformin [drugbank:DB00914]
p12150
sasS'F13A1'
p12151
(lp12152
(dp12153
g4
Vunknown
p12154
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01839_6
p12155
sg8
Vdrug-target interaction 1,2-Propanediol and Coagulation factor XIII A chain [drugbank_resource:DB01839_6]
p12156
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6
p12157
sg14
Vhttp://bio2rdf.org/drugbank:DB01839
p12158
sg16
V1,2-Propanediol [drugbank:DB01839]
p12159
sa(dp12160
g4
Vunknown
p12161
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02340_6
p12162
sg8
Vdrug-target interaction N-Acetyl-Serine and Coagulation factor XIII A chain [drugbank_resource:DB02340_6]
p12163
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6
p12164
sg14
Vhttp://bio2rdf.org/drugbank:DB02340
p12165
sg16
VN-Acetyl-Serine [drugbank:DB02340]
p12166
sasS'PRSS3'
p12167
(lp12168
(dp12169
g4
Vunknown
p12170
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02541_2886
p12171
sg8
Vdrug-target interaction 4-Hydroxybutan-1-Aminium and Trypsin-3 [drugbank_resource:DB02541_2886]
p12172
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2886
p12173
sg14
Vhttp://bio2rdf.org/drugbank:DB02541
p12174
sg16
V4-Hydroxybutan-1-Aminium [drugbank:DB02541]
p12175
sa(dp12176
g4
Vunknown
p12177
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02585_2886
p12178
sg8
Vdrug-target interaction 4-(Hydroxymethyl)Benzamidine and Trypsin-3 [drugbank_resource:DB02585_2886]
p12179
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2886
p12180
sg14
Vhttp://bio2rdf.org/drugbank:DB02585
p12181
sg16
V4-(Hydroxymethyl)Benzamidine [drugbank:DB02585]
p12182
sa(dp12183
g4
Vunknown
p12184
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03127_2886
p12185
sg8
Vdrug-target interaction Benzamidine and Trypsin-3 [drugbank_resource:DB03127_2886]
p12186
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2886
p12187
sg14
Vhttp://bio2rdf.org/drugbank:DB03127
p12188
sg16
VBenzamidine [drugbank:DB03127]
p12189
sa(dp12190
g4
Vunknown
p12191
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02308_2886
p12192
sg8
Vdrug-target interaction 4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium and Trypsin-3 [drugbank_resource:DB02308_2886]
p12193
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2886
p12194
sg14
Vhttp://bio2rdf.org/drugbank:DB02308
p12195
sg16
V4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium [drugbank:DB02308]
p12196
sa(dp12197
g4
Vunknown
p12198
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03129_2886
p12199
sg8
Vdrug-target interaction [3-(1,3,2-Dioxaborolan-2-Yloxy)Propyl]Guanidine and Trypsin-3 [drugbank_resource:DB03129_2886]
p12200
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2886
p12201
sg14
Vhttp://bio2rdf.org/drugbank:DB03129
p12202
sg16
V[3-(1,3,2-Dioxaborolan-2-Yloxy)Propyl]Guanidine [drugbank:DB03129]
p12203
sa(dp12204
g4
Vunknown
p12205
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03637_2886
p12206
sg8
Vdrug-target interaction Guanidine-3-Propanol and Trypsin-3 [drugbank_resource:DB03637_2886]
p12207
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2886
p12208
sg14
Vhttp://bio2rdf.org/drugbank:DB03637
p12209
sg16
VGuanidine-3-Propanol [drugbank:DB03637]
p12210
sa(dp12211
g4
Vunknown
p12212
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04109_2886
p12213
sg8
Vdrug-target interaction [4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine and Trypsin-3 [drugbank_resource:DB04109_2886]
p12214
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2886
p12215
sg14
Vhttp://bio2rdf.org/drugbank:DB04109
p12216
sg16
V[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine [drugbank:DB04109]
p12217
sa(dp12218
g4
Vunknown
p12219
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04369_2886
p12220
sg8
Vdrug-target interaction 1,3,2-Dioxaborolan-2-Ol and Trypsin-3 [drugbank_resource:DB04369_2886]
p12221
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2886
p12222
sg14
Vhttp://bio2rdf.org/drugbank:DB04369
p12223
sg16
V1,3,2-Dioxaborolan-2-Ol [drugbank:DB04369]
p12224
sasS'RNASE2'
p12225
(lp12226
(dp12227
g4
Vunknown
p12228
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02098_2390
p12229
sg8
Vdrug-target interaction Adenosine-2'-5'-Diphosphate and Nonsecretory ribonuclease [drugbank_resource:DB02098_2390]
p12230
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2390
p12231
sg14
Vhttp://bio2rdf.org/drugbank:DB02098
p12232
sg16
VAdenosine-2'-5'-Diphosphate [drugbank:DB02098]
p12233
sa(dp12234
g4
Vunknown
p12235
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01812_2390
p12236
sg8
Vdrug-target interaction Adenosine-3'-5'-Diphosphate and Nonsecretory ribonuclease [drugbank_resource:DB01812_2390]
p12237
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2390
p12238
sg14
Vhttp://bio2rdf.org/drugbank:DB01812
p12239
sg16
VAdenosine-3'-5'-Diphosphate [drugbank:DB01812]
p12240
sa(dp12241
g4
Vunknown
p12242
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03431_2390
p12243
sg8
Vdrug-target interaction Adenosine-5'-Diphosphate and Nonsecretory ribonuclease [drugbank_resource:DB03431_2390]
p12244
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2390
p12245
sg14
Vhttp://bio2rdf.org/drugbank:DB03431
p12246
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p12247
sasS'RRM2'
p12248
(lp12249
(dp12250
g4
Vyes
p12251
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00242_4218
p12252
sg8
Vdrug-target interaction Cladribine and Ribonucleoside-diphosphate reductase M2 subunit [drugbank_resource:DB00242_4218]
p12253
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4218
p12254
sg14
Vhttp://bio2rdf.org/drugbank:DB00242
p12255
sg16
VCladribine [drugbank:DB00242]
p12256
sa(dp12257
g4
Vyes
p12258
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB05260_4218
p12259
sg8
Vdrug-target interaction Gallium nitrate and Ribonucleoside-diphosphate reductase M2 subunit [drugbank_resource:DB05260_4218]
p12260
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4218
p12261
sg14
Vhttp://bio2rdf.org/drugbank:DB05260
p12262
sg16
VGallium nitrate [drugbank:DB05260]
p12263
sasS'COL3A1'
p12264
(lp12265
(dp12266
g4
Vunknown
p12267
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00048_3853
p12268
sg8
Vdrug-target interaction Collagenase and Collagen alpha-1(III) chain [drugbank_resource:DB00048_3853]
p12269
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3853
p12270
sg14
Vhttp://bio2rdf.org/drugbank:DB00048
p12271
sg16
VCollagenase [drugbank:DB00048]
p12272
sasS'SYK'
p12273
(lp12274
(dp12275
g4
Vunknown
p12276
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02010_2408
p12277
sg8
Vdrug-target interaction Staurosporine and Tyrosine-protein kinase SYK [drugbank_resource:DB02010_2408]
p12278
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2408
p12279
sg14
Vhttp://bio2rdf.org/drugbank:DB02010
p12280
sg16
VStaurosporine [drugbank:DB02010]
p12281
sa(dp12282
g4
Vunknown
p12283
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06834_2408
p12284
sg8
Vdrug-target interaction N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide and Tyrosine-protein kinase SYK [drugbank_resource:DB06834_2408]
p12285
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2408
p12286
sg14
Vhttp://bio2rdf.org/drugbank:DB06834
p12287
sg16
VN-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide [drugbank:DB06834]
p12288
sa(dp12289
g4
Vunknown
p12290
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07194_2408
p12291
sg8
Vdrug-target interaction 2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide and Tyrosine-protein kinase SYK [drugbank_resource:DB07194_2408]
p12292
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2408
p12293
sg14
Vhttp://bio2rdf.org/drugbank:DB07194
p12294
sg16
V2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide [drugbank:DB07194]
p12295
sa(dp12296
g4
Vunknown
p12297
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07159_2408
p12298
sg8
Vdrug-target interaction 6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one and Tyrosine-protein kinase SYK [drugbank_resource:DB07159_2408]
p12299
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2408
p12300
sg14
Vhttp://bio2rdf.org/drugbank:DB07159
p12301
sg16
V6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one [drugbank:DB07159]
p12302
sa(dp12303
g4
Vunknown
p12304
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08361_2408
p12305
sg8
Vdrug-target interaction 2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide and Tyrosine-protein kinase SYK [drugbank_resource:DB08361_2408]
p12306
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2408
p12307
sg14
Vhttp://bio2rdf.org/drugbank:DB08361
p12308
sg16
V2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide [drugbank:DB08361]
p12309
sasS'PIN1'
p12310
(lp12311
(dp12312
g4
Vunknown
p12313
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01766_6240
p12314
sg8
Vdrug-target interaction Beta-(2-Naphthyl)-Alanine and Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 [drugbank_resource:DB01766_6240]
p12315
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6240
p12316
sg14
Vhttp://bio2rdf.org/drugbank:DB01766
p12317
sg16
VBeta-(2-Naphthyl)-Alanine [drugbank:DB01766]
p12318
sa(dp12319
g4
Vunknown
p12320
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06867_6240
p12321
sg8
Vdrug-target interaction 3,6,9,12,15,18-HEXAOXAICOSANE and Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 [drugbank_resource:DB06867_6240]
p12322
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6240
p12323
sg14
Vhttp://bio2rdf.org/drugbank:DB06867
p12324
sg16
V3,6,9,12,15,18-HEXAOXAICOSANE [drugbank:DB06867]
p12325
sasS'CA4'
p12326
(lp12327
(dp12328
g4
Vunknown
p12329
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00232_592
p12330
sg8
Vdrug-target interaction Methyclothiazide and Carbonic anhydrase 4 [drugbank_resource:DB00232_592]
p12331
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12332
sg14
Vhttp://bio2rdf.org/drugbank:DB00232
p12333
sg16
VMethyclothiazide [drugbank:DB00232]
p12334
sa(dp12335
g4
Vyes
p12336
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00273_592
p12337
sg8
Vdrug-target interaction Topiramate and Carbonic anhydrase 4 [drugbank_resource:DB00273_592]
p12338
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12339
sg14
Vhttp://bio2rdf.org/drugbank:DB00273
p12340
sg16
VTopiramate [drugbank:DB00273]
p12341
sa(dp12342
g4
Vunknown
p12343
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00436_592
p12344
sg8
Vdrug-target interaction Bendroflumethiazide and Carbonic anhydrase 4 [drugbank_resource:DB00436_592]
p12345
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12346
sg14
Vhttp://bio2rdf.org/drugbank:DB00436
p12347
sg16
VBendroflumethiazide [drugbank:DB00436]
p12348
sa(dp12349
g4
Vunknown
p12350
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00606_592
p12351
sg8
Vdrug-target interaction Cyclothiazide and Carbonic anhydrase 4 [drugbank_resource:DB00606_592]
p12352
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12353
sg14
Vhttp://bio2rdf.org/drugbank:DB00606
p12354
sg16
VCyclothiazide [drugbank:DB00606]
p12355
sa(dp12356
g4
Vyes
p12357
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00311_592
p12358
sg8
Vdrug-target interaction Ethoxzolamide and Carbonic anhydrase 4 [drugbank_resource:DB00311_592]
p12359
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12360
sg14
Vhttp://bio2rdf.org/drugbank:DB00311
p12361
sg16
VEthoxzolamide [drugbank:DB00311]
p12362
sa(dp12363
g4
Vunknown
p12364
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00562_592
p12365
sg8
Vdrug-target interaction Benzthiazide and Carbonic anhydrase 4 [drugbank_resource:DB00562_592]
p12366
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12367
sg14
Vhttp://bio2rdf.org/drugbank:DB00562
p12368
sg16
VBenzthiazide [drugbank:DB00562]
p12369
sa(dp12370
g4
Vyes
p12371
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00703_592
p12372
sg8
Vdrug-target interaction Methazolamide and Carbonic anhydrase 4 [drugbank_resource:DB00703_592]
p12373
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12374
sg14
Vhttp://bio2rdf.org/drugbank:DB00703
p12375
sg16
VMethazolamide [drugbank:DB00703]
p12376
sa(dp12377
g4
Vyes
p12378
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00819_592
p12379
sg8
Vdrug-target interaction Acetazolamide and Carbonic anhydrase 4 [drugbank_resource:DB00819_592]
p12380
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12381
sg14
Vhttp://bio2rdf.org/drugbank:DB00819
p12382
sg16
VAcetazolamide [drugbank:DB00819]
p12383
sa(dp12384
g4
Vyes
p12385
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00880_592
p12386
sg8
Vdrug-target interaction Chlorothiazide and Carbonic anhydrase 4 [drugbank_resource:DB00880_592]
p12387
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12388
sg14
Vhttp://bio2rdf.org/drugbank:DB00880
p12389
sg16
VChlorothiazide [drugbank:DB00880]
p12390
sa(dp12391
g4
Vunknown
p12392
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00909_592
p12393
sg8
Vdrug-target interaction Zonisamide and Carbonic anhydrase 4 [drugbank_resource:DB00909_592]
p12394
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12395
sg14
Vhttp://bio2rdf.org/drugbank:DB00909
p12396
sg16
VZonisamide [drugbank:DB00909]
p12397
sa(dp12398
g4
Vunknown
p12399
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00999_592
p12400
sg8
Vdrug-target interaction Hydrochlorothiazide and Carbonic anhydrase 4 [drugbank_resource:DB00999_592]
p12401
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12402
sg14
Vhttp://bio2rdf.org/drugbank:DB00999
p12403
sg16
VHydrochlorothiazide [drugbank:DB00999]
p12404
sa(dp12405
g4
Vunknown
p12406
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00869_592
p12407
sg8
Vdrug-target interaction Dorzolamide and Carbonic anhydrase 4 [drugbank_resource:DB00869_592]
p12408
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12409
sg14
Vhttp://bio2rdf.org/drugbank:DB00869
p12410
sg16
VDorzolamide [drugbank:DB00869]
p12411
sa(dp12412
g4
Vunknown
p12413
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00774_592
p12414
sg8
Vdrug-target interaction Hydroflumethiazide and Carbonic anhydrase 4 [drugbank_resource:DB00774_592]
p12415
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12416
sg14
Vhttp://bio2rdf.org/drugbank:DB00774
p12417
sg16
VHydroflumethiazide [drugbank:DB00774]
p12418
sa(dp12419
g4
Vunknown
p12420
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01021_592
p12421
sg8
Vdrug-target interaction Trichlormethiazide and Carbonic anhydrase 4 [drugbank_resource:DB01021_592]
p12422
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12423
sg14
Vhttp://bio2rdf.org/drugbank:DB01021
p12424
sg16
VTrichlormethiazide [drugbank:DB01021]
p12425
sa(dp12426
g4
Vyes
p12427
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01144_592
p12428
sg8
Vdrug-target interaction Dichlorphenamide and Carbonic anhydrase 4 [drugbank_resource:DB01144_592]
p12429
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12430
sg14
Vhttp://bio2rdf.org/drugbank:DB01144
p12431
sg16
VDichlorphenamide [drugbank:DB01144]
p12432
sa(dp12433
g4
Vunknown
p12434
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01194_592
p12435
sg8
Vdrug-target interaction Brinzolamide and Carbonic anhydrase 4 [drugbank_resource:DB01194_592]
p12436
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:592
p12437
sg14
Vhttp://bio2rdf.org/drugbank:DB01194
p12438
sg16
VBrinzolamide [drugbank:DB01194]
p12439
sasS'CRH'
p12440
(lp12441
(dp12442
g4
Vunknown
p12443
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01285_1566
p12444
sg8
Vdrug-target interaction Corticotropin and Corticoliberin [drugbank_resource:DB01285_1566]
p12445
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1566
p12446
sg14
Vhttp://bio2rdf.org/drugbank:DB01285
p12447
sg16
VCorticotropin [drugbank:DB01285]
p12448
sa(dp12449
g4
Vunknown
p12450
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02556_1566
p12451
sg8
Vdrug-target interaction D-Phenylalanine and Corticoliberin [drugbank_resource:DB02556_1566]
p12452
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1566
p12453
sg14
Vhttp://bio2rdf.org/drugbank:DB02556
p12454
sg16
VD-Phenylalanine [drugbank:DB02556]
p12455
sa(dp12456
g4
Vunknown
p12457
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02952_1566
p12458
sg8
Vdrug-target interaction Alpha-Aminoisobutyric Acid and Corticoliberin [drugbank_resource:DB02952_1566]
p12459
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1566
p12460
sg14
Vhttp://bio2rdf.org/drugbank:DB02952
p12461
sg16
VAlpha-Aminoisobutyric Acid [drugbank:DB02952]
p12462
sasS'TNFRSF1A'
p12463
(lp12464
(dp12465
g4
Vunknown
p12466
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03507_1984
p12467
sg8
Vdrug-target interaction 6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One and Tumor necrosis factor receptor superfamily member 1A [drugbank_resource:DB03507_1984]
p12468
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1984
p12469
sg14
Vhttp://bio2rdf.org/drugbank:DB03507
p12470
sg16
V6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One [drugbank:DB03507]
p12471
sasS'HDAC3'
p12472
(lp12473
(dp12474
g4
Vyes
p12475
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02546_4123
p12476
sg8
Vdrug-target interaction Vorinostat and Histone deacetylase 3 [drugbank_resource:DB02546_4123]
p12477
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4123
p12478
sg14
Vhttp://bio2rdf.org/drugbank:DB02546
p12479
sg16
VVorinostat [drugbank:DB02546]
p12480
sasS'CCNA2'
p12481
(lp12482
(dp12483
g4
Vunknown
p12484
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02091_6235
p12485
sg8
Vdrug-target interaction 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine and Cyclin-A2 [drugbank_resource:DB02091_6235]
p12486
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12487
sg14
Vhttp://bio2rdf.org/drugbank:DB02091
p12488
sg16
V4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine [drugbank:DB02091]
p12489
sa(dp12490
g4
Vunknown
p12491
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02407_6235
p12492
sg8
Vdrug-target interaction 6-O-Cyclohexylmethyl Guanine and Cyclin-A2 [drugbank_resource:DB02407_6235]
p12493
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12494
sg14
Vhttp://bio2rdf.org/drugbank:DB02407
p12495
sg16
V6-O-Cyclohexylmethyl Guanine [drugbank:DB02407]
p12496
sa(dp12497
g4
Vunknown
p12498
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02915_6235
p12499
sg8
Vdrug-target interaction 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine and Cyclin-A2 [drugbank_resource:DB02915_6235]
p12500
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12501
sg14
Vhttp://bio2rdf.org/drugbank:DB02915
p12502
sg16
V4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine [drugbank:DB02915]
p12503
sa(dp12504
g4
Vunknown
p12505
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02833_6235
p12506
sg8
Vdrug-target interaction [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine and Cyclin-A2 [drugbank_resource:DB02833_6235]
p12507
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12508
sg14
Vhttp://bio2rdf.org/drugbank:DB02833
p12509
sg16
V[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine [drugbank:DB02833]
p12510
sa(dp12511
g4
Vunknown
p12512
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06844_6235
p12513
sg8
Vdrug-target interaction 4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB06844_6235]
p12514
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12515
sg14
Vhttp://bio2rdf.org/drugbank:DB06844
p12516
sg16
V4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE [drugbank:DB06844]
p12517
sa(dp12518
g4
Vunknown
p12519
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06944_6235
p12520
sg8
Vdrug-target interaction N-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE and Cyclin-A2 [drugbank_resource:DB06944_6235]
p12521
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12522
sg14
Vhttp://bio2rdf.org/drugbank:DB06944
p12523
sg16
VN-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE [drugbank:DB06944]
p12524
sa(dp12525
g4
Vunknown
p12526
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07126_6235
p12527
sg8
Vdrug-target interaction O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE and Cyclin-A2 [drugbank_resource:DB07126_6235]
p12528
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12529
sg14
Vhttp://bio2rdf.org/drugbank:DB07126
p12530
sg16
VO6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE [drugbank:DB07126]
p12531
sa(dp12532
g4
Vunknown
p12533
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07137_6235
p12534
sg8
Vdrug-target interaction (2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE and Cyclin-A2 [drugbank_resource:DB07137_6235]
p12535
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12536
sg14
Vhttp://bio2rdf.org/drugbank:DB07137
p12537
sg16
V(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE [drugbank:DB07137]
p12538
sa(dp12539
g4
Vunknown
p12540
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07164_6235
p12541
sg8
Vdrug-target interaction N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine and Cyclin-A2 [drugbank_resource:DB07164_6235]
p12542
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12543
sg14
Vhttp://bio2rdf.org/drugbank:DB07164
p12544
sg16
VN-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine [drugbank:DB07164]
p12545
sa(dp12546
g4
Vunknown
p12547
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07203_6235
p12548
sg8
Vdrug-target interaction 6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE and Cyclin-A2 [drugbank_resource:DB07203_6235]
p12549
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12550
sg14
Vhttp://bio2rdf.org/drugbank:DB07203
p12551
sg16
V6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE [drugbank:DB07203]
p12552
sa(dp12553
g4
Vunknown
p12554
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06948_6235
p12555
sg8
Vdrug-target interaction 2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE and Cyclin-A2 [drugbank_resource:DB06948_6235]
p12556
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12557
sg14
Vhttp://bio2rdf.org/drugbank:DB06948
p12558
sg16
V2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE [drugbank:DB06948]
p12559
sa(dp12560
g4
Vunknown
p12561
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07538_6235
p12562
sg8
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB07538_6235]
p12563
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12564
sg14
Vhttp://bio2rdf.org/drugbank:DB07538
p12565
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE [drugbank:DB07538]
p12566
sa(dp12567
g4
Vunknown
p12568
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07471_6235
p12569
sg8
Vdrug-target interaction 5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE and Cyclin-A2 [drugbank_resource:DB07471_6235]
p12570
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12571
sg14
Vhttp://bio2rdf.org/drugbank:DB07471
p12572
sg16
V5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE [drugbank:DB07471]
p12573
sa(dp12574
g4
Vunknown
p12575
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07533_6235
p12576
sg8
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB07533_6235]
p12577
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12578
sg14
Vhttp://bio2rdf.org/drugbank:DB07533
p12579
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE [drugbank:DB07533]
p12580
sa(dp12581
g4
Vunknown
p12582
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07534_6235
p12583
sg8
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB07534_6235]
p12584
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12585
sg14
Vhttp://bio2rdf.org/drugbank:DB07534
p12586
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE [drugbank:DB07534]
p12587
sa(dp12588
g4
Vunknown
p12589
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07539_6235
p12590
sg8
Vdrug-target interaction 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID and Cyclin-A2 [drugbank_resource:DB07539_6235]
p12591
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12592
sg14
Vhttp://bio2rdf.org/drugbank:DB07539
p12593
sg16
V4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID [drugbank:DB07539]
p12594
sa(dp12595
g4
Vunknown
p12596
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07688_6235
p12597
sg8
Vdrug-target interaction 4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB07688_6235]
p12598
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12599
sg14
Vhttp://bio2rdf.org/drugbank:DB07688
p12600
sg16
V4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE [drugbank:DB07688]
p12601
sa(dp12602
g4
Vunknown
p12603
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07852_6235
p12604
sg8
Vdrug-target interaction 1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID and Cyclin-A2 [drugbank_resource:DB07852_6235]
p12605
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12606
sg14
Vhttp://bio2rdf.org/drugbank:DB07852
p12607
sg16
V1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID [drugbank:DB07852]
p12608
sa(dp12609
g4
Vunknown
p12610
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08182_6235
p12611
sg8
Vdrug-target interaction 4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine and Cyclin-A2 [drugbank_resource:DB08182_6235]
p12612
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12613
sg14
Vhttp://bio2rdf.org/drugbank:DB08182
p12614
sg16
V4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine [drugbank:DB08182]
p12615
sa(dp12616
g4
Vunknown
p12617
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08241_6235
p12618
sg8
Vdrug-target interaction 4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE and Cyclin-A2 [drugbank_resource:DB08241_6235]
p12619
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12620
sg14
Vhttp://bio2rdf.org/drugbank:DB08241
p12621
sg16
V4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE [drugbank:DB08241]
p12622
sa(dp12623
g4
Vunknown
p12624
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08248_6235
p12625
sg8
Vdrug-target interaction 3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE and Cyclin-A2 [drugbank_resource:DB08248_6235]
p12626
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12627
sg14
Vhttp://bio2rdf.org/drugbank:DB08248
p12628
sg16
V3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE [drugbank:DB08248]
p12629
sa(dp12630
g4
Vunknown
p12631
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08285_6235
p12632
sg8
Vdrug-target interaction (2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol and Cyclin-A2 [drugbank_resource:DB08285_6235]
p12633
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12634
sg14
Vhttp://bio2rdf.org/drugbank:DB08285
p12635
sg16
V(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol [drugbank:DB08285]
p12636
sa(dp12637
g4
Vunknown
p12638
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08463_6235
p12639
sg8
Vdrug-target interaction (2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol and Cyclin-A2 [drugbank_resource:DB08463_6235]
p12640
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12641
sg14
Vhttp://bio2rdf.org/drugbank:DB08463
p12642
sg16
V(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol [drugbank:DB08463]
p12643
sa(dp12644
g4
Vunknown
p12645
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08218_6235
p12646
sg8
Vdrug-target interaction HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM and Cyclin-A2 [drugbank_resource:DB08218_6235]
p12647
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12648
sg14
Vhttp://bio2rdf.org/drugbank:DB08218
p12649
sg16
VHYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM [drugbank:DB08218]
p12650
sa(dp12651
g4
Vunknown
p12652
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08219_6235
p12653
sg8
Vdrug-target interaction 4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE and Cyclin-A2 [drugbank_resource:DB08219_6235]
p12654
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12655
sg14
Vhttp://bio2rdf.org/drugbank:DB08219
p12656
sg16
V4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE [drugbank:DB08219]
p12657
sa(dp12658
g4
Vunknown
p12659
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08233_6235
p12660
sg8
Vdrug-target interaction 6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE and Cyclin-A2 [drugbank_resource:DB08233_6235]
p12661
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12662
sg14
Vhttp://bio2rdf.org/drugbank:DB08233
p12663
sg16
V6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE [drugbank:DB08233]
p12664
sa(dp12665
g4
Vunknown
p12666
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07562_6235
p12667
sg8
Vdrug-target interaction N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE and Cyclin-A2 [drugbank_resource:DB07562_6235]
p12668
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12669
sg14
Vhttp://bio2rdf.org/drugbank:DB07562
p12670
sg16
VN-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE [drugbank:DB07562]
p12671
sa(dp12672
g4
Vunknown
p12673
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08178_6235
p12674
sg8
Vdrug-target interaction 4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine and Cyclin-A2 [drugbank_resource:DB08178_6235]
p12675
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12676
sg14
Vhttp://bio2rdf.org/drugbank:DB08178
p12677
sg16
V4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine [drugbank:DB08178]
p12678
sa(dp12679
g4
Vunknown
p12680
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08309_6235
p12681
sg8
Vdrug-target interaction 3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL and Cyclin-A2 [drugbank_resource:DB08309_6235]
p12682
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12683
sg14
Vhttp://bio2rdf.org/drugbank:DB08309
p12684
sg16
V3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL [drugbank:DB08309]
p12685
sa(dp12686
g4
Vunknown
p12687
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08355_6235
p12688
sg8
Vdrug-target interaction 1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid and Cyclin-A2 [drugbank_resource:DB08355_6235]
p12689
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12690
sg14
Vhttp://bio2rdf.org/drugbank:DB08355
p12691
sg16
V1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid [drugbank:DB08355]
p12692
sa(dp12693
g4
Vunknown
p12694
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08527_6235
p12695
sg8
Vdrug-target interaction 1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE and Cyclin-A2 [drugbank_resource:DB08527_6235]
p12696
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12697
sg14
Vhttp://bio2rdf.org/drugbank:DB08527
p12698
sg16
V1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE [drugbank:DB08527]
p12699
sa(dp12700
g4
Vunknown
p12701
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08572_6235
p12702
sg8
Vdrug-target interaction 4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE and Cyclin-A2 [drugbank_resource:DB08572_6235]
p12703
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12704
sg14
Vhttp://bio2rdf.org/drugbank:DB08572
p12705
sg16
V4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE [drugbank:DB08572]
p12706
sa(dp12707
g4
Vunknown
p12708
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08694_6235
p12709
sg8
Vdrug-target interaction 9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol and Cyclin-A2 [drugbank_resource:DB08694_6235]
p12710
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6235
p12711
sg14
Vhttp://bio2rdf.org/drugbank:DB08694
p12712
sg16
V9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol [drugbank:DB08694]
p12713
sasS'DPYD'
p12714
(lp12715
(dp12716
g4
Vunknown
p12717
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02303_1302
p12718
sg8
Vdrug-target interaction (5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione and Dihydropyrimidine dehydrogenase [NADP+] [drugbank_resource:DB02303_1302]
p12719
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1302
p12720
sg14
Vhttp://bio2rdf.org/drugbank:DB02303
p12721
sg16
V(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione [drugbank:DB02303]
p12722
sa(dp12723
g4
Vunknown
p12724
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03147_1302
p12725
sg8
Vdrug-target interaction Flavin-Adenine Dinucleotide and Dihydropyrimidine dehydrogenase [NADP+] [drugbank_resource:DB03147_1302]
p12726
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1302
p12727
sg14
Vhttp://bio2rdf.org/drugbank:DB03147
p12728
sg16
VFlavin-Adenine Dinucleotide [drugbank:DB03147]
p12729
sa(dp12730
g4
Vunknown
p12731
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02338_1302
p12732
sg8
Vdrug-target interaction Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate and Dihydropyrimidine dehydrogenase [NADP+] [drugbank_resource:DB02338_1302]
p12733
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1302
p12734
sg14
Vhttp://bio2rdf.org/drugbank:DB02338
p12735
sg16
VNadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate [drugbank:DB02338]
p12736
sa(dp12737
g4
Vunknown
p12738
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03247_1302
p12739
sg8
Vdrug-target interaction Riboflavin Monophosphate and Dihydropyrimidine dehydrogenase [NADP+] [drugbank_resource:DB03247_1302]
p12740
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1302
p12741
sg14
Vhttp://bio2rdf.org/drugbank:DB03247
p12742
sg16
VRiboflavin Monophosphate [drugbank:DB03247]
p12743
sa(dp12744
g4
Vunknown
p12745
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03048_1302
p12746
sg8
Vdrug-target interaction 6-Carboxymethyluracil and Dihydropyrimidine dehydrogenase [NADP+] [drugbank_resource:DB03048_1302]
p12747
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1302
p12748
sg14
Vhttp://bio2rdf.org/drugbank:DB03048
p12749
sg16
V6-Carboxymethyluracil [drugbank:DB03048]
p12750
sa(dp12751
g4
Vunknown
p12752
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03554_1302
p12753
sg8
Vdrug-target interaction 5-Iodouracil and Dihydropyrimidine dehydrogenase [NADP+] [drugbank_resource:DB03554_1302]
p12754
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1302
p12755
sg14
Vhttp://bio2rdf.org/drugbank:DB03554
p12756
sg16
V5-Iodouracil [drugbank:DB03554]
p12757
sa(dp12758
g4
Vunknown
p12759
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03419_1302
p12760
sg8
Vdrug-target interaction Uracil and Dihydropyrimidine dehydrogenase [NADP+] [drugbank_resource:DB03419_1302]
p12761
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1302
p12762
sg14
Vhttp://bio2rdf.org/drugbank:DB03419
p12763
sg16
VUracil [drugbank:DB03419]
p12764
sasS'PLOD2'
p12765
(lp12766
(dp12767
g4
Vunknown
p12768
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00126_3935
p12769
sg8
Vdrug-target interaction Vitamin C and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 [drugbank_resource:DB00126_3935]
p12770
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3935
p12771
sg14
Vhttp://bio2rdf.org/drugbank:DB00126
p12772
sg16
VVitamin C [drugbank:DB00126]
p12773
sasS'PLOD3'
p12774
(lp12775
(dp12776
g4
Vunknown
p12777
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00126_3938
p12778
sg8
Vdrug-target interaction Vitamin C and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 [drugbank_resource:DB00126_3938]
p12779
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3938
p12780
sg14
Vhttp://bio2rdf.org/drugbank:DB00126
p12781
sg16
VVitamin C [drugbank:DB00126]
p12782
sa(dp12783
g4
Vunknown
p12784
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00139_3938
p12785
sg8
Vdrug-target interaction Succinic acid and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 [drugbank_resource:DB00139_3938]
p12786
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3938
p12787
sg14
Vhttp://bio2rdf.org/drugbank:DB00139
p12788
sg16
VSuccinic acid [drugbank:DB00139]
p12789
sasS'PDE1A'
p12790
(lp12791
(dp12792
g4
Vunknown
p12793
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00622_6047
p12794
sg8
Vdrug-target interaction Nicardipine and Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A [drugbank_resource:DB00622_6047]
p12795
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6047
p12796
sg14
Vhttp://bio2rdf.org/drugbank:DB00622
p12797
sg16
VNicardipine [drugbank:DB00622]
p12798
sa(dp12799
g4
Vunknown
p12800
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01023_6047
p12801
sg8
Vdrug-target interaction Felodipine and Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A [drugbank_resource:DB01023_6047]
p12802
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6047
p12803
sg14
Vhttp://bio2rdf.org/drugbank:DB01023
p12804
sg16
VFelodipine [drugbank:DB01023]
p12805
sa(dp12806
g4
Vunknown
p12807
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01244_6047
p12808
sg8
Vdrug-target interaction Bepridil and Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A [drugbank_resource:DB01244_6047]
p12809
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6047
p12810
sg14
Vhttp://bio2rdf.org/drugbank:DB01244
p12811
sg16
VBepridil [drugbank:DB01244]
p12812
sasS'PLOD1'
p12813
(lp12814
(dp12815
g4
Vunknown
p12816
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00126_97
p12817
sg8
Vdrug-target interaction Vitamin C and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 [drugbank_resource:DB00126_97]
p12818
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:97
p12819
sg14
Vhttp://bio2rdf.org/drugbank:DB00126
p12820
sg16
VVitamin C [drugbank:DB00126]
p12821
sa(dp12822
g4
Vunknown
p12823
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00139_97
p12824
sg8
Vdrug-target interaction Succinic acid and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 [drugbank_resource:DB00139_97]
p12825
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:97
p12826
sg14
Vhttp://bio2rdf.org/drugbank:DB00139
p12827
sg16
VSuccinic acid [drugbank:DB00139]
p12828
sasS'KCNK1'
p12829
(lp12830
(dp12831
g4
Vunknown
p12832
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00308_172
p12833
sg8
Vdrug-target interaction Ibutilide and Potassium channel subfamily K member 1 [drugbank_resource:DB00308_172]
p12834
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:172
p12835
sg14
Vhttp://bio2rdf.org/drugbank:DB00308
p12836
sg16
VIbutilide [drugbank:DB00308]
p12837
sa(dp12838
g4
Vunknown
p12839
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00908_172
p12840
sg8
Vdrug-target interaction Quinidine and Potassium channel subfamily K member 1 [drugbank_resource:DB00908_172]
p12841
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:172
p12842
sg14
Vhttp://bio2rdf.org/drugbank:DB00908
p12843
sg16
VQuinidine [drugbank:DB00908]
p12844
sa(dp12845
g4
Vunknown
p12846
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01346_172
p12847
sg8
Vdrug-target interaction Quinidine barbiturate and Potassium channel subfamily K member 1 [drugbank_resource:DB01346_172]
p12848
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:172
p12849
sg14
Vhttp://bio2rdf.org/drugbank:DB01346
p12850
sg16
VQuinidine barbiturate [drugbank:DB01346]
p12851
sasS'NSF'
p12852
(lp12853
(dp12854
g4
Vunknown
p12855
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01902_7018
p12856
sg8
Vdrug-target interaction 1-Ethyl-Pyrrolidine-2,5-Dione and Vesicle-fusing ATPase [drugbank_resource:DB01902_7018]
p12857
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7018
p12858
sg14
Vhttp://bio2rdf.org/drugbank:DB01902
p12859
sg16
V1-Ethyl-Pyrrolidine-2,5-Dione [drugbank:DB01902]
p12860
sasS'SCN2A'
p12861
(lp12862
(dp12863
g4
Vunknown
p12864
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00555_3802
p12865
sg8
Vdrug-target interaction Lamotrigine and Sodium channel protein type 2 subunit alpha [drugbank_resource:DB00555_3802]
p12866
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3802
p12867
sg14
Vhttp://bio2rdf.org/drugbank:DB00555
p12868
sg16
VLamotrigine [drugbank:DB00555]
p12869
sa(dp12870
g4
Vunknown
p12871
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00818_3802
p12872
sg8
Vdrug-target interaction Propofol and Sodium channel protein type 2 subunit alpha [drugbank_resource:DB00818_3802]
p12873
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3802
p12874
sg14
Vhttp://bio2rdf.org/drugbank:DB00818
p12875
sg16
VPropofol [drugbank:DB00818]
p12876
sa(dp12877
g4
Vyes
p12878
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00909_3802
p12879
sg8
Vdrug-target interaction Zonisamide and Sodium channel protein type 2 subunit alpha [drugbank_resource:DB00909_3802]
p12880
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3802
p12881
sg14
Vhttp://bio2rdf.org/drugbank:DB00909
p12882
sg16
VZonisamide [drugbank:DB00909]
p12883
sa(dp12884
g4
Vunknown
p12885
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06716_3802
p12886
sg8
Vdrug-target interaction Fospropofol and Sodium channel protein type 2 subunit alpha [drugbank_resource:DB06716_3802]
p12887
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3802
p12888
sg14
Vhttp://bio2rdf.org/drugbank:DB06716
p12889
sg16
VFospropofol [drugbank:DB06716]
p12890
sasS'PGR'
p12891
(lp12892
(dp12893
g4
Vyes
p12894
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00294_614
p12895
sg8
Vdrug-target interaction Etonogestrel and Progesterone receptor [drugbank_resource:DB00294_614]
p12896
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p12897
sg14
Vhttp://bio2rdf.org/drugbank:DB00294
p12898
sg16
VEtonogestrel [drugbank:DB00294]
p12899
sa(dp12900
g4
Vyes
p12901
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00351_614
p12902
sg8
Vdrug-target interaction Megestrol and Progesterone receptor [drugbank_resource:DB00351_614]
p12903
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p12904
sg14
Vhttp://bio2rdf.org/drugbank:DB00351
p12905
sg16
VMegestrol [drugbank:DB00351]
p12906
sa(dp12907
g4
Vyes
p12908
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00378_614
p12909
sg8
Vdrug-target interaction Dydrogesterone and Progesterone receptor [drugbank_resource:DB00378_614]
p12910
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p12911
sg14
Vhttp://bio2rdf.org/drugbank:DB00378
p12912
sg16
VDydrogesterone [drugbank:DB00378]
p12913
sa(dp12914
g4
Vyes
p12915
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00304_614
p12916
sg8
Vdrug-target interaction Desogestrel and Progesterone receptor [drugbank_resource:DB00304_614]
p12917
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p12918
sg14
Vhttp://bio2rdf.org/drugbank:DB00304
p12919
sg16
VDesogestrel [drugbank:DB00304]
p12920
sa(dp12921
g4
Vunknown
p12922
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00588_614
p12923
sg8
Vdrug-target interaction Fluticasone Propionate and Progesterone receptor [drugbank_resource:DB00588_614]
p12924
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p12925
sg14
Vhttp://bio2rdf.org/drugbank:DB00588
p12926
sg16
VFluticasone Propionate [drugbank:DB00588]
p12927
sa(dp12928
g4
Vyes
p12929
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00367_614
p12930
sg8
Vdrug-target interaction Levonorgestrel and Progesterone receptor [drugbank_resource:DB00367_614]
p12931
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p12932
sg14
Vhttp://bio2rdf.org/drugbank:DB00367
p12933
sg16
VLevonorgestrel [drugbank:DB00367]
p12934
sa(dp12935
g4
Vyes
p12936
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00396_614
p12937
sg8
Vdrug-target interaction Progesterone and Progesterone receptor [drugbank_resource:DB00396_614]
p12938
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p12939
sg14
Vhttp://bio2rdf.org/drugbank:DB00396
p12940
sg16
VProgesterone [drugbank:DB00396]
p12941
sa(dp12942
g4
Vyes
p12943
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00603_614
p12944
sg8
Vdrug-target interaction Medroxyprogesterone and Progesterone receptor [drugbank_resource:DB00603_614]
p12945
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p12946
sg14
Vhttp://bio2rdf.org/drugbank:DB00603
p12947
sg16
VMedroxyprogesterone [drugbank:DB00603]
p12948
sa(dp12949
g4
Vyes
p12950
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00823_614
p12951
sg8
Vdrug-target interaction Ethynodiol Diacetate and Progesterone receptor [drugbank_resource:DB00823_614]
p12952
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p12953
sg14
Vhttp://bio2rdf.org/drugbank:DB00823
p12954
sg16
VEthynodiol Diacetate [drugbank:DB00823]
p12955
sa(dp12956
g4
Vunknown
p12957
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00717_614
p12958
sg8
Vdrug-target interaction Norethindrone and Progesterone receptor [drugbank_resource:DB00717_614]
p12959
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p12960
sg14
Vhttp://bio2rdf.org/drugbank:DB00717
p12961
sg16
VNorethindrone [drugbank:DB00717]
p12962
sa(dp12963
g4
Vyes
p12964
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00834_614
p12965
sg8
Vdrug-target interaction Mifepristone and Progesterone receptor [drugbank_resource:DB00834_614]
p12966
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p12967
sg14
Vhttp://bio2rdf.org/drugbank:DB00834
p12968
sg16
VMifepristone [drugbank:DB00834]
p12969
sa(dp12970
g4
Vyes
p12971
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00957_614
p12972
sg8
Vdrug-target interaction Norgestimate and Progesterone receptor [drugbank_resource:DB00957_614]
p12973
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p12974
sg14
Vhttp://bio2rdf.org/drugbank:DB00957
p12975
sg16
VNorgestimate [drugbank:DB00957]
p12976
sa(dp12977
g4
Vyes
p12978
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01406_614
p12979
sg8
Vdrug-target interaction Danazol and Progesterone receptor [drugbank_resource:DB01406_614]
p12980
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p12981
sg14
Vhttp://bio2rdf.org/drugbank:DB01406
p12982
sg16
VDanazol [drugbank:DB01406]
p12983
sa(dp12984
g4
Vyes
p12985
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01431_614
p12986
sg8
Vdrug-target interaction Allylestrenol and Progesterone receptor [drugbank_resource:DB01431_614]
p12987
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p12988
sg14
Vhttp://bio2rdf.org/drugbank:DB01431
p12989
sg16
VAllylestrenol [drugbank:DB01431]
p12990
sa(dp12991
g4
Vyes
p12992
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01395_614
p12993
sg8
Vdrug-target interaction Drospirenone and Progesterone receptor [drugbank_resource:DB01395_614]
p12994
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p12995
sg14
Vhttp://bio2rdf.org/drugbank:DB01395
p12996
sg16
VDrospirenone [drugbank:DB01395]
p12997
sa(dp12998
g4
Vunknown
p12999
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02998_614
p13000
sg8
Vdrug-target interaction Methyltrienolone and Progesterone receptor [drugbank_resource:DB02998_614]
p13001
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p13002
sg14
Vhttp://bio2rdf.org/drugbank:DB02998
p13003
sg16
VMethyltrienolone [drugbank:DB02998]
p13004
sa(dp13005
g4
Vunknown
p13006
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04787_614
p13007
sg8
Vdrug-target interaction Tanaproget and Progesterone receptor [drugbank_resource:DB04787_614]
p13008
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p13009
sg14
Vhttp://bio2rdf.org/drugbank:DB04787
p13010
sg16
VTanaproget [drugbank:DB04787]
p13011
sa(dp13012
g4
Vyes
p13013
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06713_614
p13014
sg8
Vdrug-target interaction Norelgestromin and Progesterone receptor [drugbank_resource:DB06713_614]
p13015
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:614
p13016
sg14
Vhttp://bio2rdf.org/drugbank:DB06713
p13017
sg16
VNorelgestromin [drugbank:DB06713]
p13018
sasS'ZAP70'
p13019
(lp13020
(dp13021
g4
Vunknown
p13022
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02010_2398
p13023
sg8
Vdrug-target interaction Staurosporine and Tyrosine-protein kinase ZAP-70 [drugbank_resource:DB02010_2398]
p13024
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2398
p13025
sg14
Vhttp://bio2rdf.org/drugbank:DB02010
p13026
sg16
VStaurosporine [drugbank:DB02010]
p13027
sasS'AURKB'
p13028
(lp13029
(dp13030
g4
Vunknown
p13031
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07340_5817
p13032
sg8
Vdrug-target interaction N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine and Serine/threonine-protein kinase 12 [drugbank_resource:DB07340_5817]
p13033
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5817
p13034
sg14
Vhttp://bio2rdf.org/drugbank:DB07340
p13035
sg16
VN~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine [drugbank:DB07340]
p13036
sa(dp13037
g4
Vunknown
p13038
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04703_5817
p13039
sg8
Vdrug-target interaction HESPERIDIN and Serine/threonine-protein kinase 12 [drugbank_resource:DB04703_5817]
p13040
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5817
p13041
sg14
Vhttp://bio2rdf.org/drugbank:DB04703
p13042
sg16
VHESPERIDIN [drugbank:DB04703]
p13043
sasS'CXCR4'
p13044
(lp13045
(dp13046
g4
Vunknown
p13047
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00452_1162
p13048
sg8
Vdrug-target interaction Framycetin and C-X-C chemokine receptor type 4 [drugbank_resource:DB00452_1162]
p13049
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1162
p13050
sg14
Vhttp://bio2rdf.org/drugbank:DB00452
p13051
sg16
VFramycetin [drugbank:DB00452]
p13052
sa(dp13053
g4
Vunknown
p13054
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06809_1162
p13055
sg8
Vdrug-target interaction Plerixafor and C-X-C chemokine receptor type 4 [drugbank_resource:DB06809_1162]
p13056
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1162
p13057
sg14
Vhttp://bio2rdf.org/drugbank:DB06809
p13058
sg16
VPlerixafor [drugbank:DB06809]
p13059
sasS'ATP6V1B2'
p13060
(lp13061
(dp13062
g4
Vyes
p13063
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB05260_6315
p13064
sg8
Vdrug-target interaction Gallium nitrate and V-type proton ATPase subunit B, brain isoform [drugbank_resource:DB05260_6315]
p13065
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6315
p13066
sg14
Vhttp://bio2rdf.org/drugbank:DB05260
p13067
sg16
VGallium nitrate [drugbank:DB05260]
p13068
sa(dp13069
g4
Vunknown
p13070
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07347_6315
p13071
sg8
Vdrug-target interaction 4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE and V-type proton ATPase subunit B, brain isoform [drugbank_resource:DB07347_6315]
p13072
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6315
p13073
sg14
Vhttp://bio2rdf.org/drugbank:DB07347
p13074
sg16
V4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE [drugbank:DB07347]
p13075
sasS'KCND2'
p13076
(lp13077
(dp13078
g4
Vunknown
p13079
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00280_6098
p13080
sg8
Vdrug-target interaction Disopyramide and Potassium voltage-gated channel subfamily D member 2 [drugbank_resource:DB00280_6098]
p13081
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6098
p13082
sg14
Vhttp://bio2rdf.org/drugbank:DB00280
p13083
sg16
VDisopyramide [drugbank:DB00280]
p13084
sa(dp13085
g4
Vno
p13086
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00321_6098
p13087
sg8
Vdrug-target interaction Amitriptyline and Potassium voltage-gated channel subfamily D member 2 [drugbank_resource:DB00321_6098]
p13088
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6098
p13089
sg14
Vhttp://bio2rdf.org/drugbank:DB00321
p13090
sg16
VAmitriptyline [drugbank:DB00321]
p13091
sa(dp13092
g4
Vno
p13093
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00458_6098
p13094
sg8
Vdrug-target interaction Imipramine and Potassium voltage-gated channel subfamily D member 2 [drugbank_resource:DB00458_6098]
p13095
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6098
p13096
sg14
Vhttp://bio2rdf.org/drugbank:DB00458
p13097
sg16
VImipramine [drugbank:DB00458]
p13098
sasS'YWHAE'
p13099
(lp13100
(dp13101
g4
Vunknown
p13102
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01780_7080
p13103
sg8
Vdrug-target interaction Fusicoccin and 14-3-3 protein epsilon [drugbank_resource:DB01780_7080]
p13104
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7080
p13105
sg14
Vhttp://bio2rdf.org/drugbank:DB01780
p13106
sg16
VFusicoccin [drugbank:DB01780]
p13107
sasS'ANXA1'
p13108
(lp13109
(dp13110
g4
Vunknown
p13111
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00288_469
p13112
sg8
Vdrug-target interaction Amcinonide and Annexin A1 [drugbank_resource:DB00288_469]
p13113
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:469
p13114
sg14
Vhttp://bio2rdf.org/drugbank:DB00288
p13115
sg16
VAmcinonide [drugbank:DB00288]
p13116
sa(dp13117
g4
Vyes
p13118
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00741_469
p13119
sg8
Vdrug-target interaction Hydrocortisone and Annexin A1 [drugbank_resource:DB00741_469]
p13120
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:469
p13121
sg14
Vhttp://bio2rdf.org/drugbank:DB00741
p13122
sg16
VHydrocortisone [drugbank:DB00741]
p13123
sa(dp13124
g4
Vunknown
p13125
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01234_469
p13126
sg8
Vdrug-target interaction Dexamethasone and Annexin A1 [drugbank_resource:DB01234_469]
p13127
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:469
p13128
sg14
Vhttp://bio2rdf.org/drugbank:DB01234
p13129
sg16
VDexamethasone [drugbank:DB01234]
p13130
sasS'CCKBR'
p13131
(lp13132
(dp13133
g4
Vyes
p13134
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00183_2049
p13135
sg8
Vdrug-target interaction Pentagastrin and Gastrin/cholecystokinin type B receptor [drugbank_resource:DB00183_2049]
p13136
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2049
p13137
sg14
Vhttp://bio2rdf.org/drugbank:DB00183
p13138
sg16
VPentagastrin [drugbank:DB00183]
p13139
sasS'ANXA3'
p13140
(lp13141
(dp13142
g4
Vunknown
p13143
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03994_5483
p13144
sg8
Vdrug-target interaction Ethanolamine and Annexin A3 [drugbank_resource:DB03994_5483]
p13145
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5483
p13146
sg14
Vhttp://bio2rdf.org/drugbank:DB03994
p13147
sg16
VEthanolamine [drugbank:DB03994]
p13148
sasS'ANXA2'
p13149
(lp13150
(dp13151
g4
Vunknown
p13152
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00031_2111
p13153
sg8
Vdrug-target interaction Tenecteplase and Annexin A2 [drugbank_resource:DB00031_2111]
p13154
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2111
p13155
sg14
Vhttp://bio2rdf.org/drugbank:DB00031
p13156
sg16
VTenecteplase [drugbank:DB00031]
p13157
sasS'ANXA5'
p13158
(lp13159
(dp13160
g4
Vunknown
p13161
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02929_6654
p13162
sg8
Vdrug-target interaction K201 and Annexin A5 [drugbank_resource:DB02929_6654]
p13163
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6654
p13164
sg14
Vhttp://bio2rdf.org/drugbank:DB02929
p13165
sg16
VK201 [drugbank:DB02929]
p13166
sa(dp13167
g4
Vunknown
p13168
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02497_6654
p13169
sg8
Vdrug-target interaction L-Alpha-Glycerophosphorylserine and Annexin A5 [drugbank_resource:DB02497_6654]
p13170
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6654
p13171
sg14
Vhttp://bio2rdf.org/drugbank:DB02497
p13172
sg16
VL-Alpha-Glycerophosphorylserine [drugbank:DB02497]
p13173
sa(dp13174
g4
Vunknown
p13175
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02846_6654
p13176
sg8
Vdrug-target interaction Thioproline and Annexin A5 [drugbank_resource:DB02846_6654]
p13177
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6654
p13178
sg14
Vhttp://bio2rdf.org/drugbank:DB02846
p13179
sg16
VThioproline [drugbank:DB02846]
p13180
sa(dp13181
g4
Vunknown
p13182
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03935_6654
p13183
sg8
Vdrug-target interaction 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid and Annexin A5 [drugbank_resource:DB03935_6654]
p13184
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6654
p13185
sg14
Vhttp://bio2rdf.org/drugbank:DB03935
p13186
sg16
V1,4-Dideoxy-O2-Sulfo-Glucuronic Acid [drugbank:DB03935]
p13187
sa(dp13188
g4
Vunknown
p13189
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03959_6654
p13190
sg8
Vdrug-target interaction N,O6-Disulfo-Glucosamine and Annexin A5 [drugbank_resource:DB03959_6654]
p13191
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6654
p13192
sg14
Vhttp://bio2rdf.org/drugbank:DB03959
p13193
sg16
VN,O6-Disulfo-Glucosamine [drugbank:DB03959]
p13194
sa(dp13195
g4
Vunknown
p13196
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03484_6654
p13197
sg8
Vdrug-target interaction L-Alpha-Glycerophosphorylethanolamine and Annexin A5 [drugbank_resource:DB03484_6654]
p13198
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6654
p13199
sg14
Vhttp://bio2rdf.org/drugbank:DB03484
p13200
sg16
VL-Alpha-Glycerophosphorylethanolamine [drugbank:DB03484]
p13201
sa(dp13202
g4
Vunknown
p13203
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03981_6654
p13204
sg8
Vdrug-target interaction 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid and Annexin A5 [drugbank_resource:DB03981_6654]
p13205
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6654
p13206
sg14
Vhttp://bio2rdf.org/drugbank:DB03981
p13207
sg16
V1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid [drugbank:DB03981]
p13208
sasS'RAC1'
p13209
(lp13210
(dp13211
g4
Vunknown
p13212
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04315_1882
p13213
sg8
Vdrug-target interaction Guanosine-5'-Diphosphate and Ras-related C3 botulinum toxin substrate 1 [drugbank_resource:DB04315_1882]
p13214
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1882
p13215
sg14
Vhttp://bio2rdf.org/drugbank:DB04315
p13216
sg16
VGuanosine-5'-Diphosphate [drugbank:DB04315]
p13217
sasS'PRKCA'
p13218
(lp13219
(dp13220
g4
Vunknown
p13221
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00144_1970
p13222
sg8
Vdrug-target interaction Phosphatidylserine and Protein kinase C alpha type [drugbank_resource:DB00144_1970]
p13223
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1970
p13224
sg14
Vhttp://bio2rdf.org/drugbank:DB00144
p13225
sg16
VPhosphatidylserine [drugbank:DB00144]
p13226
sa(dp13227
g4
Vunknown
p13228
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00163_1970
p13229
sg8
Vdrug-target interaction Vitamin E and Protein kinase C alpha type [drugbank_resource:DB00163_1970]
p13230
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1970
p13231
sg14
Vhttp://bio2rdf.org/drugbank:DB00163
p13232
sg16
VVitamin E [drugbank:DB00163]
p13233
sasS'CD44'
p13234
(lp13235
(dp13236
g4
Vyes
p13237
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08818_1901
p13238
sg8
Vdrug-target interaction Hyaluronan and CD44 antigen [drugbank_resource:DB08818_1901]
p13239
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1901
p13240
sg14
Vhttp://bio2rdf.org/drugbank:DB08818
p13241
sg16
VHyaluronan [drugbank:DB08818]
p13242
sasS'FCGR2B'
p13243
(lp13244
(dp13245
g4
Vunknown
p13246
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00002_3820
p13247
sg8
Vdrug-target interaction Cetuximab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00002_3820]
p13248
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13249
sg14
Vhttp://bio2rdf.org/drugbank:DB00002
p13250
sg16
VCetuximab [drugbank:DB00002]
p13251
sa(dp13252
g4
Vyes
p13253
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00028_3820
p13254
sg8
Vdrug-target interaction Intravenous Immunoglobulin and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00028_3820]
p13255
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13256
sg14
Vhttp://bio2rdf.org/drugbank:DB00028
p13257
sg16
VIntravenous Immunoglobulin [drugbank:DB00028]
p13258
sa(dp13259
g4
Vunknown
p13260
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00054_3820
p13261
sg8
Vdrug-target interaction Abciximab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00054_3820]
p13262
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13263
sg14
Vhttp://bio2rdf.org/drugbank:DB00054
p13264
sg16
VAbciximab [drugbank:DB00054]
p13265
sa(dp13266
g4
Vunknown
p13267
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00078_3820
p13268
sg8
Vdrug-target interaction Ibritumomab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00078_3820]
p13269
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13270
sg14
Vhttp://bio2rdf.org/drugbank:DB00078
p13271
sg16
VIbritumomab [drugbank:DB00078]
p13272
sa(dp13273
g4
Vunknown
p13274
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00081_3820
p13275
sg8
Vdrug-target interaction Tositumomab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00081_3820]
p13276
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13277
sg14
Vhttp://bio2rdf.org/drugbank:DB00081
p13278
sg16
VTositumomab [drugbank:DB00081]
p13279
sa(dp13280
g4
Vunknown
p13281
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00051_3820
p13282
sg8
Vdrug-target interaction Adalimumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00051_3820]
p13283
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13284
sg14
Vhttp://bio2rdf.org/drugbank:DB00051
p13285
sg16
VAdalimumab [drugbank:DB00051]
p13286
sa(dp13287
g4
Vunknown
p13288
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00073_3820
p13289
sg8
Vdrug-target interaction Rituximab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00073_3820]
p13290
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13291
sg14
Vhttp://bio2rdf.org/drugbank:DB00073
p13292
sg16
VRituximab [drugbank:DB00073]
p13293
sa(dp13294
g4
Vunknown
p13295
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00074_3820
p13296
sg8
Vdrug-target interaction Basiliximab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00074_3820]
p13297
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13298
sg14
Vhttp://bio2rdf.org/drugbank:DB00074
p13299
sg16
VBasiliximab [drugbank:DB00074]
p13300
sa(dp13301
g4
Vunknown
p13302
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00110_3820
p13303
sg8
Vdrug-target interaction Palivizumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00110_3820]
p13304
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13305
sg14
Vhttp://bio2rdf.org/drugbank:DB00110
p13306
sg16
VPalivizumab [drugbank:DB00110]
p13307
sa(dp13308
g4
Vunknown
p13309
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00112_3820
p13310
sg8
Vdrug-target interaction Bevacizumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00112_3820]
p13311
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13312
sg14
Vhttp://bio2rdf.org/drugbank:DB00112
p13313
sg16
VBevacizumab [drugbank:DB00112]
p13314
sa(dp13315
g4
Vunknown
p13316
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00005_3820
p13317
sg8
Vdrug-target interaction Etanercept and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00005_3820]
p13318
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13319
sg14
Vhttp://bio2rdf.org/drugbank:DB00005
p13320
sg16
VEtanercept [drugbank:DB00005]
p13321
sa(dp13322
g4
Vunknown
p13323
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00056_3820
p13324
sg8
Vdrug-target interaction Gemtuzumab ozogamicin and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00056_3820]
p13325
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13326
sg14
Vhttp://bio2rdf.org/drugbank:DB00056
p13327
sg16
VGemtuzumab ozogamicin [drugbank:DB00056]
p13328
sa(dp13329
g4
Vunknown
p13330
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00072_3820
p13331
sg8
Vdrug-target interaction Trastuzumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00072_3820]
p13332
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13333
sg14
Vhttp://bio2rdf.org/drugbank:DB00072
p13334
sg16
VTrastuzumab [drugbank:DB00072]
p13335
sa(dp13336
g4
Vunknown
p13337
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00075_3820
p13338
sg8
Vdrug-target interaction Muromonab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00075_3820]
p13339
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13340
sg14
Vhttp://bio2rdf.org/drugbank:DB00075
p13341
sg16
VMuromonab [drugbank:DB00075]
p13342
sa(dp13343
g4
Vunknown
p13344
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00087_3820
p13345
sg8
Vdrug-target interaction Alemtuzumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00087_3820]
p13346
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13347
sg14
Vhttp://bio2rdf.org/drugbank:DB00087
p13348
sg16
VAlemtuzumab [drugbank:DB00087]
p13349
sa(dp13350
g4
Vunknown
p13351
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00092_3820
p13352
sg8
Vdrug-target interaction Alefacept and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00092_3820]
p13353
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13354
sg14
Vhttp://bio2rdf.org/drugbank:DB00092
p13355
sg16
VAlefacept [drugbank:DB00092]
p13356
sa(dp13357
g4
Vunknown
p13358
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00095_3820
p13359
sg8
Vdrug-target interaction Efalizumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00095_3820]
p13360
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13361
sg14
Vhttp://bio2rdf.org/drugbank:DB00095
p13362
sg16
VEfalizumab [drugbank:DB00095]
p13363
sa(dp13364
g4
Vyes
p13365
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00098_3820
p13366
sg8
Vdrug-target interaction Antithymocyte globulin and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00098_3820]
p13367
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13368
sg14
Vhttp://bio2rdf.org/drugbank:DB00098
p13369
sg16
VAntithymocyte globulin [drugbank:DB00098]
p13370
sa(dp13371
g4
Vunknown
p13372
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00108_3820
p13373
sg8
Vdrug-target interaction Natalizumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00108_3820]
p13374
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13375
sg14
Vhttp://bio2rdf.org/drugbank:DB00108
p13376
sg16
VNatalizumab [drugbank:DB00108]
p13377
sa(dp13378
g4
Vunknown
p13379
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00111_3820
p13380
sg8
Vdrug-target interaction Daclizumab and Low affinity immunoglobulin gamma Fc region receptor II-b [drugbank_resource:DB00111_3820]
p13381
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3820
p13382
sg14
Vhttp://bio2rdf.org/drugbank:DB00111
p13383
sg16
VDaclizumab [drugbank:DB00111]
p13384
sasS'PRKCD'
p13385
(lp13386
(dp13387
g4
Vunknown
p13388
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04376_4184
p13389
sg8
Vdrug-target interaction 13-Acetylphorbol and Protein kinase C delta type [drugbank_resource:DB04376_4184]
p13390
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:4184
p13391
sg14
Vhttp://bio2rdf.org/drugbank:DB04376
p13392
sg16
V13-Acetylphorbol [drugbank:DB04376]
p13393
sasS'CD4'
p13394
(lp13395
(dp13396
g4
Vyes
p13397
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00098_5955
p13398
sg8
Vdrug-target interaction Antithymocyte globulin and T-cell surface glycoprotein CD4 [drugbank_resource:DB00098_5955]
p13399
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:5955
p13400
sg14
Vhttp://bio2rdf.org/drugbank:DB00098
p13401
sg16
VAntithymocyte globulin [drugbank:DB00098]
p13402
sasS'PLAT'
p13403
(lp13404
(dp13405
g4
Vyes
p13406
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00013_1792
p13407
sg8
Vdrug-target interaction Urokinase and Tissue-type plasminogen activator [drugbank_resource:DB00013_1792]
p13408
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1792
p13409
sg14
Vhttp://bio2rdf.org/drugbank:DB00013
p13410
sg16
VUrokinase [drugbank:DB00013]
p13411
sa(dp13412
g4
Vyes
p13413
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00513_1792
p13414
sg8
Vdrug-target interaction Aminocaproic Acid and Tissue-type plasminogen activator [drugbank_resource:DB00513_1792]
p13415
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1792
p13416
sg14
Vhttp://bio2rdf.org/drugbank:DB00513
p13417
sg16
VAminocaproic Acid [drugbank:DB00513]
p13418
sa(dp13419
g4
Vunknown
p13420
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01088_1792
p13421
sg8
Vdrug-target interaction Iloprost and Tissue-type plasminogen activator [drugbank_resource:DB01088_1792]
p13422
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1792
p13423
sg14
Vhttp://bio2rdf.org/drugbank:DB01088
p13424
sg16
VIloprost [drugbank:DB01088]
p13425
sa(dp13426
g4
Vunknown
p13427
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04134_1792
p13428
sg8
Vdrug-target interaction 6-Amino Hexanoic Acid and Tissue-type plasminogen activator [drugbank_resource:DB04134_1792]
p13429
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1792
p13430
sg14
Vhttp://bio2rdf.org/drugbank:DB04134
p13431
sg16
V6-Amino Hexanoic Acid [drugbank:DB04134]
p13432
sa(dp13433
g4
Vunknown
p13434
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07684_1792
p13435
sg8
Vdrug-target interaction 5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID and Tissue-type plasminogen activator [drugbank_resource:DB07684_1792]
p13436
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1792
p13437
sg14
Vhttp://bio2rdf.org/drugbank:DB07684
p13438
sg16
V5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID [drugbank:DB07684]
p13439
sasS'VCP'
p13440
(lp13441
(dp13442
g4
Vunknown
p13443
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03431_7082
p13444
sg8
Vdrug-target interaction Adenosine-5'-Diphosphate and Transitional endoplasmic reticulum ATPase [drugbank_resource:DB03431_7082]
p13445
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7082
p13446
sg14
Vhttp://bio2rdf.org/drugbank:DB03431
p13447
sg16
VAdenosine-5'-Diphosphate [drugbank:DB03431]
p13448
sa(dp13449
g4
Vunknown
p13450
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04395_7082
p13451
sg8
Vdrug-target interaction Phosphoaminophosphonic Acid-Adenylate Ester and Transitional endoplasmic reticulum ATPase [drugbank_resource:DB04395_7082]
p13452
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:7082
p13453
sg14
Vhttp://bio2rdf.org/drugbank:DB04395
p13454
sg16
VPhosphoaminophosphonic Acid-Adenylate Ester [drugbank:DB04395]
p13455
sasS'HTR2A'
p13456
(lp13457
(dp13458
g4
Vunknown
p13459
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00248_502
p13460
sg8
Vdrug-target interaction Cabergoline and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00248_502]
p13461
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13462
sg14
Vhttp://bio2rdf.org/drugbank:DB00248
p13463
sg16
VCabergoline [drugbank:DB00248]
p13464
sa(dp13465
g4
Vyes
p13466
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00246_502
p13467
sg8
Vdrug-target interaction Ziprasidone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00246_502]
p13468
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13469
sg14
Vhttp://bio2rdf.org/drugbank:DB00246
p13470
sg16
VZiprasidone [drugbank:DB00246]
p13471
sa(dp13472
g4
Vyes
p13473
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00247_502
p13474
sg8
Vdrug-target interaction Methysergide and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00247_502]
p13475
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13476
sg14
Vhttp://bio2rdf.org/drugbank:DB00247
p13477
sg16
VMethysergide [drugbank:DB00247]
p13478
sa(dp13479
g4
Vunknown
p13480
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00268_502
p13481
sg8
Vdrug-target interaction Ropinirole and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00268_502]
p13482
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13483
sg14
Vhttp://bio2rdf.org/drugbank:DB00268
p13484
sg16
VRopinirole [drugbank:DB00268]
p13485
sa(dp13486
g4
Vyes
p13487
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00363_502
p13488
sg8
Vdrug-target interaction Clozapine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00363_502]
p13489
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13490
sg14
Vhttp://bio2rdf.org/drugbank:DB00363
p13491
sg16
VClozapine [drugbank:DB00363]
p13492
sa(dp13493
g4
Vunknown
p13494
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00413_502
p13495
sg8
Vdrug-target interaction Pramipexole and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00413_502]
p13496
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13497
sg14
Vhttp://bio2rdf.org/drugbank:DB00413
p13498
sg16
VPramipexole [drugbank:DB00413]
p13499
sa(dp13500
g4
Vunknown
p13501
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00420_502
p13502
sg8
Vdrug-target interaction Promazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00420_502]
p13503
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13504
sg14
Vhttp://bio2rdf.org/drugbank:DB00420
p13505
sg16
VPromazine [drugbank:DB00420]
p13506
sa(dp13507
g4
Vyes
p13508
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00477_502
p13509
sg8
Vdrug-target interaction Chlorpromazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00477_502]
p13510
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13511
sg14
Vhttp://bio2rdf.org/drugbank:DB00477
p13512
sg16
VChlorpromazine [drugbank:DB00477]
p13513
sa(dp13514
g4
Vyes
p13515
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00321_502
p13516
sg8
Vdrug-target interaction Amitriptyline and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00321_502]
p13517
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13518
sg14
Vhttp://bio2rdf.org/drugbank:DB00321
p13519
sg16
VAmitriptyline [drugbank:DB00321]
p13520
sa(dp13521
g4
Vyes
p13522
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00334_502
p13523
sg8
Vdrug-target interaction Olanzapine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00334_502]
p13524
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13525
sg14
Vhttp://bio2rdf.org/drugbank:DB00334
p13526
sg16
VOlanzapine [drugbank:DB00334]
p13527
sa(dp13528
g4
Vyes
p13529
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00370_502
p13530
sg8
Vdrug-target interaction Mirtazapine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00370_502]
p13531
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13532
sg14
Vhttp://bio2rdf.org/drugbank:DB00370
p13533
sg16
VMirtazapine [drugbank:DB00370]
p13534
sa(dp13535
g4
Vyes
p13536
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00408_502
p13537
sg8
Vdrug-target interaction Loxapine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00408_502]
p13538
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13539
sg14
Vhttp://bio2rdf.org/drugbank:DB00408
p13540
sg16
VLoxapine [drugbank:DB00408]
p13541
sa(dp13542
g4
Vunknown
p13543
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00409_502
p13544
sg8
Vdrug-target interaction Remoxipride and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00409_502]
p13545
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13546
sg14
Vhttp://bio2rdf.org/drugbank:DB00409
p13547
sg16
VRemoxipride [drugbank:DB00409]
p13548
sa(dp13549
g4
Vunknown
p13550
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00458_502
p13551
sg8
Vdrug-target interaction Imipramine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00458_502]
p13552
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13553
sg14
Vhttp://bio2rdf.org/drugbank:DB00458
p13554
sg16
VImipramine [drugbank:DB00458]
p13555
sa(dp13556
g4
Vunknown
p13557
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00472_502
p13558
sg8
Vdrug-target interaction Fluoxetine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00472_502]
p13559
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13560
sg14
Vhttp://bio2rdf.org/drugbank:DB00472
p13561
sg16
VFluoxetine [drugbank:DB00472]
p13562
sa(dp13563
g4
Vyes
p13564
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00540_502
p13565
sg8
Vdrug-target interaction Nortriptyline and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00540_502]
p13566
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13567
sg14
Vhttp://bio2rdf.org/drugbank:DB00540
p13568
sg16
VNortriptyline [drugbank:DB00540]
p13569
sa(dp13570
g4
Vyes
p13571
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00589_502
p13572
sg8
Vdrug-target interaction Lisuride and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00589_502]
p13573
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13574
sg14
Vhttp://bio2rdf.org/drugbank:DB00589
p13575
sg16
VLisuride [drugbank:DB00589]
p13576
sa(dp13577
g4
Vyes
p13578
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00604_502
p13579
sg8
Vdrug-target interaction Cisapride and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00604_502]
p13580
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13581
sg14
Vhttp://bio2rdf.org/drugbank:DB00604
p13582
sg16
VCisapride [drugbank:DB00604]
p13583
sa(dp13584
g4
Vyes
p13585
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00656_502
p13586
sg8
Vdrug-target interaction Trazodone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00656_502]
p13587
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13588
sg14
Vhttp://bio2rdf.org/drugbank:DB00656
p13589
sg16
VTrazodone [drugbank:DB00656]
p13590
sa(dp13591
g4
Vyes
p13592
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00434_502
p13593
sg8
Vdrug-target interaction Cyproheptadine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00434_502]
p13594
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13595
sg14
Vhttp://bio2rdf.org/drugbank:DB00434
p13596
sg16
VCyproheptadine [drugbank:DB00434]
p13597
sa(dp13598
g4
Vunknown
p13599
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00502_502
p13600
sg8
Vdrug-target interaction Haloperidol and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00502_502]
p13601
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13602
sg14
Vhttp://bio2rdf.org/drugbank:DB00502
p13603
sg16
VHaloperidol [drugbank:DB00502]
p13604
sa(dp13605
g4
Vyes
p13606
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00679_502
p13607
sg8
Vdrug-target interaction Thioridazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00679_502]
p13608
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13609
sg14
Vhttp://bio2rdf.org/drugbank:DB00679
p13610
sg16
VThioridazine [drugbank:DB00679]
p13611
sa(dp13612
g4
Vyes
p13613
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00696_502
p13614
sg8
Vdrug-target interaction Ergotamine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00696_502]
p13615
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13616
sg14
Vhttp://bio2rdf.org/drugbank:DB00696
p13617
sg16
VErgotamine [drugbank:DB00696]
p13618
sa(dp13619
g4
Vunknown
p13620
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00714_502
p13621
sg8
Vdrug-target interaction Apomorphine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00714_502]
p13622
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13623
sg14
Vhttp://bio2rdf.org/drugbank:DB00714
p13624
sg16
VApomorphine [drugbank:DB00714]
p13625
sa(dp13626
g4
Vunknown
p13627
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00715_502
p13628
sg8
Vdrug-target interaction Paroxetine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00715_502]
p13629
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13630
sg14
Vhttp://bio2rdf.org/drugbank:DB00715
p13631
sg16
VParoxetine [drugbank:DB00715]
p13632
sa(dp13633
g4
Vunknown
p13634
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00726_502
p13635
sg8
Vdrug-target interaction Trimipramine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00726_502]
p13636
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13637
sg14
Vhttp://bio2rdf.org/drugbank:DB00726
p13638
sg16
VTrimipramine [drugbank:DB00726]
p13639
sa(dp13640
g4
Vunknown
p13641
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00751_502
p13642
sg8
Vdrug-target interaction Epinastine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00751_502]
p13643
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13644
sg14
Vhttp://bio2rdf.org/drugbank:DB00751
p13645
sg16
VEpinastine [drugbank:DB00751]
p13646
sa(dp13647
g4
Vyes
p13648
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00805_502
p13649
sg8
Vdrug-target interaction Minaprine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00805_502]
p13650
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13651
sg14
Vhttp://bio2rdf.org/drugbank:DB00805
p13652
sg16
VMinaprine [drugbank:DB00805]
p13653
sa(dp13654
g4
Vyes
p13655
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00875_502
p13656
sg8
Vdrug-target interaction Flupenthixol and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00875_502]
p13657
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13658
sg14
Vhttp://bio2rdf.org/drugbank:DB00875
p13659
sg16
VFlupenthixol [drugbank:DB00875]
p13660
sa(dp13661
g4
Vyes
p13662
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00924_502
p13663
sg8
Vdrug-target interaction Cyclobenzaprine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00924_502]
p13664
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13665
sg14
Vhttp://bio2rdf.org/drugbank:DB00924
p13666
sg16
VCyclobenzaprine [drugbank:DB00924]
p13667
sa(dp13668
g4
Vyes
p13669
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00933_502
p13670
sg8
Vdrug-target interaction Mesoridazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00933_502]
p13671
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13672
sg14
Vhttp://bio2rdf.org/drugbank:DB00933
p13673
sg16
VMesoridazine [drugbank:DB00933]
p13674
sa(dp13675
g4
Vyes
p13676
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00734_502
p13677
sg8
Vdrug-target interaction Risperidone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00734_502]
p13678
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13679
sg14
Vhttp://bio2rdf.org/drugbank:DB00734
p13680
sg16
VRisperidone [drugbank:DB00734]
p13681
sa(dp13682
g4
Vunknown
p13683
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00843_502
p13684
sg8
Vdrug-target interaction Donepezil and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00843_502]
p13685
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13686
sg14
Vhttp://bio2rdf.org/drugbank:DB00843
p13687
sg16
VDonepezil [drugbank:DB00843]
p13688
sa(dp13689
g4
Vunknown
p13690
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01069_502
p13691
sg8
Vdrug-target interaction Promethazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01069_502]
p13692
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13693
sg14
Vhttp://bio2rdf.org/drugbank:DB01069
p13694
sg16
VPromethazine [drugbank:DB01069]
p13695
sa(dp13696
g4
Vunknown
p13697
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01079_502
p13698
sg8
Vdrug-target interaction Tegaserod and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01079_502]
p13699
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13700
sg14
Vhttp://bio2rdf.org/drugbank:DB01079
p13701
sg16
VTegaserod [drugbank:DB01079]
p13702
sa(dp13703
g4
Vunknown
p13704
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00777_502
p13705
sg8
Vdrug-target interaction Propiomazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB00777_502]
p13706
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13707
sg14
Vhttp://bio2rdf.org/drugbank:DB00777
p13708
sg16
VPropiomazine [drugbank:DB00777]
p13709
sa(dp13710
g4
Vyes
p13711
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01149_502
p13712
sg8
Vdrug-target interaction Nefazodone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01149_502]
p13713
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13714
sg14
Vhttp://bio2rdf.org/drugbank:DB01149
p13715
sg16
VNefazodone [drugbank:DB01149]
p13716
sa(dp13717
g4
Vyes
p13718
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01151_502
p13719
sg8
Vdrug-target interaction Desipramine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01151_502]
p13720
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13721
sg14
Vhttp://bio2rdf.org/drugbank:DB01151
p13722
sg16
VDesipramine [drugbank:DB01151]
p13723
sa(dp13724
g4
Vyes
p13725
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01142_502
p13726
sg8
Vdrug-target interaction Doxepin and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01142_502]
p13727
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13728
sg14
Vhttp://bio2rdf.org/drugbank:DB01142
p13729
sg16
VDoxepin [drugbank:DB01142]
p13730
sa(dp13731
g4
Vyes
p13732
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01614_502
p13733
sg8
Vdrug-target interaction Acepromazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01614_502]
p13734
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13735
sg14
Vhttp://bio2rdf.org/drugbank:DB01614
p13736
sg16
VAcepromazine [drugbank:DB01614]
p13737
sa(dp13738
g4
Vunknown
p13739
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01618_502
p13740
sg8
Vdrug-target interaction Molindone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01618_502]
p13741
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13742
sg14
Vhttp://bio2rdf.org/drugbank:DB01618
p13743
sg16
VMolindone [drugbank:DB01618]
p13744
sa(dp13745
g4
Vunknown
p13746
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01287_502
p13747
sg8
Vdrug-target interaction Dihydroergotoxine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01287_502]
p13748
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13749
sg14
Vhttp://bio2rdf.org/drugbank:DB01287
p13750
sg16
VDihydroergotoxine [drugbank:DB01287]
p13751
sa(dp13752
g4
Vunknown
p13753
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01403_502
p13754
sg8
Vdrug-target interaction Methotrimeprazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01403_502]
p13755
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13756
sg14
Vhttp://bio2rdf.org/drugbank:DB01403
p13757
sg16
VMethotrimeprazine [drugbank:DB01403]
p13758
sa(dp13759
g4
Vunknown
p13760
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01454_502
p13761
sg8
Vdrug-target interaction 3,4-Methylenedioxymethamphetamine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01454_502]
p13762
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13763
sg14
Vhttp://bio2rdf.org/drugbank:DB01454
p13764
sg16
V3,4-Methylenedioxymethamphetamine [drugbank:DB01454]
p13765
sa(dp13766
g4
Vyes
p13767
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01621_502
p13768
sg8
Vdrug-target interaction Pipotiazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01621_502]
p13769
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13770
sg14
Vhttp://bio2rdf.org/drugbank:DB01621
p13771
sg16
VPipotiazine [drugbank:DB01621]
p13772
sa(dp13773
g4
Vyes
p13774
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01623_502
p13775
sg8
Vdrug-target interaction Thiothixene and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01623_502]
p13776
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13777
sg14
Vhttp://bio2rdf.org/drugbank:DB01623
p13778
sg16
VThiothixene [drugbank:DB01623]
p13779
sa(dp13780
g4
Vunknown
p13781
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01186_502
p13782
sg8
Vdrug-target interaction Pergolide and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01186_502]
p13783
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13784
sg14
Vhttp://bio2rdf.org/drugbank:DB01186
p13785
sg16
VPergolide [drugbank:DB01186]
p13786
sa(dp13787
g4
Vunknown
p13788
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01200_502
p13789
sg8
Vdrug-target interaction Bromocriptine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01200_502]
p13790
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13791
sg14
Vhttp://bio2rdf.org/drugbank:DB01200
p13792
sg16
VBromocriptine [drugbank:DB01200]
p13793
sa(dp13794
g4
Vyes
p13795
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01224_502
p13796
sg8
Vdrug-target interaction Quetiapine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01224_502]
p13797
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13798
sg14
Vhttp://bio2rdf.org/drugbank:DB01224
p13799
sg16
VQuetiapine [drugbank:DB01224]
p13800
sa(dp13801
g4
Vyes
p13802
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01238_502
p13803
sg8
Vdrug-target interaction Aripiprazole and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01238_502]
p13804
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13805
sg14
Vhttp://bio2rdf.org/drugbank:DB01238
p13806
sg16
VAripiprazole [drugbank:DB01238]
p13807
sa(dp13808
g4
Vyes
p13809
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01239_502
p13810
sg8
Vdrug-target interaction Chlorprothixene and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01239_502]
p13811
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13812
sg14
Vhttp://bio2rdf.org/drugbank:DB01239
p13813
sg16
VChlorprothixene [drugbank:DB01239]
p13814
sa(dp13815
g4
Vyes
p13816
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01242_502
p13817
sg8
Vdrug-target interaction Clomipramine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01242_502]
p13818
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13819
sg14
Vhttp://bio2rdf.org/drugbank:DB01242
p13820
sg16
VClomipramine [drugbank:DB01242]
p13821
sa(dp13822
g4
Vyes
p13823
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01267_502
p13824
sg8
Vdrug-target interaction Paliperidone and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01267_502]
p13825
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13826
sg14
Vhttp://bio2rdf.org/drugbank:DB01267
p13827
sg16
VPaliperidone [drugbank:DB01267]
p13828
sa(dp13829
g4
Vunknown
p13830
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01392_502
p13831
sg8
Vdrug-target interaction Yohimbine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01392_502]
p13832
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13833
sg14
Vhttp://bio2rdf.org/drugbank:DB01392
p13834
sg16
VYohimbine [drugbank:DB01392]
p13835
sa(dp13836
g4
Vyes
p13837
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01442_502
p13838
sg8
Vdrug-target interaction MMDA and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01442_502]
p13839
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13840
sg14
Vhttp://bio2rdf.org/drugbank:DB01442
p13841
sg16
VMMDA [drugbank:DB01442]
p13842
sa(dp13843
g4
Vunknown
p13844
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01488_502
p13845
sg8
Vdrug-target interaction Dimethyltryptamine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01488_502]
p13846
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13847
sg14
Vhttp://bio2rdf.org/drugbank:DB01488
p13848
sg16
VDimethyltryptamine [drugbank:DB01488]
p13849
sa(dp13850
g4
Vyes
p13851
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01622_502
p13852
sg8
Vdrug-target interaction Thioproperazine and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01622_502]
p13853
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13854
sg14
Vhttp://bio2rdf.org/drugbank:DB01622
p13855
sg16
VThioproperazine [drugbank:DB01622]
p13856
sa(dp13857
g4
Vunknown
p13858
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01624_502
p13859
sg8
Vdrug-target interaction Zuclopenthixol and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB01624_502]
p13860
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13861
sg14
Vhttp://bio2rdf.org/drugbank:DB01624
p13862
sg16
VZuclopenthixol [drugbank:DB01624]
p13863
sa(dp13864
g4
Vunknown
p13865
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04842_502
p13866
sg8
Vdrug-target interaction Fluspirilene and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB04842_502]
p13867
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13868
sg14
Vhttp://bio2rdf.org/drugbank:DB04842
p13869
sg16
VFluspirilene [drugbank:DB04842]
p13870
sa(dp13871
g4
Vunknown
p13872
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06288_502
p13873
sg8
Vdrug-target interaction Amisulpride and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB06288_502]
p13874
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13875
sg14
Vhttp://bio2rdf.org/drugbank:DB06288
p13876
sg16
VAmisulpride [drugbank:DB06288]
p13877
sa(dp13878
g4
Vyes
p13879
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06144_502
p13880
sg8
Vdrug-target interaction Sertindole and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB06144_502]
p13881
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13882
sg14
Vhttp://bio2rdf.org/drugbank:DB06144
p13883
sg16
VSertindole [drugbank:DB06144]
p13884
sa(dp13885
g4
Vunknown
p13886
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04599_502
p13887
sg8
Vdrug-target interaction Aniracetam and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB04599_502]
p13888
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13889
sg14
Vhttp://bio2rdf.org/drugbank:DB04599
p13890
sg16
VAniracetam [drugbank:DB04599]
p13891
sa(dp13892
g4
Vunknown
p13893
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06148_502
p13894
sg8
Vdrug-target interaction Mianserin and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB06148_502]
p13895
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13896
sg14
Vhttp://bio2rdf.org/drugbank:DB06148
p13897
sg16
VMianserin [drugbank:DB06148]
p13898
sa(dp13899
g4
Vyes
p13900
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08810_502
p13901
sg8
Vdrug-target interaction Cinitapride and 5-hydroxytryptamine 2A receptor [drugbank_resource:DB08810_502]
p13902
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:502
p13903
sg14
Vhttp://bio2rdf.org/drugbank:DB08810
p13904
sg16
VCinitapride [drugbank:DB08810]
p13905
sasS'VDR'
p13906
(lp13907
(dp13908
g4
Vyes
p13909
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00136_856
p13910
sg8
Vdrug-target interaction Calcitriol and Vitamin D3 receptor [drugbank_resource:DB00136_856]
p13911
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:856
p13912
sg14
Vhttp://bio2rdf.org/drugbank:DB00136
p13913
sg16
VCalcitriol [drugbank:DB00136]
p13914
sa(dp13915
g4
Vyes
p13916
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00169_856
p13917
sg8
Vdrug-target interaction Cholecalciferol and Vitamin D3 receptor [drugbank_resource:DB00169_856]
p13918
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:856
p13919
sg14
Vhttp://bio2rdf.org/drugbank:DB00169
p13920
sg16
VCholecalciferol [drugbank:DB00169]
p13921
sa(dp13922
g4
Vyes
p13923
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00146_856
p13924
sg8
Vdrug-target interaction Calcidiol and Vitamin D3 receptor [drugbank_resource:DB00146_856]
p13925
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:856
p13926
sg14
Vhttp://bio2rdf.org/drugbank:DB00146
p13927
sg16
VCalcidiol [drugbank:DB00146]
p13928
sa(dp13929
g4
Vyes
p13930
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00153_856
p13931
sg8
Vdrug-target interaction Ergocalciferol and Vitamin D3 receptor [drugbank_resource:DB00153_856]
p13932
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:856
p13933
sg14
Vhttp://bio2rdf.org/drugbank:DB00153
p13934
sg16
VErgocalciferol [drugbank:DB00153]
p13935
sa(dp13936
g4
Vyes
p13937
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01070_856
p13938
sg8
Vdrug-target interaction Dihydrotachysterol and Vitamin D3 receptor [drugbank_resource:DB01070_856]
p13939
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:856
p13940
sg14
Vhttp://bio2rdf.org/drugbank:DB01070
p13941
sg16
VDihydrotachysterol [drugbank:DB01070]
p13942
sa(dp13943
g4
Vyes
p13944
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00910_856
p13945
sg8
Vdrug-target interaction Paricalcitol and Vitamin D3 receptor [drugbank_resource:DB00910_856]
p13946
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:856
p13947
sg14
Vhttp://bio2rdf.org/drugbank:DB00910
p13948
sg16
VParicalcitol [drugbank:DB00910]
p13949
sa(dp13950
g4
Vyes
p13951
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01436_856
p13952
sg8
Vdrug-target interaction Alfacalcidol and Vitamin D3 receptor [drugbank_resource:DB01436_856]
p13953
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:856
p13954
sg14
Vhttp://bio2rdf.org/drugbank:DB01436
p13955
sg16
VAlfacalcidol [drugbank:DB01436]
p13956
sa(dp13957
g4
Vunknown
p13958
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02300_856
p13959
sg8
Vdrug-target interaction Calcipotriol and Vitamin D3 receptor [drugbank_resource:DB02300_856]
p13960
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:856
p13961
sg14
Vhttp://bio2rdf.org/drugbank:DB02300
p13962
sg16
VCalcipotriol [drugbank:DB02300]
p13963
sa(dp13964
g4
Vunknown
p13965
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03451_856
p13966
sg8
Vdrug-target interaction 1alpha,25-Dihydroxyl-20-Epi-22-Oxa-24,26,27-Trihomovitamin D3 and Vitamin D3 receptor [drugbank_resource:DB03451_856]
p13967
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:856
p13968
sg14
Vhttp://bio2rdf.org/drugbank:DB03451
p13969
sg16
V1alpha,25-Dihydroxyl-20-Epi-22-Oxa-24,26,27-Trihomovitamin D3 [drugbank:DB03451]
p13970
sa(dp13971
g4
Vunknown
p13972
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04258_856
p13973
sg8
Vdrug-target interaction Seocalcitol and Vitamin D3 receptor [drugbank_resource:DB04258_856]
p13974
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:856
p13975
sg14
Vhttp://bio2rdf.org/drugbank:DB04258
p13976
sg16
VSeocalcitol [drugbank:DB04258]
p13977
sa(dp13978
g4
Vunknown
p13979
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04796_856
p13980
sg8
Vdrug-target interaction Inecalcitol and Vitamin D3 receptor [drugbank_resource:DB04796_856]
p13981
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:856
p13982
sg14
Vhttp://bio2rdf.org/drugbank:DB04796
p13983
sg16
VInecalcitol [drugbank:DB04796]
p13984
sa(dp13985
g4
Vunknown
p13986
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07530_856
p13987
sg8
Vdrug-target interaction (1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol and Vitamin D3 receptor [drugbank_resource:DB07530_856]
p13988
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:856
p13989
sg14
Vhttp://bio2rdf.org/drugbank:DB07530
p13990
sg16
V(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol [drugbank:DB07530]
p13991
sa(dp13992
g4
Vunknown
p13993
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08696_856
p13994
sg8
Vdrug-target interaction 5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL and Vitamin D3 receptor [drugbank_resource:DB08696_856]
p13995
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:856
p13996
sg14
Vhttp://bio2rdf.org/drugbank:DB08696
p13997
sg16
V5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL [drugbank:DB08696]
p13998
sa(dp13999
g4
Vunknown
p14000
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08742_856
p14001
sg8
Vdrug-target interaction 1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z) and Vitamin D3 receptor [drugbank_resource:DB08742_856]
p14002
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:856
p14003
sg14
Vhttp://bio2rdf.org/drugbank:DB08742
p14004
sg16
V1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z) [drugbank:DB08742]
p14005
sasS'CREB1'
p14006
(lp14007
(dp14008
g4
Vunknown
p14009
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00131_1291
p14010
sg8
Vdrug-target interaction Adenosine monophosphate and cAMP response element-binding protein [drugbank_resource:DB00131_1291]
p14011
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1291
p14012
sg14
Vhttp://bio2rdf.org/drugbank:DB00131
p14013
sg16
VAdenosine monophosphate [drugbank:DB00131]
p14014
sa(dp14015
g4
Vno
p14016
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01183_1291
p14017
sg8
Vdrug-target interaction Naloxone and cAMP response element-binding protein [drugbank_resource:DB01183_1291]
p14018
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1291
p14019
sg14
Vhttp://bio2rdf.org/drugbank:DB01183
p14020
sg16
VNaloxone [drugbank:DB01183]
p14021
sasS'PDPK1'
p14022
(lp14023
(dp14024
g4
Vunknown
p14025
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00482_2180
p14026
sg8
Vdrug-target interaction Celecoxib and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB00482_2180]
p14027
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2180
p14028
sg14
Vhttp://bio2rdf.org/drugbank:DB00482
p14029
sg16
VCelecoxib [drugbank:DB00482]
p14030
sa(dp14031
g4
Vunknown
p14032
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02010_2180
p14033
sg8
Vdrug-target interaction Staurosporine and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB02010_2180]
p14034
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2180
p14035
sg14
Vhttp://bio2rdf.org/drugbank:DB02010
p14036
sg16
VStaurosporine [drugbank:DB02010]
p14037
sa(dp14038
g4
Vunknown
p14039
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01933_2180
p14040
sg8
Vdrug-target interaction 7-Hydroxystaurosporine and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB01933_2180]
p14041
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2180
p14042
sg14
Vhttp://bio2rdf.org/drugbank:DB01933
p14043
sg16
V7-Hydroxystaurosporine [drugbank:DB01933]
p14044
sa(dp14045
g4
Vunknown
p14046
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01863_2180
p14047
sg8
Vdrug-target interaction Inositol 1,3,4,5-Tetrakisphosphate and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB01863_2180]
p14048
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2180
p14049
sg14
Vhttp://bio2rdf.org/drugbank:DB01863
p14050
sg16
VInositol 1,3,4,5-Tetrakisphosphate [drugbank:DB01863]
p14051
sa(dp14052
g4
Vunknown
p14053
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01946_2180
p14054
sg8
Vdrug-target interaction 3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB01946_2180]
p14055
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2180
p14056
sg14
Vhttp://bio2rdf.org/drugbank:DB01946
p14057
sg16
V3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione [drugbank:DB01946]
p14058
sa(dp14059
g4
Vunknown
p14060
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03777_2180
p14061
sg8
Vdrug-target interaction Rbt205 Inhibitor and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB03777_2180]
p14062
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2180
p14063
sg14
Vhttp://bio2rdf.org/drugbank:DB03777
p14064
sg16
VRbt205 Inhibitor [drugbank:DB03777]
p14065
sa(dp14066
g4
Vunknown
p14067
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06932_2180
p14068
sg8
Vdrug-target interaction 10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB06932_2180]
p14069
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2180
p14070
sg14
Vhttp://bio2rdf.org/drugbank:DB06932
p14071
sg16
V10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine [drugbank:DB06932]
p14072
sa(dp14073
g4
Vunknown
p14074
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07033_2180
p14075
sg8
Vdrug-target interaction 5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB07033_2180]
p14076
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2180
p14077
sg14
Vhttp://bio2rdf.org/drugbank:DB07033
p14078
sg16
V5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE [drugbank:DB07033]
p14079
sa(dp14080
g4
Vunknown
p14081
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07132_2180
p14082
sg8
Vdrug-target interaction 1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB07132_2180]
p14083
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2180
p14084
sg14
Vhttp://bio2rdf.org/drugbank:DB07132
p14085
sg16
V1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA [drugbank:DB07132]
p14086
sa(dp14087
g4
Vunknown
p14088
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07457_2180
p14089
sg8
Vdrug-target interaction 3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB07457_2180]
p14090
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2180
p14091
sg14
Vhttp://bio2rdf.org/drugbank:DB07457
p14092
sg16
V3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE [drugbank:DB07457]
p14093
sa(dp14094
g4
Vunknown
p14095
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04522_2180
p14096
sg8
Vdrug-target interaction Phosphonoserine and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB04522_2180]
p14097
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2180
p14098
sg14
Vhttp://bio2rdf.org/drugbank:DB04522
p14099
sg16
VPhosphonoserine [drugbank:DB04522]
p14100
sa(dp14101
g4
Vunknown
p14102
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07300_2180
p14103
sg8
Vdrug-target interaction 2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB07300_2180]
p14104
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2180
p14105
sg14
Vhttp://bio2rdf.org/drugbank:DB07300
p14106
sg16
V2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine [drugbank:DB07300]
p14107
sa(dp14108
g4
Vunknown
p14109
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07456_2180
p14110
sg8
Vdrug-target interaction 3-(1H-INDOL-3-YL)-4-(1-{2-[(2S)-1-METHYLPYRROLIDINYL]ETHYL}-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE and 3-phosphoinositide-dependent protein kinase 1 [drugbank_resource:DB07456_2180]
p14111
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2180
p14112
sg14
Vhttp://bio2rdf.org/drugbank:DB07456
p14113
sg16
V3-(1H-INDOL-3-YL)-4-(1-{2-[(2S)-1-METHYLPYRROLIDINYL]ETHYL}-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE [drugbank:DB07456]
p14114
sasS'OPRK1'
p14115
(lp14116
(dp14117
g4
Vunknown
p14118
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00193_696
p14119
sg8
Vdrug-target interaction Tramadol and Kappa-type opioid receptor [drugbank_resource:DB00193_696]
p14120
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14121
sg14
Vhttp://bio2rdf.org/drugbank:DB00193
p14122
sg16
VTramadol [drugbank:DB00193]
p14123
sa(dp14124
g4
Vyes
p14125
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00295_696
p14126
sg8
Vdrug-target interaction Morphine and Kappa-type opioid receptor [drugbank_resource:DB00295_696]
p14127
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14128
sg14
Vhttp://bio2rdf.org/drugbank:DB00295
p14129
sg16
VMorphine [drugbank:DB00295]
p14130
sa(dp14131
g4
Vyes
p14132
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00318_696
p14133
sg8
Vdrug-target interaction Codeine and Kappa-type opioid receptor [drugbank_resource:DB00318_696]
p14134
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14135
sg14
Vhttp://bio2rdf.org/drugbank:DB00318
p14136
sg16
VCodeine [drugbank:DB00318]
p14137
sa(dp14138
g4
Vunknown
p14139
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00321_696
p14140
sg8
Vdrug-target interaction Amitriptyline and Kappa-type opioid receptor [drugbank_resource:DB00321_696]
p14141
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14142
sg14
Vhttp://bio2rdf.org/drugbank:DB00321
p14143
sg16
VAmitriptyline [drugbank:DB00321]
p14144
sa(dp14145
g4
Vyes
p14146
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00327_696
p14147
sg8
Vdrug-target interaction Hydromorphone and Kappa-type opioid receptor [drugbank_resource:DB00327_696]
p14148
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14149
sg14
Vhttp://bio2rdf.org/drugbank:DB00327
p14150
sg16
VHydromorphone [drugbank:DB00327]
p14151
sa(dp14152
g4
Vunknown
p14153
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00370_696
p14154
sg8
Vdrug-target interaction Mirtazapine and Kappa-type opioid receptor [drugbank_resource:DB00370_696]
p14155
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14156
sg14
Vhttp://bio2rdf.org/drugbank:DB00370
p14157
sg16
VMirtazapine [drugbank:DB00370]
p14158
sa(dp14159
g4
Vyes
p14160
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00454_696
p14161
sg8
Vdrug-target interaction Meperidine and Kappa-type opioid receptor [drugbank_resource:DB00454_696]
p14162
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14163
sg14
Vhttp://bio2rdf.org/drugbank:DB00454
p14164
sg16
VMeperidine [drugbank:DB00454]
p14165
sa(dp14166
g4
Vyes
p14167
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00497_696
p14168
sg8
Vdrug-target interaction Oxycodone and Kappa-type opioid receptor [drugbank_resource:DB00497_696]
p14169
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14170
sg14
Vhttp://bio2rdf.org/drugbank:DB00497
p14171
sg16
VOxycodone [drugbank:DB00497]
p14172
sa(dp14173
g4
Vyes
p14174
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00611_696
p14175
sg8
Vdrug-target interaction Butorphanol and Kappa-type opioid receptor [drugbank_resource:DB00611_696]
p14176
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14177
sg14
Vhttp://bio2rdf.org/drugbank:DB00611
p14178
sg16
VButorphanol [drugbank:DB00611]
p14179
sa(dp14180
g4
Vyes
p14181
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00647_696
p14182
sg8
Vdrug-target interaction Propoxyphene and Kappa-type opioid receptor [drugbank_resource:DB00647_696]
p14183
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14184
sg14
Vhttp://bio2rdf.org/drugbank:DB00647
p14185
sg16
VPropoxyphene [drugbank:DB00647]
p14186
sa(dp14187
g4
Vyes
p14188
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00652_696
p14189
sg8
Vdrug-target interaction Pentazocine and Kappa-type opioid receptor [drugbank_resource:DB00652_696]
p14190
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14191
sg14
Vhttp://bio2rdf.org/drugbank:DB00652
p14192
sg16
VPentazocine [drugbank:DB00652]
p14193
sa(dp14194
g4
Vunknown
p14195
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00813_696
p14196
sg8
Vdrug-target interaction Fentanyl and Kappa-type opioid receptor [drugbank_resource:DB00813_696]
p14197
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14198
sg14
Vhttp://bio2rdf.org/drugbank:DB00813
p14199
sg16
VFentanyl [drugbank:DB00813]
p14200
sa(dp14201
g4
Vunknown
p14202
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00825_696
p14203
sg8
Vdrug-target interaction Menthol and Kappa-type opioid receptor [drugbank_resource:DB00825_696]
p14204
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14205
sg14
Vhttp://bio2rdf.org/drugbank:DB00825
p14206
sg16
VMenthol [drugbank:DB00825]
p14207
sa(dp14208
g4
Vyes
p14209
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00836_696
p14210
sg8
Vdrug-target interaction Loperamide and Kappa-type opioid receptor [drugbank_resource:DB00836_696]
p14211
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14212
sg14
Vhttp://bio2rdf.org/drugbank:DB00836
p14213
sg16
VLoperamide [drugbank:DB00836]
p14214
sa(dp14215
g4
Vyes
p14216
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00844_696
p14217
sg8
Vdrug-target interaction Nalbuphine and Kappa-type opioid receptor [drugbank_resource:DB00844_696]
p14218
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14219
sg14
Vhttp://bio2rdf.org/drugbank:DB00844
p14220
sg16
VNalbuphine [drugbank:DB00844]
p14221
sa(dp14222
g4
Vyes
p14223
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00704_696
p14224
sg8
Vdrug-target interaction Naltrexone and Kappa-type opioid receptor [drugbank_resource:DB00704_696]
p14225
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14226
sg14
Vhttp://bio2rdf.org/drugbank:DB00704
p14227
sg16
VNaltrexone [drugbank:DB00704]
p14228
sa(dp14229
g4
Vunknown
p14230
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00708_696
p14231
sg8
Vdrug-target interaction Sufentanil and Kappa-type opioid receptor [drugbank_resource:DB00708_696]
p14232
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14233
sg14
Vhttp://bio2rdf.org/drugbank:DB00708
p14234
sg16
VSufentanil [drugbank:DB00708]
p14235
sa(dp14236
g4
Vunknown
p14237
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00854_696
p14238
sg8
Vdrug-target interaction Levorphanol and Kappa-type opioid receptor [drugbank_resource:DB00854_696]
p14239
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14240
sg14
Vhttp://bio2rdf.org/drugbank:DB00854
p14241
sg16
VLevorphanol [drugbank:DB00854]
p14242
sa(dp14243
g4
Vunknown
p14244
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00899_696
p14245
sg8
Vdrug-target interaction Remifentanil and Kappa-type opioid receptor [drugbank_resource:DB00899_696]
p14246
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14247
sg14
Vhttp://bio2rdf.org/drugbank:DB00899
p14248
sg16
VRemifentanil [drugbank:DB00899]
p14249
sa(dp14250
g4
Vyes
p14251
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00921_696
p14252
sg8
Vdrug-target interaction Buprenorphine and Kappa-type opioid receptor [drugbank_resource:DB00921_696]
p14253
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14254
sg14
Vhttp://bio2rdf.org/drugbank:DB00921
p14255
sg16
VBuprenorphine [drugbank:DB00921]
p14256
sa(dp14257
g4
Vunknown
p14258
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01535_696
p14259
sg8
Vdrug-target interaction Carfentanil and Kappa-type opioid receptor [drugbank_resource:DB01535_696]
p14260
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14261
sg14
Vhttp://bio2rdf.org/drugbank:DB01535
p14262
sg16
VCarfentanil [drugbank:DB01535]
p14263
sa(dp14264
g4
Vunknown
p14265
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01548_696
p14266
sg8
Vdrug-target interaction Diprenorphine and Kappa-type opioid receptor [drugbank_resource:DB01548_696]
p14267
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14268
sg14
Vhttp://bio2rdf.org/drugbank:DB01548
p14269
sg16
VDiprenorphine [drugbank:DB01548]
p14270
sa(dp14271
g4
Vyes
p14272
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01439_696
p14273
sg8
Vdrug-target interaction 3-Methylthiofentanyl and Kappa-type opioid receptor [drugbank_resource:DB01439_696]
p14274
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14275
sg14
Vhttp://bio2rdf.org/drugbank:DB01439
p14276
sg16
V3-Methylthiofentanyl [drugbank:DB01439]
p14277
sa(dp14278
g4
Vyes
p14279
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01497_696
p14280
sg8
Vdrug-target interaction Etorphine and Kappa-type opioid receptor [drugbank_resource:DB01497_696]
p14281
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14282
sg14
Vhttp://bio2rdf.org/drugbank:DB01497
p14283
sg16
VEtorphine [drugbank:DB01497]
p14284
sa(dp14285
g4
Vyes
p14286
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01183_696
p14287
sg8
Vdrug-target interaction Naloxone and Kappa-type opioid receptor [drugbank_resource:DB01183_696]
p14288
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14289
sg14
Vhttp://bio2rdf.org/drugbank:DB01183
p14290
sg16
VNaloxone [drugbank:DB01183]
p14291
sa(dp14292
g4
Vyes
p14293
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01209_696
p14294
sg8
Vdrug-target interaction Dezocine and Kappa-type opioid receptor [drugbank_resource:DB01209_696]
p14295
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14296
sg14
Vhttp://bio2rdf.org/drugbank:DB01209
p14297
sg16
VDezocine [drugbank:DB01209]
p14298
sa(dp14299
g4
Vunknown
p14300
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01452_696
p14301
sg8
Vdrug-target interaction Heroin and Kappa-type opioid receptor [drugbank_resource:DB01452_696]
p14302
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14303
sg14
Vhttp://bio2rdf.org/drugbank:DB01452
p14304
sg16
VHeroin [drugbank:DB01452]
p14305
sa(dp14306
g4
Vunknown
p14307
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01565_696
p14308
sg8
Vdrug-target interaction Dihydromorphine and Kappa-type opioid receptor [drugbank_resource:DB01565_696]
p14309
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14310
sg14
Vhttp://bio2rdf.org/drugbank:DB01565
p14311
sg16
VDihydromorphine [drugbank:DB01565]
p14312
sa(dp14313
g4
Vyes
p14314
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01571_696
p14315
sg8
Vdrug-target interaction 3-Methylfentanyl and Kappa-type opioid receptor [drugbank_resource:DB01571_696]
p14316
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14317
sg14
Vhttp://bio2rdf.org/drugbank:DB01571
p14318
sg16
V3-Methylfentanyl [drugbank:DB01571]
p14319
sa(dp14320
g4
Vunknown
p14321
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06274_696
p14322
sg8
Vdrug-target interaction Alvimopan and Kappa-type opioid receptor [drugbank_resource:DB06274_696]
p14323
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:696
p14324
sg14
Vhttp://bio2rdf.org/drugbank:DB06274
p14325
sg16
VAlvimopan [drugbank:DB06274]
p14326
sasS'TUBA4A'
p14327
(lp14328
(dp14329
g4
Vunknown
p14330
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00541_2539
p14331
sg8
Vdrug-target interaction Vincristine and Tubulin alpha-1 chain [drugbank_resource:DB00541_2539]
p14332
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2539
p14333
sg14
Vhttp://bio2rdf.org/drugbank:DB00541
p14334
sg16
VVincristine [drugbank:DB00541]
p14335
sa(dp14336
g4
Vyes
p14337
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01179_2539
p14338
sg8
Vdrug-target interaction Podofilox and Tubulin alpha-1 chain [drugbank_resource:DB01179_2539]
p14339
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2539
p14340
sg14
Vhttp://bio2rdf.org/drugbank:DB01179
p14341
sg16
VPodofilox [drugbank:DB01179]
p14342
sa(dp14343
g4
Vunknown
p14344
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01873_2539
p14345
sg8
Vdrug-target interaction Epothilone D and Tubulin alpha-1 chain [drugbank_resource:DB01873_2539]
p14346
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2539
p14347
sg14
Vhttp://bio2rdf.org/drugbank:DB01873
p14348
sg16
VEpothilone D [drugbank:DB01873]
p14349
sa(dp14350
g4
Vunknown
p14351
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03010_2539
p14352
sg8
Vdrug-target interaction Epothilone B and Tubulin alpha-1 chain [drugbank_resource:DB03010_2539]
p14353
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2539
p14354
sg14
Vhttp://bio2rdf.org/drugbank:DB03010
p14355
sg16
VEpothilone B [drugbank:DB03010]
p14356
sa(dp14357
g4
Vyes
p14358
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06772_2539
p14359
sg8
Vdrug-target interaction Cabazitaxel and Tubulin alpha-1 chain [drugbank_resource:DB06772_2539]
p14360
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2539
p14361
sg14
Vhttp://bio2rdf.org/drugbank:DB06772
p14362
sg16
VCabazitaxel [drugbank:DB06772]
p14363
sasS'TOP2A'
p14364
(lp14365
(dp14366
g4
Vunknown
p14367
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00218_817
p14368
sg8
Vdrug-target interaction Moxifloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00218_817]
p14369
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14370
sg14
Vhttp://bio2rdf.org/drugbank:DB00218
p14371
sg16
VMoxifloxacin [drugbank:DB00218]
p14372
sa(dp14373
g4
Vyes
p14374
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00276_817
p14375
sg8
Vdrug-target interaction Amsacrine and DNA topoisomerase 2-alpha [drugbank_resource:DB00276_817]
p14376
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14377
sg14
Vhttp://bio2rdf.org/drugbank:DB00276
p14378
sg16
VAmsacrine [drugbank:DB00276]
p14379
sa(dp14380
g4
Vno
p14381
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00467_817
p14382
sg8
Vdrug-target interaction Enoxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00467_817]
p14383
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14384
sg14
Vhttp://bio2rdf.org/drugbank:DB00467
p14385
sg16
VEnoxacin [drugbank:DB00467]
p14386
sa(dp14387
g4
Vunknown
p14388
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00487_817
p14389
sg8
Vdrug-target interaction Pefloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00487_817]
p14390
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14391
sg14
Vhttp://bio2rdf.org/drugbank:DB00487
p14392
sg16
VPefloxacin [drugbank:DB00487]
p14393
sa(dp14394
g4
Vyes
p14395
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00380_817
p14396
sg8
Vdrug-target interaction Dexrazoxane and DNA topoisomerase 2-alpha [drugbank_resource:DB00380_817]
p14397
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14398
sg14
Vhttp://bio2rdf.org/drugbank:DB00380
p14399
sg16
VDexrazoxane [drugbank:DB00380]
p14400
sa(dp14401
g4
Vyes
p14402
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00385_817
p14403
sg8
Vdrug-target interaction Valrubicin and DNA topoisomerase 2-alpha [drugbank_resource:DB00385_817]
p14404
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14405
sg14
Vhttp://bio2rdf.org/drugbank:DB00385
p14406
sg16
VValrubicin [drugbank:DB00385]
p14407
sa(dp14408
g4
Vyes
p14409
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00444_817
p14410
sg8
Vdrug-target interaction Teniposide and DNA topoisomerase 2-alpha [drugbank_resource:DB00444_817]
p14411
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14412
sg14
Vhttp://bio2rdf.org/drugbank:DB00444
p14413
sg16
VTeniposide [drugbank:DB00444]
p14414
sa(dp14415
g4
Vunknown
p14416
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00445_817
p14417
sg8
Vdrug-target interaction Epirubicin and DNA topoisomerase 2-alpha [drugbank_resource:DB00445_817]
p14418
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14419
sg14
Vhttp://bio2rdf.org/drugbank:DB00445
p14420
sg16
VEpirubicin [drugbank:DB00445]
p14421
sa(dp14422
g4
Vunknown
p14423
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00537_817
p14424
sg8
Vdrug-target interaction Ciprofloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00537_817]
p14425
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14426
sg14
Vhttp://bio2rdf.org/drugbank:DB00537
p14427
sg16
VCiprofloxacin [drugbank:DB00537]
p14428
sa(dp14429
g4
Vyes
p14430
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00773_817
p14431
sg8
Vdrug-target interaction Etoposide and DNA topoisomerase 2-alpha [drugbank_resource:DB00773_817]
p14432
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14433
sg14
Vhttp://bio2rdf.org/drugbank:DB00773
p14434
sg16
VEtoposide [drugbank:DB00773]
p14435
sa(dp14436
g4
Vunknown
p14437
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00685_817
p14438
sg8
Vdrug-target interaction Trovafloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00685_817]
p14439
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14440
sg14
Vhttp://bio2rdf.org/drugbank:DB00685
p14441
sg16
VTrovafloxacin [drugbank:DB00685]
p14442
sa(dp14443
g4
Vyes
p14444
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00694_817
p14445
sg8
Vdrug-target interaction Daunorubicin and DNA topoisomerase 2-alpha [drugbank_resource:DB00694_817]
p14446
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14447
sg14
Vhttp://bio2rdf.org/drugbank:DB00694
p14448
sg16
VDaunorubicin [drugbank:DB00694]
p14449
sa(dp14450
g4
Vyes
p14451
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00997_817
p14452
sg8
Vdrug-target interaction Doxorubicin and DNA topoisomerase 2-alpha [drugbank_resource:DB00997_817]
p14453
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14454
sg14
Vhttp://bio2rdf.org/drugbank:DB00997
p14455
sg16
VDoxorubicin [drugbank:DB00997]
p14456
sa(dp14457
g4
Vyes
p14458
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01137_817
p14459
sg8
Vdrug-target interaction Levofloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB01137_817]
p14460
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14461
sg14
Vhttp://bio2rdf.org/drugbank:DB01137
p14462
sg16
VLevofloxacin [drugbank:DB01137]
p14463
sa(dp14464
g4
Vunknown
p14465
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00978_817
p14466
sg8
Vdrug-target interaction Lomefloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB00978_817]
p14467
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14468
sg14
Vhttp://bio2rdf.org/drugbank:DB00978
p14469
sg16
VLomefloxacin [drugbank:DB00978]
p14470
sa(dp14471
g4
Vunknown
p14472
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01059_817
p14473
sg8
Vdrug-target interaction Norfloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB01059_817]
p14474
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14475
sg14
Vhttp://bio2rdf.org/drugbank:DB01059
p14476
sg16
VNorfloxacin [drugbank:DB01059]
p14477
sa(dp14478
g4
Vunknown
p14479
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01165_817
p14480
sg8
Vdrug-target interaction Ofloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB01165_817]
p14481
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14482
sg14
Vhttp://bio2rdf.org/drugbank:DB01165
p14483
sg16
VOfloxacin [drugbank:DB01165]
p14484
sa(dp14485
g4
Vunknown
p14486
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01645_817
p14487
sg8
Vdrug-target interaction Genistein and DNA topoisomerase 2-alpha [drugbank_resource:DB01645_817]
p14488
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14489
sg14
Vhttp://bio2rdf.org/drugbank:DB01645
p14490
sg16
VGenistein [drugbank:DB01645]
p14491
sa(dp14492
g4
Vyes
p14493
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01177_817
p14494
sg8
Vdrug-target interaction Idarubicin and DNA topoisomerase 2-alpha [drugbank_resource:DB01177_817]
p14495
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14496
sg14
Vhttp://bio2rdf.org/drugbank:DB01177
p14497
sg16
VIdarubicin [drugbank:DB01177]
p14498
sa(dp14499
g4
Vyes
p14500
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01179_817
p14501
sg8
Vdrug-target interaction Podofilox and DNA topoisomerase 2-alpha [drugbank_resource:DB01179_817]
p14502
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14503
sg14
Vhttp://bio2rdf.org/drugbank:DB01179
p14504
sg16
VPodofilox [drugbank:DB01179]
p14505
sa(dp14506
g4
Vyes
p14507
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01208_817
p14508
sg8
Vdrug-target interaction Sparfloxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB01208_817]
p14509
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14510
sg14
Vhttp://bio2rdf.org/drugbank:DB01208
p14511
sg16
VSparfloxacin [drugbank:DB01208]
p14512
sa(dp14513
g4
Vyes
p14514
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01204_817
p14515
sg8
Vdrug-target interaction Mitoxantrone and DNA topoisomerase 2-alpha [drugbank_resource:DB01204_817]
p14516
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14517
sg14
Vhttp://bio2rdf.org/drugbank:DB01204
p14518
sg16
VMitoxantrone [drugbank:DB01204]
p14519
sa(dp14520
g4
Vyes
p14521
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04576_817
p14522
sg8
Vdrug-target interaction Fleroxacin and DNA topoisomerase 2-alpha [drugbank_resource:DB04576_817]
p14523
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14524
sg14
Vhttp://bio2rdf.org/drugbank:DB04576
p14525
sg16
VFleroxacin [drugbank:DB04576]
p14526
sa(dp14527
g4
Vyes
p14528
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04967_817
p14529
sg8
Vdrug-target interaction Lucanthone and DNA topoisomerase 2-alpha [drugbank_resource:DB04967_817]
p14530
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:817
p14531
sg14
Vhttp://bio2rdf.org/drugbank:DB04967
p14532
sg16
VLucanthone [drugbank:DB04967]
p14533
sasS'CASP7'
p14534
(lp14535
(dp14536
g4
Vunknown
p14537
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03384_3320
p14538
sg8
Vdrug-target interaction Fica and Caspase-7 [drugbank_resource:DB03384_3320]
p14539
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3320
p14540
sg14
Vhttp://bio2rdf.org/drugbank:DB03384
p14541
sg16
VFica [drugbank:DB03384]
p14542
sasS'VAMP2'
p14543
(lp14544
(dp14545
g4
Vyes
p14546
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00042_3860
p14547
sg8
Vdrug-target interaction Botulinum Toxin Type B and Vesicle-associated membrane protein 2 [drugbank_resource:DB00042_3860]
p14548
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3860
p14549
sg14
Vhttp://bio2rdf.org/drugbank:DB00042
p14550
sg16
VBotulinum Toxin Type B [drugbank:DB00042]
p14551
sasS'CASP3'
p14552
(lp14553
(dp14554
g4
Vunknown
p14555
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01017_2077
p14556
sg8
Vdrug-target interaction Minocycline and Caspase-3 [drugbank_resource:DB01017_2077]
p14557
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2077
p14558
sg14
Vhttp://bio2rdf.org/drugbank:DB01017
p14559
sg16
VMinocycline [drugbank:DB01017]
p14560
sa(dp14561
g4
Vunknown
p14562
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03124_2077
p14563
sg8
Vdrug-target interaction 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid and Caspase-3 [drugbank_resource:DB03124_2077]
p14564
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2077
p14565
sg14
Vhttp://bio2rdf.org/drugbank:DB03124
p14566
sg16
V5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid [drugbank:DB03124]
p14567
sa(dp14568
g4
Vunknown
p14569
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB06862_2077
p14570
sg8
Vdrug-target interaction 2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID and Caspase-3 [drugbank_resource:DB06862_2077]
p14571
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2077
p14572
sg14
Vhttp://bio2rdf.org/drugbank:DB06862
p14573
sg16
V2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID [drugbank:DB06862]
p14574
sa(dp14575
g4
Vunknown
p14576
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08213_2077
p14577
sg8
Vdrug-target interaction 1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE and Caspase-3 [drugbank_resource:DB08213_2077]
p14578
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2077
p14579
sg14
Vhttp://bio2rdf.org/drugbank:DB08213
p14580
sg16
V1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE [drugbank:DB08213]
p14581
sa(dp14582
g4
Vunknown
p14583
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08499_2077
p14584
sg8
Vdrug-target interaction N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide and Caspase-3 [drugbank_resource:DB08499_2077]
p14585
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2077
p14586
sg14
Vhttp://bio2rdf.org/drugbank:DB08499
p14587
sg16
VN-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide [drugbank:DB08499]
p14588
sa(dp14589
g4
Vunknown
p14590
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07696_2077
p14591
sg8
Vdrug-target interaction methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate and Caspase-3 [drugbank_resource:DB07696_2077]
p14592
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2077
p14593
sg14
Vhttp://bio2rdf.org/drugbank:DB07696
p14594
sg16
Vmethyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate [drugbank:DB07696]
p14595
sa(dp14596
g4
Vunknown
p14597
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08229_2077
p14598
sg8
Vdrug-target interaction [N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID and Caspase-3 [drugbank_resource:DB08229_2077]
p14599
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2077
p14600
sg14
Vhttp://bio2rdf.org/drugbank:DB08229
p14601
sg16
V[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID [drugbank:DB08229]
p14602
sa(dp14603
g4
Vunknown
p14604
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08251_2077
p14605
sg8
Vdrug-target interaction 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID and Caspase-3 [drugbank_resource:DB08251_2077]
p14606
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2077
p14607
sg14
Vhttp://bio2rdf.org/drugbank:DB08251
p14608
sg16
V4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID [drugbank:DB08251]
p14609
sa(dp14610
g4
Vunknown
p14611
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08497_2077
p14612
sg8
Vdrug-target interaction (1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate and Caspase-3 [drugbank_resource:DB08497_2077]
p14613
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2077
p14614
sg14
Vhttp://bio2rdf.org/drugbank:DB08497
p14615
sg16
V(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate [drugbank:DB08497]
p14616
sa(dp14617
g4
Vunknown
p14618
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08498_2077
p14619
sg8
Vdrug-target interaction (1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate and Caspase-3 [drugbank_resource:DB08498_2077]
p14620
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2077
p14621
sg14
Vhttp://bio2rdf.org/drugbank:DB08498
p14622
sg16
V(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate [drugbank:DB08498]
p14623
sasS'CASP1'
p14624
(lp14625
(dp14626
g4
Vunknown
p14627
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01017_494
p14628
sg8
Vdrug-target interaction Minocycline and Caspase-1 [drugbank_resource:DB01017_494]
p14629
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:494
p14630
sg14
Vhttp://bio2rdf.org/drugbank:DB01017
p14631
sg16
VMinocycline [drugbank:DB01017]
p14632
sa(dp14633
g4
Vunknown
p14634
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07744_494
p14635
sg8
Vdrug-target interaction 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID and Caspase-1 [drugbank_resource:DB07744_494]
p14636
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:494
p14637
sg14
Vhttp://bio2rdf.org/drugbank:DB07744
p14638
sg16
V3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID [drugbank:DB07744]
p14639
sa(dp14640
g4
Vunknown
p14641
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07733_494
p14642
sg8
Vdrug-target interaction 1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE and Caspase-1 [drugbank_resource:DB07733_494]
p14643
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:494
p14644
sg14
Vhttp://bio2rdf.org/drugbank:DB07733
p14645
sg16
V1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE [drugbank:DB07733]
p14646
sa(dp14647
g4
Vunknown
p14648
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07916_494
p14649
sg8
Vdrug-target interaction 3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID and Caspase-1 [drugbank_resource:DB07916_494]
p14650
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:494
p14651
sg14
Vhttp://bio2rdf.org/drugbank:DB07916
p14652
sg16
V3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID [drugbank:DB07916]
p14653
sasS'CFD'
p14654
(lp14655
(dp14656
g4
Vunknown
p14657
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03058_3346
p14658
sg8
Vdrug-target interaction Isatoic Anhydride and Complement factor D [drugbank_resource:DB03058_3346]
p14659
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3346
p14660
sg14
Vhttp://bio2rdf.org/drugbank:DB03058
p14661
sg16
VIsatoic Anhydride [drugbank:DB03058]
p14662
sa(dp14663
g4
Vunknown
p14664
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04459_3346
p14665
sg8
Vdrug-target interaction 3,4-Dichloroisocoumarin and Complement factor D [drugbank_resource:DB04459_3346]
p14666
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3346
p14667
sg14
Vhttp://bio2rdf.org/drugbank:DB04459
p14668
sg16
V3,4-Dichloroisocoumarin [drugbank:DB04459]
p14669
sasS'DRD5'
p14670
(lp14671
(dp14672
g4
Vunknown
p14673
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00246_163
p14674
sg8
Vdrug-target interaction Ziprasidone and D(1B) dopamine receptor [drugbank_resource:DB00246_163]
p14675
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14676
sg14
Vhttp://bio2rdf.org/drugbank:DB00246
p14677
sg16
VZiprasidone [drugbank:DB00246]
p14678
sa(dp14679
g4
Vunknown
p14680
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00268_163
p14681
sg8
Vdrug-target interaction Ropinirole and D(1B) dopamine receptor [drugbank_resource:DB00268_163]
p14682
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14683
sg14
Vhttp://bio2rdf.org/drugbank:DB00268
p14684
sg16
VRopinirole [drugbank:DB00268]
p14685
sa(dp14686
g4
Vunknown
p14687
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00248_163
p14688
sg8
Vdrug-target interaction Cabergoline and D(1B) dopamine receptor [drugbank_resource:DB00248_163]
p14689
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14690
sg14
Vhttp://bio2rdf.org/drugbank:DB00248
p14691
sg16
VCabergoline [drugbank:DB00248]
p14692
sa(dp14693
g4
Vunknown
p14694
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00334_163
p14695
sg8
Vdrug-target interaction Olanzapine and D(1B) dopamine receptor [drugbank_resource:DB00334_163]
p14696
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14697
sg14
Vhttp://bio2rdf.org/drugbank:DB00334
p14698
sg16
VOlanzapine [drugbank:DB00334]
p14699
sa(dp14700
g4
Vunknown
p14701
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00413_163
p14702
sg8
Vdrug-target interaction Pramipexole and D(1B) dopamine receptor [drugbank_resource:DB00413_163]
p14703
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14704
sg14
Vhttp://bio2rdf.org/drugbank:DB00413
p14705
sg16
VPramipexole [drugbank:DB00413]
p14706
sa(dp14707
g4
Vunknown
p14708
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00589_163
p14709
sg8
Vdrug-target interaction Lisuride and D(1B) dopamine receptor [drugbank_resource:DB00589_163]
p14710
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14711
sg14
Vhttp://bio2rdf.org/drugbank:DB00589
p14712
sg16
VLisuride [drugbank:DB00589]
p14713
sa(dp14714
g4
Vyes
p14715
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01038_163
p14716
sg8
Vdrug-target interaction Carphenazine and D(1B) dopamine receptor [drugbank_resource:DB01038_163]
p14717
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14718
sg14
Vhttp://bio2rdf.org/drugbank:DB01038
p14719
sg16
VCarphenazine [drugbank:DB01038]
p14720
sa(dp14721
g4
Vunknown
p14722
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00714_163
p14723
sg8
Vdrug-target interaction Apomorphine and D(1B) dopamine receptor [drugbank_resource:DB00714_163]
p14724
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14725
sg14
Vhttp://bio2rdf.org/drugbank:DB00714
p14726
sg16
VApomorphine [drugbank:DB00714]
p14727
sa(dp14728
g4
Vyes
p14729
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00800_163
p14730
sg8
Vdrug-target interaction Fenoldopam and D(1B) dopamine receptor [drugbank_resource:DB00800_163]
p14731
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14732
sg14
Vhttp://bio2rdf.org/drugbank:DB00800
p14733
sg16
VFenoldopam [drugbank:DB00800]
p14734
sa(dp14735
g4
Vyes
p14736
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00988_163
p14737
sg8
Vdrug-target interaction Dopamine and D(1B) dopamine receptor [drugbank_resource:DB00988_163]
p14738
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14739
sg14
Vhttp://bio2rdf.org/drugbank:DB00988
p14740
sg16
VDopamine [drugbank:DB00988]
p14741
sa(dp14742
g4
Vunknown
p14743
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01200_163
p14744
sg8
Vdrug-target interaction Bromocriptine and D(1B) dopamine receptor [drugbank_resource:DB01200_163]
p14745
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14746
sg14
Vhttp://bio2rdf.org/drugbank:DB01200
p14747
sg16
VBromocriptine [drugbank:DB01200]
p14748
sa(dp14749
g4
Vyes
p14750
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01235_163
p14751
sg8
Vdrug-target interaction Levodopa and D(1B) dopamine receptor [drugbank_resource:DB01235_163]
p14752
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14753
sg14
Vhttp://bio2rdf.org/drugbank:DB01235
p14754
sg16
VLevodopa [drugbank:DB01235]
p14755
sa(dp14756
g4
Vyes
p14757
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01624_163
p14758
sg8
Vdrug-target interaction Zuclopenthixol and D(1B) dopamine receptor [drugbank_resource:DB01624_163]
p14759
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14760
sg14
Vhttp://bio2rdf.org/drugbank:DB01624
p14761
sg16
VZuclopenthixol [drugbank:DB01624]
p14762
sa(dp14763
g4
Vunknown
p14764
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01224_163
p14765
sg8
Vdrug-target interaction Quetiapine and D(1B) dopamine receptor [drugbank_resource:DB01224_163]
p14766
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14767
sg14
Vhttp://bio2rdf.org/drugbank:DB01224
p14768
sg16
VQuetiapine [drugbank:DB01224]
p14769
sa(dp14770
g4
Vunknown
p14771
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01238_163
p14772
sg8
Vdrug-target interaction Aripiprazole and D(1B) dopamine receptor [drugbank_resource:DB01238_163]
p14773
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14774
sg14
Vhttp://bio2rdf.org/drugbank:DB01238
p14775
sg16
VAripiprazole [drugbank:DB01238]
p14776
sa(dp14777
g4
Vunknown
p14778
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01186_163
p14779
sg8
Vdrug-target interaction Pergolide and D(1B) dopamine receptor [drugbank_resource:DB01186_163]
p14780
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14781
sg14
Vhttp://bio2rdf.org/drugbank:DB01186
p14782
sg16
VPergolide [drugbank:DB01186]
p14783
sa(dp14784
g4
Vunknown
p14785
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01403_163
p14786
sg8
Vdrug-target interaction Methotrimeprazine and D(1B) dopamine receptor [drugbank_resource:DB01403_163]
p14787
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14788
sg14
Vhttp://bio2rdf.org/drugbank:DB01403
p14789
sg16
VMethotrimeprazine [drugbank:DB01403]
p14790
sa(dp14791
g4
Vunknown
p14792
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB05271_163
p14793
sg8
Vdrug-target interaction Rotigotine and D(1B) dopamine receptor [drugbank_resource:DB05271_163]
p14794
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:163
p14795
sg14
Vhttp://bio2rdf.org/drugbank:DB05271
p14796
sg16
VRotigotine [drugbank:DB05271]
p14797
sasS'ROCK1'
p14798
(lp14799
(dp14800
g4
Vunknown
p14801
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04707_1531
p14802
sg8
Vdrug-target interaction HYDROXYFASUDIL and Rho-associated protein kinase 1 [drugbank_resource:DB04707_1531]
p14803
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1531
p14804
sg14
Vhttp://bio2rdf.org/drugbank:DB04707
p14805
sg16
VHYDROXYFASUDIL [drugbank:DB04707]
p14806
sa(dp14807
g4
Vunknown
p14808
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07876_1531
p14809
sg8
Vdrug-target interaction (S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE and Rho-associated protein kinase 1 [drugbank_resource:DB07876_1531]
p14810
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1531
p14811
sg14
Vhttp://bio2rdf.org/drugbank:DB07876
p14812
sg16
V(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE [drugbank:DB07876]
p14813
sa(dp14814
g4
Vunknown
p14815
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08756_1531
p14816
sg8
Vdrug-target interaction (R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE and Rho-associated protein kinase 1 [drugbank_resource:DB08756_1531]
p14817
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1531
p14818
sg14
Vhttp://bio2rdf.org/drugbank:DB08756
p14819
sg16
V(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE [drugbank:DB08756]
p14820
sa(dp14821
g4
Vunknown
p14822
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08162_1531
p14823
sg8
Vdrug-target interaction 5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE and Rho-associated protein kinase 1 [drugbank_resource:DB08162_1531]
p14824
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1531
p14825
sg14
Vhttp://bio2rdf.org/drugbank:DB08162
p14826
sg16
V5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE [drugbank:DB08162]
p14827
sasS'PDE2A'
p14828
(lp14829
(dp14830
g4
Vunknown
p14831
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02315_3806
p14832
sg8
Vdrug-target interaction Cyclic Guanosine Monophosphate and cGMP-dependent 3',5'-cyclic phosphodiesterase [drugbank_resource:DB02315_3806]
p14833
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3806
p14834
sg14
Vhttp://bio2rdf.org/drugbank:DB02315
p14835
sg16
VCyclic Guanosine Monophosphate [drugbank:DB02315]
p14836
sa(dp14837
g4
Vunknown
p14838
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07954_3806
p14839
sg8
Vdrug-target interaction 3-ISOBUTYL-1-METHYLXANTHINE and cGMP-dependent 3',5'-cyclic phosphodiesterase [drugbank_resource:DB07954_3806]
p14840
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3806
p14841
sg14
Vhttp://bio2rdf.org/drugbank:DB07954
p14842
sg16
V3-ISOBUTYL-1-METHYLXANTHINE [drugbank:DB07954]
p14843
sa(dp14844
g4
Vunknown
p14845
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08811_3806
p14846
sg8
Vdrug-target interaction Tofisopam and cGMP-dependent 3',5'-cyclic phosphodiesterase [drugbank_resource:DB08811_3806]
p14847
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:3806
p14848
sg14
Vhttp://bio2rdf.org/drugbank:DB08811
p14849
sg16
VTofisopam [drugbank:DB08811]
p14850
sasS'GRIN2B'
p14851
(lp14852
(dp14853
g4
Vunknown
p14854
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00142_464
p14855
sg8
Vdrug-target interaction L-Glutamic Acid and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB00142_464]
p14856
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:464
p14857
sg14
Vhttp://bio2rdf.org/drugbank:DB00142
p14858
sg16
VL-Glutamic Acid [drugbank:DB00142]
p14859
sa(dp14860
g4
Vunknown
p14861
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00454_464
p14862
sg8
Vdrug-target interaction Meperidine and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB00454_464]
p14863
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:464
p14864
sg14
Vhttp://bio2rdf.org/drugbank:DB00454
p14865
sg16
VMeperidine [drugbank:DB00454]
p14866
sa(dp14867
g4
Vunknown
p14868
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00502_464
p14869
sg8
Vdrug-target interaction Haloperidol and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB00502_464]
p14870
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:464
p14871
sg14
Vhttp://bio2rdf.org/drugbank:DB00502
p14872
sg16
VHaloperidol [drugbank:DB00502]
p14873
sa(dp14874
g4
Vyes
p14875
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00949_464
p14876
sg8
Vdrug-target interaction Felbamate and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB00949_464]
p14877
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:464
p14878
sg14
Vhttp://bio2rdf.org/drugbank:DB00949
p14879
sg16
VFelbamate [drugbank:DB00949]
p14880
sa(dp14881
g4
Vyes
p14882
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01043_464
p14883
sg8
Vdrug-target interaction Memantine and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB01043_464]
p14884
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:464
p14885
sg14
Vhttp://bio2rdf.org/drugbank:DB01043
p14886
sg16
VMemantine [drugbank:DB01043]
p14887
sa(dp14888
g4
Vyes
p14889
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01520_464
p14890
sg8
Vdrug-target interaction Tenocyclidine and Glutamate [NMDA] receptor subunit epsilon-2 [drugbank_resource:DB01520_464]
p14891
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:464
p14892
sg14
Vhttp://bio2rdf.org/drugbank:DB01520
p14893
sg16
VTenocyclidine [drugbank:DB01520]
p14894
sasS'TYMS'
p14895
(lp14896
(dp14897
g4
Vyes
p14898
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00293_359
p14899
sg8
Vdrug-target interaction Raltitrexed and Thymidylate synthase [drugbank_resource:DB00293_359]
p14900
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p14901
sg14
Vhttp://bio2rdf.org/drugbank:DB00293
p14902
sg16
VRaltitrexed [drugbank:DB00293]
p14903
sa(dp14904
g4
Vyes
p14905
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00322_359
p14906
sg8
Vdrug-target interaction Floxuridine and Thymidylate synthase [drugbank_resource:DB00322_359]
p14907
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p14908
sg14
Vhttp://bio2rdf.org/drugbank:DB00322
p14909
sg16
VFloxuridine [drugbank:DB00322]
p14910
sa(dp14911
g4
Vunknown
p14912
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00441_359
p14913
sg8
Vdrug-target interaction Gemcitabine and Thymidylate synthase [drugbank_resource:DB00441_359]
p14914
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p14915
sg14
Vhttp://bio2rdf.org/drugbank:DB00441
p14916
sg16
VGemcitabine [drugbank:DB00441]
p14917
sa(dp14918
g4
Vyes
p14919
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00642_359
p14920
sg8
Vdrug-target interaction Pemetrexed and Thymidylate synthase [drugbank_resource:DB00642_359]
p14921
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p14922
sg14
Vhttp://bio2rdf.org/drugbank:DB00642
p14923
sg16
VPemetrexed [drugbank:DB00642]
p14924
sa(dp14925
g4
Vyes
p14926
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00544_359
p14927
sg8
Vdrug-target interaction Fluorouracil and Thymidylate synthase [drugbank_resource:DB00544_359]
p14928
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p14929
sg14
Vhttp://bio2rdf.org/drugbank:DB00544
p14930
sg16
VFluorouracil [drugbank:DB00544]
p14931
sa(dp14932
g4
Vyes
p14933
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00544_359
p14934
sg8
Vdrug-enzyme interaction Fluorouracil and Thymidylate synthase [drugbank_resource:DB00544_359]
p14935
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p14936
sg14
Vhttp://bio2rdf.org/drugbank:DB00544
p14937
sg16
VFluorouracil [drugbank:DB00544]
p14938
sa(dp14939
g4
Vyes
p14940
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00432_359
p14941
sg8
Vdrug-target interaction Trifluridine and Thymidylate synthase [drugbank_resource:DB00432_359]
p14942
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p14943
sg14
Vhttp://bio2rdf.org/drugbank:DB00432
p14944
sg16
VTrifluridine [drugbank:DB00432]
p14945
sa(dp14946
g4
Vyes
p14947
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00440_359
p14948
sg8
Vdrug-target interaction Trimethoprim and Thymidylate synthase [drugbank_resource:DB00440_359]
p14949
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p14950
sg14
Vhttp://bio2rdf.org/drugbank:DB00440
p14951
sg16
VTrimethoprim [drugbank:DB00440]
p14952
sa(dp14953
g4
Vyes
p14954
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00650_359
p14955
sg8
Vdrug-target interaction Leucovorin and Thymidylate synthase [drugbank_resource:DB00650_359]
p14956
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p14957
sg14
Vhttp://bio2rdf.org/drugbank:DB00650
p14958
sg16
VLeucovorin [drugbank:DB00650]
p14959
sa(dp14960
g4
Vyes
p14961
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01101_359
p14962
sg8
Vdrug-target interaction Capecitabine and Thymidylate synthase [drugbank_resource:DB01101_359]
p14963
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p14964
sg14
Vhttp://bio2rdf.org/drugbank:DB01101
p14965
sg16
VCapecitabine [drugbank:DB01101]
p14966
sa(dp14967
g4
Vunknown
p14968
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01643_359
p14969
sg8
Vdrug-target interaction Thymidine-5'-Phosphate and Thymidylate synthase [drugbank_resource:DB01643_359]
p14970
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p14971
sg14
Vhttp://bio2rdf.org/drugbank:DB01643
p14972
sg16
VThymidine-5'-Phosphate [drugbank:DB01643]
p14973
sa(dp14974
g4
Vunknown
p14975
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03541_359
p14976
sg8
Vdrug-target interaction 10-Propargyl-5,8-Dideazafolic Acid and Thymidylate synthase [drugbank_resource:DB03541_359]
p14977
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p14978
sg14
Vhttp://bio2rdf.org/drugbank:DB03541
p14979
sg16
V10-Propargyl-5,8-Dideazafolic Acid [drugbank:DB03541]
p14980
sa(dp14981
g4
Vunknown
p14982
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB03800_359
p14983
sg8
Vdrug-target interaction 2'-deoxyuridylic acid and Thymidylate synthase [drugbank_resource:DB03800_359]
p14984
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p14985
sg14
Vhttp://bio2rdf.org/drugbank:DB03800
p14986
sg16
V2'-deoxyuridylic acid [drugbank:DB03800]
p14987
sa(dp14988
g4
Vunknown
p14989
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04530_359
p14990
sg8
Vdrug-target interaction S,S-(2-Hydroxyethyl)Thiocysteine and Thymidylate synthase [drugbank_resource:DB04530_359]
p14991
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p14992
sg14
Vhttp://bio2rdf.org/drugbank:DB04530
p14993
sg16
VS,S-(2-Hydroxyethyl)Thiocysteine [drugbank:DB04530]
p14994
sa(dp14995
g4
Vunknown
p14996
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB07577_359
p14997
sg8
Vdrug-target interaction 6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE and Thymidylate synthase [drugbank_resource:DB07577_359]
p14998
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p14999
sg14
Vhttp://bio2rdf.org/drugbank:DB07577
p15000
sg16
V6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE [drugbank:DB07577]
p15001
sa(dp15002
g4
Vunknown
p15003
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08479_359
p15004
sg8
Vdrug-target interaction N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide and Thymidylate synthase [drugbank_resource:DB08479_359]
p15005
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p15006
sg14
Vhttp://bio2rdf.org/drugbank:DB08479
p15007
sg16
VN-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide [drugbank:DB08479]
p15008
sa(dp15009
g4
Vunknown
p15010
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08478_359
p15011
sg8
Vdrug-target interaction N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide and Thymidylate synthase [drugbank_resource:DB08478_359]
p15012
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p15013
sg14
Vhttp://bio2rdf.org/drugbank:DB08478
p15014
sg16
VN-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide [drugbank:DB08478]
p15015
sa(dp15016
g4
Vunknown
p15017
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08734_359
p15018
sg8
Vdrug-target interaction 6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE and Thymidylate synthase [drugbank_resource:DB08734_359]
p15019
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:359
p15020
sg14
Vhttp://bio2rdf.org/drugbank:DB08734
p15021
sg16
V6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE [drugbank:DB08734]
p15022
sasS'GRIN2A'
p15023
(lp15024
(dp15025
g4
Vunknown
p15026
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00142_837
p15027
sg8
Vdrug-target interaction L-Glutamic Acid and Glutamate [NMDA] receptor subunit epsilon-1 [drugbank_resource:DB00142_837]
p15028
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:837
p15029
sg14
Vhttp://bio2rdf.org/drugbank:DB00142
p15030
sg16
VL-Glutamic Acid [drugbank:DB00142]
p15031
sa(dp15032
g4
Vunknown
p15033
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00145_837
p15034
sg8
Vdrug-target interaction Glycine and Glutamate [NMDA] receptor subunit epsilon-1 [drugbank_resource:DB00145_837]
p15035
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:837
p15036
sg14
Vhttp://bio2rdf.org/drugbank:DB00145
p15037
sg16
VGlycine [drugbank:DB00145]
p15038
sa(dp15039
g4
Vunknown
p15040
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00454_837
p15041
sg8
Vdrug-target interaction Meperidine and Glutamate [NMDA] receptor subunit epsilon-1 [drugbank_resource:DB00454_837]
p15042
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:837
p15043
sg14
Vhttp://bio2rdf.org/drugbank:DB00454
p15044
sg16
VMeperidine [drugbank:DB00454]
p15045
sa(dp15046
g4
Vyes
p15047
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00949_837
p15048
sg8
Vdrug-target interaction Felbamate and Glutamate [NMDA] receptor subunit epsilon-1 [drugbank_resource:DB00949_837]
p15049
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:837
p15050
sg14
Vhttp://bio2rdf.org/drugbank:DB00949
p15051
sg16
VFelbamate [drugbank:DB00949]
p15052
sa(dp15053
g4
Vyes
p15054
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01043_837
p15055
sg8
Vdrug-target interaction Memantine and Glutamate [NMDA] receptor subunit epsilon-1 [drugbank_resource:DB01043_837]
p15056
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:837
p15057
sg14
Vhttp://bio2rdf.org/drugbank:DB01043
p15058
sg16
VMemantine [drugbank:DB01043]
p15059
sa(dp15060
g4
Vunknown
p15061
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01159_837
p15062
sg8
Vdrug-target interaction Halothane and Glutamate [NMDA] receptor subunit epsilon-1 [drugbank_resource:DB01159_837]
p15063
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:837
p15064
sg14
Vhttp://bio2rdf.org/drugbank:DB01159
p15065
sg16
VHalothane [drugbank:DB01159]
p15066
sa(dp15067
g4
Vyes
p15068
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01520_837
p15069
sg8
Vdrug-target interaction Tenocyclidine and Glutamate [NMDA] receptor subunit epsilon-1 [drugbank_resource:DB01520_837]
p15070
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:837
p15071
sg14
Vhttp://bio2rdf.org/drugbank:DB01520
p15072
sg16
VTenocyclidine [drugbank:DB01520]
p15073
sasS'CREBBP'
p15074
(lp15075
(dp15076
g4
Vunknown
p15077
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08655_6876
p15078
sg8
Vdrug-target interaction 9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE and CREB-binding protein [drugbank_resource:DB08655_6876]
p15079
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6876
p15080
sg14
Vhttp://bio2rdf.org/drugbank:DB08655
p15081
sg16
V9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE [drugbank:DB08655]
p15082
sasS'SCN1A'
p15083
(lp15084
(dp15085
g4
Vyes
p15086
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00252_158
p15087
sg8
Vdrug-target interaction Phenytoin and Sodium channel protein type 1 subunit alpha [drugbank_resource:DB00252_158]
p15088
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:158
p15089
sg14
Vhttp://bio2rdf.org/drugbank:DB00252
p15090
sg16
VPhenytoin [drugbank:DB00252]
p15091
sa(dp15092
g4
Vyes
p15093
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00273_158
p15094
sg8
Vdrug-target interaction Topiramate and Sodium channel protein type 1 subunit alpha [drugbank_resource:DB00273_158]
p15095
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:158
p15096
sg14
Vhttp://bio2rdf.org/drugbank:DB00273
p15097
sg16
VTopiramate [drugbank:DB00273]
p15098
sa(dp15099
g4
Vyes
p15100
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00909_158
p15101
sg8
Vdrug-target interaction Zonisamide and Sodium channel protein type 1 subunit alpha [drugbank_resource:DB00909_158]
p15102
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:158
p15103
sg14
Vhttp://bio2rdf.org/drugbank:DB00909
p15104
sg16
VZonisamide [drugbank:DB00909]
p15105
sa(dp15106
g4
Vyes
p15107
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01121_158
p15108
sg8
Vdrug-target interaction Phenacemide and Sodium channel protein type 1 subunit alpha [drugbank_resource:DB01121_158]
p15109
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:158
p15110
sg14
Vhttp://bio2rdf.org/drugbank:DB01121
p15111
sg16
VPhenacemide [drugbank:DB01121]
p15112
sa(dp15113
g4
Vyes
p15114
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01438_158
p15115
sg8
Vdrug-target interaction Phenazopyridine and Sodium channel protein type 1 subunit alpha [drugbank_resource:DB01438_158]
p15116
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:158
p15117
sg14
Vhttp://bio2rdf.org/drugbank:DB01438
p15118
sg16
VPhenazopyridine [drugbank:DB01438]
p15119
sa(dp15120
g4
Vunknown
p15121
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01595_158
p15122
sg8
Vdrug-target interaction Nitrazepam and Sodium channel protein type 1 subunit alpha [drugbank_resource:DB01595_158]
p15123
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:158
p15124
sg14
Vhttp://bio2rdf.org/drugbank:DB01595
p15125
sg16
VNitrazepam [drugbank:DB01595]
p15126
sa(dp15127
g4
Vyes
p15128
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB04930_158
p15129
sg8
Vdrug-target interaction Permethrin and Sodium channel protein type 1 subunit alpha [drugbank_resource:DB04930_158]
p15130
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:158
p15131
sg14
Vhttp://bio2rdf.org/drugbank:DB04930
p15132
sg16
VPermethrin [drugbank:DB04930]
p15133
sasS'C1S'
p15134
(lp15135
(dp15136
g4
Vunknown
p15137
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00054_2782
p15138
sg8
Vdrug-target interaction Abciximab and Complement C1s subcomponent [drugbank_resource:DB00054_2782]
p15139
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2782
p15140
sg14
Vhttp://bio2rdf.org/drugbank:DB00054
p15141
sg16
VAbciximab [drugbank:DB00054]
p15142
sa(dp15143
g4
Vunknown
p15144
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00072_2782
p15145
sg8
Vdrug-target interaction Trastuzumab and Complement C1s subcomponent [drugbank_resource:DB00072_2782]
p15146
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2782
p15147
sg14
Vhttp://bio2rdf.org/drugbank:DB00072
p15148
sg16
VTrastuzumab [drugbank:DB00072]
p15149
sa(dp15150
g4
Vunknown
p15151
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00073_2782
p15152
sg8
Vdrug-target interaction Rituximab and Complement C1s subcomponent [drugbank_resource:DB00073_2782]
p15153
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2782
p15154
sg14
Vhttp://bio2rdf.org/drugbank:DB00073
p15155
sg16
VRituximab [drugbank:DB00073]
p15156
sa(dp15157
g4
Vunknown
p15158
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00075_2782
p15159
sg8
Vdrug-target interaction Muromonab and Complement C1s subcomponent [drugbank_resource:DB00075_2782]
p15160
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2782
p15161
sg14
Vhttp://bio2rdf.org/drugbank:DB00075
p15162
sg16
VMuromonab [drugbank:DB00075]
p15163
sa(dp15164
g4
Vunknown
p15165
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00051_2782
p15166
sg8
Vdrug-target interaction Adalimumab and Complement C1s subcomponent [drugbank_resource:DB00051_2782]
p15167
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2782
p15168
sg14
Vhttp://bio2rdf.org/drugbank:DB00051
p15169
sg16
VAdalimumab [drugbank:DB00051]
p15170
sa(dp15171
g4
Vunknown
p15172
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00056_2782
p15173
sg8
Vdrug-target interaction Gemtuzumab ozogamicin and Complement C1s subcomponent [drugbank_resource:DB00056_2782]
p15174
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2782
p15175
sg14
Vhttp://bio2rdf.org/drugbank:DB00056
p15176
sg16
VGemtuzumab ozogamicin [drugbank:DB00056]
p15177
sa(dp15178
g4
Vunknown
p15179
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00074_2782
p15180
sg8
Vdrug-target interaction Basiliximab and Complement C1s subcomponent [drugbank_resource:DB00074_2782]
p15181
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2782
p15182
sg14
Vhttp://bio2rdf.org/drugbank:DB00074
p15183
sg16
VBasiliximab [drugbank:DB00074]
p15184
sa(dp15185
g4
Vunknown
p15186
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00078_2782
p15187
sg8
Vdrug-target interaction Ibritumomab and Complement C1s subcomponent [drugbank_resource:DB00078_2782]
p15188
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2782
p15189
sg14
Vhttp://bio2rdf.org/drugbank:DB00078
p15190
sg16
VIbritumomab [drugbank:DB00078]
p15191
sa(dp15192
g4
Vunknown
p15193
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00002_2782
p15194
sg8
Vdrug-target interaction Cetuximab and Complement C1s subcomponent [drugbank_resource:DB00002_2782]
p15195
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2782
p15196
sg14
Vhttp://bio2rdf.org/drugbank:DB00002
p15197
sg16
VCetuximab [drugbank:DB00002]
p15198
sa(dp15199
g4
Vunknown
p15200
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00005_2782
p15201
sg8
Vdrug-target interaction Etanercept and Complement C1s subcomponent [drugbank_resource:DB00005_2782]
p15202
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2782
p15203
sg14
Vhttp://bio2rdf.org/drugbank:DB00005
p15204
sg16
VEtanercept [drugbank:DB00005]
p15205
sa(dp15206
g4
Vunknown
p15207
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB02371_2782
p15208
sg8
Vdrug-target interaction 2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid and Complement C1s subcomponent [drugbank_resource:DB02371_2782]
p15209
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:2782
p15210
sg14
Vhttp://bio2rdf.org/drugbank:DB02371
p15211
sg16
V2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid [drugbank:DB02371]
p15212
sasS'PPP3CA'
p15213
(lp15214
(dp15215
g4
Vunknown
p15216
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB08231_6746
p15217
sg8
Vdrug-target interaction MYRISTIC ACID and Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform [drugbank_resource:DB08231_6746]
p15218
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:6746
p15219
sg14
Vhttp://bio2rdf.org/drugbank:DB08231
p15220
sg16
VMYRISTIC ACID [drugbank:DB08231]
p15221
sasS'SLC1A2'
p15222
(lp15223
(dp15224
g4
Vunknown
p15225
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB00142_1047
p15226
sg8
Vdrug-target interaction L-Glutamic Acid and Excitatory amino acid transporter 2 [drugbank_resource:DB00142_1047]
p15227
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1047
p15228
sg14
Vhttp://bio2rdf.org/drugbank:DB00142
p15229
sg16
VL-Glutamic Acid [drugbank:DB00142]
p15230
sasS'VCAM1'
p15231
(lp15232
(dp15233
g4
Vunknown
p15234
sg6
Vhttp://bio2rdf.org/drugbank_resource:DB01136_1908
p15235
sg8
Vdrug-target interaction Carvedilol and Vascular cell adhesion protein 1 [drugbank_resource:DB01136_1908]
p15236
sg10
g11
sg12
Vhttp://bio2rdf.org/drugbank_target:1908
p15237
sg14
Vhttp://bio2rdf.org/drugbank:DB01136
p15238
sg16
VCarvedilol [drugbank:DB01136]
p15239
sas.